'hyperlaxité ligamentaire'
(id=15546500 ; fe=hyperlaxité ligamentaire ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=10548 creation date=2020-10-25 touchdate=2025-12-08 19:52:40.000) ≈ 3357 relations sortantes
- hyperlaxité ligamentaire --
r_associated #0: 179 / 1 ->
médecine
n1=hyperlaxité ligamentaire | n2=médecine | rel=r_associated | relid=0 | w=179
- hyperlaxité ligamentaire --
r_associated #0: 97 / 0.542 ->
orthodontie
n1=hyperlaxité ligamentaire | n2=orthodontie | rel=r_associated | relid=0 | w=97
- hyperlaxité ligamentaire --
r_associated #0: 58 / 0.324 ->
hyperlaxité
n1=hyperlaxité ligamentaire | n2=hyperlaxité | rel=r_associated | relid=0 | w=58
- hyperlaxité ligamentaire --
r_associated #0: 52 / 0.291 ->
ligamentaire
n1=hyperlaxité ligamentaire | n2=ligamentaire | rel=r_associated | relid=0 | w=52
- hyperlaxité ligamentaire --
r_associated #0: 50 / 0.279 ->
en:kuskokwim disease
n1=hyperlaxité ligamentaire | n2=en:kuskokwim disease | rel=r_associated | relid=0 | w=50
- hyperlaxité ligamentaire --
r_associated #0: 48 / 0.268 ->
en:ossicular erosion
n1=hyperlaxité ligamentaire | n2=en:ossicular erosion | rel=r_associated | relid=0 | w=48
- hyperlaxité ligamentaire --
r_associated #0: 46 / 0.257 ->
en:clinical significant laxity
n1=hyperlaxité ligamentaire | n2=en:clinical significant laxity | rel=r_associated | relid=0 | w=46
- hyperlaxité ligamentaire --
r_associated #0: 46 / 0.257 ->
en:joint stiffness
n1=hyperlaxité ligamentaire | n2=en:joint stiffness | rel=r_associated | relid=0 | w=46
- hyperlaxité ligamentaire --
r_associated #0: 46 / 0.257 ->
en:other symptoms referable to joint, hand
n1=hyperlaxité ligamentaire | n2=en:other symptoms referable to joint, hand | rel=r_associated | relid=0 | w=46
- hyperlaxité ligamentaire --
r_associated #0: 46 / 0.257 ->
en:whyte hemingway carpal tarsal phalangeal osteolyses
n1=hyperlaxité ligamentaire | n2=en:whyte hemingway carpal tarsal phalangeal osteolyses | rel=r_associated | relid=0 | w=46
- hyperlaxité ligamentaire --
r_associated #0: 45 / 0.251 ->
Ehlers-Danlos
n1=hyperlaxité ligamentaire | n2=Ehlers-Danlos | rel=r_associated | relid=0 | w=45
- hyperlaxité ligamentaire --
r_associated #0: 45 / 0.251 ->
en:disorder of wrist joint
n1=hyperlaxité ligamentaire | n2=en:disorder of wrist joint | rel=r_associated | relid=0 | w=45
- hyperlaxité ligamentaire --
r_associated #0: 45 / 0.251 ->
en:fibular hypoplasia and complex brachydactyly
n1=hyperlaxité ligamentaire | n2=en:fibular hypoplasia and complex brachydactyly | rel=r_associated | relid=0 | w=45
- hyperlaxité ligamentaire --
r_associated #0: 45 / 0.251 ->
en:infective arthritis
n1=hyperlaxité ligamentaire | n2=en:infective arthritis | rel=r_associated | relid=0 | w=45
- hyperlaxité ligamentaire --
r_associated #0: 45 / 0.251 ->
en:joint adhesion
n1=hyperlaxité ligamentaire | n2=en:joint adhesion | rel=r_associated | relid=0 | w=45
- hyperlaxité ligamentaire --
r_associated #0: 45 / 0.251 ->
en:loose-jointedness
n1=hyperlaxité ligamentaire | n2=en:loose-jointedness | rel=r_associated | relid=0 | w=45
- hyperlaxité ligamentaire --
r_associated #0: 45 / 0.251 ->
en:smith-mccort dysplasia
n1=hyperlaxité ligamentaire | n2=en:smith-mccort dysplasia | rel=r_associated | relid=0 | w=45
- hyperlaxité ligamentaire --
r_associated #0: 45 / 0.251 ->
en:synovial osteochondromatosis
n1=hyperlaxité ligamentaire | n2=en:synovial osteochondromatosis | rel=r_associated | relid=0 | w=45
- hyperlaxité ligamentaire --
r_associated #0: 45 / 0.251 ->
en:syphilis of synovium
n1=hyperlaxité ligamentaire | n2=en:syphilis of synovium | rel=r_associated | relid=0 | w=45
- hyperlaxité ligamentaire --
r_associated #0: 45 / 0.251 ->
syndrome de Hunter-Thompson-Reed
n1=hyperlaxité ligamentaire | n2=syndrome de Hunter-Thompson-Reed | rel=r_associated | relid=0 | w=45
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:arthropathy associated with other endocrine and metabolic disorders
n1=hyperlaxité ligamentaire | n2=en:arthropathy associated with other endocrine and metabolic disorders | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:chronic infantile neurological cutaneous and articular syndrome
n1=hyperlaxité ligamentaire | n2=en:chronic infantile neurological cutaneous and articular syndrome | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:complete tear, rib ligament
n1=hyperlaxité ligamentaire | n2=en:complete tear, rib ligament | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:cystinosis, infantile nephropathic
n1=hyperlaxité ligamentaire | n2=en:cystinosis, infantile nephropathic | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:east (epilepsy, ataxia, sensorineural deafness, and tubulopathy) syndrome
n1=hyperlaxité ligamentaire | n2=en:east (epilepsy, ataxia, sensorineural deafness, and tubulopathy) syndrome | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:excessive joint laxity
n1=hyperlaxité ligamentaire | n2=en:excessive joint laxity | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:hereditary myopathy with early respiratory failure
n1=hyperlaxité ligamentaire | n2=en:hereditary myopathy with early respiratory failure | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:hypermobility syndrome
n1=hyperlaxité ligamentaire | n2=en:hypermobility syndrome | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:hypophosphatemic rickets with hypercalciuria, hereditary
n1=hyperlaxité ligamentaire | n2=en:hypophosphatemic rickets with hypercalciuria, hereditary | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:nail-patella syndrome
n1=hyperlaxité ligamentaire | n2=en:nail-patella syndrome | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:neurogenic arthropathy
n1=hyperlaxité ligamentaire | n2=en:neurogenic arthropathy | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:non-traumatic rupture of tendon of left shoulder
n1=hyperlaxité ligamentaire | n2=en:non-traumatic rupture of tendon of left shoulder | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:okihiro syndrome
n1=hyperlaxité ligamentaire | n2=en:okihiro syndrome | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:other specified arthropathy, forearm
n1=hyperlaxité ligamentaire | n2=en:other specified arthropathy, forearm | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:other specified arthropathy, upper arm
n1=hyperlaxité ligamentaire | n2=en:other specified arthropathy, upper arm | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:other symptoms referable to joint, lower leg
n1=hyperlaxité ligamentaire | n2=en:other symptoms referable to joint, lower leg | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:other systemic involvement of connective tissue
n1=hyperlaxité ligamentaire | n2=en:other systemic involvement of connective tissue | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:rotator cuff syndrome
n1=hyperlaxité ligamentaire | n2=en:rotator cuff syndrome | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:spondyloenchondrodysplasia
n1=hyperlaxité ligamentaire | n2=en:spondyloenchondrodysplasia | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:spondyloenchondrodysplasia with immune dysregulation
n1=hyperlaxité ligamentaire | n2=en:spondyloenchondrodysplasia with immune dysregulation | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:syndrome, branchio-oculo-facial
n1=hyperlaxité ligamentaire | n2=en:syndrome, branchio-oculo-facial | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
en:tmem70 related mitochondrial encephalo-cardio-myopathy
n1=hyperlaxité ligamentaire | n2=en:tmem70 related mitochondrial encephalo-cardio-myopathy | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 44 / 0.246 ->
syndrome d'hypermobilité
n1=hyperlaxité ligamentaire | n2=syndrome d'hypermobilité | rel=r_associated | relid=0 | w=44
- hyperlaxité ligamentaire --
r_associated #0: 43 / 0.24 ->
en:autosomal recessive muscular dystrophy with limb girdle distribution
n1=hyperlaxité ligamentaire | n2=en:autosomal recessive muscular dystrophy with limb girdle distribution | rel=r_associated | relid=0 | w=43
- hyperlaxité ligamentaire --
r_associated #0: 43 / 0.24 ->
en:beare-stevenson cutis gyrata syndrome
n1=hyperlaxité ligamentaire | n2=en:beare-stevenson cutis gyrata syndrome | rel=r_associated | relid=0 | w=43
- hyperlaxité ligamentaire --
r_associated #0: 43 / 0.24 ->
en:eosinophilic fasciitis
n1=hyperlaxité ligamentaire | n2=en:eosinophilic fasciitis | rel=r_associated | relid=0 | w=43
- hyperlaxité ligamentaire --
r_associated #0: 43 / 0.24 ->
en:glycogen storage disease, muscular form
n1=hyperlaxité ligamentaire | n2=en:glycogen storage disease, muscular form | rel=r_associated | relid=0 | w=43
- hyperlaxité ligamentaire --
r_associated #0: 43 / 0.24 ->
en:hereditary multiple exostoses
n1=hyperlaxité ligamentaire | n2=en:hereditary multiple exostoses | rel=r_associated | relid=0 | w=43
- hyperlaxité ligamentaire --
r_associated #0: 43 / 0.24 ->
en:other arthrosis
n1=hyperlaxité ligamentaire | n2=en:other arthrosis | rel=r_associated | relid=0 | w=43
- hyperlaxité ligamentaire --
r_associated #0: 43 / 0.24 ->
en:panniculitis, nodular nonsuppurative
n1=hyperlaxité ligamentaire | n2=en:panniculitis, nodular nonsuppurative | rel=r_associated | relid=0 | w=43
- hyperlaxité ligamentaire --
r_associated #0: 43 / 0.24 ->
en:papillon-lefevre syndrome
n1=hyperlaxité ligamentaire | n2=en:papillon-lefevre syndrome | rel=r_associated | relid=0 | w=43
- hyperlaxité ligamentaire --
r_associated #0: 43 / 0.24 ->
en:rheumatoid arthropathies
n1=hyperlaxité ligamentaire | n2=en:rheumatoid arthropathies | rel=r_associated | relid=0 | w=43
- hyperlaxité ligamentaire --
r_associated #0: 43 / 0.24 ->
en:synovitis
n1=hyperlaxité ligamentaire | n2=en:synovitis | rel=r_associated | relid=0 | w=43
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:acquired deformity of joint of upper limb
n1=hyperlaxité ligamentaire | n2=en:acquired deformity of joint of upper limb | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:ankle impingement
n1=hyperlaxité ligamentaire | n2=en:ankle impingement | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:arthropathies nec
n1=hyperlaxité ligamentaire | n2=en:arthropathies nec | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:arthropathy of joint of hand
n1=hyperlaxité ligamentaire | n2=en:arthropathy of joint of hand | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:arthropathy of pelvis
n1=hyperlaxité ligamentaire | n2=en:arthropathy of pelvis | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:arthropathy, unspecified, lower leg
n1=hyperlaxité ligamentaire | n2=en:arthropathy, unspecified, lower leg | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:arthropathy, unspecified, shoulder region
n1=hyperlaxité ligamentaire | n2=en:arthropathy, unspecified, shoulder region | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:arthropathy, unspecified, upper arm
n1=hyperlaxité ligamentaire | n2=en:arthropathy, unspecified, upper arm | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:benign autosomal dominant osteopetrosis
n1=hyperlaxité ligamentaire | n2=en:benign autosomal dominant osteopetrosis | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:benign congenital myopathy
n1=hyperlaxité ligamentaire | n2=en:benign congenital myopathy | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:corneal dystrophy, congenital stromal
n1=hyperlaxité ligamentaire | n2=en:corneal dystrophy, congenital stromal | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:crowned dens syndrome
n1=hyperlaxité ligamentaire | n2=en:crowned dens syndrome | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:crystal arthropathy
n1=hyperlaxité ligamentaire | n2=en:crystal arthropathy | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:deposit joint
n1=hyperlaxité ligamentaire | n2=en:deposit joint | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:disorder of joint of shoulder region
n1=hyperlaxité ligamentaire | n2=en:disorder of joint of shoulder region | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:dorsopathy, unspecified
n1=hyperlaxité ligamentaire | n2=en:dorsopathy, unspecified | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:dysostosis multiplex group
n1=hyperlaxité ligamentaire | n2=en:dysostosis multiplex group | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:farber lipogranulomatosis
n1=hyperlaxité ligamentaire | n2=en:farber lipogranulomatosis | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:ganglion/synovial cyst - multiple joints
n1=hyperlaxité ligamentaire | n2=en:ganglion/synovial cyst - multiple joints | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:hallux rigidus
n1=hyperlaxité ligamentaire | n2=en:hallux rigidus | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:heide syndrome
n1=hyperlaxité ligamentaire | n2=en:heide syndrome | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:joint infection
n1=hyperlaxité ligamentaire | n2=en:joint infection | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:knobloch syndrome
n1=hyperlaxité ligamentaire | n2=en:knobloch syndrome | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:laurin-sandrow syndrome
n1=hyperlaxité ligamentaire | n2=en:laurin-sandrow syndrome | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:lethal congenital contracture syndrome type 3
n1=hyperlaxité ligamentaire | n2=en:lethal congenital contracture syndrome type 3 | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:lissencephaly syndrome, norman-roberts type
n1=hyperlaxité ligamentaire | n2=en:lissencephaly syndrome, norman-roberts type | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:macdermot winter syndrome
n1=hyperlaxité ligamentaire | n2=en:macdermot winter syndrome | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:muscle amp deaminase deficiency
n1=hyperlaxité ligamentaire | n2=en:muscle amp deaminase deficiency | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:osteoarthritis
n1=hyperlaxité ligamentaire | n2=en:osteoarthritis | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:other and unspecified arthropathies
n1=hyperlaxité ligamentaire | n2=en:other and unspecified arthropathies | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:other arthropathy
n1=hyperlaxité ligamentaire | n2=en:other arthropathy | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:other general diseases with articular involvement
n1=hyperlaxité ligamentaire | n2=en:other general diseases with articular involvement | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:other specified arthropathy, ankle and foot
n1=hyperlaxité ligamentaire | n2=en:other specified arthropathy, ankle and foot | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:other specified arthropathy, multiple sites
n1=hyperlaxité ligamentaire | n2=en:other specified arthropathy, multiple sites | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:other specified joint disorders; lower leg
n1=hyperlaxité ligamentaire | n2=en:other specified joint disorders; lower leg | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:other symptoms referable to joint, multiple sites
n1=hyperlaxité ligamentaire | n2=en:other symptoms referable to joint, multiple sites | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:rheumatoid arthritis
n1=hyperlaxité ligamentaire | n2=en:rheumatoid arthritis | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:rupture subscapularis tendon
n1=hyperlaxité ligamentaire | n2=en:rupture subscapularis tendon | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:schnyder crystalline corneal dystrophy
n1=hyperlaxité ligamentaire | n2=en:schnyder crystalline corneal dystrophy | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:spondyloepiphyseal dysplasia tarda, toledo type
n1=hyperlaxité ligamentaire | n2=en:spondyloepiphyseal dysplasia tarda, toledo type | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:stickler syndrome
n1=hyperlaxité ligamentaire | n2=en:stickler syndrome | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:transient arthropathy, forearm
n1=hyperlaxité ligamentaire | n2=en:transient arthropathy, forearm | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:transient arthropathy, upper arm
n1=hyperlaxité ligamentaire | n2=en:transient arthropathy, upper arm | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 42 / 0.235 ->
en:villonodular synovitis of sternoclavicular joint
n1=hyperlaxité ligamentaire | n2=en:villonodular synovitis of sternoclavicular joint | rel=r_associated | relid=0 | w=42
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:acrodysostosis
n1=hyperlaxité ligamentaire | n2=en:acrodysostosis | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:arthropathy associated with a hypersensitivity reaction
n1=hyperlaxité ligamentaire | n2=en:arthropathy associated with a hypersensitivity reaction | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:arthropathy associated with another disorder
n1=hyperlaxité ligamentaire | n2=en:arthropathy associated with another disorder | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:arthropathy of elbow
n1=hyperlaxité ligamentaire | n2=en:arthropathy of elbow | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:arthropathy, unspecified, ankle and foot
n1=hyperlaxité ligamentaire | n2=en:arthropathy, unspecified, ankle and foot | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:arthrosis, unspecified; multiple sites
n1=hyperlaxité ligamentaire | n2=en:arthrosis, unspecified; multiple sites | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:arthrosis, unspecified; other
n1=hyperlaxité ligamentaire | n2=en:arthrosis, unspecified; other | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:arthrosis, unspecified; upper arm
n1=hyperlaxité ligamentaire | n2=en:arthrosis, unspecified; upper arm | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:becker generalized myotonia
n1=hyperlaxité ligamentaire | n2=en:becker generalized myotonia | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:brachydactyly, type a1 (disorder)
n1=hyperlaxité ligamentaire | n2=en:brachydactyly, type a1 (disorder) | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:brachyolmia type 3
n1=hyperlaxité ligamentaire | n2=en:brachyolmia type 3 | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:calcification of joint
n1=hyperlaxité ligamentaire | n2=en:calcification of joint | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:capsulitis
n1=hyperlaxité ligamentaire | n2=en:capsulitis | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:centronuclear myopathy 1
n1=hyperlaxité ligamentaire | n2=en:centronuclear myopathy 1 | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:fistula of joint
n1=hyperlaxité ligamentaire | n2=en:fistula of joint | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:fronto-facio-nasal dysplasia
n1=hyperlaxité ligamentaire | n2=en:fronto-facio-nasal dysplasia | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:gouty tophus of prepatellar bursa
n1=hyperlaxité ligamentaire | n2=en:gouty tophus of prepatellar bursa | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:infectious myositis
n1=hyperlaxité ligamentaire | n2=en:infectious myositis | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:inherited arthrogryposis
n1=hyperlaxité ligamentaire | n2=en:inherited arthrogryposis | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:joint disorder, unspecified; forearm
n1=hyperlaxité ligamentaire | n2=en:joint disorder, unspecified; forearm | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:joint hyperextensibility
n1=hyperlaxité ligamentaire | n2=en:joint hyperextensibility | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:mesomelic dwarfism reinhardt pfeiffer type
n1=hyperlaxité ligamentaire | n2=en:mesomelic dwarfism reinhardt pfeiffer type | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:metatarsalgia
n1=hyperlaxité ligamentaire | n2=en:metatarsalgia | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:miller-mckusick-malvaux-syndrome (3m syndrome)
n1=hyperlaxité ligamentaire | n2=en:miller-mckusick-malvaux-syndrome (3m syndrome) | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:osteoarthropathy, secondary hypertrophic
n1=hyperlaxité ligamentaire | n2=en:osteoarthropathy, secondary hypertrophic | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:other joint disorders
n1=hyperlaxité ligamentaire | n2=en:other joint disorders | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:other specified arthropathy, pelvic region and thigh
n1=hyperlaxité ligamentaire | n2=en:other specified arthropathy, pelvic region and thigh | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:other specified disorders of joint, other specified sites
n1=hyperlaxité ligamentaire | n2=en:other specified disorders of joint, other specified sites | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:other specified disorders of muscle
n1=hyperlaxité ligamentaire | n2=en:other specified disorders of muscle | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:other specified joint disorders; multiple sites
n1=hyperlaxité ligamentaire | n2=en:other specified joint disorders; multiple sites | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:other specified systemic involvement of connective tissue
n1=hyperlaxité ligamentaire | n2=en:other specified systemic involvement of connective tissue | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:rhizomelic chondrodysplasia punctata
n1=hyperlaxité ligamentaire | n2=en:rhizomelic chondrodysplasia punctata | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:transient arthropathy
n1=hyperlaxité ligamentaire | n2=en:transient arthropathy | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:transient arthropathy of the hand
n1=hyperlaxité ligamentaire | n2=en:transient arthropathy of the hand | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:treacher collins syndrome
n1=hyperlaxité ligamentaire | n2=en:treacher collins syndrome | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:triglyceride storage disease with ichthyosis
n1=hyperlaxité ligamentaire | n2=en:triglyceride storage disease with ichthyosis | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:type v acrocephalosyndactyly
n1=hyperlaxité ligamentaire | n2=en:type v acrocephalosyndactyly | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
en:wells jankovic syndrome
n1=hyperlaxité ligamentaire | n2=en:wells jankovic syndrome | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 41 / 0.229 ->
hyperlaxité articulaire
n1=hyperlaxité ligamentaire | n2=hyperlaxité articulaire | rel=r_associated | relid=0 | w=41
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:antley-bixler syndrome, autosomal dominant
n1=hyperlaxité ligamentaire | n2=en:antley-bixler syndrome, autosomal dominant | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:arthrogryposis multiplex congenita, neurogenic type (disorder)
n1=hyperlaxité ligamentaire | n2=en:arthrogryposis multiplex congenita, neurogenic type (disorder) | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:arthropathy associated with non-infective gastrointestinal disorder
n1=hyperlaxité ligamentaire | n2=en:arthropathy associated with non-infective gastrointestinal disorder | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:arthropathy, unspecified, other specified sites
n1=hyperlaxité ligamentaire | n2=en:arthropathy, unspecified, other specified sites | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:arthrosis of first carpometacarpal joint, unspecified
n1=hyperlaxité ligamentaire | n2=en:arthrosis of first carpometacarpal joint, unspecified | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:arthrosis, unspecified; lower leg
n1=hyperlaxité ligamentaire | n2=en:arthrosis, unspecified; lower leg | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:auriculo-condylar syndrome
n1=hyperlaxité ligamentaire | n2=en:auriculo-condylar syndrome | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:baller-gerold syndrome
n1=hyperlaxité ligamentaire | n2=en:baller-gerold syndrome | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:brachydactyly syndrome type b
n1=hyperlaxité ligamentaire | n2=en:brachydactyly syndrome type b | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:bursitis
n1=hyperlaxité ligamentaire | n2=en:bursitis | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:cap myopathy
n1=hyperlaxité ligamentaire | n2=en:cap myopathy | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:carpal collapse
n1=hyperlaxité ligamentaire | n2=en:carpal collapse | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:chondrodysplasia punctata syndrome
n1=hyperlaxité ligamentaire | n2=en:chondrodysplasia punctata syndrome | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:chondromalacias
n1=hyperlaxité ligamentaire | n2=en:chondromalacias | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:col1a1 associated connective tissue disorder
n1=hyperlaxité ligamentaire | n2=en:col1a1 associated connective tissue disorder | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:complete tear, sternum ligament
n1=hyperlaxité ligamentaire | n2=en:complete tear, sternum ligament | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:congenital anomaly of joint
n1=hyperlaxité ligamentaire | n2=en:congenital anomaly of joint | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:congenital bowing of long bone
n1=hyperlaxité ligamentaire | n2=en:congenital bowing of long bone | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:disorder of joint of ankle and/or foot
n1=hyperlaxité ligamentaire | n2=en:disorder of joint of ankle and/or foot | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:familial interstitial nephritis
n1=hyperlaxité ligamentaire | n2=en:familial interstitial nephritis | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:femoracetabular impingement
n1=hyperlaxité ligamentaire | n2=en:femoracetabular impingement | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:fibrodysplasia ossificans progressiva
n1=hyperlaxité ligamentaire | n2=en:fibrodysplasia ossificans progressiva | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:haspeslagh fryns muelenaere syndrome
n1=hyperlaxité ligamentaire | n2=en:haspeslagh fryns muelenaere syndrome | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:hemarthrosis
n1=hyperlaxité ligamentaire | n2=en:hemarthrosis | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 1
n1=hyperlaxité ligamentaire | n2=en:inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 1 | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:ischiopubic synchondrosis of van neck
n1=hyperlaxité ligamentaire | n2=en:ischiopubic synchondrosis of van neck | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:joint contracture
n1=hyperlaxité ligamentaire | n2=en:joint contracture | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:joint dislocation
n1=hyperlaxité ligamentaire | n2=en:joint dislocation | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:joint disorder, unspecified; lower leg
n1=hyperlaxité ligamentaire | n2=en:joint disorder, unspecified; lower leg | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:joint disorder, unspecified; pelvic region and thigh
n1=hyperlaxité ligamentaire | n2=en:joint disorder, unspecified; pelvic region and thigh | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:joint effusion
n1=hyperlaxité ligamentaire | n2=en:joint effusion | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:joint instability
n1=hyperlaxité ligamentaire | n2=en:joint instability | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:joint pain adverse event
n1=hyperlaxité ligamentaire | n2=en:joint pain adverse event | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:joint related disorders nec
n1=hyperlaxité ligamentaire | n2=en:joint related disorders nec | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:juxta-articular yaws nodules
n1=hyperlaxité ligamentaire | n2=en:juxta-articular yaws nodules | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:knee impingement syndrome
n1=hyperlaxité ligamentaire | n2=en:knee impingement syndrome | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:locking of joint
n1=hyperlaxité ligamentaire | n2=en:locking of joint | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:long-leg arthropathy
n1=hyperlaxité ligamentaire | n2=en:long-leg arthropathy | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:multifocal fibrosclerosis
n1=hyperlaxité ligamentaire | n2=en:multifocal fibrosclerosis | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:muscle, ligament and fascia disorders
n1=hyperlaxité ligamentaire | n2=en:muscle, ligament and fascia disorders | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:myopathy with exercise intolerance, swedish type
n1=hyperlaxité ligamentaire | n2=en:myopathy with exercise intolerance, swedish type | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:myopathy, distal, tateyama type
n1=hyperlaxité ligamentaire | n2=en:myopathy, distal, tateyama type | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:nathalie syndrome
n1=hyperlaxité ligamentaire | n2=en:nathalie syndrome | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:nemaline myopathy 3
n1=hyperlaxité ligamentaire | n2=en:nemaline myopathy 3 | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:o/e - joint - passive greater than active movement
n1=hyperlaxité ligamentaire | n2=en:o/e - joint - passive greater than active movement | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:o/e - shoulder joint abnormal
n1=hyperlaxité ligamentaire | n2=en:o/e - shoulder joint abnormal | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:other disorders of muscle, ligament, and fascia
n1=hyperlaxité ligamentaire | n2=en:other disorders of muscle, ligament, and fascia | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:parietal foramina
n1=hyperlaxité ligamentaire | n2=en:parietal foramina | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:primary hypertrophic osteoarthropathy
n1=hyperlaxité ligamentaire | n2=en:primary hypertrophic osteoarthropathy | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:pseudogout
n1=hyperlaxité ligamentaire | n2=en:pseudogout | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:pyle metaphyseal dysplasia
n1=hyperlaxité ligamentaire | n2=en:pyle metaphyseal dysplasia | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:spondylo-ocular syndrome
n1=hyperlaxité ligamentaire | n2=en:spondylo-ocular syndrome | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:spondylocostal dysostosis 4, autosomal dominant
n1=hyperlaxité ligamentaire | n2=en:spondylocostal dysostosis 4, autosomal dominant | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:synovial-like neoplasm
n1=hyperlaxité ligamentaire | n2=en:synovial-like neoplasm | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:transient arthropathy, pelvic region and thigh
n1=hyperlaxité ligamentaire | n2=en:transient arthropathy, pelvic region and thigh | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:transient arthropathy, shoulder region
n1=hyperlaxité ligamentaire | n2=en:transient arthropathy, shoulder region | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
en:villonodular synovitis of tibiofibular joint
n1=hyperlaxité ligamentaire | n2=en:villonodular synovitis of tibiofibular joint | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 40 / 0.223 ->
hyperkératose nævoïde (hamartomateuse) du mamelon
n1=hyperlaxité ligamentaire | n2=hyperkératose nævoïde (hamartomateuse) du mamelon | rel=r_associated | relid=0 | w=40
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:acquired deformity of joint of lower limb
n1=hyperlaxité ligamentaire | n2=en:acquired deformity of joint of lower limb | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:acquired fixed flexion deformity of joint of upper limb
n1=hyperlaxité ligamentaire | n2=en:acquired fixed flexion deformity of joint of upper limb | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:acromicric dysplasia
n1=hyperlaxité ligamentaire | n2=en:acromicric dysplasia | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:arthritis of knee
n1=hyperlaxité ligamentaire | n2=en:arthritis of knee | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:arthropathy associated with a hematological disorder
n1=hyperlaxité ligamentaire | n2=en:arthropathy associated with a hematological disorder | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:arthrosis, unspecified; ankle and foot
n1=hyperlaxité ligamentaire | n2=en:arthrosis, unspecified; ankle and foot | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:arthrosis, unspecified; hand
n1=hyperlaxité ligamentaire | n2=en:arthrosis, unspecified; hand | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:arthrosis, unspecified; site unspecified
n1=hyperlaxité ligamentaire | n2=en:arthrosis, unspecified; site unspecified | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:articular cartilage disorder
n1=hyperlaxité ligamentaire | n2=en:articular cartilage disorder | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:atlantoaxial instability
n1=hyperlaxité ligamentaire | n2=en:atlantoaxial instability | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:autosomal dominant hypophosphatemic bone disease
n1=hyperlaxité ligamentaire | n2=en:autosomal dominant hypophosphatemic bone disease | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:chronic arthropathy
n1=hyperlaxité ligamentaire | n2=en:chronic arthropathy | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:cleidocranial dysplasia
n1=hyperlaxité ligamentaire | n2=en:cleidocranial dysplasia | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:cutis laxa, autosomal recessive
n1=hyperlaxité ligamentaire | n2=en:cutis laxa, autosomal recessive | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:disorder of prosthetic joint
n1=hyperlaxité ligamentaire | n2=en:disorder of prosthetic joint | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:fibrocartilage lesion of joint
n1=hyperlaxité ligamentaire | n2=en:fibrocartilage lesion of joint | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:ganglion of joint
n1=hyperlaxité ligamentaire | n2=en:ganglion of joint | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:gaze palsy, familial horizontal, with progressive scoliosis
n1=hyperlaxité ligamentaire | n2=en:gaze palsy, familial horizontal, with progressive scoliosis | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:geroderma osteodysplastica
n1=hyperlaxité ligamentaire | n2=en:geroderma osteodysplastica | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:heberden's nodes with arthropathy
n1=hyperlaxité ligamentaire | n2=en:heberden's nodes with arthropathy | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:hyperextension
n1=hyperlaxité ligamentaire | n2=en:hyperextension | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:joint disorder, unspecified; multiple sites
n1=hyperlaxité ligamentaire | n2=en:joint disorder, unspecified; multiple sites | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:juxta-articular bone cyst
n1=hyperlaxité ligamentaire | n2=en:juxta-articular bone cyst | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:ligamentous laxity of elbow region
n1=hyperlaxité ligamentaire | n2=en:ligamentous laxity of elbow region | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:mandibuloacral dysplasia with type a lipodystrophy
n1=hyperlaxité ligamentaire | n2=en:mandibuloacral dysplasia with type a lipodystrophy | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:marfan syndrome
n1=hyperlaxité ligamentaire | n2=en:marfan syndrome | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:metacarpal joint disorder
n1=hyperlaxité ligamentaire | n2=en:metacarpal joint disorder | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:microcephaly cervical spine fusion anomalies
n1=hyperlaxité ligamentaire | n2=en:microcephaly cervical spine fusion anomalies | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:morquio syndrome
n1=hyperlaxité ligamentaire | n2=en:morquio syndrome | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:muscle calcification or ossification nos
n1=hyperlaxité ligamentaire | n2=en:muscle calcification or ossification nos | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:myopathy with abnormal lipid metabolism
n1=hyperlaxité ligamentaire | n2=en:myopathy with abnormal lipid metabolism | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:other overlap syndromes
n1=hyperlaxité ligamentaire | n2=en:other overlap syndromes | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:other specified joint disorders; ankle and foot
n1=hyperlaxité ligamentaire | n2=en:other specified joint disorders; ankle and foot | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:other specified joint disorders; forearm
n1=hyperlaxité ligamentaire | n2=en:other specified joint disorders; forearm | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:other specified joint disorders; hand
n1=hyperlaxité ligamentaire | n2=en:other specified joint disorders; hand | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:other specified joint disorders; shoulder region
n1=hyperlaxité ligamentaire | n2=en:other specified joint disorders; shoulder region | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:other symptoms referable to joint, pelvic region and thigh
n1=hyperlaxité ligamentaire | n2=en:other symptoms referable to joint, pelvic region and thigh | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:polyarthropathy (excl rheumatoid arthritis)
n1=hyperlaxité ligamentaire | n2=en:polyarthropathy (excl rheumatoid arthritis) | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:polyarticular arthritis
n1=hyperlaxité ligamentaire | n2=en:polyarticular arthritis | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:polyarticular arthropathy
n1=hyperlaxité ligamentaire | n2=en:polyarticular arthropathy | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:polymyalgia rheumatica
n1=hyperlaxité ligamentaire | n2=en:polymyalgia rheumatica | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:potassium aggravated myotonia
n1=hyperlaxité ligamentaire | n2=en:potassium aggravated myotonia | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:radial hypoplasia, triphalangeal thumbs and hypospadias
n1=hyperlaxité ligamentaire | n2=en:radial hypoplasia, triphalangeal thumbs and hypospadias | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:rupture of synovium - knee
n1=hyperlaxité ligamentaire | n2=en:rupture of synovium - knee | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:scaphycephaly
n1=hyperlaxité ligamentaire | n2=en:scaphycephaly | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:shoulder impingement syndrome
n1=hyperlaxité ligamentaire | n2=en:shoulder impingement syndrome | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:spondylocamptodactyly
n1=hyperlaxité ligamentaire | n2=en:spondylocamptodactyly | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:supraspinatus tear
n1=hyperlaxité ligamentaire | n2=en:supraspinatus tear | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:temporomandibular joint dysfunction syndrome
n1=hyperlaxité ligamentaire | n2=en:temporomandibular joint dysfunction syndrome | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:transient arthropathy, other specified sites
n1=hyperlaxité ligamentaire | n2=en:transient arthropathy, other specified sites | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:type ii acrocephalopolysyndactyly
n1=hyperlaxité ligamentaire | n2=en:type ii acrocephalopolysyndactyly | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:unspecified disorder of knee joint
n1=hyperlaxité ligamentaire | n2=en:unspecified disorder of knee joint | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 39 / 0.218 ->
en:verloes bourguignon syndrome
n1=hyperlaxité ligamentaire | n2=en:verloes bourguignon syndrome | rel=r_associated | relid=0 | w=39
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:ankylosis
n1=hyperlaxité ligamentaire | n2=en:ankylosis | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:arthrosis, unspecified; shoulder region
n1=hyperlaxité ligamentaire | n2=en:arthrosis, unspecified; shoulder region | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:articular disc disorder of temporomandibular joint
n1=hyperlaxité ligamentaire | n2=en:articular disc disorder of temporomandibular joint | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:atelosteogenesis, type 1
n1=hyperlaxité ligamentaire | n2=en:atelosteogenesis, type 1 | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:brachydactyly type a6
n1=hyperlaxité ligamentaire | n2=en:brachydactyly type a6 | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:brachymesophalangy 2 and 5
n1=hyperlaxité ligamentaire | n2=en:brachymesophalangy 2 and 5 | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:familial amyloid polyneuropathy, type v
n1=hyperlaxité ligamentaire | n2=en:familial amyloid polyneuropathy, type v | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:familial partial lipodystrophy, type 2
n1=hyperlaxité ligamentaire | n2=en:familial partial lipodystrophy, type 2 | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:glycogen storage disease 0, liver
n1=hyperlaxité ligamentaire | n2=en:glycogen storage disease 0, liver | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:hypoplastic tibia and postaxial polydactyly syndrome
n1=hyperlaxité ligamentaire | n2=en:hypoplastic tibia and postaxial polydactyly syndrome | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:inflammatory polyarthropathy
n1=hyperlaxité ligamentaire | n2=en:inflammatory polyarthropathy | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:joint disorder, unspecified; shoulder region
n1=hyperlaxité ligamentaire | n2=en:joint disorder, unspecified; shoulder region | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:joint loose bodies
n1=hyperlaxité ligamentaire | n2=en:joint loose bodies | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:menkes disease
n1=hyperlaxité ligamentaire | n2=en:menkes disease | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:metaphyseal dysplasia, braun-tinschert type
n1=hyperlaxité ligamentaire | n2=en:metaphyseal dysplasia, braun-tinschert type | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:mild spondyloepiphyseal dysplasia due to col2a1 mutation with early onset osteoarthritis
n1=hyperlaxité ligamentaire | n2=en:mild spondyloepiphyseal dysplasia due to col2a1 mutation with early onset osteoarthritis | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:muscle l-lactate dehydrogenase deficiency
n1=hyperlaxité ligamentaire | n2=en:muscle l-lactate dehydrogenase deficiency | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:non-dystrophic myotonia
n1=hyperlaxité ligamentaire | n2=en:non-dystrophic myotonia | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:other specified arthropathy, lower leg
n1=hyperlaxité ligamentaire | n2=en:other specified arthropathy, lower leg | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:other symptoms referable to joint
n1=hyperlaxité ligamentaire | n2=en:other symptoms referable to joint | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:other symptoms referable to joint, ankle and foot
n1=hyperlaxité ligamentaire | n2=en:other symptoms referable to joint, ankle and foot | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:periarthritis
n1=hyperlaxité ligamentaire | n2=en:periarthritis | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:prune belly syndrome
n1=hyperlaxité ligamentaire | n2=en:prune belly syndrome | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:spondyloepiphyseal dysplasia tarda, x-linked
n1=hyperlaxité ligamentaire | n2=en:spondyloepiphyseal dysplasia tarda, x-linked | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 38 / 0.212 ->
en:spondyloepiphyseal dysplasia, omani type
n1=hyperlaxité ligamentaire | n2=en:spondyloepiphyseal dysplasia, omani type | rel=r_associated | relid=0 | w=38
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:abscess of bursa of knee
n1=hyperlaxité ligamentaire | n2=en:abscess of bursa of knee | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:arthralgia
n1=hyperlaxité ligamentaire | n2=en:arthralgia | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:arthropathy associated with respiratory disorder
n1=hyperlaxité ligamentaire | n2=en:arthropathy associated with respiratory disorder | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:arthropathy in behcet's syndrome
n1=hyperlaxité ligamentaire | n2=en:arthropathy in behcet's syndrome | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:arthropathy of multiple joints
n1=hyperlaxité ligamentaire | n2=en:arthropathy of multiple joints | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:arthropathy, unspecified, multiple sites
n1=hyperlaxité ligamentaire | n2=en:arthropathy, unspecified, multiple sites | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:arthropathy, unspecified, pelvic region and thigh
n1=hyperlaxité ligamentaire | n2=en:arthropathy, unspecified, pelvic region and thigh | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:behcet syndrome
n1=hyperlaxité ligamentaire | n2=en:behcet syndrome | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:complete tear, wrist and/or hand
n1=hyperlaxité ligamentaire | n2=en:complete tear, wrist and/or hand | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:craniocervical syndrome
n1=hyperlaxité ligamentaire | n2=en:craniocervical syndrome | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:crystal arthropathic disorders
n1=hyperlaxité ligamentaire | n2=en:crystal arthropathic disorders | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:dysplasia, saddan
n1=hyperlaxité ligamentaire | n2=en:dysplasia, saddan | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:dystrophia myotonica 2
n1=hyperlaxité ligamentaire | n2=en:dystrophia myotonica 2 | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:ectodermal dysplasia/ skin fragility syndrome
n1=hyperlaxité ligamentaire | n2=en:ectodermal dysplasia/ skin fragility syndrome | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:epidermolysis bullosa simplex with pyloric atresia
n1=hyperlaxité ligamentaire | n2=en:epidermolysis bullosa simplex with pyloric atresia | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:facet joint pain
n1=hyperlaxité ligamentaire | n2=en:facet joint pain | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:familial digital arthropathy and brachydactyly syndrome
n1=hyperlaxité ligamentaire | n2=en:familial digital arthropathy and brachydactyly syndrome | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:femoral trochlear dysplasia
n1=hyperlaxité ligamentaire | n2=en:femoral trochlear dysplasia | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:femur bifid with monodactylous ectrodactyly
n1=hyperlaxité ligamentaire | n2=en:femur bifid with monodactylous ectrodactyly | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:ganglion/synovial cyst - ankle/foot
n1=hyperlaxité ligamentaire | n2=en:ganglion/synovial cyst - ankle/foot | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:generalized myotonia of thomsen
n1=hyperlaxité ligamentaire | n2=en:generalized myotonia of thomsen | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:gurrieri sammito bellussi syndrome
n1=hyperlaxité ligamentaire | n2=en:gurrieri sammito bellussi syndrome | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:hereditary tubulointerstitial disorder
n1=hyperlaxité ligamentaire | n2=en:hereditary tubulointerstitial disorder | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:hypertrophic osteoarthropathy
n1=hyperlaxité ligamentaire | n2=en:hypertrophic osteoarthropathy | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:infrapatellar fat pad inflammation
n1=hyperlaxité ligamentaire | n2=en:infrapatellar fat pad inflammation | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:internasal dysostosis
n1=hyperlaxité ligamentaire | n2=en:internasal dysostosis | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:jackson-weiss syndrome
n1=hyperlaxité ligamentaire | n2=en:jackson-weiss syndrome | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:joint injury
n1=hyperlaxité ligamentaire | n2=en:joint injury | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:joint laxity
n1=hyperlaxité ligamentaire | n2=en:joint laxity | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:klippel-trenaunay-weber syndrome
n1=hyperlaxité ligamentaire | n2=en:klippel-trenaunay-weber syndrome | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:marden-walker syndrome
n1=hyperlaxité ligamentaire | n2=en:marden-walker syndrome | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:mitochondrial neurogastrointestinal encephalomyopathy syndrome
n1=hyperlaxité ligamentaire | n2=en:mitochondrial neurogastrointestinal encephalomyopathy syndrome | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:multicentric osteolysis nodulosis arthropathy spectrum
n1=hyperlaxité ligamentaire | n2=en:multicentric osteolysis nodulosis arthropathy spectrum | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:muscle contracture
n1=hyperlaxité ligamentaire | n2=en:muscle contracture | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:non-traumatic rupture of tendon of right shoulder
n1=hyperlaxité ligamentaire | n2=en:non-traumatic rupture of tendon of right shoulder | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:other specified disorders of joint, site unspecified
n1=hyperlaxité ligamentaire | n2=en:other specified disorders of joint, site unspecified | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:other symptoms referable to joint, shoulder region
n1=hyperlaxité ligamentaire | n2=en:other symptoms referable to joint, shoulder region | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:patellofemoral pain syndrome
n1=hyperlaxité ligamentaire | n2=en:patellofemoral pain syndrome | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:polyarthropathy
n1=hyperlaxité ligamentaire | n2=en:polyarthropathy | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:posterior perimaxillary faciosynostosis
n1=hyperlaxité ligamentaire | n2=en:posterior perimaxillary faciosynostosis | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:robinow syndrome
n1=hyperlaxité ligamentaire | n2=en:robinow syndrome | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:saito kuba tsuruta syndrome
n1=hyperlaxité ligamentaire | n2=en:saito kuba tsuruta syndrome | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:shwachman-diamond syndrome
n1=hyperlaxité ligamentaire | n2=en:shwachman-diamond syndrome | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:synovial chondromatosis
n1=hyperlaxité ligamentaire | n2=en:synovial chondromatosis | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
en:transient arthropathy, ankle and foot
n1=hyperlaxité ligamentaire | n2=en:transient arthropathy, ankle and foot | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 37 / 0.207 ->
instabilité ligamentaire
n1=hyperlaxité ligamentaire | n2=instabilité ligamentaire | rel=r_associated | relid=0 | w=37
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:acute arthropathy
n1=hyperlaxité ligamentaire | n2=en:acute arthropathy | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:andersen syndrome
n1=hyperlaxité ligamentaire | n2=en:andersen syndrome | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:arthritis
n1=hyperlaxité ligamentaire | n2=en:arthritis | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:arthropathy aggravated
n1=hyperlaxité ligamentaire | n2=en:arthropathy aggravated | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:arthropathy of knee joint
n1=hyperlaxité ligamentaire | n2=en:arthropathy of knee joint | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:arthropathy, unspecified, forearm
n1=hyperlaxité ligamentaire | n2=en:arthropathy, unspecified, forearm | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:arthrosis, unspecified; pelvic region and thigh
n1=hyperlaxité ligamentaire | n2=en:arthrosis, unspecified; pelvic region and thigh | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:autosomal dominant epidermolysis bullosa simplex
n1=hyperlaxité ligamentaire | n2=en:autosomal dominant epidermolysis bullosa simplex | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:brody myopathy
n1=hyperlaxité ligamentaire | n2=en:brody myopathy | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:cutis laxa, autosomal dominant
n1=hyperlaxité ligamentaire | n2=en:cutis laxa, autosomal dominant | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:destruction joint
n1=hyperlaxité ligamentaire | n2=en:destruction joint | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:disorder of skeletal system
n1=hyperlaxité ligamentaire | n2=en:disorder of skeletal system | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:distal arthrogryposis syndrome
n1=hyperlaxité ligamentaire | n2=en:distal arthrogryposis syndrome | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:ehlers-danlos syndrome
n1=hyperlaxité ligamentaire | n2=en:ehlers-danlos syndrome | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:freeman-sheldon syndrome
n1=hyperlaxité ligamentaire | n2=en:freeman-sheldon syndrome | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:full thickness rotator cuff tear
n1=hyperlaxité ligamentaire | n2=en:full thickness rotator cuff tear | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:glycogen storage disease type x
n1=hyperlaxité ligamentaire | n2=en:glycogen storage disease type x | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:joint capsule rupture
n1=hyperlaxité ligamentaire | n2=en:joint capsule rupture | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:joint related signs and symptoms
n1=hyperlaxité ligamentaire | n2=en:joint related signs and symptoms | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:lethal congenital contracture syndrome 1
n1=hyperlaxité ligamentaire | n2=en:lethal congenital contracture syndrome 1 | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:macular corneal dystrophy
n1=hyperlaxité ligamentaire | n2=en:macular corneal dystrophy | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:mechanical joint disorder
n1=hyperlaxité ligamentaire | n2=en:mechanical joint disorder | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:multiple congenital articular rigidities
n1=hyperlaxité ligamentaire | n2=en:multiple congenital articular rigidities | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:osteogenesis imperfecta, levin type
n1=hyperlaxité ligamentaire | n2=en:osteogenesis imperfecta, levin type | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:other specified arthropathy, hand
n1=hyperlaxité ligamentaire | n2=en:other specified arthropathy, hand | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:other specified arthropathy, shoulder region
n1=hyperlaxité ligamentaire | n2=en:other specified arthropathy, shoulder region | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:other specified joint disorders; pelvic region and thigh
n1=hyperlaxité ligamentaire | n2=en:other specified joint disorders; pelvic region and thigh | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:other specified joint disorders; upper arm
n1=hyperlaxité ligamentaire | n2=en:other specified joint disorders; upper arm | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:other symptoms referable to joint, other specified sites
n1=hyperlaxité ligamentaire | n2=en:other symptoms referable to joint, other specified sites | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:pseudocholinesterase deficiency
n1=hyperlaxité ligamentaire | n2=en:pseudocholinesterase deficiency | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:pulmonary interstitial glycogenosis
n1=hyperlaxité ligamentaire | n2=en:pulmonary interstitial glycogenosis | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:systemic involvement of connective tissue, unspecified
n1=hyperlaxité ligamentaire | n2=en:systemic involvement of connective tissue, unspecified | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:temporomandibular joint disorder
n1=hyperlaxité ligamentaire | n2=en:temporomandibular joint disorder | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:ulna metaphyseal dysplasia syndrome
n1=hyperlaxité ligamentaire | n2=en:ulna metaphyseal dysplasia syndrome | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 36 / 0.201 ->
en:unspecified disorder of joint, other specified sites
n1=hyperlaxité ligamentaire | n2=en:unspecified disorder of joint, other specified sites | rel=r_associated | relid=0 | w=36
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:acquired fixed flexion deformity of joint of lower limb
n1=hyperlaxité ligamentaire | n2=en:acquired fixed flexion deformity of joint of lower limb | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:arthrofibrosis
n1=hyperlaxité ligamentaire | n2=en:arthrofibrosis | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:arthropathy associated with dermatological disorder
n1=hyperlaxité ligamentaire | n2=en:arthropathy associated with dermatological disorder | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:autosomal recessive distal osteolysis syndrome
n1=hyperlaxité ligamentaire | n2=en:autosomal recessive distal osteolysis syndrome | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:brachydactylous dwarfism mseleni type
n1=hyperlaxité ligamentaire | n2=en:brachydactylous dwarfism mseleni type | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:cartilage diseases
n1=hyperlaxité ligamentaire | n2=en:cartilage diseases | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:crouzon syndrome with acanthosis nigricans (disorder)
n1=hyperlaxité ligamentaire | n2=en:crouzon syndrome with acanthosis nigricans (disorder) | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:familial osteochondritis dissecans
n1=hyperlaxité ligamentaire | n2=en:familial osteochondritis dissecans | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:fleck corneal dystrophy
n1=hyperlaxité ligamentaire | n2=en:fleck corneal dystrophy | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:hip osteoarthritis
n1=hyperlaxité ligamentaire | n2=en:hip osteoarthritis | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:holoprosencephaly with fetal akinesia-hypokinesia sequence
n1=hyperlaxité ligamentaire | n2=en:holoprosencephaly with fetal akinesia-hypokinesia sequence | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:joint disorder, unspecified; ankle and foot
n1=hyperlaxité ligamentaire | n2=en:joint disorder, unspecified; ankle and foot | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:joint disorder, unspecified; upper arm
n1=hyperlaxité ligamentaire | n2=en:joint disorder, unspecified; upper arm | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:lethal congenital contracture syndrome 2
n1=hyperlaxité ligamentaire | n2=en:lethal congenital contracture syndrome 2 | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:ligamentous laxity of wrist and/or hand
n1=hyperlaxité ligamentaire | n2=en:ligamentous laxity of wrist and/or hand | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:malignant neoplasm of costovertebral joint
n1=hyperlaxité ligamentaire | n2=en:malignant neoplasm of costovertebral joint | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:muscular wasting and disuse atrophy, not elsewhere classified in icd9cm
n1=hyperlaxité ligamentaire | n2=en:muscular wasting and disuse atrophy, not elsewhere classified in icd9cm | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:other specified arthropathy, other specified sites
n1=hyperlaxité ligamentaire | n2=en:other specified arthropathy, other specified sites | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:other symptoms referable to joint, forearm
n1=hyperlaxité ligamentaire | n2=en:other symptoms referable to joint, forearm | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:palmar fibromatosis
n1=hyperlaxité ligamentaire | n2=en:palmar fibromatosis | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:pelvic girdle pain
n1=hyperlaxité ligamentaire | n2=en:pelvic girdle pain | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:periarticular disorder
n1=hyperlaxité ligamentaire | n2=en:periarticular disorder | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy
n1=hyperlaxité ligamentaire | n2=en:polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:psoriatic arthritis
n1=hyperlaxité ligamentaire | n2=en:psoriatic arthritis | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:radial aplasia-thrombocytopenia syndrome
n1=hyperlaxité ligamentaire | n2=en:radial aplasia-thrombocytopenia syndrome | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:sjogren syndrome
n1=hyperlaxité ligamentaire | n2=en:sjogren syndrome | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:split-hand-foot malformation with long bone deficiency 1
n1=hyperlaxité ligamentaire | n2=en:split-hand-foot malformation with long bone deficiency 1 | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:spondylarthropathies
n1=hyperlaxité ligamentaire | n2=en:spondylarthropathies | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:suppurative arthritis
n1=hyperlaxité ligamentaire | n2=en:suppurative arthritis | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:transient arthropathy of multiple sites
n1=hyperlaxité ligamentaire | n2=en:transient arthropathy of multiple sites | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:traumatic arthropathy
n1=hyperlaxité ligamentaire | n2=en:traumatic arthropathy | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 35 / 0.196 ->
en:ulnocarpal abutment syndrome
n1=hyperlaxité ligamentaire | n2=en:ulnocarpal abutment syndrome | rel=r_associated | relid=0 | w=35
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:arthrogryposis
n1=hyperlaxité ligamentaire | n2=en:arthrogryposis | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:arthropathy associated with other conditions classifiable elsewhere
n1=hyperlaxité ligamentaire | n2=en:arthropathy associated with other conditions classifiable elsewhere | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:arthropathy associated with other disorders classified elsewhere
n1=hyperlaxité ligamentaire | n2=en:arthropathy associated with other disorders classified elsewhere | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:avascular necrosis of femoral head
n1=hyperlaxité ligamentaire | n2=en:avascular necrosis of femoral head | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:cricoarytenoid joint fixation
n1=hyperlaxité ligamentaire | n2=en:cricoarytenoid joint fixation | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:disorder of hip joint
n1=hyperlaxité ligamentaire | n2=en:disorder of hip joint | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:familial arthrogryposis-cholestatic hepatorenal syndrome
n1=hyperlaxité ligamentaire | n2=en:familial arthrogryposis-cholestatic hepatorenal syndrome | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:giacci familial neurogenic acroosteolysis
n1=hyperlaxité ligamentaire | n2=en:giacci familial neurogenic acroosteolysis | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:hallux limitus
n1=hyperlaxité ligamentaire | n2=en:hallux limitus | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:klippel-feil syndrome
n1=hyperlaxité ligamentaire | n2=en:klippel-feil syndrome | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:knee arthropathy
n1=hyperlaxité ligamentaire | n2=en:knee arthropathy | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:lateral patellar compression syndrome
n1=hyperlaxité ligamentaire | n2=en:lateral patellar compression syndrome | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:other fibromatoses of muscle, ligament, and fascia
n1=hyperlaxité ligamentaire | n2=en:other fibromatoses of muscle, ligament, and fascia | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:otoonychoperoneal syndrome
n1=hyperlaxité ligamentaire | n2=en:otoonychoperoneal syndrome | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:rubella arthralgia
n1=hyperlaxité ligamentaire | n2=en:rubella arthralgia | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:tarsal-carpal coalition syndrome
n1=hyperlaxité ligamentaire | n2=en:tarsal-carpal coalition syndrome | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:transient arthropathy, lower leg
n1=hyperlaxité ligamentaire | n2=en:transient arthropathy, lower leg | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:vertebral foraminal stenosis
n1=hyperlaxité ligamentaire | n2=en:vertebral foraminal stenosis | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 34 / 0.19 ->
en:villonodular synovitis of distal radioulnar joint
n1=hyperlaxité ligamentaire | n2=en:villonodular synovitis of distal radioulnar joint | rel=r_associated | relid=0 | w=34
- hyperlaxité ligamentaire --
r_associated #0: 33 / 0.184 ->
en:lesion of ligament of wrist and/or hand
n1=hyperlaxité ligamentaire | n2=en:lesion of ligament of wrist and/or hand | rel=r_associated | relid=0 | w=33
- hyperlaxité ligamentaire --
r_associated #0: 33 / 0.184 ->
en:ossicular ankylosis
n1=hyperlaxité ligamentaire | n2=en:ossicular ankylosis | rel=r_associated | relid=0 | w=33
- hyperlaxité ligamentaire --
r_associated #0: 32 / 0.179 ->
en:congenital hereditary muscular dystrophy
n1=hyperlaxité ligamentaire | n2=en:congenital hereditary muscular dystrophy | rel=r_associated | relid=0 | w=32
- hyperlaxité ligamentaire --
r_associated #0: 32 / 0.179 ->
en:joint deformities, acquired
n1=hyperlaxité ligamentaire | n2=en:joint deformities, acquired | rel=r_associated | relid=0 | w=32
- hyperlaxité ligamentaire --
r_associated #0: 32 / 0.179 ->
en:joint derangement
n1=hyperlaxité ligamentaire | n2=en:joint derangement | rel=r_associated | relid=0 | w=32
- hyperlaxité ligamentaire --
r_associated #0: 32 / 0.179 ->
en:majeed syndrome
n1=hyperlaxité ligamentaire | n2=en:majeed syndrome | rel=r_associated | relid=0 | w=32
- hyperlaxité ligamentaire --
r_associated #0: 32 / 0.179 ->
en:reardon hall slaney syndrome
n1=hyperlaxité ligamentaire | n2=en:reardon hall slaney syndrome | rel=r_associated | relid=0 | w=32
- hyperlaxité ligamentaire --
r_associated #0: 32 / 0.179 ->
en:subacute arthropathy
n1=hyperlaxité ligamentaire | n2=en:subacute arthropathy | rel=r_associated | relid=0 | w=32
- hyperlaxité ligamentaire --
r_associated #0: 32 / 0.179 ->
laxité ligamentaire familiale
n1=hyperlaxité ligamentaire | n2=laxité ligamentaire familiale | rel=r_associated | relid=0 | w=32
- hyperlaxité ligamentaire --
r_associated #0: 31 / 0.173 ->
en:craniodiaphyseal dysplasia
n1=hyperlaxité ligamentaire | n2=en:craniodiaphyseal dysplasia | rel=r_associated | relid=0 | w=31
- hyperlaxité ligamentaire --
r_associated #0: 31 / 0.173 ->
en:laxity of ligament
n1=hyperlaxité ligamentaire | n2=en:laxity of ligament | rel=r_associated | relid=0 | w=31
- hyperlaxité ligamentaire --
r_associated #0: 31 / 0.173 ->
en:rupture of infraspinatus tendon
n1=hyperlaxité ligamentaire | n2=en:rupture of infraspinatus tendon | rel=r_associated | relid=0 | w=31
- hyperlaxité ligamentaire --
r_associated #0: 31 / 0.173 ->
en:type i acrocephalosyndactyly
n1=hyperlaxité ligamentaire | n2=en:type i acrocephalosyndactyly | rel=r_associated | relid=0 | w=31
- hyperlaxité ligamentaire --
r_associated #0: 30 / 0.168 ->
en:arthrosis, unspecified; forearm
n1=hyperlaxité ligamentaire | n2=en:arthrosis, unspecified; forearm | rel=r_associated | relid=0 | w=30
- hyperlaxité ligamentaire --
r_associated #0: 30 / 0.168 ->
hyperkinésie volitionnelle
n1=hyperlaxité ligamentaire | n2=hyperkinésie volitionnelle | rel=r_associated | relid=0 | w=30
- hyperlaxité ligamentaire --
r_associated #0: 29 / 0.162 ->
en:other symptoms referable to joint, site unspecified
n1=hyperlaxité ligamentaire | n2=en:other symptoms referable to joint, site unspecified | rel=r_associated | relid=0 | w=29
- hyperlaxité ligamentaire --
r_associated #0: 28 / 0.156 ->
en:nonaka myopathy
n1=hyperlaxité ligamentaire | n2=en:nonaka myopathy | rel=r_associated | relid=0 | w=28
- hyperlaxité ligamentaire --
r_associated #0: 27 / 0.151 ->
en:other symptoms referable to joint, upper arm
n1=hyperlaxité ligamentaire | n2=en:other symptoms referable to joint, upper arm | rel=r_associated | relid=0 | w=27
- hyperlaxité ligamentaire --
r_associated #0: 26 / 0.145 ->
en:polyostotic fibrous dysplasia
n1=hyperlaxité ligamentaire | n2=en:polyostotic fibrous dysplasia | rel=r_associated | relid=0 | w=26
- hyperlaxité ligamentaire --
r_associated #0: 24 / 0.134 ->
hyperkinésie
n1=hyperlaxité ligamentaire | n2=hyperkinésie | rel=r_associated | relid=0 | w=24
- hyperlaxité ligamentaire --
r_associated #0: 22 / 0.123 ->
en:hypercinesia
n1=hyperlaxité ligamentaire | n2=en:hypercinesia | rel=r_associated | relid=0 | w=22
- hyperlaxité ligamentaire --
r_associated #0: 21 / 0.117 ->
en:hyperkeratosis of nipple and areola
n1=hyperlaxité ligamentaire | n2=en:hyperkeratosis of nipple and areola | rel=r_associated | relid=0 | w=21
- hyperlaxité ligamentaire --
r_associated #0: 20 / 0.112 ->
en:Hunter-Thompson-Reed's syndrome
n1=hyperlaxité ligamentaire | n2=en:Hunter-Thompson-Reed's syndrome | rel=r_associated | relid=0 | w=20
- hyperlaxité ligamentaire --
r_associated #0: 15 / 0.084 ->
hamartomateuse
n1=hyperlaxité ligamentaire | n2=hamartomateuse | rel=r_associated | relid=0 | w=15
- hyperlaxité ligamentaire --
r_associated #0: 15 / 0.084 ->
hyperkératose
n1=hyperlaxité ligamentaire | n2=hyperkératose | rel=r_associated | relid=0 | w=15
- hyperlaxité ligamentaire --
r_associated #0: 15 / 0.084 ->
hyperkératose talonnière fissurée
n1=hyperlaxité ligamentaire | n2=hyperkératose talonnière fissurée | rel=r_associated | relid=0 | w=15
- hyperlaxité ligamentaire --
r_associated #0: 15 / 0.084 ->
hyperkeratosis follicularis et parafollicularis in cutem penetrans de Kyrle
n1=hyperlaxité ligamentaire | n2=hyperkeratosis follicularis et parafollicularis in cutem penetrans de Kyrle | rel=r_associated | relid=0 | w=15
- hyperlaxité ligamentaire --
r_associated #0: 15 / 0.084 ->
hyperkeratosis lenticularis perstans de Flegel
n1=hyperlaxité ligamentaire | n2=hyperkeratosis lenticularis perstans de Flegel | rel=r_associated | relid=0 | w=15
- hyperlaxité ligamentaire --
r_associated #0: 15 / 0.084 ->
hyperlacrymie
n1=hyperlaxité ligamentaire | n2=hyperlacrymie | rel=r_associated | relid=0 | w=15
- hyperlaxité ligamentaire --
r_associated #0: 15 / 0.084 ->
hyperlactacidémie
n1=hyperlaxité ligamentaire | n2=hyperlactacidémie | rel=r_associated | relid=0 | w=15
- hyperlaxité ligamentaire --
r_associated #0: 15 / 0.084 ->
hyperlaxité articulaire familiale
n1=hyperlaxité ligamentaire | n2=hyperlaxité articulaire familiale | rel=r_associated | relid=0 | w=15
- hyperlaxité ligamentaire --
r_associated #0: 15 / 0.084 ->
hyperleucocytose
n1=hyperlaxité ligamentaire | n2=hyperleucocytose | rel=r_associated | relid=0 | w=15
- hyperlaxité ligamentaire --
r_associated #0: 15 / 0.084 ->
hyperlipémie
n1=hyperlaxité ligamentaire | n2=hyperlipémie | rel=r_associated | relid=0 | w=15
- hyperlaxité ligamentaire --
r_associated #0: 15 / 0.084 ->
mamelon
n1=hyperlaxité ligamentaire | n2=mamelon | rel=r_associated | relid=0 | w=15
- hyperlaxité ligamentaire --
r_associated #0: 15 / 0.084 ->
nævoïde
n1=hyperlaxité ligamentaire | n2=nævoïde | rel=r_associated | relid=0 | w=15
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
en:clinical
n1=hyperlaxité ligamentaire | n2=en:clinical | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
en:excessive
n1=hyperlaxité ligamentaire | n2=en:excessive | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
en:hyperlactemia
n1=hyperlaxité ligamentaire | n2=en:hyperlactemia | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
en:hypermobility
n1=hyperlaxité ligamentaire | n2=en:hypermobility | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
en:in cerebrospinal fluid
n1=hyperlaxité ligamentaire | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
en:joint
n1=hyperlaxité ligamentaire | n2=en:joint | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
en:leukocytosis
n1=hyperlaxité ligamentaire | n2=en:leukocytosis | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
en:medicine
n1=hyperlaxité ligamentaire | n2=en:medicine | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
en:microbiological
n1=hyperlaxité ligamentaire | n2=en:microbiological | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
en:parasitology
n1=hyperlaxité ligamentaire | n2=en:parasitology | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
en:pharmacotherapeutic
n1=hyperlaxité ligamentaire | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
en:roentgenographic
n1=hyperlaxité ligamentaire | n2=en:roentgenographic | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
en:taxonomic
n1=hyperlaxité ligamentaire | n2=en:taxonomic | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
en:use of ultrasonography
n1=hyperlaxité ligamentaire | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
en:viruses
n1=hyperlaxité ligamentaire | n2=en:viruses | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
excès
n1=hyperlaxité ligamentaire | n2=excès | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
pathologie
n1=hyperlaxité ligamentaire | n2=pathologie | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
processus pathologique
n1=hyperlaxité ligamentaire | n2=processus pathologique | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 10 / 0.056 ->
sang
n1=hyperlaxité ligamentaire | n2=sang | rel=r_associated | relid=0 | w=10
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
alimentation
n1=hyperlaxité ligamentaire | n2=alimentation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
analyse sanguine
n1=hyperlaxité ligamentaire | n2=analyse sanguine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
basophile
n1=hyperlaxité ligamentaire | n2=basophile | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
cortisol
n1=hyperlaxité ligamentaire | n2=cortisol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
dyscinésie
n1=hyperlaxité ligamentaire | n2=dyscinésie | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
dyskinésie
n1=hyperlaxité ligamentaire | n2=dyskinésie | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:'cloudy' or 'pink' blood (lipemia)
n1=hyperlaxité ligamentaire | n2=en:'cloudy' or 'pink' blood (lipemia) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:'compensated hypothyroidism' with increased tsh and normal t4
n1=hyperlaxité ligamentaire | n2=en:'compensated hypothyroidism' with increased tsh and normal t4 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:'rectilinear profiles' ultrastructurally in cells
n1=hyperlaxité ligamentaire | n2=en:'rectilinear profiles' ultrastructurally in cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:1,25-dihydroxyvitamin d was elevated in childhood but deficient in adulthood
n1=hyperlaxité ligamentaire | n2=en:1,25-dihydroxyvitamin d was elevated in childhood but deficient in adulthood | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:1.61- and 1.76-mb microduplication of 3q29
n1=hyperlaxité ligamentaire | n2=en:1.61- and 1.76-mb microduplication of 3q29 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:2-aminoadipic aciduria
n1=hyperlaxité ligamentaire | n2=en:2-aminoadipic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:2-oxoadipic aciduria
n1=hyperlaxité ligamentaire | n2=en:2-oxoadipic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:2,8-dihydroxyadenine (dha) urinary stones
n1=hyperlaxité ligamentaire | n2=en:2,8-dihydroxyadenine (dha) urinary stones | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:3-methylglutaconic aciduria
n1=hyperlaxité ligamentaire | n2=en:3-methylglutaconic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:3-methylglutaconic aciduria (3-mgc)
n1=hyperlaxité ligamentaire | n2=en:3-methylglutaconic aciduria (3-mgc) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:3-methylglutaric aciduria
n1=hyperlaxité ligamentaire | n2=en:3-methylglutaric aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:3-methylglutaric aciduria (3-mga)
n1=hyperlaxité ligamentaire | n2=en:3-methylglutaric aciduria (3-mga) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:4-hydroxycyclohexylacetic aciduria (adults)
n1=hyperlaxité ligamentaire | n2=en:4-hydroxycyclohexylacetic aciduria (adults) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:4-hydroxyphenylacetic aciduria
n1=hyperlaxité ligamentaire | n2=en:4-hydroxyphenylacetic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:4-hydroxyphenylactic aciduria
n1=hyperlaxité ligamentaire | n2=en:4-hydroxyphenylactic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:4-hydroxyphenyllactic aciduria
n1=hyperlaxité ligamentaire | n2=en:4-hydroxyphenyllactic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:4-hydroxyphenylpyruvic acid dioxygenase deficiency (hpd)
n1=hyperlaxité ligamentaire | n2=en:4-hydroxyphenylpyruvic acid dioxygenase deficiency (hpd) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:4-hydroxyphenylpyruvic aciduria
n1=hyperlaxité ligamentaire | n2=en:4-hydroxyphenylpyruvic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:5 alpha steroid reductase 2 deficiency
n1=hyperlaxité ligamentaire | n2=en:5 alpha steroid reductase 2 deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:5-alpha-reductase-2 enzyme deficiency
n1=hyperlaxité ligamentaire | n2=en:5-alpha-reductase-2 enzyme deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:5-hiaa csf may be normal or decreased
n1=hyperlaxité ligamentaire | n2=en:5-hiaa csf may be normal or decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:5-oxoprolinase deficiency
n1=hyperlaxité ligamentaire | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:5' 10' methylenetetrahydrofolate reductase deficiency
n1=hyperlaxité ligamentaire | n2=en:5' 10' methylenetetrahydrofolate reductase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:85-90% dgs patients have deletion of 22q11.2
n1=hyperlaxité ligamentaire | n2=en:85-90% dgs patients have deletion of 22q11.2 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:a small minority of patients have translocations and inversions involving 16p13.3
n1=hyperlaxité ligamentaire | n2=en:a small minority of patients have translocations and inversions involving 16p13.3 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:a subset of group b patients have absence of pc protein and mrna
n1=hyperlaxité ligamentaire | n2=en:a subset of group b patients have absence of pc protein and mrna | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:a subset of patients may have normal levels of blood lactate
n1=hyperlaxité ligamentaire | n2=en:a subset of patients may have normal levels of blood lactate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:a subset of patients may have subtle increases in blood lactate
n1=hyperlaxité ligamentaire | n2=en:a subset of patients may have subtle increases in blood lactate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aagenaes syndrome
n1=hyperlaxité ligamentaire | n2=en:aagenaes syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abacterial leukocyturia
n1=hyperlaxité ligamentaire | n2=en:abacterial leukocyturia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aberrant gamma-interferon-mediated inflammation
n1=hyperlaxité ligamentaire | n2=en:aberrant gamma-interferon-mediated inflammation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abetalipoproteinemia
n1=hyperlaxité ligamentaire | n2=en:abetalipoproteinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abetalipoproteinemia (lab finding)
n1=hyperlaxité ligamentaire | n2=en:abetalipoproteinemia (lab finding) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal acylcarnitine profiles
n1=hyperlaxité ligamentaire | n2=en:abnormal acylcarnitine profiles | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal blood antidiuretic hormone
n1=hyperlaxité ligamentaire | n2=en:abnormal blood antidiuretic hormone | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal blood gas measurement
n1=hyperlaxité ligamentaire | n2=en:abnormal blood gas measurement | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal blood gonadotrophin
n1=hyperlaxité ligamentaire | n2=en:abnormal blood gonadotrophin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal blood prolactin
n1=hyperlaxité ligamentaire | n2=en:abnormal blood prolactin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal bone marrow karyotype, t(8,21)
n1=hyperlaxité ligamentaire | n2=en:abnormal bone marrow karyotype, t(8,21) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal cardiolipin subspecies composition
n1=hyperlaxité ligamentaire | n2=en:abnormal cardiolipin subspecies composition | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal cartilage collagen on em
n1=hyperlaxité ligamentaire | n2=en:abnormal cartilage collagen on em | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal cholesterol homeostasis
n1=hyperlaxité ligamentaire | n2=en:abnormal cholesterol homeostasis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal columnization of chondrocytes
n1=hyperlaxité ligamentaire | n2=en:abnormal columnization of chondrocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal dystrophin on muscle biopsy
n1=hyperlaxité ligamentaire | n2=en:abnormal dystrophin on muscle biopsy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal eeg in 25% hospitalized patients
n1=hyperlaxité ligamentaire | n2=en:abnormal eeg in 25% hospitalized patients | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal electrophoretic mobility of type ii collagen
n1=hyperlaxité ligamentaire | n2=en:abnormal electrophoretic mobility of type ii collagen | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal extrarenal response to ddavp (no increase in von willebrand factor or factor viii)
n1=hyperlaxité ligamentaire | n2=en:abnormal extrarenal response to ddavp (no increase in von willebrand factor or factor viii) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal fecal fat
n1=hyperlaxité ligamentaire | n2=en:abnormal fecal fat | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal glycosylation of serum transferrin, type 1 pattern
n1=hyperlaxité ligamentaire | n2=en:abnormal glycosylation of serum transferrin, type 1 pattern | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal growth hormone
n1=hyperlaxité ligamentaire | n2=en:abnormal growth hormone | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal hematology test result
n1=hyperlaxité ligamentaire | n2=en:abnormal hematology test result | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal igfr1 function
n1=hyperlaxité ligamentaire | n2=en:abnormal igfr1 function | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal isoelectric focusing of serum transferrin
n1=hyperlaxité ligamentaire | n2=en:abnormal isoelectric focusing of serum transferrin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal isoelectric focusing of serum transferrin (type 1 pattern without increase of asialotransferrin)
n1=hyperlaxité ligamentaire | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern without increase of asialotransferrin) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal isoelectric focusing of serum transferrin (type 1 pattern)
n1=hyperlaxité ligamentaire | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) (in 1 patient)
n1=hyperlaxité ligamentaire | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) (in 1 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) loss of complete n-glycans
n1=hyperlaxité ligamentaire | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) loss of complete n-glycans | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal isoelectric focusing of serum transferrin (type 2 pattern)
n1=hyperlaxité ligamentaire | n2=en:abnormal isoelectric focusing of serum transferrin (type 2 pattern) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal karyotype in 3 patients involving distal 6p
n1=hyperlaxité ligamentaire | n2=en:abnormal karyotype in 3 patients involving distal 6p | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal karyotype in single reported female patient 46, xx,r(18)(p14q23)
n1=hyperlaxité ligamentaire | n2=en:abnormal karyotype in single reported female patient 46, xx,r(18)(p14q23) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal level of phospholipids
n1=hyperlaxité ligamentaire | n2=en:abnormal level of phospholipids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal lipid profile
n1=hyperlaxité ligamentaire | n2=en:abnormal lipid profile | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal liver enzymes (1 patient)
n1=hyperlaxité ligamentaire | n2=en:abnormal liver enzymes (1 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal liver enzymes (in some patients)
n1=hyperlaxité ligamentaire | n2=en:abnormal liver enzymes (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal liver enzymes (rare)
n1=hyperlaxité ligamentaire | n2=en:abnormal liver enzymes (rare) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal liver enzymes during illness
n1=hyperlaxité ligamentaire | n2=en:abnormal liver enzymes during illness | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal liver enzymes in those with hepatic cysts or fibrosis
n1=hyperlaxité ligamentaire | n2=en:abnormal liver enzymes in those with hepatic cysts or fibrosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal liver enzymes, episodic
n1=hyperlaxité ligamentaire | n2=en:abnormal liver enzymes, episodic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal liver enzymes, intermittent
n1=hyperlaxité ligamentaire | n2=en:abnormal liver enzymes, intermittent | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal liver enzymes, intermittent (1 patient)
n1=hyperlaxité ligamentaire | n2=en:abnormal liver enzymes, intermittent (1 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal liver function test
n1=hyperlaxité ligamentaire | n2=en:abnormal liver function test | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal liver function tests (in some patients)
n1=hyperlaxité ligamentaire | n2=en:abnormal liver function tests (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal liver function tests (less common)
n1=hyperlaxité ligamentaire | n2=en:abnormal liver function tests (less common) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal liver function tests (sgot, sgpt)
n1=hyperlaxité ligamentaire | n2=en:abnormal liver function tests (sgot, sgpt) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal liver function tests during pregnancy, resolves postpartum
n1=hyperlaxité ligamentaire | n2=en:abnormal liver function tests during pregnancy, resolves postpartum | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal metabolic state in diabetes mellitus
n1=hyperlaxité ligamentaire | n2=en:abnormal metabolic state in diabetes mellitus | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal myelination in sural nerve biopsies
n1=hyperlaxité ligamentaire | n2=en:abnormal myelination in sural nerve biopsies | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal n-glycosylation of transferrin
n1=hyperlaxité ligamentaire | n2=en:abnormal n-glycosylation of transferrin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal nasal potential difference
n1=hyperlaxité ligamentaire | n2=en:abnormal nasal potential difference | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal nuclear morphology
n1=hyperlaxité ligamentaire | n2=en:abnormal nuclear morphology | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal oral glucose tolerance
n1=hyperlaxité ligamentaire | n2=en:abnormal oral glucose tolerance | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal phenolsulfonphthalein test result
n1=hyperlaxité ligamentaire | n2=en:abnormal phenolsulfonphthalein test result | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal phosphatidylglycerol profile (increased 34-to-1 and decreased 36-to-1 ratio)
n1=hyperlaxité ligamentaire | n2=en:abnormal phosphatidylglycerol profile (increased 34-to-1 and decreased 36-to-1 ratio) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal phospholipid profile
n1=hyperlaxité ligamentaire | n2=en:abnormal phospholipid profile | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal platelet
n1=hyperlaxité ligamentaire | n2=en:abnormal platelet | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal response of 25-hydroxyvitamin d-1-alpha-hydroxylase activity (609506) to hypophosphatemia
n1=hyperlaxité ligamentaire | n2=en:abnormal response of 25-hydroxyvitamin d-1-alpha-hydroxylase activity (609506) to hypophosphatemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal response to human chorionic gonadotropin indicates decreased testosterone
n1=hyperlaxité ligamentaire | n2=en:abnormal response to human chorionic gonadotropin indicates decreased testosterone | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal schilling test (not normalized by addition of intrinsic factor)
n1=hyperlaxité ligamentaire | n2=en:abnormal schilling test (not normalized by addition of intrinsic factor) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal secretin test
n1=hyperlaxité ligamentaire | n2=en:abnormal secretin test | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal serum glycoproteins
n1=hyperlaxité ligamentaire | n2=en:abnormal serum glycoproteins | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal serum lipoprotein levels (in 3 of 10 patients)
n1=hyperlaxité ligamentaire | n2=en:abnormal serum lipoprotein levels (in 3 of 10 patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal serum liver enzyme levels
n1=hyperlaxité ligamentaire | n2=en:abnormal serum liver enzyme levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal serum protein electrophoresis (elevated alpha-2 band)
n1=hyperlaxité ligamentaire | n2=en:abnormal serum protein electrophoresis (elevated alpha-2 band) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal serum transferrin pattern (in some patients)
n1=hyperlaxité ligamentaire | n2=en:abnormal serum transferrin pattern (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal serum transferrin pattern by isoelectric focusing (hyposialylation)
n1=hyperlaxité ligamentaire | n2=en:abnormal serum transferrin pattern by isoelectric focusing (hyposialylation) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal spinocerebellar tracts, dorsal columns, pyramidal tracts, cerebellum and brainstem
n1=hyperlaxité ligamentaire | n2=en:abnormal spinocerebellar tracts, dorsal columns, pyramidal tracts, cerebellum and brainstem | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal transaminases (1 patient)
n1=hyperlaxité ligamentaire | n2=en:abnormal transaminases (1 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal transferrin isoelectric focusing (ief)
n1=hyperlaxité ligamentaire | n2=en:abnormal transferrin isoelectric focusing (ief) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal urinary collagen-derived pyridinium crosslinks (absent glc-gal-pyd)
n1=hyperlaxité ligamentaire | n2=en:abnormal urinary collagen-derived pyridinium crosslinks (absent glc-gal-pyd) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal urinary compounds
n1=hyperlaxité ligamentaire | n2=en:abnormal urinary compounds | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal urinary mucopolysaccharides (elevated unsaturated nonsulfated disaccharides and decreased unsaturated 6-sulfated disaccharides)
n1=hyperlaxité ligamentaire | n2=en:abnormal urinary mucopolysaccharides (elevated unsaturated nonsulfated disaccharides and decreased unsaturated 6-sulfated disaccharides) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal urinary oligosaccharides
n1=hyperlaxité ligamentaire | n2=en:abnormal urinary oligosaccharides | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal urinary organic acids
n1=hyperlaxité ligamentaire | n2=en:abnormal urinary organic acids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormal urine oligosaccharides (keratan sulfate, heparan sulfate, and chondroitin sulfate)
n1=hyperlaxité ligamentaire | n2=en:abnormal urine oligosaccharides (keratan sulfate, heparan sulfate, and chondroitin sulfate) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormality of cholesterol metabolism
n1=hyperlaxité ligamentaire | n2=en:abnormality of cholesterol metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormality of fatty-acid metabolism
n1=hyperlaxité ligamentaire | n2=en:abnormality of fatty-acid metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormality of liposaccharide metabolism
n1=hyperlaxité ligamentaire | n2=en:abnormality of liposaccharide metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormality of red blood cells
n1=hyperlaxité ligamentaire | n2=en:abnormality of red blood cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormality of temperature regulation
n1=hyperlaxité ligamentaire | n2=en:abnormality of temperature regulation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormally low cerebrospinal fluid cystatin c
n1=hyperlaxité ligamentaire | n2=en:abnormally low cerebrospinal fluid cystatin c | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:abnormally triglyceride-rich low and high density lipoproteins and beta-migrating very low density lipoproteins
n1=hyperlaxité ligamentaire | n2=en:abnormally triglyceride-rich low and high density lipoproteins and beta-migrating very low density lipoproteins | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absence of beta-ureidopropionase activity and protein in liver biopsy
n1=hyperlaxité ligamentaire | n2=en:absence of beta-ureidopropionase activity and protein in liver biopsy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absence of cd59 expression on red cells
n1=hyperlaxité ligamentaire | n2=en:absence of cd59 expression on red cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absence of chylomicrons in lymph and plasma
n1=hyperlaxité ligamentaire | n2=en:absence of chylomicrons in lymph and plasma | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absence of cpt ii protein
n1=hyperlaxité ligamentaire | n2=en:absence of cpt ii protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absence of emerin by immunohistochemistry on muscle biopsy
n1=hyperlaxité ligamentaire | n2=en:absence of emerin by immunohistochemistry on muscle biopsy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absence of hepatic udp-glucuronyl-transferase
n1=hyperlaxité ligamentaire | n2=en:absence of hepatic udp-glucuronyl-transferase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absence of hypertension
n1=hyperlaxité ligamentaire | n2=en:absence of hypertension | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absence of outer dynein arms
n1=hyperlaxité ligamentaire | n2=en:absence of outer dynein arms | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absence of peroxidase staining in neutrophils and monocytes
n1=hyperlaxité ligamentaire | n2=en:absence of peroxidase staining in neutrophils and monocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent 7-dehydrocholesterol
n1=hyperlaxité ligamentaire | n2=en:absent 7-dehydrocholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent alkyl-dhap synthase activity
n1=hyperlaxité ligamentaire | n2=en:absent alkyl-dhap synthase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent anti-insulin receptor antibodies
n1=hyperlaxité ligamentaire | n2=en:absent anti-insulin receptor antibodies | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent axonal flare response after intradermal histamine injection
n1=hyperlaxité ligamentaire | n2=en:absent axonal flare response after intradermal histamine injection | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent axonal flare response to intradermal histamine injection
n1=hyperlaxité ligamentaire | n2=en:absent axonal flare response to intradermal histamine injection | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent ch50 activity in complete c4 deficiency
n1=hyperlaxité ligamentaire | n2=en:absent ch50 activity in complete c4 deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent dystrophin on muscle biopsy
n1=hyperlaxité ligamentaire | n2=en:absent dystrophin on muscle biopsy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent enteric ganglia beginning at rectum and extending proximally by varying degrees
n1=hyperlaxité ligamentaire | n2=en:absent enteric ganglia beginning at rectum and extending proximally by varying degrees | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent igg2 subclass
n1=hyperlaxité ligamentaire | n2=en:absent igg2 subclass | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent or abnormal thyroglobulin
n1=hyperlaxité ligamentaire | n2=en:absent or abnormal thyroglobulin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent or severely reduced levels of serum immunoglobulins
n1=hyperlaxité ligamentaire | n2=en:absent or severely reduced levels of serum immunoglobulins | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent platelet agglutination in presence of ristocetin
n1=hyperlaxité ligamentaire | n2=en:absent platelet agglutination in presence of ristocetin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent pro alpha 2(i) chain synthesis (fibroblasts)
n1=hyperlaxité ligamentaire | n2=en:absent pro alpha 2(i) chain synthesis (fibroblasts) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent to trace urine and plasma ketones
n1=hyperlaxité ligamentaire | n2=en:absent to trace urine and plasma ketones | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent tyrosinase activity
n1=hyperlaxité ligamentaire | n2=en:absent tyrosinase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent-decreased prolyl 3-hydroxylation at collagen i alpha-1 pro986
n1=hyperlaxité ligamentaire | n2=en:absent-decreased prolyl 3-hydroxylation at collagen i alpha-1 pro986 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent/reduced free proteins and absent total protein s
n1=hyperlaxité ligamentaire | n2=en:absent/reduced free proteins and absent total protein s | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:absent/reduced protein s and normal total proteins in heterozygote
n1=hyperlaxité ligamentaire | n2=en:absent/reduced protein s and normal total proteins in heterozygote | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:accumulation of cholesterol esters in various tissues
n1=hyperlaxité ligamentaire | n2=en:accumulation of cholesterol esters in various tissues | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:accumulation of guanidinoacetate in brain
n1=hyperlaxité ligamentaire | n2=en:accumulation of guanidinoacetate in brain | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:accumulation of neutral lipids (triglycerides) in leukocytes, muscle cells, fibroblasts, and cardiomyocytes
n1=hyperlaxité ligamentaire | n2=en:accumulation of neutral lipids (triglycerides) in leukocytes, muscle cells, fibroblasts, and cardiomyocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:accumulation of shortened dolichol-linked oligosaccharides in patient fibroblasts
n1=hyperlaxité ligamentaire | n2=en:accumulation of shortened dolichol-linked oligosaccharides in patient fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:accumulation of sulfatides, glycosaminoglycans, sphingolipids, and steroid sulfates in tissues and body fluids
n1=hyperlaxité ligamentaire | n2=en:accumulation of sulfatides, glycosaminoglycans, sphingolipids, and steroid sulfates in tissues and body fluids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:accumulation of unprocessed mt-trna intermediates in skeletal muscle cells and fibroblasts
n1=hyperlaxité ligamentaire | n2=en:accumulation of unprocessed mt-trna intermediates in skeletal muscle cells and fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:acetyl coa:alpha-glucosaminidase n-acetyltransferase deficiency in fibroblasts
n1=hyperlaxité ligamentaire | n2=en:acetyl coa:alpha-glucosaminidase n-acetyltransferase deficiency in fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:acetylcholinesterase staining reveals nerve trunk hypertrophy
n1=hyperlaxité ligamentaire | n2=en:acetylcholinesterase staining reveals nerve trunk hypertrophy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:acid-base imbalance
n1=hyperlaxité ligamentaire | n2=en:acid-base imbalance | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:acid-labile subunit deficiency
n1=hyperlaxité ligamentaire | n2=en:acid-labile subunit deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:acquired aminoacid metabolism disorder
n1=hyperlaxité ligamentaire | n2=en:acquired aminoacid metabolism disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:acquired complement deficiency disease
n1=hyperlaxité ligamentaire | n2=en:acquired complement deficiency disease | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:acquired hemolytic anemia
n1=hyperlaxité ligamentaire | n2=en:acquired hemolytic anemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:acth normal
n1=hyperlaxité ligamentaire | n2=en:acth normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:acute hyperammonemia
n1=hyperlaxité ligamentaire | n2=en:acute hyperammonemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:acute metabolic decompensation
n1=hyperlaxité ligamentaire | n2=en:acute metabolic decompensation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:acute metabolic disorder
n1=hyperlaxité ligamentaire | n2=en:acute metabolic disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:acute-phase reactants during fever
n1=hyperlaxité ligamentaire | n2=en:acute-phase reactants during fever | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:acyl-coa:dihydroxyacetonephosphate acyltransferase deficiency
n1=hyperlaxité ligamentaire | n2=en:acyl-coa:dihydroxyacetonephosphate acyltransferase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:acylglycinuria
n1=hyperlaxité ligamentaire | n2=en:acylglycinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:adenylosuccinase deficiency (finding)
n1=hyperlaxité ligamentaire | n2=en:adenylosuccinase deficiency (finding) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:adrenal gland myelolipoma
n1=hyperlaxité ligamentaire | n2=en:adrenal gland myelolipoma | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:adrenocorticotropic hormone, increased
n1=hyperlaxité ligamentaire | n2=en:adrenocorticotropic hormone, increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:adult fanconi syndrome
n1=hyperlaxité ligamentaire | n2=en:adult fanconi syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:affected mother has normal plasma zinc levels and is not zinc-deficient
n1=hyperlaxité ligamentaire | n2=en:affected mother has normal plasma zinc levels and is not zinc-deficient | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:affected mother has reduced zinc levels in breast milk (may be up to 40% less than normal breast milk)
n1=hyperlaxité ligamentaire | n2=en:affected mother has reduced zinc levels in breast milk (may be up to 40% less than normal breast milk) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:agammaglobulinemia
n1=hyperlaxité ligamentaire | n2=en:agammaglobulinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:alanine aminotransferase increased
n1=hyperlaxité ligamentaire | n2=en:alanine aminotransferase increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:albuminuria
n1=hyperlaxité ligamentaire | n2=en:albuminuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:alcohol intolerance
n1=hyperlaxité ligamentaire | n2=en:alcohol intolerance | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aldolase a deficiency
n1=hyperlaxité ligamentaire | n2=en:aldolase a deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aldosterone concentration below normal
n1=hyperlaxité ligamentaire | n2=en:aldosterone concentration below normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aldosterone level increased above normal
n1=hyperlaxité ligamentaire | n2=en:aldosterone level increased above normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:alkaline phosphatase decreased
n1=hyperlaxité ligamentaire | n2=en:alkaline phosphatase decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:alkaline phosphatase normal
n1=hyperlaxité ligamentaire | n2=en:alkaline phosphatase normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:alkaline phosphatase serum increased
n1=hyperlaxité ligamentaire | n2=en:alkaline phosphatase serum increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:alkalosis
n1=hyperlaxité ligamentaire | n2=en:alkalosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and giant cell astrocytoma
n1=hyperlaxité ligamentaire | n2=en:allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and giant cell astrocytoma | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:alpha 1 foetoprotein amniotic fluid increased
n1=hyperlaxité ligamentaire | n2=en:alpha 1 foetoprotein amniotic fluid increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:alpha fetoprotein increased
n1=hyperlaxité ligamentaire | n2=en:alpha fetoprotein increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:alpha ketoadipic aciduria
n1=hyperlaxité ligamentaire | n2=en:alpha ketoadipic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:alpha-fetoprotein normal
n1=hyperlaxité ligamentaire | n2=en:alpha-fetoprotein normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:alpha-galactosidase a deficiency in plasma, leukocytes, or fibroblasts
n1=hyperlaxité ligamentaire | n2=en:alpha-galactosidase a deficiency in plasma, leukocytes, or fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:alpha-hydroxyadipic aciduria alpha-aminoadipic aciduria
n1=hyperlaxité ligamentaire | n2=en:alpha-hydroxyadipic aciduria alpha-aminoadipic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:alstrom syndrome
n1=hyperlaxité ligamentaire | n2=en:alstrom syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:amino acid metabolism disorder
n1=hyperlaxité ligamentaire | n2=en:amino acid metabolism disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aminoaciduria
n1=hyperlaxité ligamentaire | n2=en:aminoaciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aminoaciduria (1 patient)
n1=hyperlaxité ligamentaire | n2=en:aminoaciduria (1 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aminoaciduria (in some patients)
n1=hyperlaxité ligamentaire | n2=en:aminoaciduria (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aminoaciduria (less common)
n1=hyperlaxité ligamentaire | n2=en:aminoaciduria (less common) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aminoaciduria (rare)
n1=hyperlaxité ligamentaire | n2=en:aminoaciduria (rare) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aminoaciduria, intermittent
n1=hyperlaxité ligamentaire | n2=en:aminoaciduria, intermittent | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aminoaciduria, mild (in some patients)
n1=hyperlaxité ligamentaire | n2=en:aminoaciduria, mild (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aminoadipic semialdehyde synthase (aass) deficiency
n1=hyperlaxité ligamentaire | n2=en:aminoadipic semialdehyde synthase (aass) deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:amorphous hyaline substance (skin biopsy and visceral organs)
n1=hyperlaxité ligamentaire | n2=en:amorphous hyaline substance (skin biopsy and visceral organs) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:amylo-1,6-glucosidase deficiency
n1=hyperlaxité ligamentaire | n2=en:amylo-1,6-glucosidase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:amylo(1,4 - 1,6) transglucosidase deficiency (brancher enzyme)
n1=hyperlaxité ligamentaire | n2=en:amylo(1,4 - 1,6) transglucosidase deficiency (brancher enzyme) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:amyloidosis
n1=hyperlaxité ligamentaire | n2=en:amyloidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:amyloidosis, (iowa type 107680.0010, nonneuropathic 107680.0016)
n1=hyperlaxité ligamentaire | n2=en:amyloidosis, (iowa type 107680.0010, nonneuropathic 107680.0016) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:anaphase loss or nondisjunction with trisomies, tetrasomies, monosomies
n1=hyperlaxité ligamentaire | n2=en:anaphase loss or nondisjunction with trisomies, tetrasomies, monosomies | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:androgens increased
n1=hyperlaxité ligamentaire | n2=en:androgens increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:anemia
n1=hyperlaxité ligamentaire | n2=en:anemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aneuploidy of the x chromosome
n1=hyperlaxité ligamentaire | n2=en:aneuploidy of the x chromosome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:anomalies of cholesterol levels
n1=hyperlaxité ligamentaire | n2=en:anomalies of cholesterol levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:anti-ds dna antibody
n1=hyperlaxité ligamentaire | n2=en:anti-ds dna antibody | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:anti-factor viii positive
n1=hyperlaxité ligamentaire | n2=en:anti-factor viii positive | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:anti-iga antibodies commonly present
n1=hyperlaxité ligamentaire | n2=en:anti-iga antibodies commonly present | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:anti-ssb positive
n1=hyperlaxité ligamentaire | n2=en:anti-ssb positive | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:anti-tissue transglutaminase antibodies (anti-ttg)
n1=hyperlaxité ligamentaire | n2=en:anti-tissue transglutaminase antibodies (anti-ttg) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:antilipemic agent
n1=hyperlaxité ligamentaire | n2=en:antilipemic agent | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:antineutrophil antibody positivity
n1=hyperlaxité ligamentaire | n2=en:antineutrophil antibody positivity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:antineutrophil cytoplasmic antibody
n1=hyperlaxité ligamentaire | n2=en:antineutrophil cytoplasmic antibody | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:antiphospholipid antibody
n1=hyperlaxité ligamentaire | n2=en:antiphospholipid antibody | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:antiribonuclear protein positive
n1=hyperlaxité ligamentaire | n2=en:antiribonuclear protein positive | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:antithrombin iii decreased
n1=hyperlaxité ligamentaire | n2=en:antithrombin iii decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:antithrombin iii deficiency
n1=hyperlaxité ligamentaire | n2=en:antithrombin iii deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aplastic anemia and other bone marrow failure syndromes
n1=hyperlaxité ligamentaire | n2=en:aplastic anemia and other bone marrow failure syndromes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:appropriately increased serum 1,25-dihydroxyvitamin d3
n1=hyperlaxité ligamentaire | n2=en:appropriately increased serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aprt deficiency measured in erythrocyte lysate
n1=hyperlaxité ligamentaire | n2=en:aprt deficiency measured in erythrocyte lysate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:arginine deficiency
n1=hyperlaxité ligamentaire | n2=en:arginine deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:argininosuccinic aciduria
n1=hyperlaxité ligamentaire | n2=en:argininosuccinic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:arylsulfatase b deficiency in fibroblasts and white blood cells
n1=hyperlaxité ligamentaire | n2=en:arylsulfatase b deficiency in fibroblasts and white blood cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aspartate aminotransferase increased
n1=hyperlaxité ligamentaire | n2=en:aspartate aminotransferase increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aspartylglycosaminuria
n1=hyperlaxité ligamentaire | n2=en:aspartylglycosaminuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aspects of mortality statistics
n1=hyperlaxité ligamentaire | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:aspects of radionuclide imaging
n1=hyperlaxité ligamentaire | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:associated with serum anti-phospholipid antibodies in about 50% of patients
n1=hyperlaxité ligamentaire | n2=en:associated with serum anti-phospholipid antibodies in about 50% of patients | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:at least 2 complementation groups
n1=hyperlaxité ligamentaire | n2=en:at least 2 complementation groups | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:atrial abnormalities on electrocardiogram
n1=hyperlaxité ligamentaire | n2=en:atrial abnormalities on electrocardiogram | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:autoimmune hyperlipidaemia
n1=hyperlaxité ligamentaire | n2=en:autoimmune hyperlipidaemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:avitaminosis
n1=hyperlaxité ligamentaire | n2=en:avitaminosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:axonemes show normal structure
n1=hyperlaxité ligamentaire | n2=en:axonemes show normal structure | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:azoospermia/oligospermia (present at diagnosis)
n1=hyperlaxité ligamentaire | n2=en:azoospermia/oligospermia (present at diagnosis) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:azotemia
n1=hyperlaxité ligamentaire | n2=en:azotemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:b lymphocytopenia
n1=hyperlaxité ligamentaire | n2=en:b lymphocytopenia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bacteremia
n1=hyperlaxité ligamentaire | n2=en:bacteremia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:balanced translocation carrier 46,xy,+(11:18)(p13:q21)mat
n1=hyperlaxité ligamentaire | n2=en:balanced translocation carrier 46,xy,+(11:18)(p13:q21)mat | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:balanced/unbalanced chromosomal translocation t(2,13)(q36,q11)
n1=hyperlaxité ligamentaire | n2=en:balanced/unbalanced chromosomal translocation t(2,13)(q36,q11) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ballooned neurons
n1=hyperlaxité ligamentaire | n2=en:ballooned neurons | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:benign symmetrical lipomatosis
n1=hyperlaxité ligamentaire | n2=en:benign symmetrical lipomatosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:beta-2 microglobulin greater than 5.5 g/ml
n1=hyperlaxité ligamentaire | n2=en:beta-2 microglobulin greater than 5.5 g/ml | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:beta-galactosidase deficiency in fibroblasts and white blood cells
n1=hyperlaxité ligamentaire | n2=en:beta-galactosidase deficiency in fibroblasts and white blood cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:beta-glucuronidase deficiency in fibroblasts and leukocytes
n1=hyperlaxité ligamentaire | n2=en:beta-glucuronidase deficiency in fibroblasts and leukocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bicarbonaturia
n1=hyperlaxité ligamentaire | n2=en:bicarbonaturia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:biclonal gammopathy
n1=hyperlaxité ligamentaire | n2=en:biclonal gammopathy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bile contains cholesterol crystals
n1=hyperlaxité ligamentaire | n2=en:bile contains cholesterol crystals | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bile shows increased cholesterol/phospholipid ratio
n1=hyperlaxité ligamentaire | n2=en:bile shows increased cholesterol/phospholipid ratio | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bilirubin conjugated increased
n1=hyperlaxité ligamentaire | n2=en:bilirubin conjugated increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bilirubin may or may not be increased
n1=hyperlaxité ligamentaire | n2=en:bilirubin may or may not be increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:biotinidase deficiency
n1=hyperlaxité ligamentaire | n2=en:biotinidase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:blastic phase
n1=hyperlaxité ligamentaire | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bleeding time normal
n1=hyperlaxité ligamentaire | n2=en:bleeding time normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:blood alkaline phosphatase increased
n1=hyperlaxité ligamentaire | n2=en:blood alkaline phosphatase increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:blood cardiac troponin increased
n1=hyperlaxité ligamentaire | n2=en:blood cardiac troponin increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:blood corticotrophin decreased
n1=hyperlaxité ligamentaire | n2=en:blood corticotrophin decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:blood glucose normal
n1=hyperlaxité ligamentaire | n2=en:blood glucose normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:blood group incompatibility
n1=hyperlaxité ligamentaire | n2=en:blood group incompatibility | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:blood platelet disorders
n1=hyperlaxité ligamentaire | n2=en:blood platelet disorders | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:blood protein disorders
n1=hyperlaxité ligamentaire | n2=en:blood protein disorders | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:blood pyruvic acid increased
n1=hyperlaxité ligamentaire | n2=en:blood pyruvic acid increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:blood urea nitrogen increased
n1=hyperlaxité ligamentaire | n2=en:blood urea nitrogen increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:blood/lymphatic neoplasm
n1=hyperlaxité ligamentaire | n2=en:blood/lymphatic neoplasm | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:blunted cortisol response to adrenocorticotropic hormone (acth)
n1=hyperlaxité ligamentaire | n2=en:blunted cortisol response to adrenocorticotropic hormone (acth) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:body temperature instability
n1=hyperlaxité ligamentaire | n2=en:body temperature instability | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bone marrow
n1=hyperlaxité ligamentaire | n2=en:bone marrow | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bone marrow disorder
n1=hyperlaxité ligamentaire | n2=en:bone marrow disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bone marrow granulomas
n1=hyperlaxité ligamentaire | n2=en:bone marrow granulomas | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bone marrow haemorrhage
n1=hyperlaxité ligamentaire | n2=en:bone marrow haemorrhage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bone marrow hypoplasia (in some patients)
n1=hyperlaxité ligamentaire | n2=en:bone marrow hypoplasia (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bone marrow infiltration
n1=hyperlaxité ligamentaire | n2=en:bone marrow infiltration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bone marrow ischemia
n1=hyperlaxité ligamentaire | n2=en:bone marrow ischemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bone marrow necrosis
n1=hyperlaxité ligamentaire | n2=en:bone marrow necrosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bone marrow oedema
n1=hyperlaxité ligamentaire | n2=en:bone marrow oedema | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bone marrow oedema syndrome
n1=hyperlaxité ligamentaire | n2=en:bone marrow oedema syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bone marrow transplant rejection
n1=hyperlaxité ligamentaire | n2=en:bone marrow transplant rejection | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:borderline elevated low-density lipoprotein
n1=hyperlaxité ligamentaire | n2=en:borderline elevated low-density lipoprotein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:brain diseases, metabolic
n1=hyperlaxité ligamentaire | n2=en:brain diseases, metabolic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:branched chain ketoaciduria (alpha-keto isocaproate, alpha-keto-beta methylisovalerate, alpha-keto isovalerate)
n1=hyperlaxité ligamentaire | n2=en:branched chain ketoaciduria (alpha-keto isocaproate, alpha-keto-beta methylisovalerate, alpha-keto isovalerate) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:breastfed offspring have transient decrease of plasma zinc levels
n1=hyperlaxité ligamentaire | n2=en:breastfed offspring have transient decrease of plasma zinc levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:broad tissue deposition of amylopectin-like material
n1=hyperlaxité ligamentaire | n2=en:broad tissue deposition of amylopectin-like material | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:bromosulfophthalein test - secondary rise at 90 minutes
n1=hyperlaxité ligamentaire | n2=en:bromosulfophthalein test - secondary rise at 90 minutes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:c-band karyotype shows 'railroad track' appearance
n1=hyperlaxité ligamentaire | n2=en:c-band karyotype shows 'railroad track' appearance | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:calcium metabolism disorders
n1=hyperlaxité ligamentaire | n2=en:calcium metabolism disorders | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:calcium normal
n1=hyperlaxité ligamentaire | n2=en:calcium normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:calcium/phosphate abnormality
n1=hyperlaxité ligamentaire | n2=en:calcium/phosphate abnormality | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:calciuria
n1=hyperlaxité ligamentaire | n2=en:calciuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:carbohydrate metabolism disorder
n1=hyperlaxité ligamentaire | n2=en:carbohydrate metabolism disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:carboxyhemoglobinemia
n1=hyperlaxité ligamentaire | n2=en:carboxyhemoglobinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cardiac enzyme elevation
n1=hyperlaxité ligamentaire | n2=en:cardiac enzyme elevation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:carnitine deficiency
n1=hyperlaxité ligamentaire | n2=en:carnitine deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:carnitine palmitoyltransferase i deficiency (fibroblast, liver, leukocytes)
n1=hyperlaxité ligamentaire | n2=en:carnitine palmitoyltransferase i deficiency (fibroblast, liver, leukocytes) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:carnitine palmitoyltransferase ii deficiency (25% of controls)
n1=hyperlaxité ligamentaire | n2=en:carnitine palmitoyltransferase ii deficiency (25% of controls) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:carnosinemia
n1=hyperlaxité ligamentaire | n2=en:carnosinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:carotenemia
n1=hyperlaxité ligamentaire | n2=en:carotenemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:carriers have balanced constitutional translocation - 46,xx(or xy), +(11:22)(q23:q11)
n1=hyperlaxité ligamentaire | n2=en:carriers have balanced constitutional translocation - 46,xx(or xy), +(11:22)(q23:q11) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cd4/cd8 ratio decreased
n1=hyperlaxité ligamentaire | n2=en:cd4/cd8 ratio decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cd4+/cd8+ ratio is reversed
n1=hyperlaxité ligamentaire | n2=en:cd4+/cd8+ ratio is reversed | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cd4+/cd8+ ratio often reversed
n1=hyperlaxité ligamentaire | n2=en:cd4+/cd8+ ratio often reversed | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cell studies show increased dna breakage
n1=hyperlaxité ligamentaire | n2=en:cell studies show increased dna breakage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cells show defective transcription-coupled nucleotide excision repair (tc-ner) after uv irradiation
n1=hyperlaxité ligamentaire | n2=en:cells show defective transcription-coupled nucleotide excision repair (tc-ner) after uv irradiation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cells show increased sensitivity to ionizing radiation
n1=hyperlaxité ligamentaire | n2=en:cells show increased sensitivity to ionizing radiation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cellular arrest at g2 of the cell cycle
n1=hyperlaxité ligamentaire | n2=en:cellular arrest at g2 of the cell cycle | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cerebrospinal fluid lymphocytosis
n1=hyperlaxité ligamentaire | n2=en:cerebrospinal fluid lymphocytosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cerebrospinal fluid oligoclonal bands
n1=hyperlaxité ligamentaire | n2=en:cerebrospinal fluid oligoclonal bands | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ceruloplasmin decreased
n1=hyperlaxité ligamentaire | n2=en:ceruloplasmin decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:characteristic spheroids can be found in peripheral tissue, such as skin and conjunctiva
n1=hyperlaxité ligamentaire | n2=en:characteristic spheroids can be found in peripheral tissue, such as skin and conjunctiva | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:characteristic urinary coproporphyrin pattern (mostly isomer i (80%) instead of isomer iii)
n1=hyperlaxité ligamentaire | n2=en:characteristic urinary coproporphyrin pattern (mostly isomer i (80%) instead of isomer iii) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chemically induced
n1=hyperlaxité ligamentaire | n2=en:chemically induced | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cholesterol
n1=hyperlaxité ligamentaire | n2=en:cholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cholesterol low
n1=hyperlaxité ligamentaire | n2=en:cholesterol low | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cholesterol normal
n1=hyperlaxité ligamentaire | n2=en:cholesterol normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chondroitin 4-, 6-sulfate excretion in urine
n1=hyperlaxité ligamentaire | n2=en:chondroitin 4-, 6-sulfate excretion in urine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chondroitin 6-sulfate excretion in urine
n1=hyperlaxité ligamentaire | n2=en:chondroitin 6-sulfate excretion in urine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chromosomal breakage and abnormalities of the juxtacentromeric regions of chromosomes 1, 9, and 16
n1=hyperlaxité ligamentaire | n2=en:chromosomal breakage and abnormalities of the juxtacentromeric regions of chromosomes 1, 9, and 16 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chromosomal instability
n1=hyperlaxité ligamentaire | n2=en:chromosomal instability | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chromosomal mosaicism in cultured cells
n1=hyperlaxité ligamentaire | n2=en:chromosomal mosaicism in cultured cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chromosomal mosaicism in fibroblast and/or peripheral lymphocytes no consistent karyotypic finding
n1=hyperlaxité ligamentaire | n2=en:chromosomal mosaicism in fibroblast and/or peripheral lymphocytes no consistent karyotypic finding | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chromosomal rearrangement
n1=hyperlaxité ligamentaire | n2=en:chromosomal rearrangement | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin heavy chain (147100, 14q32) locus
n1=hyperlaxité ligamentaire | n2=en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin heavy chain (147100, 14q32) locus | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin kappa light chain (147200, 2p12) locus
n1=hyperlaxité ligamentaire | n2=en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin kappa light chain (147200, 2p12) locus | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin lambda light chain (147220, 22q11.2) locus
n1=hyperlaxité ligamentaire | n2=en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin lambda light chain (147220, 22q11.2) locus | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chromosome 11q23.3 deletion
n1=hyperlaxité ligamentaire | n2=en:chromosome 11q23.3 deletion | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chromosome deletion extending from 8q24.11 to 8q24.13
n1=hyperlaxité ligamentaire | n2=en:chromosome deletion extending from 8q24.11 to 8q24.13 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chromosome instability (hypo-/hyperdiploidy, chromosomal breaks, premature centromere division)
n1=hyperlaxité ligamentaire | n2=en:chromosome instability (hypo-/hyperdiploidy, chromosomal breaks, premature centromere division) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chromosome inversion - inv2(p12q14) in 2 patients
n1=hyperlaxité ligamentaire | n2=en:chromosome inversion - inv2(p12q14) in 2 patients | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chronic hypercapnia
n1=hyperlaxité ligamentaire | n2=en:chronic hypercapnia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chronic hypoxemia
n1=hyperlaxité ligamentaire | n2=en:chronic hypoxemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chronic lactic acidosis
n1=hyperlaxité ligamentaire | n2=en:chronic lactic acidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chronic metabolic disorder
n1=hyperlaxité ligamentaire | n2=en:chronic metabolic disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:chylomicronemia, refractory fasting
n1=hyperlaxité ligamentaire | n2=en:chylomicronemia, refractory fasting | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cilia may also be static, with slow activity
n1=hyperlaxité ligamentaire | n2=en:cilia may also be static, with slow activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cilia show inner and outer dynein arm defects
n1=hyperlaxité ligamentaire | n2=en:cilia show inner and outer dynein arm defects | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cilia show nonflexible and hyperkinetic beating of axonemes
n1=hyperlaxité ligamentaire | n2=en:cilia show nonflexible and hyperkinetic beating of axonemes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:citrullinemia
n1=hyperlaxité ligamentaire | n2=en:citrullinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:classical phenylketonuria
n1=hyperlaxité ligamentaire | n2=en:classical phenylketonuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:clinical manifestation of enzyme deficiency
n1=hyperlaxité ligamentaire | n2=en:clinical manifestation of enzyme deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:clotting decreased
n1=hyperlaxité ligamentaire | n2=en:clotting decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:clotting increased
n1=hyperlaxité ligamentaire | n2=en:clotting increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:coagulation and hemorrhagic disorders
n1=hyperlaxité ligamentaire | n2=en:coagulation and hemorrhagic disorders | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:coagulation disorder
n1=hyperlaxité ligamentaire | n2=en:coagulation disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:coagulopathy (inr = 2.2 - 3.5)
n1=hyperlaxité ligamentaire | n2=en:coagulopathy (inr = 2.2 - 3.5) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:coarse metachromatic granules in white blood cells
n1=hyperlaxité ligamentaire | n2=en:coarse metachromatic granules in white blood cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:combined oxidative phosphorylation deficiency 1
n1=hyperlaxité ligamentaire | n2=en:combined oxidative phosphorylation deficiency 1 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:complement deficiency
n1=hyperlaxité ligamentaire | n2=en:complement deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:complex dyslipidemia
n1=hyperlaxité ligamentaire | n2=en:complex dyslipidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:complex organic aciduria
n1=hyperlaxité ligamentaire | n2=en:complex organic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:complication aspects
n1=hyperlaxité ligamentaire | n2=en:complication aspects | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:congenital blood disorder
n1=hyperlaxité ligamentaire | n2=en:congenital blood disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:congenital hematological disorder
n1=hyperlaxité ligamentaire | n2=en:congenital hematological disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:congenital mesh qualifier
n1=hyperlaxité ligamentaire | n2=en:congenital mesh qualifier | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:congenital metabolic disorder
n1=hyperlaxité ligamentaire | n2=en:congenital metabolic disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:congenital methemoglobinemia
n1=hyperlaxité ligamentaire | n2=en:congenital methemoglobinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:contiguous gene deletion syndrome
n1=hyperlaxité ligamentaire | n2=en:contiguous gene deletion syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:continuous urinary iodine loss
n1=hyperlaxité ligamentaire | n2=en:continuous urinary iodine loss | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:coombs positive hemolytic anemia
n1=hyperlaxité ligamentaire | n2=en:coombs positive hemolytic anemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:coronary artery disease, autosomal dominant 2 (disorder)
n1=hyperlaxité ligamentaire | n2=en:coronary artery disease, autosomal dominant 2 (disorder) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cortisol does not decrease on dexamethasone suppression test
n1=hyperlaxité ligamentaire | n2=en:cortisol does not decrease on dexamethasone suppression test | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:creatine decreased
n1=hyperlaxité ligamentaire | n2=en:creatine decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:creatine kinase levels may normalize with disease progression
n1=hyperlaxité ligamentaire | n2=en:creatine kinase levels may normalize with disease progression | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:creatine kinase normal between episodes
n1=hyperlaxité ligamentaire | n2=en:creatine kinase normal between episodes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:creatine phosphokinase increased
n1=hyperlaxité ligamentaire | n2=en:creatine phosphokinase increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:creatine phosphokinase serum increased
n1=hyperlaxité ligamentaire | n2=en:creatine phosphokinase serum increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:csf pleocytosis, particularly of lymphocytes
n1=hyperlaxité ligamentaire | n2=en:csf pleocytosis, particularly of lymphocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ctrp terminology
n1=hyperlaxité ligamentaire | n2=en:ctrp terminology | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:curvilinear intracellular accumulation of autofluorescent lipopigment storage material
n1=hyperlaxité ligamentaire | n2=en:curvilinear intracellular accumulation of autofluorescent lipopigment storage material | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cutaneous anergy
n1=hyperlaxité ligamentaire | n2=en:cutaneous anergy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cutaneous extramedullary haemopoiesis
n1=hyperlaxité ligamentaire | n2=en:cutaneous extramedullary haemopoiesis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cutaneous t-cell dyscrasia
n1=hyperlaxité ligamentaire | n2=en:cutaneous t-cell dyscrasia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cystathionine beta-synthase deficiency disease
n1=hyperlaxité ligamentaire | n2=en:cystathionine beta-synthase deficiency disease | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cystathioninemia
n1=hyperlaxité ligamentaire | n2=en:cystathioninemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cystathioninuria (lab finding)
n1=hyperlaxité ligamentaire | n2=en:cystathioninuria (lab finding) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cystic fibrosis
n1=hyperlaxité ligamentaire | n2=en:cystic fibrosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cystinuria, type i (hcs and 2p21del)
n1=hyperlaxité ligamentaire | n2=en:cystinuria, type i (hcs and 2p21del) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cytochrome c oxidase deficiency in skeletal muscle and brain
n1=hyperlaxité ligamentaire | n2=en:cytochrome c oxidase deficiency in skeletal muscle and brain | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cytogenetic breakpoints range from 10q23.3-q26.2
n1=hyperlaxité ligamentaire | n2=en:cytogenetic breakpoints range from 10q23.3-q26.2 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cytogenetic deletion of chromosome 17p13.3
n1=hyperlaxité ligamentaire | n2=en:cytogenetic deletion of chromosome 17p13.3 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cytogenetic deletion of chromosome 19q13
n1=hyperlaxité ligamentaire | n2=en:cytogenetic deletion of chromosome 19q13 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cytogenetic deletion of the terminal region of chromosome 10 (del(10)(q23.3-qter))
n1=hyperlaxité ligamentaire | n2=en:cytogenetic deletion of the terminal region of chromosome 10 (del(10)(q23.3-qter)) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cytogenetics - recombinant chromosome 8 characterized by duplication of 8q22.1-qter and deletion of 8pter-p23.1
n1=hyperlaxité ligamentaire | n2=en:cytogenetics - recombinant chromosome 8 characterized by duplication of 8q22.1-qter and deletion of 8pter-p23.1 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cytoplasmic lamellar concentric inclusions
n1=hyperlaxité ligamentaire | n2=en:cytoplasmic lamellar concentric inclusions | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cytoplasmic lamellar inclusions consistent with neuronal ceroid lipofuscinosis (in some patients)
n1=hyperlaxité ligamentaire | n2=en:cytoplasmic lamellar inclusions consistent with neuronal ceroid lipofuscinosis (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:cytosolic phosphoenolpyruvate carboxykinase deficiency
n1=hyperlaxité ligamentaire | n2=en:cytosolic phosphoenolpyruvate carboxykinase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:d-2-hydroxyglutaric aciduria
n1=hyperlaxité ligamentaire | n2=en:d-2-hydroxyglutaric aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decrease or absence of cathepsin d (ctsd) protein immunostaining
n1=hyperlaxité ligamentaire | n2=en:decrease or absence of cathepsin d (ctsd) protein immunostaining | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decrease plasma serine (fasting)
n1=hyperlaxité ligamentaire | n2=en:decrease plasma serine (fasting) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased 3-beta-hydroxysteroid-delta-5-desaturase (sc5d)
n1=hyperlaxité ligamentaire | n2=en:decreased 3-beta-hydroxysteroid-delta-5-desaturase (sc5d) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased 5-hydroxyindoleacetic acid (5-hiaa) in csf
n1=hyperlaxité ligamentaire | n2=en:decreased 5-hydroxyindoleacetic acid (5-hiaa) in csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased acetyl-coa carboxylase activity
n1=hyperlaxité ligamentaire | n2=en:decreased acetyl-coa carboxylase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased acid beta galactosidase protein and activity
n1=hyperlaxité ligamentaire | n2=en:decreased acid beta galactosidase protein and activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased acid sphingomyelinase activity
n1=hyperlaxité ligamentaire | n2=en:decreased acid sphingomyelinase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased acid sphingomyelinase activity (less than 5%)
n1=hyperlaxité ligamentaire | n2=en:decreased acid sphingomyelinase activity (less than 5%) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activities of multiple sulfatases
n1=hyperlaxité ligamentaire | n2=en:decreased activities of multiple sulfatases | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activities of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acid dehydrogenase complex
n1=hyperlaxité ligamentaire | n2=en:decreased activities of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acid dehydrogenase complex | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of 2-methyl-3-hydroxybutyryl co-a dehydrogenase
n1=hyperlaxité ligamentaire | n2=en:decreased activity of 2-methyl-3-hydroxybutyryl co-a dehydrogenase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of 2-oxoacid dehydrogenases
n1=hyperlaxité ligamentaire | n2=en:decreased activity of 2-oxoacid dehydrogenases | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of 3-hydroxyacyl-coa dehydrogenase in various tissues (liver, muscle, fibroblasts)
n1=hyperlaxité ligamentaire | n2=en:decreased activity of 3-hydroxyacyl-coa dehydrogenase in various tissues (liver, muscle, fibroblasts) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of 3-methylcrotonyl-coa carboxylase (less than 2%)
n1=hyperlaxité ligamentaire | n2=en:decreased activity of 3-methylcrotonyl-coa carboxylase (less than 2%) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of 3-methylglutaconyl-coa hydratase
n1=hyperlaxité ligamentaire | n2=en:decreased activity of 3-methylglutaconyl-coa hydratase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of ampd1 in skeletal muscle increased serum creatine kinase
n1=hyperlaxité ligamentaire | n2=en:decreased activity of ampd1 in skeletal muscle increased serum creatine kinase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of aromatic l-amino acid decarboxylase (aadc)
n1=hyperlaxité ligamentaire | n2=en:decreased activity of aromatic l-amino acid decarboxylase (aadc) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of coenzyme q10-dependent respiratory chain complexes
n1=hyperlaxité ligamentaire | n2=en:decreased activity of coenzyme q10-dependent respiratory chain complexes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of complement factor d
n1=hyperlaxité ligamentaire | n2=en:decreased activity of complement factor d | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of cytochrome c oxidase in muscle and fibroblasts
n1=hyperlaxité ligamentaire | n2=en:decreased activity of cytochrome c oxidase in muscle and fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of cytosolic acetoacetyl-coa thiolase (acat2, 100678)
n1=hyperlaxité ligamentaire | n2=en:decreased activity of cytosolic acetoacetyl-coa thiolase (acat2, 100678) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of dihydrofolate reductase
n1=hyperlaxité ligamentaire | n2=en:decreased activity of dihydrofolate reductase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of galactocerebrosidase
n1=hyperlaxité ligamentaire | n2=en:decreased activity of galactocerebrosidase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of glycosylceramidase, galactosylceramidase, ceramidase, and other lysosomal enzymes
n1=hyperlaxité ligamentaire | n2=en:decreased activity of glycosylceramidase, galactosylceramidase, ceramidase, and other lysosomal enzymes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of long-chain 3-hydroxyacyl-coa dehydrogenase, long-chain 3-oxoacyl-coa thiolase, and long-chain 2-enoyl-coa hydratase
n1=hyperlaxité ligamentaire | n2=en:decreased activity of long-chain 3-hydroxyacyl-coa dehydrogenase, long-chain 3-oxoacyl-coa thiolase, and long-chain 2-enoyl-coa hydratase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of mitochondrial complex i
n1=hyperlaxité ligamentaire | n2=en:decreased activity of mitochondrial complex i | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of mitochondrial complex ii (succinate dehydrogenase)
n1=hyperlaxité ligamentaire | n2=en:decreased activity of mitochondrial complex ii (succinate dehydrogenase) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of mitochondrial respiratory chain complex i
n1=hyperlaxité ligamentaire | n2=en:decreased activity of mitochondrial respiratory chain complex i | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of mitochondrial respiratory complexes
n1=hyperlaxité ligamentaire | n2=en:decreased activity of mitochondrial respiratory complexes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of mitochondrial respiratory complexes i, ii+iii, iv, and v
n1=hyperlaxité ligamentaire | n2=en:decreased activity of mitochondrial respiratory complexes i, ii+iii, iv, and v | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of mitochondrial respiratory complexes i, iii, and iv
n1=hyperlaxité ligamentaire | n2=en:decreased activity of mitochondrial respiratory complexes i, iii, and iv | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of nadph oxidase
n1=hyperlaxité ligamentaire | n2=en:decreased activity of nadph oxidase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of phosphoglycerate kinase 1
n1=hyperlaxité ligamentaire | n2=en:decreased activity of phosphoglycerate kinase 1 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of ppt1
n1=hyperlaxité ligamentaire | n2=en:decreased activity of ppt1 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of pyruvate decarboxylase (e1 component)
n1=hyperlaxité ligamentaire | n2=en:decreased activity of pyruvate decarboxylase (e1 component) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of pyruvate dehydrogenase complex
n1=hyperlaxité ligamentaire | n2=en:decreased activity of pyruvate dehydrogenase complex | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of succinic semialdehyde dehydrogenase (ssadh, aldh5a1), less than 5% of control values
n1=hyperlaxité ligamentaire | n2=en:decreased activity of succinic semialdehyde dehydrogenase (ssadh, aldh5a1), less than 5% of control values | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of the e2 subunit (lipoyl transacetylase, 608770) of the pdh
n1=hyperlaxité ligamentaire | n2=en:decreased activity of the e2 subunit (lipoyl transacetylase, 608770) of the pdh | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of the pdh phosphatase
n1=hyperlaxité ligamentaire | n2=en:decreased activity of the pdh phosphatase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of the pyruvate dehydrogenase (pdh) complex
n1=hyperlaxité ligamentaire | n2=en:decreased activity of the pyruvate dehydrogenase (pdh) complex | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of the pyruvate dehydrogenase complex (highly variable, 1-70% of controls)
n1=hyperlaxité ligamentaire | n2=en:decreased activity of the pyruvate dehydrogenase complex (highly variable, 1-70% of controls) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of thiopurine s-methyltransferase
n1=hyperlaxité ligamentaire | n2=en:decreased activity of thiopurine s-methyltransferase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of thymidine phosphorylase
n1=hyperlaxité ligamentaire | n2=en:decreased activity of thymidine phosphorylase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of triosephosphate isomerase
n1=hyperlaxité ligamentaire | n2=en:decreased activity of triosephosphate isomerase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased activity of tyrosine hydroxylase
n1=hyperlaxité ligamentaire | n2=en:decreased activity of tyrosine hydroxylase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased adenosylcobalamin
n1=hyperlaxité ligamentaire | n2=en:decreased adenosylcobalamin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased adiponectin
n1=hyperlaxité ligamentaire | n2=en:decreased adiponectin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased agt activity
n1=hyperlaxité ligamentaire | n2=en:decreased agt activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased alpha-n-acetylgalactosaminidase activity (less than 2% of control)
n1=hyperlaxité ligamentaire | n2=en:decreased alpha-n-acetylgalactosaminidase activity (less than 2% of control) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased alpha-n-acetylgalactosaminidase protein
n1=hyperlaxité ligamentaire | n2=en:decreased alpha-n-acetylgalactosaminidase protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased aminoacylase-1 activity
n1=hyperlaxité ligamentaire | n2=en:decreased aminoacylase-1 activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased amount and activity of mitochondrial complexes i and iv
n1=hyperlaxité ligamentaire | n2=en:decreased amount and activity of mitochondrial complexes i and iv | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased antithrombin iii (rare)
n1=hyperlaxité ligamentaire | n2=en:decreased antithrombin iii (rare) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased apoa-i and apoa-ii
n1=hyperlaxité ligamentaire | n2=en:decreased apoa-i and apoa-ii | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased arylsulfatase a (arsa) activity in urine, leukocytes, fibroblasts
n1=hyperlaxité ligamentaire | n2=en:decreased arylsulfatase a (arsa) activity in urine, leukocytes, fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased asparagine levels (in some patients)
n1=hyperlaxité ligamentaire | n2=en:decreased asparagine levels (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased atp synthase in muscle, heart, liver, and brain
n1=hyperlaxité ligamentaire | n2=en:decreased atp synthase in muscle, heart, liver, and brain | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased axonal flare response after intradermal histamine injection
n1=hyperlaxité ligamentaire | n2=en:decreased axonal flare response after intradermal histamine injection | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased b cells
n1=hyperlaxité ligamentaire | n2=en:decreased b cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased basal body temperature
n1=hyperlaxité ligamentaire | n2=en:decreased basal body temperature | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased basal metabolic rate
n1=hyperlaxité ligamentaire | n2=en:decreased basal metabolic rate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased beta-galactosidase activity
n1=hyperlaxité ligamentaire | n2=en:decreased beta-galactosidase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased beta-glucocerebrosidase protein and activity
n1=hyperlaxité ligamentaire | n2=en:decreased beta-glucocerebrosidase protein and activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased beta-glucosidase protein and activity
n1=hyperlaxité ligamentaire | n2=en:decreased beta-glucosidase protein and activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased beta-mannosidase activity in plasma, fibroblasts, and leukocytes
n1=hyperlaxité ligamentaire | n2=en:decreased beta-mannosidase activity in plasma, fibroblasts, and leukocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased beta-oxidation of pristanic acid
n1=hyperlaxité ligamentaire | n2=en:decreased beta-oxidation of pristanic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased beta-thromboglobulin
n1=hyperlaxité ligamentaire | n2=en:decreased beta-thromboglobulin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased blood levels of cationic amino acids
n1=hyperlaxité ligamentaire | n2=en:decreased blood levels of cationic amino acids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased c3 activity
n1=hyperlaxité ligamentaire | n2=en:decreased c3 activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased c3 antigen
n1=hyperlaxité ligamentaire | n2=en:decreased c3 antigen | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased carnitine in serum, muscle, heart, and liver
n1=hyperlaxité ligamentaire | n2=en:decreased carnitine in serum, muscle, heart, and liver | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased carnitine palmitoyltransferase ii (cpt2) activity
n1=hyperlaxité ligamentaire | n2=en:decreased carnitine palmitoyltransferase ii (cpt2) activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased cerebrospinal fluid folic acid
n1=hyperlaxité ligamentaire | n2=en:decreased cerebrospinal fluid folic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased cholesterol (less common)
n1=hyperlaxité ligamentaire | n2=en:decreased cholesterol (less common) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased ciliary motility
n1=hyperlaxité ligamentaire | n2=en:decreased ciliary motility | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased circulating aldosterone level
n1=hyperlaxité ligamentaire | n2=en:decreased circulating aldosterone level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased circulating cortisol level
n1=hyperlaxité ligamentaire | n2=en:decreased circulating cortisol level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased circulating renin level
n1=hyperlaxité ligamentaire | n2=en:decreased circulating renin level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased clot retraction
n1=hyperlaxité ligamentaire | n2=en:decreased clot retraction | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased cobalamin in liver, kidney, and cultured fibroblasts
n1=hyperlaxité ligamentaire | n2=en:decreased cobalamin in liver, kidney, and cultured fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased complement factor d
n1=hyperlaxité ligamentaire | n2=en:decreased complement factor d | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased conversion of beta-carotene to vitamin a (retinol)
n1=hyperlaxité ligamentaire | n2=en:decreased conversion of beta-carotene to vitamin a (retinol) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased copper, iron, zinc
n1=hyperlaxité ligamentaire | n2=en:decreased copper, iron, zinc | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased coproporphyrinogen oxidase activity (hcp, lymphocytes, 50% of normal)
n1=hyperlaxité ligamentaire | n2=en:decreased coproporphyrinogen oxidase activity (hcp, lymphocytes, 50% of normal) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased coq10 levels in lymphoblasts or fibroblasts
n1=hyperlaxité ligamentaire | n2=en:decreased coq10 levels in lymphoblasts or fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased core body temperature
n1=hyperlaxité ligamentaire | n2=en:decreased core body temperature | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased cortisol-binding globulin
n1=hyperlaxité ligamentaire | n2=en:decreased cortisol-binding globulin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased cpt1 activity
n1=hyperlaxité ligamentaire | n2=en:decreased cpt1 activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased csf 3-methoxy-4-hydroxyphenylethyleneglycol (mhpg)
n1=hyperlaxité ligamentaire | n2=en:decreased csf 3-methoxy-4-hydroxyphenylethyleneglycol (mhpg) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased csf 5-hydroxyindoleacetic acid (5-hiaa)
n1=hyperlaxité ligamentaire | n2=en:decreased csf 5-hydroxyindoleacetic acid (5-hiaa) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased csf 5-hydroxyindoleacetic acid (5hiaa)
n1=hyperlaxité ligamentaire | n2=en:decreased csf 5-hydroxyindoleacetic acid (5hiaa) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased csf arginine
n1=hyperlaxité ligamentaire | n2=en:decreased csf arginine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased csf ferritin despite normal serum ferritin levels
n1=hyperlaxité ligamentaire | n2=en:decreased csf ferritin despite normal serum ferritin levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased csf folate
n1=hyperlaxité ligamentaire | n2=en:decreased csf folate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased csf glycine
n1=hyperlaxité ligamentaire | n2=en:decreased csf glycine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased csf homovanillic acid (hva)
n1=hyperlaxité ligamentaire | n2=en:decreased csf homovanillic acid (hva) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased csf hypocretin
n1=hyperlaxité ligamentaire | n2=en:decreased csf hypocretin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased csf methyltetrahydrofolate (mthf)
n1=hyperlaxité ligamentaire | n2=en:decreased csf methyltetrahydrofolate (mthf) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased csf pyridoxal
n1=hyperlaxité ligamentaire | n2=en:decreased csf pyridoxal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased csf pyridoxal 5-prime-phosphate (plp)
n1=hyperlaxité ligamentaire | n2=en:decreased csf pyridoxal 5-prime-phosphate (plp) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased csf serine
n1=hyperlaxité ligamentaire | n2=en:decreased csf serine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased csf tetrahydrofolate and 5-methyltetrahydrofolate
n1=hyperlaxité ligamentaire | n2=en:decreased csf tetrahydrofolate and 5-methyltetrahydrofolate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased cytochrome c oxidase activity in skin fibroblasts, liver, and skeletal muscle
n1=hyperlaxité ligamentaire | n2=en:decreased cytochrome c oxidase activity in skin fibroblasts, liver, and skeletal muscle | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased decr enzyme activity
n1=hyperlaxité ligamentaire | n2=en:decreased decr enzyme activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased dermal hydroxylysine content
n1=hyperlaxité ligamentaire | n2=en:decreased dermal hydroxylysine content | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased dihydroxyacetone phosphate acyltransferase (dhap-at) activity
n1=hyperlaxité ligamentaire | n2=en:decreased dihydroxyacetone phosphate acyltransferase (dhap-at) activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased dihydroxyacetonephosphate acyltransferase (dhap-at) activity
n1=hyperlaxité ligamentaire | n2=en:decreased dihydroxyacetonephosphate acyltransferase (dhap-at) activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased dna excision repair
n1=hyperlaxité ligamentaire | n2=en:decreased dna excision repair | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased dna polymerase-gamma (polg, 174763) activity
n1=hyperlaxité ligamentaire | n2=en:decreased dna polymerase-gamma (polg, 174763) activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased eno3 activity
n1=hyperlaxité ligamentaire | n2=en:decreased eno3 activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased erythrocyte 2,3-diphosphoglycerate (2,3-dpg)
n1=hyperlaxité ligamentaire | n2=en:decreased erythrocyte 2,3-diphosphoglycerate (2,3-dpg) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased erythrocyte lactate clearance (transport), 40 to 50% of normal values
n1=hyperlaxité ligamentaire | n2=en:decreased erythrocyte lactate clearance (transport), 40 to 50% of normal values | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased erythrocyte plasmalogen
n1=hyperlaxité ligamentaire | n2=en:decreased erythrocyte plasmalogen | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased expression of glycosylphosphatidylinositol-anchored membrane proteins
n1=hyperlaxité ligamentaire | n2=en:decreased expression of glycosylphosphatidylinositol-anchored membrane proteins | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased expression of glycosylphosphatidylinositol-linked proteins (e.g., cd59 107271 and cd24 600274) on hematopoietic cells
n1=hyperlaxité ligamentaire | n2=en:decreased expression of glycosylphosphatidylinositol-linked proteins (e.g., cd59 107271 and cd24 600274) on hematopoietic cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased expression of gpi-anchored proteins on blood cells
n1=hyperlaxité ligamentaire | n2=en:decreased expression of gpi-anchored proteins on blood cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased factor xi
n1=hyperlaxité ligamentaire | n2=en:decreased factor xi | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased fbp1 enzyme activity
n1=hyperlaxité ligamentaire | n2=en:decreased fbp1 enzyme activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased fibrillin-1 immunostaining in the dermis
n1=hyperlaxité ligamentaire | n2=en:decreased fibrillin-1 immunostaining in the dermis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased fibrinogen (in some patients)
n1=hyperlaxité ligamentaire | n2=en:decreased fibrinogen (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased fibroblast alpha-mannosidase
n1=hyperlaxité ligamentaire | n2=en:decreased fibroblast alpha-mannosidase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased fibroblast arylsulfatase a
n1=hyperlaxité ligamentaire | n2=en:decreased fibroblast arylsulfatase a | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased fibroblast beta-hexosaminidase
n1=hyperlaxité ligamentaire | n2=en:decreased fibroblast beta-hexosaminidase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased fibroblast iduronate sulfatase
n1=hyperlaxité ligamentaire | n2=en:decreased fibroblast iduronate sulfatase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased formation of complex (tri-, tetra-antennary) n-glycans
n1=hyperlaxité ligamentaire | n2=en:decreased formation of complex (tri-, tetra-antennary) n-glycans | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased free t(3)/free t(4)
n1=hyperlaxité ligamentaire | n2=en:decreased free t(3)/free t(4) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased fumarate hydratase activity
n1=hyperlaxité ligamentaire | n2=en:decreased fumarate hydratase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased galactokinase activity
n1=hyperlaxité ligamentaire | n2=en:decreased galactokinase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased glomerular filtration rate (gfr)
n1=hyperlaxité ligamentaire | n2=en:decreased glomerular filtration rate (gfr) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased glutamine in bodily fluids
n1=hyperlaxité ligamentaire | n2=en:decreased glutamine in bodily fluids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased glycerol kinase activity
n1=hyperlaxité ligamentaire | n2=en:decreased glycerol kinase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased grhpr activity
n1=hyperlaxité ligamentaire | n2=en:decreased grhpr activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased gtp cyclohydrolase i activity (about 20% of normal)
n1=hyperlaxité ligamentaire | n2=en:decreased gtp cyclohydrolase i activity (about 20% of normal) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased hdl cholesterol
n1=hyperlaxité ligamentaire | n2=en:decreased hdl cholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased heme-heme interaction (e.g. hb kanagawa 141800.0169)
n1=hyperlaxité ligamentaire | n2=en:decreased heme-heme interaction (e.g. hb kanagawa 141800.0169) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased hepatic gaba transaminase activity
n1=hyperlaxité ligamentaire | n2=en:decreased hepatic gaba transaminase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased hepatic udp-glucuronyl-transferase activity
n1=hyperlaxité ligamentaire | n2=en:decreased hepatic udp-glucuronyl-transferase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased hexokinase activity in red blood cells
n1=hyperlaxité ligamentaire | n2=en:decreased hexokinase activity in red blood cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased high molecular weight plasma factor viii/ vwf multimers
n1=hyperlaxité ligamentaire | n2=en:decreased high molecular weight plasma factor viii/ vwf multimers | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased homovanillic acid (hva) and 5-hydroxyindoleacetic acid (5hiaa) in csf
n1=hyperlaxité ligamentaire | n2=en:decreased homovanillic acid (hva) and 5-hydroxyindoleacetic acid (5hiaa) in csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased iga, igg, igm
n1=hyperlaxité ligamentaire | n2=en:decreased iga, igg, igm | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased insulin receptor binding
n1=hyperlaxité ligamentaire | n2=en:decreased insulin receptor binding | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased intracellular fmr protein
n1=hyperlaxité ligamentaire | n2=en:decreased intracellular fmr protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased ldl cholesterol
n1=hyperlaxité ligamentaire | n2=en:decreased ldl cholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased lecithin:cholesterol acyltransferase mass and activity
n1=hyperlaxité ligamentaire | n2=en:decreased lecithin:cholesterol acyltransferase mass and activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased leptin
n1=hyperlaxité ligamentaire | n2=en:decreased leptin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased levels of cellular and mitochondrial fes-containing proteins
n1=hyperlaxité ligamentaire | n2=en:decreased levels of cellular and mitochondrial fes-containing proteins | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased levels of certain coagulation factors
n1=hyperlaxité ligamentaire | n2=en:decreased levels of certain coagulation factors | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased levels of coenzyme q10 in skeletal muscle (5-35%)
n1=hyperlaxité ligamentaire | n2=en:decreased levels of coenzyme q10 in skeletal muscle (5-35%) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased levels of component x protein of the pdh complex
n1=hyperlaxité ligamentaire | n2=en:decreased levels of component x protein of the pdh complex | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased levels of cpt2 protein
n1=hyperlaxité ligamentaire | n2=en:decreased levels of cpt2 protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased levels of csf hypocretin (hcrt, 602358)
n1=hyperlaxité ligamentaire | n2=en:decreased levels of csf hypocretin (hcrt, 602358) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased levels of plasma factor viii
n1=hyperlaxité ligamentaire | n2=en:decreased levels of plasma factor viii | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased levels of plasma factor viii in patients with type 2n
n1=hyperlaxité ligamentaire | n2=en:decreased levels of plasma factor viii in patients with type 2n | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased levels of plasma vwf antigen
n1=hyperlaxité ligamentaire | n2=en:decreased levels of plasma vwf antigen | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased levels of serum vitamin b12
n1=hyperlaxité ligamentaire | n2=en:decreased levels of serum vitamin b12 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased levels of the e2 subunit protein
n1=hyperlaxité ligamentaire | n2=en:decreased levels of the e2 subunit protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased lipid
n1=hyperlaxité ligamentaire | n2=en:decreased lipid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased lipid-linked oligosaccharides (llo)
n1=hyperlaxité ligamentaire | n2=en:decreased lipid-linked oligosaccharides (llo) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased liver homogentisate 1,2-dioxygenase activity
n1=hyperlaxité ligamentaire | n2=en:decreased liver homogentisate 1,2-dioxygenase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased long-chain fatty acid oxidation
n1=hyperlaxité ligamentaire | n2=en:decreased long-chain fatty acid oxidation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased lysosomal alpha-mannosidase activity in plasma and leukocytes
n1=hyperlaxité ligamentaire | n2=en:decreased lysosomal alpha-mannosidase activity in plasma and leukocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased metabolism of thiopurine drugs
n1=hyperlaxité ligamentaire | n2=en:decreased metabolism of thiopurine drugs | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased methionine synthase activity
n1=hyperlaxité ligamentaire | n2=en:decreased methionine synthase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased methylcobalamin (mecbl)
n1=hyperlaxité ligamentaire | n2=en:decreased methylcobalamin (mecbl) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased methylmalonyl-coa mutase activity
n1=hyperlaxité ligamentaire | n2=en:decreased methylmalonyl-coa mutase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased mitochondrial complex iii activity (in fibroblasts of 1 patient)
n1=hyperlaxité ligamentaire | n2=en:decreased mitochondrial complex iii activity (in fibroblasts of 1 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased mitochondrial complex iii activity (in liver, muscle, and fibroblasts)
n1=hyperlaxité ligamentaire | n2=en:decreased mitochondrial complex iii activity (in liver, muscle, and fibroblasts) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased mitochondrial complex iii activity (skeletal muscle, fibroblasts)
n1=hyperlaxité ligamentaire | n2=en:decreased mitochondrial complex iii activity (skeletal muscle, fibroblasts) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased mitochondrial complex iii activity in liver and fibroblasts
n1=hyperlaxité ligamentaire | n2=en:decreased mitochondrial complex iii activity in liver and fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased mitochondrial complex iii activity in muscle
n1=hyperlaxité ligamentaire | n2=en:decreased mitochondrial complex iii activity in muscle | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased mitochondrial complex iii activity seen in muscle
n1=hyperlaxité ligamentaire | n2=en:decreased mitochondrial complex iii activity seen in muscle | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased mitochondrial complex v assembly
n1=hyperlaxité ligamentaire | n2=en:decreased mitochondrial complex v assembly | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased mitochondrial nadp(h)
n1=hyperlaxité ligamentaire | n2=en:decreased mitochondrial nadp(h) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased mitochondrial respiratory chain complex (2p21del)
n1=hyperlaxité ligamentaire | n2=en:decreased mitochondrial respiratory chain complex (2p21del) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased mitochondrial respiratory complexes i, iii, and iv in brain, heart, and skeletal muscle
n1=hyperlaxité ligamentaire | n2=en:decreased mitochondrial respiratory complexes i, iii, and iv in brain, heart, and skeletal muscle | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased monoamine oxidase a activity
n1=hyperlaxité ligamentaire | n2=en:decreased monoamine oxidase a activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased mucosal alkaline phosphatase
n1=hyperlaxité ligamentaire | n2=en:decreased mucosal alkaline phosphatase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased n-acetylglucosamine-1-phosphotransferase (glcnac - phosphotransferase) using lysosomal enzymes
n1=hyperlaxité ligamentaire | n2=en:decreased n-acetylglucosamine-1-phosphotransferase (glcnac - phosphotransferase) using lysosomal enzymes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased nasal nitric oxide
n1=hyperlaxité ligamentaire | n2=en:decreased nasal nitric oxide | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased nasal nitric oxide (in some patients)
n1=hyperlaxité ligamentaire | n2=en:decreased nasal nitric oxide (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased natural killer cells
n1=hyperlaxité ligamentaire | n2=en:decreased natural killer cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased neopterin and biopterin in csf
n1=hyperlaxité ligamentaire | n2=en:decreased neopterin and biopterin in csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased neopterin and biopterin in urine
n1=hyperlaxité ligamentaire | n2=en:decreased neopterin and biopterin in urine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased nk cells (in some patients)
n1=hyperlaxité ligamentaire | n2=en:decreased nk cells (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased number of igf1 receptors (igf1r, 147370) on cell surface
n1=hyperlaxité ligamentaire | n2=en:decreased number of igf1 receptors (igf1r, 147370) on cell surface | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased numbers of t regulatory cells
n1=hyperlaxité ligamentaire | n2=en:decreased numbers of t regulatory cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent alpha-n-acetylgalactosaminidase activity
n1=hyperlaxité ligamentaire | n2=en:decreased or absent alpha-n-acetylgalactosaminidase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent alpha-n-acetylgalactosaminidase protein
n1=hyperlaxité ligamentaire | n2=en:decreased or absent alpha-n-acetylgalactosaminidase protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent apolipoprotein a-i
n1=hyperlaxité ligamentaire | n2=en:decreased or absent apolipoprotein a-i | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent ciliary motility
n1=hyperlaxité ligamentaire | n2=en:decreased or absent ciliary motility | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent d-bifunctional protein activity and protein
n1=hyperlaxité ligamentaire | n2=en:decreased or absent d-bifunctional protein activity and protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent dihydropteridine reductase activity
n1=hyperlaxité ligamentaire | n2=en:decreased or absent dihydropteridine reductase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent dihydropyrimidine dehydrogenase activity
n1=hyperlaxité ligamentaire | n2=en:decreased or absent dihydropyrimidine dehydrogenase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent gch1 activity
n1=hyperlaxité ligamentaire | n2=en:decreased or absent gch1 activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent glycogen branching enzyme activity
n1=hyperlaxité ligamentaire | n2=en:decreased or absent glycogen branching enzyme activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent histidase activity
n1=hyperlaxité ligamentaire | n2=en:decreased or absent histidase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent peroxisome acyl-coa oxidase activity and protein
n1=hyperlaxité ligamentaire | n2=en:decreased or absent peroxisome acyl-coa oxidase activity and protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent pts activity
n1=hyperlaxité ligamentaire | n2=en:decreased or absent pts activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent serum and urinary chenodeoxycholic acid and cholic acid
n1=hyperlaxité ligamentaire | n2=en:decreased or absent serum and urinary chenodeoxycholic acid and cholic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent serum ceruloplasmin
n1=hyperlaxité ligamentaire | n2=en:decreased or absent serum ceruloplasmin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent serum citrulline
n1=hyperlaxité ligamentaire | n2=en:decreased or absent serum citrulline | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent steroid sulfatase activity
n1=hyperlaxité ligamentaire | n2=en:decreased or absent steroid sulfatase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or absent udp-glucuronyl-transferase activity
n1=hyperlaxité ligamentaire | n2=en:decreased or absent udp-glucuronyl-transferase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or increased serum testosterone
n1=hyperlaxité ligamentaire | n2=en:decreased or increased serum testosterone | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or low-normal serum parathyroid hormone (pth)
n1=hyperlaxité ligamentaire | n2=en:decreased or low-normal serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or normal plasma insulin
n1=hyperlaxité ligamentaire | n2=en:decreased or normal plasma insulin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or normal serum c3
n1=hyperlaxité ligamentaire | n2=en:decreased or normal serum c3 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or normal serum factor b
n1=hyperlaxité ligamentaire | n2=en:decreased or normal serum factor b | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased or normal serum factor i
n1=hyperlaxité ligamentaire | n2=en:decreased or normal serum factor i | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased palmitate oxidation
n1=hyperlaxité ligamentaire | n2=en:decreased palmitate oxidation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased peroxisomal fatty acid beta-oxidation
n1=hyperlaxité ligamentaire | n2=en:decreased peroxisomal fatty acid beta-oxidation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased phgdh activity (fibroblasts)
n1=hyperlaxité ligamentaire | n2=en:decreased phgdh activity (fibroblasts) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased phk activity in liver
n1=hyperlaxité ligamentaire | n2=en:decreased phk activity in liver | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased phosphoglucomutase 1 (pgm1) activity (less than 10% of normal values)
n1=hyperlaxité ligamentaire | n2=en:decreased phosphoglucomutase 1 (pgm1) activity (less than 10% of normal values) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased phosphoglycerate mutase 1 (pgam2) activity (2 to 6% of normal values)
n1=hyperlaxité ligamentaire | n2=en:decreased phosphoglycerate mutase 1 (pgam2) activity (2 to 6% of normal values) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased phytanic acid oxidase activity
n1=hyperlaxité ligamentaire | n2=en:decreased phytanic acid oxidase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma and urinary guanidinoacetate (gaa)
n1=hyperlaxité ligamentaire | n2=en:decreased plasma and urinary guanidinoacetate (gaa) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma and urinary ornithine
n1=hyperlaxité ligamentaire | n2=en:decreased plasma and urinary ornithine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma apolipoprotein b (apob, 107730)
n1=hyperlaxité ligamentaire | n2=en:decreased plasma apolipoprotein b (apob, 107730) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma apolipoprotein c-ii
n1=hyperlaxité ligamentaire | n2=en:decreased plasma apolipoprotein c-ii | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma arginine
n1=hyperlaxité ligamentaire | n2=en:decreased plasma arginine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma esterified cholesterol
n1=hyperlaxité ligamentaire | n2=en:decreased plasma esterified cholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma free carnitine
n1=hyperlaxité ligamentaire | n2=en:decreased plasma free carnitine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma glycine
n1=hyperlaxité ligamentaire | n2=en:decreased plasma glycine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma gonadotrophin
n1=hyperlaxité ligamentaire | n2=en:decreased plasma gonadotrophin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma hdl (<1/10 of normal levels)
n1=hyperlaxité ligamentaire | n2=en:decreased plasma hdl (<1/10 of normal levels) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma lpl levels (in some patients)
n1=hyperlaxité ligamentaire | n2=en:decreased plasma lpl levels (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma lysine, glutamic acid, and glutamine
n1=hyperlaxité ligamentaire | n2=en:decreased plasma lysine, glutamic acid, and glutamine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma serine
n1=hyperlaxité ligamentaire | n2=en:decreased plasma serine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma total and free carnitine
n1=hyperlaxité ligamentaire | n2=en:decreased plasma total and free carnitine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma total cholesterol
n1=hyperlaxité ligamentaire | n2=en:decreased plasma total cholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma triglycerides
n1=hyperlaxité ligamentaire | n2=en:decreased plasma triglycerides | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasma zinc levels
n1=hyperlaxité ligamentaire | n2=en:decreased plasma zinc levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasmalogens
n1=hyperlaxité ligamentaire | n2=en:decreased plasmalogens | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasminogen activity
n1=hyperlaxité ligamentaire | n2=en:decreased plasminogen activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased plasminogen antigen
n1=hyperlaxité ligamentaire | n2=en:decreased plasminogen antigen | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased platelet count
n1=hyperlaxité ligamentaire | n2=en:decreased platelet count | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased platelet derived growth factor
n1=hyperlaxité ligamentaire | n2=en:decreased platelet derived growth factor | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased prpp synthetase activity in erythrocytes and fibroblasts
n1=hyperlaxité ligamentaire | n2=en:decreased prpp synthetase activity in erythrocytes and fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased pyruvate carboxylase (pc) activity (less than 5%)
n1=hyperlaxité ligamentaire | n2=en:decreased pyruvate carboxylase (pc) activity (less than 5%) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased red cell pyruvate kinase activity
n1=hyperlaxité ligamentaire | n2=en:decreased red cell pyruvate kinase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased renal calcium excretion
n1=hyperlaxité ligamentaire | n2=en:decreased renal calcium excretion | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased respiratory chain complex iii activity in multiple tissues
n1=hyperlaxité ligamentaire | n2=en:decreased respiratory chain complex iii activity in multiple tissues | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased reversible oxygen-binding capacity (e.g. hb l (bombay) 141800.9999)
n1=hyperlaxité ligamentaire | n2=en:decreased reversible oxygen-binding capacity (e.g. hb l (bombay) 141800.9999) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased s-ado:saicar ratio
n1=hyperlaxité ligamentaire | n2=en:decreased s-ado:saicar ratio | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased scad activity
n1=hyperlaxité ligamentaire | n2=en:decreased scad activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased secretion of igf1 in response to gh administration
n1=hyperlaxité ligamentaire | n2=en:decreased secretion of igf1 in response to gh administration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum 18-ohb
n1=hyperlaxité ligamentaire | n2=en:decreased serum 18-ohb | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum 25-hydroxyvitamin d
n1=hyperlaxité ligamentaire | n2=en:decreased serum 25-hydroxyvitamin d | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum acth
n1=hyperlaxité ligamentaire | n2=en:decreased serum acth | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum alpha-2 macroglobulin levels
n1=hyperlaxité ligamentaire | n2=en:decreased serum alpha-2 macroglobulin levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum and muscle coenzyme q
n1=hyperlaxité ligamentaire | n2=en:decreased serum and muscle coenzyme q | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum and salivary lactoferrin has been described in 1 family
n1=hyperlaxité ligamentaire | n2=en:decreased serum and salivary lactoferrin has been described in 1 family | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum androgens
n1=hyperlaxité ligamentaire | n2=en:decreased serum androgens | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum b12 levels
n1=hyperlaxité ligamentaire | n2=en:decreased serum b12 levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum bun
n1=hyperlaxité ligamentaire | n2=en:decreased serum bun | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum c3 (atypical hus)
n1=hyperlaxité ligamentaire | n2=en:decreased serum c3 (atypical hus) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum carnitine in acute stage
n1=hyperlaxité ligamentaire | n2=en:decreased serum carnitine in acute stage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum ceruloplasmin
n1=hyperlaxité ligamentaire | n2=en:decreased serum ceruloplasmin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum cholesterol (in some)
n1=hyperlaxité ligamentaire | n2=en:decreased serum cholesterol (in some) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum cobalamin
n1=hyperlaxité ligamentaire | n2=en:decreased serum cobalamin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum complement factor h
n1=hyperlaxité ligamentaire | n2=en:decreased serum complement factor h | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum factor b (atypical hus)
n1=hyperlaxité ligamentaire | n2=en:decreased serum factor b (atypical hus) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum factor h (atypical hus)
n1=hyperlaxité ligamentaire | n2=en:decreased serum factor h (atypical hus) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum factor i (atypical hus)
n1=hyperlaxité ligamentaire | n2=en:decreased serum factor i (atypical hus) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum ferritin
n1=hyperlaxité ligamentaire | n2=en:decreased serum ferritin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum follicle-stimulating hormone (fsh)
n1=hyperlaxité ligamentaire | n2=en:decreased serum follicle-stimulating hormone (fsh) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum free thyroxine
n1=hyperlaxité ligamentaire | n2=en:decreased serum free thyroxine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum glucosyltransferase (ggt) activity
n1=hyperlaxité ligamentaire | n2=en:decreased serum glucosyltransferase (ggt) activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum haptoglobin
n1=hyperlaxité ligamentaire | n2=en:decreased serum haptoglobin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum haptoglobin (in some patients)
n1=hyperlaxité ligamentaire | n2=en:decreased serum haptoglobin (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum iga
n1=hyperlaxité ligamentaire | n2=en:decreased serum iga | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum igm
n1=hyperlaxité ligamentaire | n2=en:decreased serum igm | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum insulin-like growth factor-1 (igf1, 147440)
n1=hyperlaxité ligamentaire | n2=en:decreased serum insulin-like growth factor-1 (igf1, 147440) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum insulin-like growth factor-1 (igf1)
n1=hyperlaxité ligamentaire | n2=en:decreased serum insulin-like growth factor-1 (igf1) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum iron (in some patients)
n1=hyperlaxité ligamentaire | n2=en:decreased serum iron (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum l-transferrin (heterozygous patient)
n1=hyperlaxité ligamentaire | n2=en:decreased serum l-transferrin (heterozygous patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum leptin
n1=hyperlaxité ligamentaire | n2=en:decreased serum leptin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum levels of maoa products
n1=hyperlaxité ligamentaire | n2=en:decreased serum levels of maoa products | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum luteinizing hormone (lh)
n1=hyperlaxité ligamentaire | n2=en:decreased serum luteinizing hormone (lh) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum rt3
n1=hyperlaxité ligamentaire | n2=en:decreased serum rt3 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum thiamine pyrophosphate
n1=hyperlaxité ligamentaire | n2=en:decreased serum thiamine pyrophosphate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum thyroid-stimulating hormone (tsh)
n1=hyperlaxité ligamentaire | n2=en:decreased serum thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum thyroxine (t4)
n1=hyperlaxité ligamentaire | n2=en:decreased serum thyroxine (t4) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum trypsinogen
n1=hyperlaxité ligamentaire | n2=en:decreased serum trypsinogen | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased serum vitamin a
n1=hyperlaxité ligamentaire | n2=en:decreased serum vitamin a | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased short/branched-chain acyl-coa dehydrogenase protein levels and enzyme activity
n1=hyperlaxité ligamentaire | n2=en:decreased short/branched-chain acyl-coa dehydrogenase protein levels and enzyme activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased sulfite oxidase activity
n1=hyperlaxité ligamentaire | n2=en:decreased sulfite oxidase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased sulfite oxidase activity in fibroblasts
n1=hyperlaxité ligamentaire | n2=en:decreased sulfite oxidase activity in fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased switched memory b cells
n1=hyperlaxité ligamentaire | n2=en:decreased switched memory b cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased switched memory b cells (in some patients)
n1=hyperlaxité ligamentaire | n2=en:decreased switched memory b cells (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased t cells
n1=hyperlaxité ligamentaire | n2=en:decreased t cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased telomerase activity
n1=hyperlaxité ligamentaire | n2=en:decreased telomerase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased telomere length in lymphocytes
n1=hyperlaxité ligamentaire | n2=en:decreased telomere length in lymphocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased testosterone level
n1=hyperlaxité ligamentaire | n2=en:decreased testosterone level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased tetrahydrobiopterin (bh4) in csf
n1=hyperlaxité ligamentaire | n2=en:decreased tetrahydrobiopterin (bh4) in csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased tetrasialo-transferrin
n1=hyperlaxité ligamentaire | n2=en:decreased tetrasialo-transferrin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased tetrasialotransferrin levels
n1=hyperlaxité ligamentaire | n2=en:decreased tetrasialotransferrin levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased thrombospondin
n1=hyperlaxité ligamentaire | n2=en:decreased thrombospondin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased thyroxine level
n1=hyperlaxité ligamentaire | n2=en:decreased thyroxine level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased tissue and serum alkaline phosphatase
n1=hyperlaxité ligamentaire | n2=en:decreased tissue and serum alkaline phosphatase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased tissue total and free carnitine
n1=hyperlaxité ligamentaire | n2=en:decreased tissue total and free carnitine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased transcobalamin i in saliva, serum, gastric juice, and cerebrospinal fluid
n1=hyperlaxité ligamentaire | n2=en:decreased transcobalamin i in saliva, serum, gastric juice, and cerebrospinal fluid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased transferrin increased serum iron
n1=hyperlaxité ligamentaire | n2=en:decreased transferrin increased serum iron | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased triiodothyronine level
n1=hyperlaxité ligamentaire | n2=en:decreased triiodothyronine level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased ubiquinone-10
n1=hyperlaxité ligamentaire | n2=en:decreased ubiquinone-10 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased udp-glcnac
n1=hyperlaxité ligamentaire | n2=en:decreased udp-glcnac | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased urinary calcium and phosphate excretion
n1=hyperlaxité ligamentaire | n2=en:decreased urinary calcium and phosphate excretion | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased urinary excretion of uromodulin
n1=hyperlaxité ligamentaire | n2=en:decreased urinary excretion of uromodulin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased urinary hva, 5-hiaa, and vanillyl mandelic acid (vma)
n1=hyperlaxité ligamentaire | n2=en:decreased urinary hva, 5-hiaa, and vanillyl mandelic acid (vma) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased urinary sulfate
n1=hyperlaxité ligamentaire | n2=en:decreased urinary sulfate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased urocanic acid in blood, urine, and skin cells
n1=hyperlaxité ligamentaire | n2=en:decreased urocanic acid in blood, urine, and skin cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased uros activity (1 patient)
n1=hyperlaxité ligamentaire | n2=en:decreased uros activity (1 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased very long-chain acyl-coa dehydrogenase protein and activity
n1=hyperlaxité ligamentaire | n2=en:decreased very long-chain acyl-coa dehydrogenase protein and activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased von willebrand factor
n1=hyperlaxité ligamentaire | n2=en:decreased von willebrand factor | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased whole blood serotonin
n1=hyperlaxité ligamentaire | n2=en:decreased whole blood serotonin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased xanthine dehydrogenase activity
n1=hyperlaxité ligamentaire | n2=en:decreased xanthine dehydrogenase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:decreased-absent intestinal mucosa lactase activity
n1=hyperlaxité ligamentaire | n2=en:decreased-absent intestinal mucosa lactase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defect in chylomicron secretion
n1=hyperlaxité ligamentaire | n2=en:defect in chylomicron secretion | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defect in dna repair
n1=hyperlaxité ligamentaire | n2=en:defect in dna repair | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defect in double-stranded dna repair
n1=hyperlaxité ligamentaire | n2=en:defect in double-stranded dna repair | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defect in mitochondrial and peroxisomal fission
n1=hyperlaxité ligamentaire | n2=en:defect in mitochondrial and peroxisomal fission | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defect in n- and o-glycosylation
n1=hyperlaxité ligamentaire | n2=en:defect in n- and o-glycosylation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defect in oxidative phosphorylation
n1=hyperlaxité ligamentaire | n2=en:defect in oxidative phosphorylation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defect in retrograde intraflagellar transport in cilia
n1=hyperlaxité ligamentaire | n2=en:defect in retrograde intraflagellar transport in cilia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defective (ca2+) mobilization in t cells
n1=hyperlaxité ligamentaire | n2=en:defective (ca2+) mobilization in t cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defective bile acid metabolism
n1=hyperlaxité ligamentaire | n2=en:defective bile acid metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defective dna repair
n1=hyperlaxité ligamentaire | n2=en:defective dna repair | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defective dna repair after ultraviolet radiation damage
n1=hyperlaxité ligamentaire | n2=en:defective dna repair after ultraviolet radiation damage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defective glcnac-pi synthesis
n1=hyperlaxité ligamentaire | n2=en:defective glcnac-pi synthesis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defective glycerol release during exercise
n1=hyperlaxité ligamentaire | n2=en:defective glycerol release during exercise | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defective heavy chain present
n1=hyperlaxité ligamentaire | n2=en:defective heavy chain present | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defective mitochondrial respiratory enzyme activity
n1=hyperlaxité ligamentaire | n2=en:defective mitochondrial respiratory enzyme activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defective t-cell proliferative responses (in some patients)
n1=hyperlaxité ligamentaire | n2=en:defective t-cell proliferative responses (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:defects in mitochondrial oxidative phosphorylation
n1=hyperlaxité ligamentaire | n2=en:defects in mitochondrial oxidative phosphorylation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency of alpha-1,4-glucosidase (acid maltase)
n1=hyperlaxité ligamentaire | n2=en:deficiency of alpha-1,4-glucosidase (acid maltase) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency of creatine phosphate in brain
n1=hyperlaxité ligamentaire | n2=en:deficiency of creatine phosphate in brain | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency of fat-soluble vitamins
n1=hyperlaxité ligamentaire | n2=en:deficiency of fat-soluble vitamins | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency of fructokinase
n1=hyperlaxité ligamentaire | n2=en:deficiency of fructokinase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency of glycoprotein (gp)iib-iiia complex
n1=hyperlaxité ligamentaire | n2=en:deficiency of glycoprotein (gp)iib-iiia complex | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency of laminin alpha-2 chain of merosin (lama2, 156225) in muscle
n1=hyperlaxité ligamentaire | n2=en:deficiency of laminin alpha-2 chain of merosin (lama2, 156225) in muscle | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency of laminin in basement membranes
n1=hyperlaxité ligamentaire | n2=en:deficiency of laminin in basement membranes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency of mitochondrial isovaleryl-coa dehydrogenase in fibroblasts
n1=hyperlaxité ligamentaire | n2=en:deficiency of mitochondrial isovaleryl-coa dehydrogenase in fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency of phosphatidylinositol (4,5) bisphosphate 5-phosphatase (ptdins(4,5)p(2) 5-phosphatase) in cultured fibroblasts
n1=hyperlaxité ligamentaire | n2=en:deficiency of phosphatidylinositol (4,5) bisphosphate 5-phosphatase (ptdins(4,5)p(2) 5-phosphatase) in cultured fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts
n1=hyperlaxité ligamentaire | n2=en:deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency of saposins a, b, c, and d
n1=hyperlaxité ligamentaire | n2=en:deficiency of saposins a, b, c, and d | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency of serum properdin p factor
n1=hyperlaxité ligamentaire | n2=en:deficiency of serum properdin p factor | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency or absence of cytochrome b(-245)
n1=hyperlaxité ligamentaire | n2=en:deficiency or absence of cytochrome b(-245) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency or absence of p22-phox (608508) protein
n1=hyperlaxité ligamentaire | n2=en:deficiency or absence of p22-phox (608508) protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency or absence of p22-phox protein
n1=hyperlaxité ligamentaire | n2=en:deficiency or absence of p22-phox protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency or absence of p47-phox protein (type i)
n1=hyperlaxité ligamentaire | n2=en:deficiency or absence of p47-phox protein (type i) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency or absence of p67-phox protein (type ii)
n1=hyperlaxité ligamentaire | n2=en:deficiency or absence of p67-phox protein (type ii) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency or absence of p91-phox (300481) protein
n1=hyperlaxité ligamentaire | n2=en:deficiency or absence of p91-phox (300481) protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficiency or absence of p91-phox protein
n1=hyperlaxité ligamentaire | n2=en:deficiency or absence of p91-phox protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficient efflux of intracellular cholesterol
n1=hyperlaxité ligamentaire | n2=en:deficient efflux of intracellular cholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficient fibroblast aicar-tf activity
n1=hyperlaxité ligamentaire | n2=en:deficient fibroblast aicar-tf activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficient hepatic 4-hydroxyphenylpyruvate dioxygenase
n1=hyperlaxité ligamentaire | n2=en:deficient hepatic 4-hydroxyphenylpyruvate dioxygenase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficient plasma alpha-lecithin:cholesterol acyltransferase (high-density) activity
n1=hyperlaxité ligamentaire | n2=en:deficient plasma alpha-lecithin:cholesterol acyltransferase (high-density) activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deficient ribose-s-phosphate isomerase (rpi) in fibroblasts
n1=hyperlaxité ligamentaire | n2=en:deficient ribose-s-phosphate isomerase (rpi) in fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dehydration
n1=hyperlaxité ligamentaire | n2=en:dehydration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dehydroepiandrosterone (dhea) at upper level of normal range
n1=hyperlaxité ligamentaire | n2=en:dehydroepiandrosterone (dhea) at upper level of normal range | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:delayed plasma clearance of unconjugated bromsulphthalein, an anionic diagnostic dye
n1=hyperlaxité ligamentaire | n2=en:delayed plasma clearance of unconjugated bromsulphthalein, an anionic diagnostic dye | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deletion (78kb to 1mb) of chromosome 8q24.3 including the scrib (607733) and puf60 (604819) genes
n1=hyperlaxité ligamentaire | n2=en:deletion (78kb to 1mb) of chromosome 8q24.3 including the scrib (607733) and puf60 (604819) genes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:deletion of chromosome 18p11.2
n1=hyperlaxité ligamentaire | n2=en:deletion of chromosome 18p11.2 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:delta-1-pyrroline-3-hydroxy-5-carboxylate levels increased in urine
n1=hyperlaxité ligamentaire | n2=en:delta-1-pyrroline-3-hydroxy-5-carboxylate levels increased in urine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:delta-1-pyrroline-5-carboxylate (p5c) levels increased in plasma
n1=hyperlaxité ligamentaire | n2=en:delta-1-pyrroline-5-carboxylate (p5c) levels increased in plasma | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:delta-1-pyrroline-5-carboxylate dehydrogenase activity decreased in fibroblasts or leukocytes
n1=hyperlaxité ligamentaire | n2=en:delta-1-pyrroline-5-carboxylate dehydrogenase activity decreased in fibroblasts or leukocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:depletion of mtdna (skeletal muscle, fibroblasts)
n1=hyperlaxité ligamentaire | n2=en:depletion of mtdna (skeletal muscle, fibroblasts) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dermatan and heparan sulfate excretion in urine
n1=hyperlaxité ligamentaire | n2=en:dermatan and heparan sulfate excretion in urine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dermatan sulfate excretion in urine
n1=hyperlaxité ligamentaire | n2=en:dermatan sulfate excretion in urine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:detection by rt-pcr and southern blot analysis for primary diagnosis and follow up for residual disease
n1=hyperlaxité ligamentaire | n2=en:detection by rt-pcr and southern blot analysis for primary diagnosis and follow up for residual disease | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:detection by rt-pcr, southern blot analysis, and fish for primary diagnosis and follow up for residual disease
n1=hyperlaxité ligamentaire | n2=en:detection by rt-pcr, southern blot analysis, and fish for primary diagnosis and follow up for residual disease | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dhea sulfotransferase below limit of detection
n1=hyperlaxité ligamentaire | n2=en:dhea sulfotransferase below limit of detection | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:di- and trihydroxycholestanoic acid accumulation
n1=hyperlaxité ligamentaire | n2=en:di- and trihydroxycholestanoic acid accumulation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:diabetes mellitus
n1=hyperlaxité ligamentaire | n2=en:diabetes mellitus | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:diabetes, nonautoimmune (rare)
n1=hyperlaxité ligamentaire | n2=en:diabetes, nonautoimmune (rare) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:diabetic dyslipidemia associated with type 2 diabetes mellitus
n1=hyperlaxité ligamentaire | n2=en:diabetic dyslipidemia associated with type 2 diabetes mellitus | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:diagnosis aspect
n1=hyperlaxité ligamentaire | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:diagnosis by exposing muscle biopsy to caffeine and/or halothane
n1=hyperlaxité ligamentaire | n2=en:diagnosis by exposing muscle biopsy to caffeine and/or halothane | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:diaminoaciduria (arginuria, lysinuria, cystinuria, ornithinuria)
n1=hyperlaxité ligamentaire | n2=en:diaminoaciduria (arginuria, lysinuria, cystinuria, ornithinuria) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:diarrhea 7
n1=hyperlaxité ligamentaire | n2=en:diarrhea 7 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dicarboxylic aciduria
n1=hyperlaxité ligamentaire | n2=en:dicarboxylic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dietary education for hyperlipidemia
n1=hyperlaxité ligamentaire | n2=en:dietary education for hyperlipidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:diffuse deposition of calcium oxalate in various tissues
n1=hyperlaxité ligamentaire | n2=en:diffuse deposition of calcium oxalate in various tissues | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dihydrouracil dehydrogenase deficiency
n1=hyperlaxité ligamentaire | n2=en:dihydrouracil dehydrogenase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dilated rough endoplasmic reticulum (rer)
n1=hyperlaxité ligamentaire | n2=en:dilated rough endoplasmic reticulum (rer) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dimethylglycine dehydrogenase (dmgdh) deficiency
n1=hyperlaxité ligamentaire | n2=en:dimethylglycine dehydrogenase (dmgdh) deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:diminished lymphocyte response to phytohemaglutinin
n1=hyperlaxité ligamentaire | n2=en:diminished lymphocyte response to phytohemaglutinin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:direct coombs test negative
n1=hyperlaxité ligamentaire | n2=en:direct coombs test negative | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:direct hyperbilirubinemia
n1=hyperlaxité ligamentaire | n2=en:direct hyperbilirubinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder characterized by fever
n1=hyperlaxité ligamentaire | n2=en:disorder characterized by fever | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of acid-base balance
n1=hyperlaxité ligamentaire | n2=en:disorder of acid-base balance | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of aromatic amino acid metabolism
n1=hyperlaxité ligamentaire | n2=en:disorder of aromatic amino acid metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of beta alanine, carnosine and/or homocarnosine metabolism
n1=hyperlaxité ligamentaire | n2=en:disorder of beta alanine, carnosine and/or homocarnosine metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of blood gas
n1=hyperlaxité ligamentaire | n2=en:disorder of blood gas | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of cholesterol metabolism
n1=hyperlaxité ligamentaire | n2=en:disorder of cholesterol metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of fluid and/or electrolyte
n1=hyperlaxité ligamentaire | n2=en:disorder of fluid and/or electrolyte | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of glycoprotein metabolism
n1=hyperlaxité ligamentaire | n2=en:disorder of glycoprotein metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of glycosaminoglycan metabolism
n1=hyperlaxité ligamentaire | n2=en:disorder of glycosaminoglycan metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of iodine metabolism
n1=hyperlaxité ligamentaire | n2=en:disorder of iodine metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of ketone metabolism
n1=hyperlaxité ligamentaire | n2=en:disorder of ketone metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of lipoprotein and/or lipid metabolism
n1=hyperlaxité ligamentaire | n2=en:disorder of lipoprotein and/or lipid metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of mineral metabolism
n1=hyperlaxité ligamentaire | n2=en:disorder of mineral metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of neurometabolic regulation
n1=hyperlaxité ligamentaire | n2=en:disorder of neurometabolic regulation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of osmoregulation
n1=hyperlaxité ligamentaire | n2=en:disorder of osmoregulation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of protein metabolism
n1=hyperlaxité ligamentaire | n2=en:disorder of protein metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of pyrimidine metabolism
n1=hyperlaxité ligamentaire | n2=en:disorder of pyrimidine metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorder of steroid metabolism
n1=hyperlaxité ligamentaire | n2=en:disorder of steroid metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorders of bile acid and cholesterol metabolism
n1=hyperlaxité ligamentaire | n2=en:disorders of bile acid and cholesterol metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
n1=hyperlaxité ligamentaire | n2=en:disorders of branched-chain amino-acid metabolism and fatty-acid metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorders of lipoprotein metabolism and other lipidaemias
n1=hyperlaxité ligamentaire | n2=en:disorders of lipoprotein metabolism and other lipidaemias | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorders of porphyrin and bilirubin metabolism
n1=hyperlaxité ligamentaire | n2=en:disorders of porphyrin and bilirubin metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorders of sphingolipid metabolism and other lipid storage disorders
n1=hyperlaxité ligamentaire | n2=en:disorders of sphingolipid metabolism and other lipid storage disorders | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disorganized growth plate cartilage
n1=hyperlaxité ligamentaire | n2=en:disorganized growth plate cartilage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disproportionate work-related increase in blood lactate and pyruvate
n1=hyperlaxité ligamentaire | n2=en:disproportionate work-related increase in blood lactate and pyruvate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disseminated intravascular coagulation
n1=hyperlaxité ligamentaire | n2=en:disseminated intravascular coagulation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:distal xp22.3 segmental monosomy
n1=hyperlaxité ligamentaire | n2=en:distal xp22.3 segmental monosomy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:disturbed visual and brainstem auditory evoked responses indicative of cns demyelination
n1=hyperlaxité ligamentaire | n2=en:disturbed visual and brainstem auditory evoked responses indicative of cns demyelination | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:diverse tissue cell types (vascular endothelial cells, adipocytes, schwann cells, leukocytes) have membrane-lined cytoplasmic vacuoles with amorphous and filamentous material
n1=hyperlaxité ligamentaire | n2=en:diverse tissue cell types (vascular endothelial cells, adipocytes, schwann cells, leukocytes) have membrane-lined cytoplasmic vacuoles with amorphous and filamentous material | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dna repair-deficiency disorders
n1=hyperlaxité ligamentaire | n2=en:dna repair-deficiency disorders | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dolichyl-p-glc:man(9)glcnac(2)-pp-dolichyl glucosyltransferase deficiency
n1=hyperlaxité ligamentaire | n2=en:dolichyl-p-glc:man(9)glcnac(2)-pp-dolichyl glucosyltransferase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dolichyl-p-man:man(5)glcnac(2)-pp-dolichyl mannosyltransferase deficiency
n1=hyperlaxité ligamentaire | n2=en:dolichyl-p-man:man(5)glcnac(2)-pp-dolichyl mannosyltransferase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:duplication or deletion at 11p15.5
n1=hyperlaxité ligamentaire | n2=en:duplication or deletion at 11p15.5 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dysglobulinemia
n1=hyperlaxité ligamentaire | n2=en:dysglobulinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dyskinetic ciliary motility
n1=hyperlaxité ligamentaire | n2=en:dyskinetic ciliary motility | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dyslipidemia
n1=hyperlaxité ligamentaire | n2=en:dyslipidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dyslipidemia due to type 1 diabetes mellitus
n1=hyperlaxité ligamentaire | n2=en:dyslipidemia due to type 1 diabetes mellitus | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:dyslipoproteinemia
n1=hyperlaxité ligamentaire | n2=en:dyslipoproteinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:echocardiogram abnormal
n1=hyperlaxité ligamentaire | n2=en:echocardiogram abnormal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:electrocardiogram abnormal
n1=hyperlaxité ligamentaire | n2=en:electrocardiogram abnormal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:electrolyte depletion
n1=hyperlaxité ligamentaire | n2=en:electrolyte depletion | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:electrolyte disorder
n1=hyperlaxité ligamentaire | n2=en:electrolyte disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:electrolyte disturbances from intractable diarrhea
n1=hyperlaxité ligamentaire | n2=en:electrolyte disturbances from intractable diarrhea | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:electrolyte disturbances in infancy (in some patients)
n1=hyperlaxité ligamentaire | n2=en:electrolyte disturbances in infancy (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:electrolytes abnormal
n1=hyperlaxité ligamentaire | n2=en:electrolytes abnormal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:electrolyturia (1 patient)
n1=hyperlaxité ligamentaire | n2=en:electrolyturia (1 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:electron microscopy of foam cells shows lamellar inclusions
n1=hyperlaxité ligamentaire | n2=en:electron microscopy of foam cells shows lamellar inclusions | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:electron microscopy of patient respiratory cells shows absent inner and outer dynein arms
n1=hyperlaxité ligamentaire | n2=en:electron microscopy of patient respiratory cells shows absent inner and outer dynein arms | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:electron microscopy of patient respiratory cells shows absent outer dynein arms
n1=hyperlaxité ligamentaire | n2=en:electron microscopy of patient respiratory cells shows absent outer dynein arms | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:electron microscopy of patient respiratory cells shows absent outer dynein arms in the axoneme
n1=hyperlaxité ligamentaire | n2=en:electron microscopy of patient respiratory cells shows absent outer dynein arms in the axoneme | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:electron microscopy of patient respiratory cells shows defects in inner and outer dynein arms
n1=hyperlaxité ligamentaire | n2=en:electron microscopy of patient respiratory cells shows defects in inner and outer dynein arms | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:electron microscopy of patient respiratory cells shows defects of outer dynein arms
n1=hyperlaxité ligamentaire | n2=en:electron microscopy of patient respiratory cells shows defects of outer dynein arms | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:electron microscopy of patient respiratory cells shows loss of ciliary outer dynein arms
n1=hyperlaxité ligamentaire | n2=en:electron microscopy of patient respiratory cells shows loss of ciliary outer dynein arms | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:electron microscopy of patient respiratory cells shows reduced inner dynein arms and nexin links
n1=hyperlaxité ligamentaire | n2=en:electron microscopy of patient respiratory cells shows reduced inner dynein arms and nexin links | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:electroretinogram is abnormal--rod responses are mildly abnormal and cone responses are markedly diminished
n1=hyperlaxité ligamentaire | n2=en:electroretinogram is abnormal--rod responses are mildly abnormal and cone responses are markedly diminished | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated 1,25(oh)2 d3
n1=hyperlaxité ligamentaire | n2=en:elevated 1,25(oh)2 d3 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated 17-hydroxyprogesterone
n1=hyperlaxité ligamentaire | n2=en:elevated 17-hydroxyprogesterone | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated 2-ketoglutarate (urine)
n1=hyperlaxité ligamentaire | n2=en:elevated 2-ketoglutarate (urine) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated 3-hydroxypropionic acid
n1=hyperlaxité ligamentaire | n2=en:elevated 3-hydroxypropionic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated 3-methylcitric acid
n1=hyperlaxité ligamentaire | n2=en:elevated 3-methylcitric acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated 7-dehydrocholesterol
n1=hyperlaxité ligamentaire | n2=en:elevated 7-dehydrocholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated 8-dehydrocholesterol
n1=hyperlaxité ligamentaire | n2=en:elevated 8-dehydrocholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated 8(9)-cholestenol
n1=hyperlaxité ligamentaire | n2=en:elevated 8(9)-cholestenol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated acth
n1=hyperlaxité ligamentaire | n2=en:elevated acth | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated afp (endodermal sinus tumor)
n1=hyperlaxité ligamentaire | n2=en:elevated afp (endodermal sinus tumor) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated alkaline phosphatase
n1=hyperlaxité ligamentaire | n2=en:elevated alkaline phosphatase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated alkaline phosphatase (if more than one affected site)
n1=hyperlaxité ligamentaire | n2=en:elevated alkaline phosphatase (if more than one affected site) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated alkaline phosphatase (in one patient)
n1=hyperlaxité ligamentaire | n2=en:elevated alkaline phosphatase (in one patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated alkaline phosphatase (varies from 1.3-20 times age-adjusted upper limit of normal)
n1=hyperlaxité ligamentaire | n2=en:elevated alkaline phosphatase (varies from 1.3-20 times age-adjusted upper limit of normal) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated alkaline phosphatase of bone origin
n1=hyperlaxité ligamentaire | n2=en:elevated alkaline phosphatase of bone origin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated alpha-ketoglutarate (in most patients)
n1=hyperlaxité ligamentaire | n2=en:elevated alpha-ketoglutarate (in most patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated ammonia
n1=hyperlaxité ligamentaire | n2=en:elevated ammonia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated androstenedione
n1=hyperlaxité ligamentaire | n2=en:elevated androstenedione | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated androstenedione and testosterone
n1=hyperlaxité ligamentaire | n2=en:elevated androstenedione and testosterone | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated antinuclear antibody (ana) (speckled pattern)
n1=hyperlaxité ligamentaire | n2=en:elevated antinuclear antibody (ana) (speckled pattern) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated apoa-i (1.8x normal) in homozygotes
n1=hyperlaxité ligamentaire | n2=en:elevated apoa-i (1.8x normal) in homozygotes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated ast (aspartate aminotransferase) and cpk (creatine phosphokinase)
n1=hyperlaxité ligamentaire | n2=en:elevated ast (aspartate aminotransferase) and cpk (creatine phosphokinase) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated ast and ldh, especially infantile-onset
n1=hyperlaxité ligamentaire | n2=en:elevated ast and ldh, especially infantile-onset | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated bilirubin (bilirubinemia)
n1=hyperlaxité ligamentaire | n2=en:elevated bilirubin (bilirubinemia) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated biopterin in csf
n1=hyperlaxité ligamentaire | n2=en:elevated biopterin in csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated blood spot hydroxybutyryl carnitine
n1=hyperlaxité ligamentaire | n2=en:elevated blood spot hydroxybutyryl carnitine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated branched-chain amino acids (in most patients)
n1=hyperlaxité ligamentaire | n2=en:elevated branched-chain amino acids (in most patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated calcitonin
n1=hyperlaxité ligamentaire | n2=en:elevated calcitonin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated catecholamines (in patients with pheochromocytoma)
n1=hyperlaxité ligamentaire | n2=en:elevated catecholamines (in patients with pheochromocytoma) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated cerebrospinal fluid (csf) protein
n1=hyperlaxité ligamentaire | n2=en:elevated cerebrospinal fluid (csf) protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated cholesta-8,14-dien-3-beta-ol in cultured fibroblasts
n1=hyperlaxité ligamentaire | n2=en:elevated cholesta-8,14-dien-3-beta-ol in cultured fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated cholesterol with elevated triglycerides
n1=hyperlaxité ligamentaire | n2=en:elevated cholesterol with elevated triglycerides | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated circulating parathyroid hormone (pth) level
n1=hyperlaxité ligamentaire | n2=en:elevated circulating parathyroid hormone (pth) level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated creatine kinase (in some patients)
n1=hyperlaxité ligamentaire | n2=en:elevated creatine kinase (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated crp
n1=hyperlaxité ligamentaire | n2=en:elevated crp | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated csf amino acids (arginine, ornithine, aspartate, threonine, glycine, and methionine)
n1=hyperlaxité ligamentaire | n2=en:elevated csf amino acids (arginine, ornithine, aspartate, threonine, glycine, and methionine) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated csf glycine
n1=hyperlaxité ligamentaire | n2=en:elevated csf glycine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated csf/plasma glycine ratio
n1=hyperlaxité ligamentaire | n2=en:elevated csf/plasma glycine ratio | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated d-2-hydroxyglutaric acid (urine, plasma, csf)
n1=hyperlaxité ligamentaire | n2=en:elevated d-2-hydroxyglutaric acid (urine, plasma, csf) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated dihydrobiopterin in csf
n1=hyperlaxité ligamentaire | n2=en:elevated dihydrobiopterin in csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated erythrocyte adenosine deaminase
n1=hyperlaxité ligamentaire | n2=en:elevated erythrocyte adenosine deaminase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated erythrocyte adenosine deaminase (eada)
n1=hyperlaxité ligamentaire | n2=en:elevated erythrocyte adenosine deaminase (eada) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated erythrocyte adenosine deaminase activity
n1=hyperlaxité ligamentaire | n2=en:elevated erythrocyte adenosine deaminase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated erythrocyte aicar (zmp)
n1=hyperlaxité ligamentaire | n2=en:elevated erythrocyte aicar (zmp) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated erythrocyte sedimentation rate (esr)
n1=hyperlaxité ligamentaire | n2=en:elevated erythrocyte sedimentation rate (esr) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated erythrocyte sedimentation rate (mean 90mm/h)
n1=hyperlaxité ligamentaire | n2=en:elevated erythrocyte sedimentation rate (mean 90mm/h) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated fasting glucose
n1=hyperlaxité ligamentaire | n2=en:elevated fasting glucose | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated fasting triglycerides
n1=hyperlaxité ligamentaire | n2=en:elevated fasting triglycerides | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated fasting triglycerides (seen in heterozygotes as well)
n1=hyperlaxité ligamentaire | n2=en:elevated fasting triglycerides (seen in heterozygotes as well) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated fecal levels of protoporphyrin and coproporphyrin at all times
n1=hyperlaxité ligamentaire | n2=en:elevated fecal levels of protoporphyrin and coproporphyrin at all times | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated ferritin l subunit
n1=hyperlaxité ligamentaire | n2=en:elevated ferritin l subunit | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated fibroblast free sialic acid
n1=hyperlaxité ligamentaire | n2=en:elevated fibroblast free sialic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated free carnitine
n1=hyperlaxité ligamentaire | n2=en:elevated free carnitine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated gamma-glutamyltransferase
n1=hyperlaxité ligamentaire | n2=en:elevated gamma-glutamyltransferase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated gamma-glutamyltransferase (ggt)
n1=hyperlaxité ligamentaire | n2=en:elevated gamma-glutamyltransferase (ggt) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated gastrin concentration
n1=hyperlaxité ligamentaire | n2=en:elevated gastrin concentration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated hcg (choriocarcinoma)
n1=hyperlaxité ligamentaire | n2=en:elevated hcg (choriocarcinoma) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated hcg or afp or both (embryonal carcinoma)
n1=hyperlaxité ligamentaire | n2=en:elevated hcg or afp or both (embryonal carcinoma) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated hdl (2-6x normal) in homozygotes
n1=hyperlaxité ligamentaire | n2=en:elevated hdl (2-6x normal) in homozygotes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated hepatic transaminases
n1=hyperlaxité ligamentaire | n2=en:elevated hepatic transaminases | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated il1-beta
n1=hyperlaxité ligamentaire | n2=en:elevated il1-beta | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated il6
n1=hyperlaxité ligamentaire | n2=en:elevated il6 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated inflammatory markers
n1=hyperlaxité ligamentaire | n2=en:elevated inflammatory markers | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated l-2-hydroxyglutaric acid (urine)
n1=hyperlaxité ligamentaire | n2=en:elevated l-2-hydroxyglutaric acid (urine) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated lathosterol
n1=hyperlaxité ligamentaire | n2=en:elevated lathosterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated leukotriene e(4)
n1=hyperlaxité ligamentaire | n2=en:elevated leukotriene e(4) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated levels of vitamin b12
n1=hyperlaxité ligamentaire | n2=en:elevated levels of vitamin b12 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated liver enzymes
n1=hyperlaxité ligamentaire | n2=en:elevated liver enzymes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated liver function tests
n1=hyperlaxité ligamentaire | n2=en:elevated liver function tests | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated liver transaminases
n1=hyperlaxité ligamentaire | n2=en:elevated liver transaminases | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated long chain fatty acids
n1=hyperlaxité ligamentaire | n2=en:elevated long chain fatty acids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated long-chain acylcarnitine species (in some patients)
n1=hyperlaxité ligamentaire | n2=en:elevated long-chain acylcarnitine species (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated low-density lipoprotein
n1=hyperlaxité ligamentaire | n2=en:elevated low-density lipoprotein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated mchc
n1=hyperlaxité ligamentaire | n2=en:elevated mchc | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma acth
n1=hyperlaxité ligamentaire | n2=en:elevated plasma acth | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma adrenocorticotropic hormone (acth)
n1=hyperlaxité ligamentaire | n2=en:elevated plasma adrenocorticotropic hormone (acth) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma alloisoleucine
n1=hyperlaxité ligamentaire | n2=en:elevated plasma alloisoleucine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma ammonia
n1=hyperlaxité ligamentaire | n2=en:elevated plasma ammonia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma and urine inorganic pyrophosphate (ppi)
n1=hyperlaxité ligamentaire | n2=en:elevated plasma and urine inorganic pyrophosphate (ppi) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma and urine succinylacetone
n1=hyperlaxité ligamentaire | n2=en:elevated plasma and urine succinylacetone | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma beta-sitosterol (sitosterolemia or phytosterolemia)
n1=hyperlaxité ligamentaire | n2=en:elevated plasma beta-sitosterol (sitosterolemia or phytosterolemia) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma branched chain amino acids (leucine, isoleucine, valine)
n1=hyperlaxité ligamentaire | n2=en:elevated plasma branched chain amino acids (leucine, isoleucine, valine) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma campesterol
n1=hyperlaxité ligamentaire | n2=en:elevated plasma campesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma cholestanol
n1=hyperlaxité ligamentaire | n2=en:elevated plasma cholestanol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma citrulline (citrullinemia)
n1=hyperlaxité ligamentaire | n2=en:elevated plasma citrulline (citrullinemia) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma desmosterol
n1=hyperlaxité ligamentaire | n2=en:elevated plasma desmosterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma estrogen
n1=hyperlaxité ligamentaire | n2=en:elevated plasma estrogen | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma follicle stimulating hormone (fsh)
n1=hyperlaxité ligamentaire | n2=en:elevated plasma follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma galactose (galactosemia)
n1=hyperlaxité ligamentaire | n2=en:elevated plasma galactose (galactosemia) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma insulin
n1=hyperlaxité ligamentaire | n2=en:elevated plasma insulin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma levels of lp(a)
n1=hyperlaxité ligamentaire | n2=en:elevated plasma levels of lp(a) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma luteinizing hormone (lh)
n1=hyperlaxité ligamentaire | n2=en:elevated plasma luteinizing hormone (lh) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma methionine (methioninemia)
n1=hyperlaxité ligamentaire | n2=en:elevated plasma methionine (methioninemia) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma ornithine (~10-fold)
n1=hyperlaxité ligamentaire | n2=en:elevated plasma ornithine (~10-fold) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma phytanic acid
n1=hyperlaxité ligamentaire | n2=en:elevated plasma phytanic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma propionylcarnitine
n1=hyperlaxité ligamentaire | n2=en:elevated plasma propionylcarnitine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated plasma stigmasterol
n1=hyperlaxité ligamentaire | n2=en:elevated plasma stigmasterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated pregnenolone
n1=hyperlaxité ligamentaire | n2=en:elevated pregnenolone | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated progesterone
n1=hyperlaxité ligamentaire | n2=en:elevated progesterone | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated propionate
n1=hyperlaxité ligamentaire | n2=en:elevated propionate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated prothrombin time
n1=hyperlaxité ligamentaire | n2=en:elevated prothrombin time | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated pth (parathyroid hormone)
n1=hyperlaxité ligamentaire | n2=en:elevated pth (parathyroid hormone) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated pyruvate (in most patients)
n1=hyperlaxité ligamentaire | n2=en:elevated pyruvate (in most patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated resting serum lactate, increased with exercise
n1=hyperlaxité ligamentaire | n2=en:elevated resting serum lactate, increased with exercise | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated sed rate
n1=hyperlaxité ligamentaire | n2=en:elevated sed rate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated sepiapterin in csf
n1=hyperlaxité ligamentaire | n2=en:elevated sepiapterin in csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum acid phosphatase
n1=hyperlaxité ligamentaire | n2=en:elevated serum acid phosphatase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum alkaline phosphatase during hyperplastic callus formation
n1=hyperlaxité ligamentaire | n2=en:elevated serum alkaline phosphatase during hyperplastic callus formation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum alpha-fetoprotein
n1=hyperlaxité ligamentaire | n2=en:elevated serum alpha-fetoprotein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum alpha-fetoprotein (dominant)
n1=hyperlaxité ligamentaire | n2=en:elevated serum alpha-fetoprotein (dominant) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum angiotensin-converting enzyme (ace)
n1=hyperlaxité ligamentaire | n2=en:elevated serum angiotensin-converting enzyme (ace) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum bile acids
n1=hyperlaxité ligamentaire | n2=en:elevated serum bile acids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum glutamic oxaloacetic transaminase (sgot)
n1=hyperlaxité ligamentaire | n2=en:elevated serum glutamic oxaloacetic transaminase (sgot) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum glutamic pyruvic transaminase (sgpt)
n1=hyperlaxité ligamentaire | n2=en:elevated serum glutamic pyruvic transaminase (sgpt) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum insulin-to-c-peptide ratio
n1=hyperlaxité ligamentaire | n2=en:elevated serum insulin-to-c-peptide ratio | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum iron
n1=hyperlaxité ligamentaire | n2=en:elevated serum iron | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum iron and iron binding capacity
n1=hyperlaxité ligamentaire | n2=en:elevated serum iron and iron binding capacity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum lactate
n1=hyperlaxité ligamentaire | n2=en:elevated serum lactate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum levels of 2-prime deoxyadenosine
n1=hyperlaxité ligamentaire | n2=en:elevated serum levels of 2-prime deoxyadenosine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum levels of adenosine
n1=hyperlaxité ligamentaire | n2=en:elevated serum levels of adenosine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum levels of follicle stimulating hormone (fsh)
n1=hyperlaxité ligamentaire | n2=en:elevated serum levels of follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum levels of luteinizing hormone (lh)
n1=hyperlaxité ligamentaire | n2=en:elevated serum levels of luteinizing hormone (lh) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum long-chain fatty acids
n1=hyperlaxité ligamentaire | n2=en:elevated serum long-chain fatty acids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum lysozyme
n1=hyperlaxité ligamentaire | n2=en:elevated serum lysozyme | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum n,n-dimethylglycine (dmg)
n1=hyperlaxité ligamentaire | n2=en:elevated serum n,n-dimethylglycine (dmg) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum parathyroid hormone (pth)
n1=hyperlaxité ligamentaire | n2=en:elevated serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum parathyroid hormone (pth) level
n1=hyperlaxité ligamentaire | n2=en:elevated serum parathyroid hormone (pth) level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum phosphate in heterozygotes
n1=hyperlaxité ligamentaire | n2=en:elevated serum phosphate in heterozygotes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum phosphorus
n1=hyperlaxité ligamentaire | n2=en:elevated serum phosphorus | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum protein
n1=hyperlaxité ligamentaire | n2=en:elevated serum protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum transaminase levels
n1=hyperlaxité ligamentaire | n2=en:elevated serum transaminase levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum transaminases during infections
n1=hyperlaxité ligamentaire | n2=en:elevated serum transaminases during infections | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum transferrin saturation
n1=hyperlaxité ligamentaire | n2=en:elevated serum transferrin saturation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated serum uric acid concentrations
n1=hyperlaxité ligamentaire | n2=en:elevated serum uric acid concentrations | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated sweat chloride
n1=hyperlaxité ligamentaire | n2=en:elevated sweat chloride | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated sweat chloride (some)
n1=hyperlaxité ligamentaire | n2=en:elevated sweat chloride (some) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated testosterone
n1=hyperlaxité ligamentaire | n2=en:elevated testosterone | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated total bilirubin
n1=hyperlaxité ligamentaire | n2=en:elevated total bilirubin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated total cholesterol (seen in heterozygotes as well)
n1=hyperlaxité ligamentaire | n2=en:elevated total cholesterol (seen in heterozygotes as well) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated total iron-binding capacity
n1=hyperlaxité ligamentaire | n2=en:elevated total iron-binding capacity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated uric acid on urinalysis (in some patients)
n1=hyperlaxité ligamentaire | n2=en:elevated uric acid on urinalysis (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary 2-ethylhydracrylate
n1=hyperlaxité ligamentaire | n2=en:elevated urinary 2-ethylhydracrylate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary 3-methylglutaconate
n1=hyperlaxité ligamentaire | n2=en:elevated urinary 3-methylglutaconate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary 3-methylglutarate
n1=hyperlaxité ligamentaire | n2=en:elevated urinary 3-methylglutarate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary 7 alpha-hydroxylated bile alcohols
n1=hyperlaxité ligamentaire | n2=en:elevated urinary 7 alpha-hydroxylated bile alcohols | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary and csf 5-amino-4-imidazolecarboxyamide (aica-riboside)
n1=hyperlaxité ligamentaire | n2=en:elevated urinary and csf 5-amino-4-imidazolecarboxyamide (aica-riboside) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary and csf ribitol and d-arabitol
n1=hyperlaxité ligamentaire | n2=en:elevated urinary and csf ribitol and d-arabitol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary delta-aminolevulinic acid
n1=hyperlaxité ligamentaire | n2=en:elevated urinary delta-aminolevulinic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary delta-aminolevulinic acid and porphyrins
n1=hyperlaxité ligamentaire | n2=en:elevated urinary delta-aminolevulinic acid and porphyrins | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary epinephrine
n1=hyperlaxité ligamentaire | n2=en:elevated urinary epinephrine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary free sialic acid (n-acetylneuraminic acid)
n1=hyperlaxité ligamentaire | n2=en:elevated urinary free sialic acid (n-acetylneuraminic acid) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary hyaluronic acid levels
n1=hyperlaxité ligamentaire | n2=en:elevated urinary hyaluronic acid levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary mevalonic acid
n1=hyperlaxité ligamentaire | n2=en:elevated urinary mevalonic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary n,n-dimethylglycine (dmg)
n1=hyperlaxité ligamentaire | n2=en:elevated urinary n,n-dimethylglycine (dmg) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary ornithine, lysine, arginine
n1=hyperlaxité ligamentaire | n2=en:elevated urinary ornithine, lysine, arginine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary pge(2) levels
n1=hyperlaxité ligamentaire | n2=en:elevated urinary pge(2) levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary phosphoethanolamine
n1=hyperlaxité ligamentaire | n2=en:elevated urinary phosphoethanolamine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urinary pyridinoline and deoxypyridinoline
n1=hyperlaxité ligamentaire | n2=en:elevated urinary pyridinoline and deoxypyridinoline | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urine ceramide levels
n1=hyperlaxité ligamentaire | n2=en:elevated urine ceramide levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated urine unsulfated chondroitin sulfate
n1=hyperlaxité ligamentaire | n2=en:elevated urine unsulfated chondroitin sulfate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:elevated white blood cell cystine
n1=hyperlaxité ligamentaire | n2=en:elevated white blood cell cystine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:emaciation
n1=hyperlaxité ligamentaire | n2=en:emaciation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:embryologic
n1=hyperlaxité ligamentaire | n2=en:embryologic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:endocrine and metabolic disturbances specific to the fetus and newborn
n1=hyperlaxité ligamentaire | n2=en:endocrine and metabolic disturbances specific to the fetus and newborn | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:endocrine and/or metabolic disorder specific to the fetus or newborn
n1=hyperlaxité ligamentaire | n2=en:endocrine and/or metabolic disorder specific to the fetus or newborn | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:engraftment syndrome
n1=hyperlaxité ligamentaire | n2=en:engraftment syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:enlarged cytoplasmic vacuoles in bone, muscle, and brain tissue
n1=hyperlaxité ligamentaire | n2=en:enlarged cytoplasmic vacuoles in bone, muscle, and brain tissue | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:enzyme abnormality (nos)
n1=hyperlaxité ligamentaire | n2=en:enzyme abnormality (nos) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:enzyme deficiency
n1=hyperlaxité ligamentaire | n2=en:enzyme deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:enzyme replacement therapy has not been effective
n1=hyperlaxité ligamentaire | n2=en:enzyme replacement therapy has not been effective | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:enzymology
n1=hyperlaxité ligamentaire | n2=en:enzymology | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:enzymopathy
n1=hyperlaxité ligamentaire | n2=en:enzymopathy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:eosinophilia
n1=hyperlaxité ligamentaire | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:eosinophilia, mild
n1=hyperlaxité ligamentaire | n2=en:eosinophilia, mild | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:epidemiologic
n1=hyperlaxité ligamentaire | n2=en:epidemiologic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:episodic ammonia intoxication
n1=hyperlaxité ligamentaire | n2=en:episodic ammonia intoxication | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:episodic decompensation
n1=hyperlaxité ligamentaire | n2=en:episodic decompensation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:episodic ketoacidosis
n1=hyperlaxité ligamentaire | n2=en:episodic ketoacidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:episodic metabolic acidosis
n1=hyperlaxité ligamentaire | n2=en:episodic metabolic acidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:epstein-barr viraemia
n1=hyperlaxité ligamentaire | n2=en:epstein-barr viraemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:erdheim-chester disease
n1=hyperlaxité ligamentaire | n2=en:erdheim-chester disease | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:erythrocyte delta-aminolevulinate dehydratase (alad) deficiency
n1=hyperlaxité ligamentaire | n2=en:erythrocyte delta-aminolevulinate dehydratase (alad) deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:erythrocyte porphobilinogen (pbg) deaminase deficiency (exception: type ii aip)
n1=hyperlaxité ligamentaire | n2=en:erythrocyte porphobilinogen (pbg) deaminase deficiency (exception: type ii aip) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:erythroid colony-forming units show spontaneous growth in the absence of epo
n1=hyperlaxité ligamentaire | n2=en:erythroid colony-forming units show spontaneous growth in the absence of epo | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:erythrosis
n1=hyperlaxité ligamentaire | n2=en:erythrosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ethanol metabolism disorder
n1=hyperlaxité ligamentaire | n2=en:ethanol metabolism disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ethnologic
n1=hyperlaxité ligamentaire | n2=en:ethnologic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ethylmalonic aciduria
n1=hyperlaxité ligamentaire | n2=en:ethylmalonic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:etiology aspects
n1=hyperlaxité ligamentaire | n2=en:etiology aspects | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:euvolemia
n1=hyperlaxité ligamentaire | n2=en:euvolemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:excess protoporphyrin in bile and feces but not in urine
n1=hyperlaxité ligamentaire | n2=en:excess protoporphyrin in bile and feces but not in urine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:excessive iodide trapping
n1=hyperlaxité ligamentaire | n2=en:excessive iodide trapping | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:excessive urinary 5-oxo-l-proline
n1=hyperlaxité ligamentaire | n2=en:excessive urinary 5-oxo-l-proline | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:excretion of dermatan sulfate and heparan sulfate in urine
n1=hyperlaxité ligamentaire | n2=en:excretion of dermatan sulfate and heparan sulfate in urine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:exercise-induced myoglobinuria
n1=hyperlaxité ligamentaire | n2=en:exercise-induced myoglobinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:exercise-induced myoglobinuria in adults
n1=hyperlaxité ligamentaire | n2=en:exercise-induced myoglobinuria in adults | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:exposure as collected domain
n1=hyperlaxité ligamentaire | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:extramedullary hematopoiesis
n1=hyperlaxité ligamentaire | n2=en:extramedullary hematopoiesis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:extremely low creatine excretion
n1=hyperlaxité ligamentaire | n2=en:extremely low creatine excretion | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:factor vii deficiency
n1=hyperlaxité ligamentaire | n2=en:factor vii deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:factor viii deficiency
n1=hyperlaxité ligamentaire | n2=en:factor viii deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:familial disease with storage of sterols (other than cholesterol)
n1=hyperlaxité ligamentaire | n2=en:familial disease with storage of sterols (other than cholesterol) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:familial hyperlipoproteinemia
n1=hyperlaxité ligamentaire | n2=en:familial hyperlipoproteinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:familial lipoprotein deficiency
n1=hyperlaxité ligamentaire | n2=en:familial lipoprotein deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fasting chylomicronemia
n1=hyperlaxité ligamentaire | n2=en:fasting chylomicronemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fasting hyperinsulinemia
n1=hyperlaxité ligamentaire | n2=en:fasting hyperinsulinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fasting hypoglycemia (early in disease course)
n1=hyperlaxité ligamentaire | n2=en:fasting hypoglycemia (early in disease course) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fasting ketosis
n1=hyperlaxité ligamentaire | n2=en:fasting ketosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fatty acid metabolism disorder
n1=hyperlaxité ligamentaire | n2=en:fatty acid metabolism disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fatty acid pattern of serum lecithin shows increased arachidonic acid and decreased linoleic acid
n1=hyperlaxité ligamentaire | n2=en:fatty acid pattern of serum lecithin shows increased arachidonic acid and decreased linoleic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fatty alcohol:nad+ oxidoreductase deficiency in leukocytes and fibroblasts
n1=hyperlaxité ligamentaire | n2=en:fatty alcohol:nad+ oxidoreductase deficiency in leukocytes and fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fatty liver
n1=hyperlaxité ligamentaire | n2=en:fatty liver | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:female carriers show markedly skewed x inactivation
n1=hyperlaxité ligamentaire | n2=en:female carriers show markedly skewed x inactivation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ferritin decreased
n1=hyperlaxité ligamentaire | n2=en:ferritin decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fever
n1=hyperlaxité ligamentaire | n2=en:fever | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fever episodes last from 3 to 10 days
n1=hyperlaxité ligamentaire | n2=en:fever episodes last from 3 to 10 days | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fever is often the presenting symptom
n1=hyperlaxité ligamentaire | n2=en:fever is often the presenting symptom | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fever of central origin
n1=hyperlaxité ligamentaire | n2=en:fever of central origin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fever, episodic, severe
n1=hyperlaxité ligamentaire | n2=en:fever, episodic, severe | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fever, high grade
n1=hyperlaxité ligamentaire | n2=en:fever, high grade | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fever, intermittent, recurrent (in some)
n1=hyperlaxité ligamentaire | n2=en:fever, intermittent, recurrent (in some) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fever, periodic, recurrent
n1=hyperlaxité ligamentaire | n2=en:fever, periodic, recurrent | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fh: raised blood lipids
n1=hyperlaxité ligamentaire | n2=en:fh: raised blood lipids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibrinogen decreased
n1=hyperlaxité ligamentaire | n2=en:fibrinogen decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibroblasts accumulate dol-pp-glcnac2man5
n1=hyperlaxité ligamentaire | n2=en:fibroblasts accumulate dol-pp-glcnac2man5 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibroblasts are small and rounded with prominent nucleoli
n1=hyperlaxité ligamentaire | n2=en:fibroblasts are small and rounded with prominent nucleoli | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibroblasts attach poorly
n1=hyperlaxité ligamentaire | n2=en:fibroblasts attach poorly | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibroblasts demonstrate rapid growth with increased dna synthesis
n1=hyperlaxité ligamentaire | n2=en:fibroblasts demonstrate rapid growth with increased dna synthesis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibroblasts have decreased levels of ceramide, sphingomyelin, lactosylceramide, ceramide trihexoside, and globoside
n1=hyperlaxité ligamentaire | n2=en:fibroblasts have decreased levels of ceramide, sphingomyelin, lactosylceramide, ceramide trihexoside, and globoside | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibroblasts have increased activity of serine palmitoyltransferase (spt, 605712)
n1=hyperlaxité ligamentaire | n2=en:fibroblasts have increased activity of serine palmitoyltransferase (spt, 605712) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibroblasts show decreased activity of mitochondrial respiratory complex i, complex iii, complex iv, and complex v
n1=hyperlaxité ligamentaire | n2=en:fibroblasts show decreased activity of mitochondrial respiratory complex i, complex iii, complex iv, and complex v | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibroblasts show decreased mitochondrial complex v activity
n1=hyperlaxité ligamentaire | n2=en:fibroblasts show decreased mitochondrial complex v activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibroblasts show decreased peroxisomes arranged in rows
n1=hyperlaxité ligamentaire | n2=en:fibroblasts show decreased peroxisomes arranged in rows | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibroblasts show elongated, tangled, tubular mitochondria
n1=hyperlaxité ligamentaire | n2=en:fibroblasts show elongated, tangled, tubular mitochondria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibroblasts show global defects in multiple mitochondrial respiratory chain activities
n1=hyperlaxité ligamentaire | n2=en:fibroblasts show global defects in multiple mitochondrial respiratory chain activities | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibroblasts show hypersensitivity to uv irradiation due to defect in transcription-coupled nucleotide excision repair (tc-ner)
n1=hyperlaxité ligamentaire | n2=en:fibroblasts show hypersensitivity to uv irradiation due to defect in transcription-coupled nucleotide excision repair (tc-ner) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibroblasts show increased sensitivity to apoptosis
n1=hyperlaxité ligamentaire | n2=en:fibroblasts show increased sensitivity to apoptosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibroblasts show lamellar lysosomal inclusions on electron microscopy
n1=hyperlaxité ligamentaire | n2=en:fibroblasts show lamellar lysosomal inclusions on electron microscopy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibroblasts shows defects in oxidative phosphorylation
n1=hyperlaxité ligamentaire | n2=en:fibroblasts shows defects in oxidative phosphorylation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fibronectin decreased
n1=hyperlaxité ligamentaire | n2=en:fibronectin decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fingerprint intracellular accumulation of autofluorescent lipopigment storage material
n1=hyperlaxité ligamentaire | n2=en:fingerprint intracellular accumulation of autofluorescent lipopigment storage material | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fluorescence in situ hybridization specific probe for mds critical region
n1=hyperlaxité ligamentaire | n2=en:fluorescence in situ hybridization specific probe for mds critical region | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fluorescence of red blood cells by uv microscopy
n1=hyperlaxité ligamentaire | n2=en:fluorescence of red blood cells by uv microscopy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:foam cells contain polymorphic cytoplasmic inclusions consisting of lamellar osmiophilic membranes on electron microscopy
n1=hyperlaxité ligamentaire | n2=en:foam cells contain polymorphic cytoplasmic inclusions consisting of lamellar osmiophilic membranes on electron microscopy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:foam cells in bone marrow and renal glomeruli
n1=hyperlaxité ligamentaire | n2=en:foam cells in bone marrow and renal glomeruli | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:foam cells in visceral organs and cns
n1=hyperlaxité ligamentaire | n2=en:foam cells in visceral organs and cns | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:folate-dependent fragile site at xq28
n1=hyperlaxité ligamentaire | n2=en:folate-dependent fragile site at xq28 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:folic acid deficiency
n1=hyperlaxité ligamentaire | n2=en:folic acid deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fragmentation of the mitochondrial network
n1=hyperlaxité ligamentaire | n2=en:fragmentation of the mitochondrial network | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fredrickson type iv lipidemia
n1=hyperlaxité ligamentaire | n2=en:fredrickson type iv lipidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:frequent deletions of chromosome 9 in melanoma
n1=hyperlaxité ligamentaire | n2=en:frequent deletions of chromosome 9 in melanoma | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:frequent inv(10)(q11.2q21) producing chimeric transforming sequence ret/ptc
n1=hyperlaxité ligamentaire | n2=en:frequent inv(10)(q11.2q21) producing chimeric transforming sequence ret/ptc | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fucosidosis
n1=hyperlaxité ligamentaire | n2=en:fucosidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fumarase activity (mitochondrial and cytosolic) is decreased
n1=hyperlaxité ligamentaire | n2=en:fumarase activity (mitochondrial and cytosolic) is decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fumarase deficiency
n1=hyperlaxité ligamentaire | n2=en:fumarase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fumarylacetoacetate hydrolase (fah) deficiency
n1=hyperlaxité ligamentaire | n2=en:fumarylacetoacetate hydrolase (fah) deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:fungemia
n1=hyperlaxité ligamentaire | n2=en:fungemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:galactocerebroside beta-galactosidase deficiency in serum, leukocytes, and fibroblasts
n1=hyperlaxité ligamentaire | n2=en:galactocerebroside beta-galactosidase deficiency in serum, leukocytes, and fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:galactosemia
n1=hyperlaxité ligamentaire | n2=en:galactosemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:galactosuria
n1=hyperlaxité ligamentaire | n2=en:galactosuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:galactosuria without galactosemia
n1=hyperlaxité ligamentaire | n2=en:galactosuria without galactosemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:galactosylation defects
n1=hyperlaxité ligamentaire | n2=en:galactosylation defects | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:galactosyltransferase i deficiency in fibroblasts
n1=hyperlaxité ligamentaire | n2=en:galactosyltransferase i deficiency in fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:gamma-glutamylcysteine deficiency
n1=hyperlaxité ligamentaire | n2=en:gamma-glutamylcysteine deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:gamma-glutamylcysteine synthetase (glutamate-cysteine ligase) deficiency
n1=hyperlaxité ligamentaire | n2=en:gamma-glutamylcysteine synthetase (glutamate-cysteine ligase) deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:gamma-glutamyltransferase increased
n1=hyperlaxité ligamentaire | n2=en:gamma-glutamyltransferase increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:gaucher cells, diffuse, in spleen, liver, lymph nodes, bone marrow, central nervous system
n1=hyperlaxité ligamentaire | n2=en:gaucher cells, diffuse, in spleen, liver, lymph nodes, bone marrow, central nervous system | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:gaucher disease, type 1
n1=hyperlaxité ligamentaire | n2=en:gaucher disease, type 1 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:gemfibrozil
n1=hyperlaxité ligamentaire | n2=en:gemfibrozil | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:generalized aminoaciduria
n1=hyperlaxité ligamentaire | n2=en:generalized aminoaciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:generalized amyloid deposition
n1=hyperlaxité ligamentaire | n2=en:generalized amyloid deposition | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:generalized fatigue
n1=hyperlaxité ligamentaire | n2=en:generalized fatigue | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:genetic aspects
n1=hyperlaxité ligamentaire | n2=en:genetic aspects | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:giant cells (degenerating chondrocytes) in resting zone of epiphyseal cartilage
n1=hyperlaxité ligamentaire | n2=en:giant cells (degenerating chondrocytes) in resting zone of epiphyseal cartilage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glcnac-transferase ii deficiency in fibroblast and mononuclear cells
n1=hyperlaxité ligamentaire | n2=en:glcnac-transferase ii deficiency in fibroblast and mononuclear cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:globulin gamma serum plasma increased result
n1=hyperlaxité ligamentaire | n2=en:globulin gamma serum plasma increased result | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glomerular filtration rate decreased
n1=hyperlaxité ligamentaire | n2=en:glomerular filtration rate decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glucose breath hydrogen test shows malabsorption of glucose and galactose
n1=hyperlaxité ligamentaire | n2=en:glucose breath hydrogen test shows malabsorption of glucose and galactose | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glucose metabolism abnormal
n1=hyperlaxité ligamentaire | n2=en:glucose metabolism abnormal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glucose metabolism disorder
n1=hyperlaxité ligamentaire | n2=en:glucose metabolism disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glucose-6-phosphate deficiency
n1=hyperlaxité ligamentaire | n2=en:glucose-6-phosphate deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glucosidase i deficiency in liver and fibroblasts
n1=hyperlaxité ligamentaire | n2=en:glucosidase i deficiency in liver and fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glucosuria, mild, intermittent
n1=hyperlaxité ligamentaire | n2=en:glucosuria, mild, intermittent | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glutaric acidemia type 1
n1=hyperlaxité ligamentaire | n2=en:glutaric acidemia type 1 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glutaric aciduria
n1=hyperlaxité ligamentaire | n2=en:glutaric aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glutathione deficiency
n1=hyperlaxité ligamentaire | n2=en:glutathione deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glycinuria
n1=hyperlaxité ligamentaire | n2=en:glycinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glycoamino aciduria
n1=hyperlaxité ligamentaire | n2=en:glycoamino aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glycogen accumulation in both liver and muscle
n1=hyperlaxité ligamentaire | n2=en:glycogen accumulation in both liver and muscle | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glycogen storage disease type i
n1=hyperlaxité ligamentaire | n2=en:glycogen storage disease type i | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glycogen storage disease type ib
n1=hyperlaxité ligamentaire | n2=en:glycogen storage disease type ib | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glycogen storage disease type iii
n1=hyperlaxité ligamentaire | n2=en:glycogen storage disease type iii | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glycogen storage disease type v
n1=hyperlaxité ligamentaire | n2=en:glycogen storage disease type v | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glycogen storage disease type vi
n1=hyperlaxité ligamentaire | n2=en:glycogen storage disease type vi | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glycogen storage disease type vii
n1=hyperlaxité ligamentaire | n2=en:glycogen storage disease type vii | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glycosuria
n1=hyperlaxité ligamentaire | n2=en:glycosuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glycosuria (less common)
n1=hyperlaxité ligamentaire | n2=en:glycosuria (less common) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:glyoxalase deficiency
n1=hyperlaxité ligamentaire | n2=en:glyoxalase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:gm1 gangliosidosis
n1=hyperlaxité ligamentaire | n2=en:gm1 gangliosidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:gm2-ganglioside accumulation
n1=hyperlaxité ligamentaire | n2=en:gm2-ganglioside accumulation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:gonadotrophin increased
n1=hyperlaxité ligamentaire | n2=en:gonadotrophin increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:gout
n1=hyperlaxité ligamentaire | n2=en:gout | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:granular osmiophilic cytoplasmic deposits (grod) ultrastructurally in cells
n1=hyperlaxité ligamentaire | n2=en:granular osmiophilic cytoplasmic deposits (grod) ultrastructurally in cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:granular osmiophilic cytoplasmic deposits ultrastructurally in cells
n1=hyperlaxité ligamentaire | n2=en:granular osmiophilic cytoplasmic deposits ultrastructurally in cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:granular osmiophilic deposits (grod) in cells
n1=hyperlaxité ligamentaire | n2=en:granular osmiophilic deposits (grod) in cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:granular osmiophilic deposits (grod) in cells resulting in 'curvilinear' profiles ultrastructurally
n1=hyperlaxité ligamentaire | n2=en:granular osmiophilic deposits (grod) in cells resulting in 'curvilinear' profiles ultrastructurally | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:granular osmiophilic deposits (grod) in cells resulting in 'fingerprint' profiles ultrastructurally
n1=hyperlaxité ligamentaire | n2=en:granular osmiophilic deposits (grod) in cells resulting in 'fingerprint' profiles ultrastructurally | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:granular osmiophilic deposits (grod) in cells resulting in 'rectilinear' profiles ultrastructurally
n1=hyperlaxité ligamentaire | n2=en:granular osmiophilic deposits (grod) in cells resulting in 'rectilinear' profiles ultrastructurally | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:greatly increased dopamine in plasma, urine, csf (approximately 10-fold increase)
n1=hyperlaxité ligamentaire | n2=en:greatly increased dopamine in plasma, urine, csf (approximately 10-fold increase) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:green serum
n1=hyperlaxité ligamentaire | n2=en:green serum | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:green urine
n1=hyperlaxité ligamentaire | n2=en:green urine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:growth cartilage disorganized, with islands of cells and abnormal collagen arrangement
n1=hyperlaxité ligamentaire | n2=en:growth cartilage disorganized, with islands of cells and abnormal collagen arrangement | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:guanidinoacetate methyltransferase (gamt) deficiency
n1=hyperlaxité ligamentaire | n2=en:guanidinoacetate methyltransferase (gamt) deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:h/o: raised blood lipids
n1=hyperlaxité ligamentaire | n2=en:h/o: raised blood lipids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:haematotoxicity
n1=hyperlaxité ligamentaire | n2=en:haematotoxicity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hair bulb tyrosinase present
n1=hyperlaxité ligamentaire | n2=en:hair bulb tyrosinase present | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hair bulbs will pigment when incubated with tyrosine
n1=hyperlaxité ligamentaire | n2=en:hair bulbs will pigment when incubated with tyrosine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:haptoglobin decreased
n1=hyperlaxité ligamentaire | n2=en:haptoglobin decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hawkinsinuria
n1=hyperlaxité ligamentaire | n2=en:hawkinsinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hb h erythrocyte inclusions
n1=hyperlaxité ligamentaire | n2=en:hb h erythrocyte inclusions | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hematologic and lymphocytic disorder
n1=hyperlaxité ligamentaire | n2=en:hematologic and lymphocytic disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hematologic tests
n1=hyperlaxité ligamentaire | n2=en:hematologic tests | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hematological disorders of fetus and newborn
n1=hyperlaxité ligamentaire | n2=en:hematological disorders of fetus and newborn | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hematopoietic and lymphoid cell neoplasm
n1=hyperlaxité ligamentaire | n2=en:hematopoietic and lymphoid cell neoplasm | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hematuria
n1=hyperlaxité ligamentaire | n2=en:hematuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hematuria (less common)
n1=hyperlaxité ligamentaire | n2=en:hematuria (less common) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hematuria, gross and microscopic
n1=hyperlaxité ligamentaire | n2=en:hematuria, gross and microscopic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hematuria, macroscopic and microscopic
n1=hyperlaxité ligamentaire | n2=en:hematuria, macroscopic and microscopic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hemizygous deletion at 4p16.3
n1=hyperlaxité ligamentaire | n2=en:hemizygous deletion at 4p16.3 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hemizygous deletion at 7q11.23
n1=hyperlaxité ligamentaire | n2=en:hemizygous deletion at 7q11.23 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hemoconcentration
n1=hyperlaxité ligamentaire | n2=en:hemoconcentration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hemodilution
n1=hyperlaxité ligamentaire | n2=en:hemodilution | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hemoglobin decreased
n1=hyperlaxité ligamentaire | n2=en:hemoglobin decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hemoglobin f increased
n1=hyperlaxité ligamentaire | n2=en:hemoglobin f increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hemoglobin increased
n1=hyperlaxité ligamentaire | n2=en:hemoglobin increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hemoglobinopathy
n1=hyperlaxité ligamentaire | n2=en:hemoglobinopathy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hemolytic disease of the newborn
n1=hyperlaxité ligamentaire | n2=en:hemolytic disease of the newborn | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hemolytic uremic syndrome, atypical, susceptibility to, 1
n1=hyperlaxité ligamentaire | n2=en:hemolytic uremic syndrome, atypical, susceptibility to, 1 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hemophagocytosis
n1=hyperlaxité ligamentaire | n2=en:hemophagocytosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hemophilia b
n1=hyperlaxité ligamentaire | n2=en:hemophilia b | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hemorrhage
n1=hyperlaxité ligamentaire | n2=en:hemorrhage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hemorrhagic disorders
n1=hyperlaxité ligamentaire | n2=en:hemorrhagic disorders | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hemosiderosis
n1=hyperlaxité ligamentaire | n2=en:hemosiderosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:heparan n-sulfatase deficiency in fibroblasts and amniocytes
n1=hyperlaxité ligamentaire | n2=en:heparan n-sulfatase deficiency in fibroblasts and amniocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:heparan sulfate excretion in urine
n1=hyperlaxité ligamentaire | n2=en:heparan sulfate excretion in urine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:heparin cofactor ii deficiency (disorder)
n1=hyperlaxité ligamentaire | n2=en:heparin cofactor ii deficiency (disorder) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hepatic argininosuccinase deficiency
n1=hyperlaxité ligamentaire | n2=en:hepatic argininosuccinase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hepatic argininosuccinate synthetase deficiency
n1=hyperlaxité ligamentaire | n2=en:hepatic argininosuccinate synthetase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hepatic carbamoylphosphate synthetase i deficiency
n1=hyperlaxité ligamentaire | n2=en:hepatic carbamoylphosphate synthetase i deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hepatic encephalopathy
n1=hyperlaxité ligamentaire | n2=en:hepatic encephalopathy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hepatic gamma-cystathionase deficiency
n1=hyperlaxité ligamentaire | n2=en:hepatic gamma-cystathionase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hepatic glycine cleavage defect
n1=hyperlaxité ligamentaire | n2=en:hepatic glycine cleavage defect | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hepatic lipase deficiency (disorder)
n1=hyperlaxité ligamentaire | n2=en:hepatic lipase deficiency (disorder) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hepatic ornithine transcarbamylase deficiency
n1=hyperlaxité ligamentaire | n2=en:hepatic ornithine transcarbamylase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hepatic triacylglycerol lipase
n1=hyperlaxité ligamentaire | n2=en:hepatic triacylglycerol lipase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hereditary angioedema
n1=hyperlaxité ligamentaire | n2=en:hereditary angioedema | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hereditary factor x deficiency
n1=hyperlaxité ligamentaire | n2=en:hereditary factor x deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hereditary fructose intolerance
n1=hyperlaxité ligamentaire | n2=en:hereditary fructose intolerance | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hereditary hemolytic anemia
n1=hyperlaxité ligamentaire | n2=en:hereditary hemolytic anemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hereditary xanthinuria
n1=hyperlaxité ligamentaire | n2=en:hereditary xanthinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:heteroplasmic partial duplication of mtdna
n1=hyperlaxité ligamentaire | n2=en:heteroplasmic partial duplication of mtdna | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high deoxypyridinoline/creatinine (in some patients)
n1=hyperlaxité ligamentaire | n2=en:high deoxypyridinoline/creatinine (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high ebv viral load
n1=hyperlaxité ligamentaire | n2=en:high ebv viral load | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high fever (38-41 degrees centigrade), recurrent with each menstrual cycle
n1=hyperlaxité ligamentaire | n2=en:high fever (38-41 degrees centigrade), recurrent with each menstrual cycle | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high ft3/ft4 ratio
n1=hyperlaxité ligamentaire | n2=en:high ft3/ft4 ratio | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high m-component
n1=hyperlaxité ligamentaire | n2=en:high m-component | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high newborn serum levels of immunoreactive trypsinogen
n1=hyperlaxité ligamentaire | n2=en:high newborn serum levels of immunoreactive trypsinogen | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high nonceruloplasmin-bound serum copper
n1=hyperlaxité ligamentaire | n2=en:high nonceruloplasmin-bound serum copper | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high ornithine
n1=hyperlaxité ligamentaire | n2=en:high ornithine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high plasma asparagine
n1=hyperlaxité ligamentaire | n2=en:high plasma asparagine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high plasma citrulline (100-300 micromolar)
n1=hyperlaxité ligamentaire | n2=en:high plasma citrulline (100-300 micromolar) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high plasma citrulline (1000-5000 micromolar)
n1=hyperlaxité ligamentaire | n2=en:high plasma citrulline (1000-5000 micromolar) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high plasma renin activity
n1=hyperlaxité ligamentaire | n2=en:high plasma renin activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high plasma triglyceride levels
n1=hyperlaxité ligamentaire | n2=en:high plasma triglyceride levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high resolution g- and t- banding karyotype shows reciprocal translocation of distal 9p-6q
n1=hyperlaxité ligamentaire | n2=en:high resolution g- and t- banding karyotype shows reciprocal translocation of distal 9p-6q | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high serum guanosine levels
n1=hyperlaxité ligamentaire | n2=en:high serum guanosine levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high serum inosine levels
n1=hyperlaxité ligamentaire | n2=en:high serum inosine levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high serum osmolality
n1=hyperlaxité ligamentaire | n2=en:high serum osmolality | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high sister chromatid exchange (sce) rate
n1=hyperlaxité ligamentaire | n2=en:high sister chromatid exchange (sce) rate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high sweat electrolyte
n1=hyperlaxité ligamentaire | n2=en:high sweat electrolyte | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high sweat sodium and chloride
n1=hyperlaxité ligamentaire | n2=en:high sweat sodium and chloride | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high urinary copper
n1=hyperlaxité ligamentaire | n2=en:high urinary copper | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high urinary excretion of inosine, 2'deoxyinosine, guanosine, and 2'deoxyguanosine
n1=hyperlaxité ligamentaire | n2=en:high urinary excretion of inosine, 2'deoxyinosine, guanosine, and 2'deoxyguanosine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high urinary orotic acid
n1=hyperlaxité ligamentaire | n2=en:high urinary orotic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high-normal plasma triglyceride concentration (in heterozygotes)
n1=hyperlaxité ligamentaire | n2=en:high-normal plasma triglyceride concentration (in heterozygotes) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:high-resolution electron microscopy tomography shows absence of projection c2b at the central pair (cp) apparatus of cilia
n1=hyperlaxité ligamentaire | n2=en:high-resolution electron microscopy tomography shows absence of projection c2b at the central pair (cp) apparatus of cilia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:histiocytic infiltration of liver, spleen, and lungs
n1=hyperlaxité ligamentaire | n2=en:histiocytic infiltration of liver, spleen, and lungs | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:historical aspects qualifier
n1=hyperlaxité ligamentaire | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hiv positivity
n1=hyperlaxité ligamentaire | n2=en:hiv positivity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hla-b27 haplotype association (95% patients)
n1=hyperlaxité ligamentaire | n2=en:hla-b27 haplotype association (95% patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hla-dqw6 association (dqb1*0602)
n1=hyperlaxité ligamentaire | n2=en:hla-dqw6 association (dqb1*0602) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:holocarboxylase synthetase deficiency
n1=hyperlaxité ligamentaire | n2=en:holocarboxylase synthetase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:homocitrullinuria
n1=hyperlaxité ligamentaire | n2=en:homocitrullinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:homocysteinemia
n1=hyperlaxité ligamentaire | n2=en:homocysteinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:homocysteinemia (in some patients)
n1=hyperlaxité ligamentaire | n2=en:homocysteinemia (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:homocystinemia
n1=hyperlaxité ligamentaire | n2=en:homocystinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:homocystinuria
n1=hyperlaxité ligamentaire | n2=en:homocystinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:homocystinuria (in some patients)
n1=hyperlaxité ligamentaire | n2=en:homocystinuria (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:homozygous 122kb deletion 11p15-p14
n1=hyperlaxité ligamentaire | n2=en:homozygous 122kb deletion 11p15-p14 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:howell-jolly bodies seen in peripheral blood smear
n1=hyperlaxité ligamentaire | n2=en:howell-jolly bodies seen in peripheral blood smear | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hydantoin toxicity
n1=hyperlaxité ligamentaire | n2=en:hydantoin toxicity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hydrocortisone decreased
n1=hyperlaxité ligamentaire | n2=en:hydrocortisone decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hydroxyprolinuria
n1=hyperlaxité ligamentaire | n2=en:hydroxyprolinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperalphalipoproteinemia
n1=hyperlaxité ligamentaire | n2=en:hyperalphalipoproteinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperammonemia
n1=hyperlaxité ligamentaire | n2=en:hyperammonemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperammonemia after protein intake
n1=hyperlaxité ligamentaire | n2=en:hyperammonemia after protein intake | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperammonemia, asymptomatic (2-5 times normal)
n1=hyperlaxité ligamentaire | n2=en:hyperammonemia, asymptomatic (2-5 times normal) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperammonemia, episodic
n1=hyperlaxité ligamentaire | n2=en:hyperammonemia, episodic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperammonemic coma
n1=hyperlaxité ligamentaire | n2=en:hyperammonemic coma | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperamylasemia
n1=hyperlaxité ligamentaire | n2=en:hyperamylasemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperarginemia
n1=hyperlaxité ligamentaire | n2=en:hyperarginemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperbilirubinemia
n1=hyperlaxité ligamentaire | n2=en:hyperbilirubinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperbilirubinemia in those with liver failure
n1=hyperlaxité ligamentaire | n2=en:hyperbilirubinemia in those with liver failure | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperbilirubinemia, non-hemolytic unconjugated (may rise with fasting or dehydration)
n1=hyperlaxité ligamentaire | n2=en:hyperbilirubinemia, non-hemolytic unconjugated (may rise with fasting or dehydration) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperbilirubinemia, unconjugated, <20mg/dl
n1=hyperlaxité ligamentaire | n2=en:hyperbilirubinemia, unconjugated, <20mg/dl | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperbilirubinemia, unconjugated, 20-30mg/dl
n1=hyperlaxité ligamentaire | n2=en:hyperbilirubinemia, unconjugated, 20-30mg/dl | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypercalcemia
n1=hyperlaxité ligamentaire | n2=en:hypercalcemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypercalciuria
n1=hyperlaxité ligamentaire | n2=en:hypercalciuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypercalciuria (in childhood)
n1=hyperlaxité ligamentaire | n2=en:hypercalciuria (in childhood) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypercalciuria (in some patients)
n1=hyperlaxité ligamentaire | n2=en:hypercalciuria (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypercarbia
n1=hyperlaxité ligamentaire | n2=en:hypercarbia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperchloremia
n1=hyperlaxité ligamentaire | n2=en:hyperchloremia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperchloremia (mean >110 mm in both dominant and recessive)
n1=hyperlaxité ligamentaire | n2=en:hyperchloremia (mean >110 mm in both dominant and recessive) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperchloremia (mean 109 mm)
n1=hyperlaxité ligamentaire | n2=en:hyperchloremia (mean 109 mm) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperchloremia (mean 111 mm)
n1=hyperlaxité ligamentaire | n2=en:hyperchloremia (mean 111 mm) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperchloremia (mean 114 mm)
n1=hyperlaxité ligamentaire | n2=en:hyperchloremia (mean 114 mm) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperchloremic metabolic acidosis
n1=hyperlaxité ligamentaire | n2=en:hyperchloremic metabolic acidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperchloremic metabolic acidosis (hco3 15.5 +/- 2.0 mm)
n1=hyperlaxité ligamentaire | n2=en:hyperchloremic metabolic acidosis (hco3 15.5 +/- 2.0 mm) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperchloremic metabolic acidosis (hco3 17.2 +/- 2.5 mm, dominant)
n1=hyperlaxité ligamentaire | n2=en:hyperchloremic metabolic acidosis (hco3 17.2 +/- 2.5 mm, dominant) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperchloremic metabolic acidosis (hco3 17.6 +/- 1.5 mm, recessive)
n1=hyperlaxité ligamentaire | n2=en:hyperchloremic metabolic acidosis (hco3 17.6 +/- 1.5 mm, recessive) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperchloremic metabolic acidosis, mild (hco3 20.8 +/- 2.3 mm)
n1=hyperlaxité ligamentaire | n2=en:hyperchloremic metabolic acidosis, mild (hco3 20.8 +/- 2.3 mm) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperchloremic metabolic acidosis, mild, in some cases (hco3 22.4 +/- 4.6 mm)
n1=hyperlaxité ligamentaire | n2=en:hyperchloremic metabolic acidosis, mild, in some cases (hco3 22.4 +/- 4.6 mm) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperchloridura
n1=hyperlaxité ligamentaire | n2=en:hyperchloridura | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypercholesterolemia
n1=hyperlaxité ligamentaire | n2=en:hypercholesterolemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypercholesterolemia (10%)
n1=hyperlaxité ligamentaire | n2=en:hypercholesterolemia (10%) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypercholesterolemia (disorder)
n1=hyperlaxité ligamentaire | n2=en:hypercholesterolemia (disorder) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypercholesterolemia (in 75%)
n1=hyperlaxité ligamentaire | n2=en:hypercholesterolemia (in 75%) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypercholesterolemia (reported in 2 patients)
n1=hyperlaxité ligamentaire | n2=en:hypercholesterolemia (reported in 2 patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypercholesterolemia, 350-550 mg/l in heterozygotes, 650-1000 mg/l in homozygotes
n1=hyperlaxité ligamentaire | n2=en:hypercholesterolemia, 350-550 mg/l in heterozygotes, 650-1000 mg/l in homozygotes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypergammaglobulinemia
n1=hyperlaxité ligamentaire | n2=en:hypergammaglobulinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperglobulinemia
n1=hyperlaxité ligamentaire | n2=en:hyperglobulinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperglucagonemia
n1=hyperlaxité ligamentaire | n2=en:hyperglucagonemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperglutaminemia
n1=hyperlaxité ligamentaire | n2=en:hyperglutaminemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperglycemia
n1=hyperlaxité ligamentaire | n2=en:hyperglycemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperglycemia during crises
n1=hyperlaxité ligamentaire | n2=en:hyperglycemia during crises | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperglycemias, postprandial
n1=hyperlaxité ligamentaire | n2=en:hyperglycemias, postprandial | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperglycinemia
n1=hyperlaxité ligamentaire | n2=en:hyperglycinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperglycinemia (1 patient)
n1=hyperlaxité ligamentaire | n2=en:hyperglycinemia (1 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperglycinuria (disorder)
n1=hyperlaxité ligamentaire | n2=en:hyperglycinuria (disorder) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperglycolic aciduria
n1=hyperlaxité ligamentaire | n2=en:hyperglycolic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperhomocystinemia
n1=hyperlaxité ligamentaire | n2=en:hyperhomocystinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperinsulinemia
n1=hyperlaxité ligamentaire | n2=en:hyperinsulinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperinsulinemic hypoglycemia, familial, 7
n1=hyperlaxité ligamentaire | n2=en:hyperinsulinemic hypoglycemia, familial, 7 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperkalemia
n1=hyperlaxité ligamentaire | n2=en:hyperkalemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperkalemia (>6.2 mm in both dominant and recessive)
n1=hyperlaxité ligamentaire | n2=en:hyperkalemia (>6.2 mm in both dominant and recessive) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperkalemia (5.8 +/- 0.8 mm)
n1=hyperlaxité ligamentaire | n2=en:hyperkalemia (5.8 +/- 0.8 mm) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperkalemia (6.4 +/- 0.7 mm)
n1=hyperlaxité ligamentaire | n2=en:hyperkalemia (6.4 +/- 0.7 mm) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperkalemia (7.5 +/- 0.9 mm)
n1=hyperlaxité ligamentaire | n2=en:hyperkalemia (7.5 +/- 0.9 mm) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperkalemia during attacks
n1=hyperlaxité ligamentaire | n2=en:hyperkalemia during attacks | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperkalemic metabolic acidosis
n1=hyperlaxité ligamentaire | n2=en:hyperkalemic metabolic acidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperkeratosis of fissured heel
n1=hyperlaxité ligamentaire | n2=en:hyperkeratosis of fissured heel | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperleukocytosis
n1=hyperlaxité ligamentaire | n2=en:hyperleukocytosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperlipaemia
n1=hyperlaxité ligamentaire | n2=en:hyperlipaemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperlipasemia
n1=hyperlaxité ligamentaire | n2=en:hyperlipasemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperlipemia with familial hypercholesterolemic xanthomatosis
n1=hyperlaxité ligamentaire | n2=en:hyperlipemia with familial hypercholesterolemic xanthomatosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperlipidaemia
n1=hyperlaxité ligamentaire | n2=en:hyperlipidaemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperlipidaemias nec
n1=hyperlaxité ligamentaire | n2=en:hyperlipidaemias nec | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperlipidemia
n1=hyperlaxité ligamentaire | n2=en:hyperlipidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperlipidemia risk assessment with new zealand table
n1=hyperlaxité ligamentaire | n2=en:hyperlipidemia risk assessment with new zealand table | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperlipidemia screening
n1=hyperlaxité ligamentaire | n2=en:hyperlipidemia screening | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperlipidemia, familial combined
n1=hyperlaxité ligamentaire | n2=en:hyperlipidemia, familial combined | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperlipidemia, group a
n1=hyperlaxité ligamentaire | n2=en:hyperlipidemia, group a | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperlipoidaemia
n1=hyperlaxité ligamentaire | n2=en:hyperlipoidaemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperlipoproteinemia
n1=hyperlaxité ligamentaire | n2=en:hyperlipoproteinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperlipoproteinemia type i
n1=hyperlaxité ligamentaire | n2=en:hyperlipoproteinemia type i | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperlipoproteinemia type iib
n1=hyperlaxité ligamentaire | n2=en:hyperlipoproteinemia type iib | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperlysinemia
n1=hyperlaxité ligamentaire | n2=en:hyperlysinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypermagnesemia
n1=hyperlaxité ligamentaire | n2=en:hypermagnesemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypermagnesiuria
n1=hyperlaxité ligamentaire | n2=en:hypermagnesiuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypermethioninemia, progressive
n1=hyperlaxité ligamentaire | n2=en:hypermethioninemia, progressive | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypernatremia
n1=hyperlaxité ligamentaire | n2=en:hypernatremia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypernatremic dehydration
n1=hyperlaxité ligamentaire | n2=en:hypernatremic dehydration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypernatriuria
n1=hyperlaxité ligamentaire | n2=en:hypernatriuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperornithinemia
n1=hyperlaxité ligamentaire | n2=en:hyperornithinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperoxalaemia
n1=hyperlaxité ligamentaire | n2=en:hyperoxalaemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperoxaluria
n1=hyperlaxité ligamentaire | n2=en:hyperoxaluria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperphenylalaninemia
n1=hyperlaxité ligamentaire | n2=en:hyperphenylalaninemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperphosphatemia
n1=hyperlaxité ligamentaire | n2=en:hyperphosphatemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperphosphatemia, transient
n1=hyperlaxité ligamentaire | n2=en:hyperphosphatemia, transient | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperpipecolatemia
n1=hyperlaxité ligamentaire | n2=en:hyperpipecolatemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperprolactinemia
n1=hyperlaxité ligamentaire | n2=en:hyperprolactinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperprolinemia (10-15 times normal)
n1=hyperlaxité ligamentaire | n2=en:hyperprolinemia (10-15 times normal) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperprolinemia (5-10 times normal)
n1=hyperlaxité ligamentaire | n2=en:hyperprolinemia (5-10 times normal) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperprolinemia type 1
n1=hyperlaxité ligamentaire | n2=en:hyperprolinemia type 1 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperprostaglandinuria
n1=hyperlaxité ligamentaire | n2=en:hyperprostaglandinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperpyrexia (less common)
n1=hyperlaxité ligamentaire | n2=en:hyperpyrexia (less common) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperpyrexia, usually associated with anesthesia
n1=hyperlaxité ligamentaire | n2=en:hyperpyrexia, usually associated with anesthesia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperthermia
n1=hyperlaxité ligamentaire | n2=en:hyperthermia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperthreoninemia
n1=hyperlaxité ligamentaire | n2=en:hyperthreoninemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperthreoninuria
n1=hyperlaxité ligamentaire | n2=en:hyperthreoninuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypertonic dehydration
n1=hyperlaxité ligamentaire | n2=en:hypertonic dehydration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypertriglyceridemia
n1=hyperlaxité ligamentaire | n2=en:hypertriglyceridemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypertriglyceridemia (in some patients)
n1=hyperlaxité ligamentaire | n2=en:hypertriglyceridemia (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypertriglyceridemia (rare)
n1=hyperlaxité ligamentaire | n2=en:hypertriglyceridemia (rare) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypertriglyceridemia, transient
n1=hyperlaxité ligamentaire | n2=en:hypertriglyceridemia, transient | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypertryptophanemia
n1=hyperlaxité ligamentaire | n2=en:hypertryptophanemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperuricemia
n1=hyperlaxité ligamentaire | n2=en:hyperuricemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperuricosuria
n1=hyperlaxité ligamentaire | n2=en:hyperuricosuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperuricuria
n1=hyperlaxité ligamentaire | n2=en:hyperuricuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyperviscosity syndrome
n1=hyperlaxité ligamentaire | n2=en:hyperviscosity syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypervolemia
n1=hyperlaxité ligamentaire | n2=en:hypervolemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoalbuminemia
n1=hyperlaxité ligamentaire | n2=en:hypoalbuminemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoalbuminemia (in 83%)
n1=hyperlaxité ligamentaire | n2=en:hypoalbuminemia (in 83%) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoalphalipoproteinemia
n1=hyperlaxité ligamentaire | n2=en:hypoalphalipoproteinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypobetalipoproteinemias
n1=hyperlaxité ligamentaire | n2=en:hypobetalipoproteinemias | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypocalcemia
n1=hyperlaxité ligamentaire | n2=en:hypocalcemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypocalcemia (64% of adults)
n1=hyperlaxité ligamentaire | n2=en:hypocalcemia (64% of adults) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypocalcemia (male)
n1=hyperlaxité ligamentaire | n2=en:hypocalcemia (male) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypocalcemia, transient
n1=hyperlaxité ligamentaire | n2=en:hypocalcemia, transient | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypocalciuria
n1=hyperlaxité ligamentaire | n2=en:hypocalciuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypocalciuria or normocalciuria
n1=hyperlaxité ligamentaire | n2=en:hypocalciuria or normocalciuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypocellular bone marrow
n1=hyperlaxité ligamentaire | n2=en:hypocellular bone marrow | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypochloremia (disorder)
n1=hyperlaxité ligamentaire | n2=en:hypochloremia (disorder) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypochloremic metabolic alkalosis
n1=hyperlaxité ligamentaire | n2=en:hypochloremic metabolic alkalosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypocholesterolemia
n1=hyperlaxité ligamentaire | n2=en:hypocholesterolemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypochromia
n1=hyperlaxité ligamentaire | n2=en:hypochromia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypocitraturia
n1=hyperlaxité ligamentaire | n2=en:hypocitraturia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypofibrinogenemia
n1=hyperlaxité ligamentaire | n2=en:hypofibrinogenemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypogammaglobulinemia
n1=hyperlaxité ligamentaire | n2=en:hypogammaglobulinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypogammaglobulinemia (in some patients)
n1=hyperlaxité ligamentaire | n2=en:hypogammaglobulinemia (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypogammaglobulinemia, profound
n1=hyperlaxité ligamentaire | n2=en:hypogammaglobulinemia, profound | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoglobulinemia
n1=hyperlaxité ligamentaire | n2=en:hypoglobulinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoglycaemic episode
n1=hyperlaxité ligamentaire | n2=en:hypoglycaemic episode | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoglycemia
n1=hyperlaxité ligamentaire | n2=en:hypoglycemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoglycemia, acute
n1=hyperlaxité ligamentaire | n2=en:hypoglycemia, acute | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoglycemia, episodic, in infants
n1=hyperlaxité ligamentaire | n2=en:hypoglycemia, episodic, in infants | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoglycemia, fasting
n1=hyperlaxité ligamentaire | n2=en:hypoglycemia, fasting | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoglycemia, intermittent
n1=hyperlaxité ligamentaire | n2=en:hypoglycemia, intermittent | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoglycemia, leucine-induced
n1=hyperlaxité ligamentaire | n2=en:hypoglycemia, leucine-induced | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoglycemia, neonatal (in some patients)
n1=hyperlaxité ligamentaire | n2=en:hypoglycemia, neonatal (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoglycemia, oral protein-induced
n1=hyperlaxité ligamentaire | n2=en:hypoglycemia, oral protein-induced | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoglycorrhachia (low glucose in csf)
n1=hyperlaxité ligamentaire | n2=en:hypoglycorrhachia (low glucose in csf) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoglycosylated serum transferrin
n1=hyperlaxité ligamentaire | n2=en:hypoglycosylated serum transferrin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoglycosylation of plasma glycoproteins
n1=hyperlaxité ligamentaire | n2=en:hypoglycosylation of plasma glycoproteins | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoinsulinemic hypoglycemia
n1=hyperlaxité ligamentaire | n2=en:hypoinsulinemic hypoglycemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypokalemia
n1=hyperlaxité ligamentaire | n2=en:hypokalemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypokalemia during attacks
n1=hyperlaxité ligamentaire | n2=en:hypokalemia during attacks | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypokalemia during periodic paralysis (most patients)
n1=hyperlaxité ligamentaire | n2=en:hypokalemia during periodic paralysis (most patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypokalemia occurs during paralytic attacks
n1=hyperlaxité ligamentaire | n2=en:hypokalemia occurs during paralytic attacks | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypokalemic alkalosis
n1=hyperlaxité ligamentaire | n2=en:hypokalemic alkalosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypokalemic hypochloremic metabolic alkalosis
n1=hyperlaxité ligamentaire | n2=en:hypokalemic hypochloremic metabolic alkalosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypokalemic metabolic alkalosis
n1=hyperlaxité ligamentaire | n2=en:hypokalemic metabolic alkalosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoketotic dicarboxylic aciduria (in some patients)
n1=hyperlaxité ligamentaire | n2=en:hypoketotic dicarboxylic aciduria (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoketotic hypoglycemia
n1=hyperlaxité ligamentaire | n2=en:hypoketotic hypoglycemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoketotic hypoglycemia (in some patients)
n1=hyperlaxité ligamentaire | n2=en:hypoketotic hypoglycemia (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoketotic hypoglycemia under fasting conditions
n1=hyperlaxité ligamentaire | n2=en:hypoketotic hypoglycemia under fasting conditions | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoketotic hypoglycemic episodes, acute
n1=hyperlaxité ligamentaire | n2=en:hypoketotic hypoglycemic episodes, acute | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypolipidemia
n1=hyperlaxité ligamentaire | n2=en:hypolipidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypolipoproteinemias
n1=hyperlaxité ligamentaire | n2=en:hypolipoproteinemias | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypomagnesemia
n1=hyperlaxité ligamentaire | n2=en:hypomagnesemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypomethioninemia
n1=hyperlaxité ligamentaire | n2=en:hypomethioninemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypomethylation of alpha-satellite repeats on chromosome 9
n1=hyperlaxité ligamentaire | n2=en:hypomethylation of alpha-satellite repeats on chromosome 9 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypomethylation of satellite repeats on chromosome 1, 9, and 16
n1=hyperlaxité ligamentaire | n2=en:hypomethylation of satellite repeats on chromosome 1, 9, and 16 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyponatremia
n1=hyperlaxité ligamentaire | n2=en:hyponatremia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyponatremia in infancy
n1=hyperlaxité ligamentaire | n2=en:hyponatremia in infancy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyponatremic dehydration, episodic
n1=hyperlaxité ligamentaire | n2=en:hyponatremic dehydration, episodic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyponatremic dehydration, rarely
n1=hyperlaxité ligamentaire | n2=en:hyponatremic dehydration, rarely | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypophosphatasia
n1=hyperlaxité ligamentaire | n2=en:hypophosphatasia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypophosphatemia
n1=hyperlaxité ligamentaire | n2=en:hypophosphatemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypophosphatemia (in some patients)
n1=hyperlaxité ligamentaire | n2=en:hypophosphatemia (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypophosphatemia (less common)
n1=hyperlaxité ligamentaire | n2=en:hypophosphatemia (less common) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypophosphatemia due to decreased renal tubular phosphate reabsorption
n1=hyperlaxité ligamentaire | n2=en:hypophosphatemia due to decreased renal tubular phosphate reabsorption | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypophosphatemic rickets
n1=hyperlaxité ligamentaire | n2=en:hypophosphatemic rickets | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypophosphatemic rickets (in some patients)
n1=hyperlaxité ligamentaire | n2=en:hypophosphatemic rickets (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoprebetalipoproteinemia
n1=hyperlaxité ligamentaire | n2=en:hypoprebetalipoproteinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoprolactinemia
n1=hyperlaxité ligamentaire | n2=en:hypoprolactinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoproteinemia
n1=hyperlaxité ligamentaire | n2=en:hypoproteinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoproteinemia (in 1 patient)
n1=hyperlaxité ligamentaire | n2=en:hypoproteinemia (in 1 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoproteinemia due to hypercatabolism
n1=hyperlaxité ligamentaire | n2=en:hypoproteinemia due to hypercatabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyposialylation of o-linked serum glycans
n1=hyperlaxité ligamentaire | n2=en:hyposialylation of o-linked serum glycans | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hyposthenuria (inability to concentrate urine normally)
n1=hyperlaxité ligamentaire | n2=en:hyposthenuria (inability to concentrate urine normally) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypothermia, episodic, in infants
n1=hyperlaxité ligamentaire | n2=en:hypothermia, episodic, in infants | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypouricemia
n1=hyperlaxité ligamentaire | n2=en:hypouricemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypovolemia
n1=hyperlaxité ligamentaire | n2=en:hypovolemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoxemia
n1=hyperlaxité ligamentaire | n2=en:hypoxemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:hypoxia
n1=hyperlaxité ligamentaire | n2=en:hypoxia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:i-cell disease
n1=hyperlaxité ligamentaire | n2=en:i-cell disease | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:idiopathic nephrotic syndrome
n1=hyperlaxité ligamentaire | n2=en:idiopathic nephrotic syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:iduronate sulfatase deficiency in fibroblasts, amniocytes and white blood cells
n1=hyperlaxité ligamentaire | n2=en:iduronate sulfatase deficiency in fibroblasts, amniocytes and white blood cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:iga antiendomysial antibodies (ema)
n1=hyperlaxité ligamentaire | n2=en:iga antiendomysial antibodies (ema) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:igg deficiency
n1=hyperlaxité ligamentaire | n2=en:igg deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:igg, decreased
n1=hyperlaxité ligamentaire | n2=en:igg, decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:igg, elevated
n1=hyperlaxité ligamentaire | n2=en:igg, elevated | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:igm deficiency
n1=hyperlaxité ligamentaire | n2=en:igm deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:iiga and igg antigliadin antibodies (aga)
n1=hyperlaxité ligamentaire | n2=en:iiga and igg antigliadin antibodies (aga) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:immediate (type i) skin test reactivity
n1=hyperlaxité ligamentaire | n2=en:immediate (type i) skin test reactivity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:immotile cilia
n1=hyperlaxité ligamentaire | n2=en:immotile cilia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:immotile or weakly motile cilia
n1=hyperlaxité ligamentaire | n2=en:immotile or weakly motile cilia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:immunoglobulin a decreased
n1=hyperlaxité ligamentaire | n2=en:immunoglobulin a decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:immunoglobulin antibodies present
n1=hyperlaxité ligamentaire | n2=en:immunoglobulin antibodies present | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:immunology aspects
n1=hyperlaxité ligamentaire | n2=en:immunology aspects | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:immunoreactive pc protein
n1=hyperlaxité ligamentaire | n2=en:immunoreactive pc protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:impaired carnitine uptake in muscle, heart, kidney, fibroblasts, and lymphocytes
n1=hyperlaxité ligamentaire | n2=en:impaired carnitine uptake in muscle, heart, kidney, fibroblasts, and lymphocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:impaired creatine uptake in fibroblasts
n1=hyperlaxité ligamentaire | n2=en:impaired creatine uptake in fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:impaired gluconeogenesis
n1=hyperlaxité ligamentaire | n2=en:impaired gluconeogenesis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:impaired glucose tolerance (in some patients)
n1=hyperlaxité ligamentaire | n2=en:impaired glucose tolerance (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:impaired lipolysis
n1=hyperlaxité ligamentaire | n2=en:impaired lipolysis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:impaired long-chain fatty acid oxidation during prolonged, low-intensity exercise
n1=hyperlaxité ligamentaire | n2=en:impaired long-chain fatty acid oxidation during prolonged, low-intensity exercise | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:impaired mitochondrial translation
n1=hyperlaxité ligamentaire | n2=en:impaired mitochondrial translation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:impaired n-glycosylation
n1=hyperlaxité ligamentaire | n2=en:impaired n-glycosylation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:impaired o-glycosylation
n1=hyperlaxité ligamentaire | n2=en:impaired o-glycosylation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:impaired oxidation of pyruvate
n1=hyperlaxité ligamentaire | n2=en:impaired oxidation of pyruvate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:impaired platelet aggregation
n1=hyperlaxité ligamentaire | n2=en:impaired platelet aggregation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:impaired response to gm-csf
n1=hyperlaxité ligamentaire | n2=en:impaired response to gm-csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:impaired synthesis of fibroblast sulfated proteoglycans
n1=hyperlaxité ligamentaire | n2=en:impaired synthesis of fibroblast sulfated proteoglycans | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:impairment of urinary concentration
n1=hyperlaxité ligamentaire | n2=en:impairment of urinary concentration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:in blood
n1=hyperlaxité ligamentaire | n2=en:in blood | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:in untreated patients - elevated blood galactose urine reducing substances (galactosuria), hyperchloremic metabolic acidosis, aminoaciduria, elevated liver enzymes, albuminuria
n1=hyperlaxité ligamentaire | n2=en:in untreated patients - elevated blood galactose urine reducing substances (galactosuria), hyperchloremic metabolic acidosis, aminoaciduria, elevated liver enzymes, albuminuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:in urine
n1=hyperlaxité ligamentaire | n2=en:in urine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:inactive mutant form of red cell carbonic anhydrase b in one sibship
n1=hyperlaxité ligamentaire | n2=en:inactive mutant form of red cell carbonic anhydrase b in one sibship | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:inappropriately increased urine osmolality
n1=hyperlaxité ligamentaire | n2=en:inappropriately increased urine osmolality | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:inappropriately low urine osmolality
n1=hyperlaxité ligamentaire | n2=en:inappropriately low urine osmolality | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:inappropriately normal or increased plasma hepcidin
n1=hyperlaxité ligamentaire | n2=en:inappropriately normal or increased plasma hepcidin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:inappropriately normal serum 1,25-dihydroxyvitamin d3
n1=hyperlaxité ligamentaire | n2=en:inappropriately normal serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:inappropriately normal to low-normal serum 1,25-dihydroxyvitamin d3
n1=hyperlaxité ligamentaire | n2=en:inappropriately normal to low-normal serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:inborn lipid/lipoprotein disorder
n1=hyperlaxité ligamentaire | n2=en:inborn lipid/lipoprotein disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:inclusion bodies (membrane-bound vacuoles) in fibroblasts
n1=hyperlaxité ligamentaire | n2=en:inclusion bodies (membrane-bound vacuoles) in fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:inclusions contain phospholipids, phosphatidylcholine, sphingolipids, gangliosides, mucopolysaccharides
n1=hyperlaxité ligamentaire | n2=en:inclusions contain phospholipids, phosphatidylcholine, sphingolipids, gangliosides, mucopolysaccharides | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:incomplete distal renal tubular acidosis
n1=hyperlaxité ligamentaire | n2=en:incomplete distal renal tubular acidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:incomplete n-glycosylation of cellular proteins
n1=hyperlaxité ligamentaire | n2=en:incomplete n-glycosylation of cellular proteins | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increase urinary excretion of lysine, arginine, and ornithine
n1=hyperlaxité ligamentaire | n2=en:increase urinary excretion of lysine, arginine, and ornithine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased 11-deoxycorticosterone
n1=hyperlaxité ligamentaire | n2=en:increased 11-deoxycorticosterone | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased 11-deoxycortisol
n1=hyperlaxité ligamentaire | n2=en:increased 11-deoxycortisol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased 18-hydroxycortisol
n1=hyperlaxité ligamentaire | n2=en:increased 18-hydroxycortisol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased 18-ohb to aldosterone ratio
n1=hyperlaxité ligamentaire | n2=en:increased 18-ohb to aldosterone ratio | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased 18-oxocortisol
n1=hyperlaxité ligamentaire | n2=en:increased 18-oxocortisol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased acetoacetate: beta-hydroxybutyrate ratio (group b)
n1=hyperlaxité ligamentaire | n2=en:increased acetoacetate: beta-hydroxybutyrate ratio (group b) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased acetylcholinesterase (ache) in amniotic fluid
n1=hyperlaxité ligamentaire | n2=en:increased acetylcholinesterase (ache) in amniotic fluid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased activity of the prpp synthetase 1 enzyme
n1=hyperlaxité ligamentaire | n2=en:increased activity of the prpp synthetase 1 enzyme | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased alpha-fetoprotein (1 patient)
n1=hyperlaxité ligamentaire | n2=en:increased alpha-fetoprotein (1 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased alpha-fetoprotein in the mother during early pregnancy while carrying an affected fetus
n1=hyperlaxité ligamentaire | n2=en:increased alpha-fetoprotein in the mother during early pregnancy while carrying an affected fetus | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased ammonia with exercise
n1=hyperlaxité ligamentaire | n2=en:increased ammonia with exercise | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased beta-alanine (in 1 of 2 patients)
n1=hyperlaxité ligamentaire | n2=en:increased beta-alanine (in 1 of 2 patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased bile acid intermediates (dhca and thca)
n1=hyperlaxité ligamentaire | n2=en:increased bile acid intermediates (dhca and thca) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased biliverdin in bodily fluids
n1=hyperlaxité ligamentaire | n2=en:increased biliverdin in bodily fluids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased biopterin in urine and csf
n1=hyperlaxité ligamentaire | n2=en:increased biopterin in urine and csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased blood alanine
n1=hyperlaxité ligamentaire | n2=en:increased blood alanine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased body temperature, episodic, in some patients
n1=hyperlaxité ligamentaire | n2=en:increased body temperature, episodic, in some patients | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased bone serum acid phosphatase
n1=hyperlaxité ligamentaire | n2=en:increased bone serum acid phosphatase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased bone-specific alkaline phosphatase
n1=hyperlaxité ligamentaire | n2=en:increased bone-specific alkaline phosphatase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased c10:2-carnitine
n1=hyperlaxité ligamentaire | n2=en:increased c10:2-carnitine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased cellular sensitivity to uv light
n1=hyperlaxité ligamentaire | n2=en:increased cellular sensitivity to uv light | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased cerebrospinal fluid (csf) protein (>100mg/dl)
n1=hyperlaxité ligamentaire | n2=en:increased cerebrospinal fluid (csf) protein (>100mg/dl) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased cholesterol
n1=hyperlaxité ligamentaire | n2=en:increased cholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased chromosomal breakage
n1=hyperlaxité ligamentaire | n2=en:increased chromosomal breakage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased chromosomal breaks in response to cross-linking agents and ionizing radiation
n1=hyperlaxité ligamentaire | n2=en:increased chromosomal breaks in response to cross-linking agents and ionizing radiation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased chromosomal rearrangements (bone marrow and fibroblast culture)
n1=hyperlaxité ligamentaire | n2=en:increased chromosomal rearrangements (bone marrow and fibroblast culture) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased circulating renin level
n1=hyperlaxité ligamentaire | n2=en:increased circulating renin level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased ck-mb
n1=hyperlaxité ligamentaire | n2=en:increased ck-mb | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased coproporphyrin isomer iii:i ratio (hcp, feces)
n1=hyperlaxité ligamentaire | n2=en:increased coproporphyrin isomer iii:i ratio (hcp, feces) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased creatine kinase (ck)
n1=hyperlaxité ligamentaire | n2=en:increased creatine kinase (ck) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased creatine kinase, mild to moderate
n1=hyperlaxité ligamentaire | n2=en:increased creatine kinase, mild to moderate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased creatinine
n1=hyperlaxité ligamentaire | n2=en:increased creatinine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased cross-linked c-terminal telopeptide of type i collagen
n1=hyperlaxité ligamentaire | n2=en:increased cross-linked c-terminal telopeptide of type i collagen | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf 3-methoxytyrosine (3-mt)
n1=hyperlaxité ligamentaire | n2=en:increased csf 3-methoxytyrosine (3-mt) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf and plasma gaba
n1=hyperlaxité ligamentaire | n2=en:increased csf and plasma gaba | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf and plasma ghb
n1=hyperlaxité ligamentaire | n2=en:increased csf and plasma ghb | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf glycine
n1=hyperlaxité ligamentaire | n2=en:increased csf glycine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf histidine
n1=hyperlaxité ligamentaire | n2=en:increased csf histidine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf homovanillic acid (hva)
n1=hyperlaxité ligamentaire | n2=en:increased csf homovanillic acid (hva) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf immunoglobulin levels
n1=hyperlaxité ligamentaire | n2=en:increased csf immunoglobulin levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf interferon
n1=hyperlaxité ligamentaire | n2=en:increased csf interferon | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf interferon alpha
n1=hyperlaxité ligamentaire | n2=en:increased csf interferon alpha | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf lactate
n1=hyperlaxité ligamentaire | n2=en:increased csf lactate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf lactate during acute episodes
n1=hyperlaxité ligamentaire | n2=en:increased csf lactate during acute episodes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf protein
n1=hyperlaxité ligamentaire | n2=en:increased csf protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf protein during acute illness
n1=hyperlaxité ligamentaire | n2=en:increased csf protein during acute illness | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf pyruvic acid
n1=hyperlaxité ligamentaire | n2=en:increased csf pyruvic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf taurine
n1=hyperlaxité ligamentaire | n2=en:increased csf taurine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf threonine
n1=hyperlaxité ligamentaire | n2=en:increased csf threonine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf transferrin despite normal serum transferrin levels
n1=hyperlaxité ligamentaire | n2=en:increased csf transferrin despite normal serum transferrin levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf, plasma, and urinary 3-methoxytyrosine
n1=hyperlaxité ligamentaire | n2=en:increased csf, plasma, and urinary 3-methoxytyrosine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf, plasma, and urinary 3-ortho-methyldopa (3-omd)
n1=hyperlaxité ligamentaire | n2=en:increased csf, plasma, and urinary 3-ortho-methyldopa (3-omd) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf, plasma, and urinary 5-hydroxytryptophan (5htp)
n1=hyperlaxité ligamentaire | n2=en:increased csf, plasma, and urinary 5-hydroxytryptophan (5htp) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased csf, plasma, and urinary l-dopa
n1=hyperlaxité ligamentaire | n2=en:increased csf, plasma, and urinary l-dopa | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased d-glyceric acid in serum, urine, and csf
n1=hyperlaxité ligamentaire | n2=en:increased d-glyceric acid in serum, urine, and csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased di- and asialo-transferrin
n1=hyperlaxité ligamentaire | n2=en:increased di- and asialo-transferrin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased di- and asialo-transferrin characteristic of type 1 pattern
n1=hyperlaxité ligamentaire | n2=en:increased di- and asialo-transferrin characteristic of type 1 pattern | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased disialo- and asialotransferrin
n1=hyperlaxité ligamentaire | n2=en:increased disialo- and asialotransferrin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased disialotransferrin and asialotransferrin levels
n1=hyperlaxité ligamentaire | n2=en:increased disialotransferrin and asialotransferrin levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased erythrocyte sedimentation rate, episodic
n1=hyperlaxité ligamentaire | n2=en:increased erythrocyte sedimentation rate, episodic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased erythrocyte-membrane calcium-magnesium-atpase
n1=hyperlaxité ligamentaire | n2=en:increased erythrocyte-membrane calcium-magnesium-atpase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased erythropoietin
n1=hyperlaxité ligamentaire | n2=en:increased erythropoietin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased excretion of urobilinogen
n1=hyperlaxité ligamentaire | n2=en:increased excretion of urobilinogen | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased fas ligand
n1=hyperlaxité ligamentaire | n2=en:increased fas ligand | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased ferritin
n1=hyperlaxité ligamentaire | n2=en:increased ferritin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased fibroblast free sialic acid
n1=hyperlaxité ligamentaire | n2=en:increased fibroblast free sialic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased fractional excretion of urate (greater than 50%)
n1=hyperlaxité ligamentaire | n2=en:increased fractional excretion of urate (greater than 50%) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased fractional excretion of uric acid
n1=hyperlaxité ligamentaire | n2=en:increased fractional excretion of uric acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased free cyanocobalamin in fibroblasts
n1=hyperlaxité ligamentaire | n2=en:increased free cyanocobalamin in fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased free erythrocyte protoporphyrin
n1=hyperlaxité ligamentaire | n2=en:increased free erythrocyte protoporphyrin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased frequency of premature centromere disjunction (pcd) in cultured fibroblasts, esp. chromosome 3
n1=hyperlaxité ligamentaire | n2=en:increased frequency of premature centromere disjunction (pcd) in cultured fibroblasts, esp. chromosome 3 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased gamma-aminobutyric acid in plasma, urine, and cerebrospinal fluid (csf)
n1=hyperlaxité ligamentaire | n2=en:increased gamma-aminobutyric acid in plasma, urine, and cerebrospinal fluid (csf) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased gamma-interferon
n1=hyperlaxité ligamentaire | n2=en:increased gamma-interferon | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased growth hormone (in 1 of 2 patients)
n1=hyperlaxité ligamentaire | n2=en:increased growth hormone (in 1 of 2 patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased harderoporphyrin excretion (feces, harderoporphyria)
n1=hyperlaxité ligamentaire | n2=en:increased harderoporphyrin excretion (feces, harderoporphyria) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased hepatic parenchymal cell stainable iron
n1=hyperlaxité ligamentaire | n2=en:increased hepatic parenchymal cell stainable iron | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased histidine in blood, urine, and csf
n1=hyperlaxité ligamentaire | n2=en:increased histidine in blood, urine, and csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased iga level
n1=hyperlaxité ligamentaire | n2=en:increased iga level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased ige level
n1=hyperlaxité ligamentaire | n2=en:increased ige level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased igg level
n1=hyperlaxité ligamentaire | n2=en:increased igg level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased igm level
n1=hyperlaxité ligamentaire | n2=en:increased igm level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased il-6
n1=hyperlaxité ligamentaire | n2=en:increased il-6 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased il-8
n1=hyperlaxité ligamentaire | n2=en:increased il-8 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased il18
n1=hyperlaxité ligamentaire | n2=en:increased il18 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased il1b increased soluble il2r
n1=hyperlaxité ligamentaire | n2=en:increased il1b increased soluble il2r | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased il6, episodic
n1=hyperlaxité ligamentaire | n2=en:increased il6, episodic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased interferon-alpha signal
n1=hyperlaxité ligamentaire | n2=en:increased interferon-alpha signal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased interleukin 10
n1=hyperlaxité ligamentaire | n2=en:increased interleukin 10 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased intracellular fmrp mrna
n1=hyperlaxité ligamentaire | n2=en:increased intracellular fmrp mrna | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased ketone body or lactate/pyruvate plasma ratios
n1=hyperlaxité ligamentaire | n2=en:increased ketone body or lactate/pyruvate plasma ratios | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased l-2-hydroxyglutaric acid in urine, serum, and csf
n1=hyperlaxité ligamentaire | n2=en:increased l-2-hydroxyglutaric acid in urine, serum, and csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased lactate in spinal fluid
n1=hyperlaxité ligamentaire | n2=en:increased lactate in spinal fluid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased lactate: pyruvate ratio (group b)
n1=hyperlaxité ligamentaire | n2=en:increased lactate: pyruvate ratio (group b) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased level of globotriaosylceramide (gb3) in plasma and urinary sediment
n1=hyperlaxité ligamentaire | n2=en:increased level of globotriaosylceramide (gb3) in plasma and urinary sediment | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased levels of 3-alpha-7-alpha-12-alpha-trihydroxy-5-beta-cholestanoic acid (thca) in bile, urine, and serum
n1=hyperlaxité ligamentaire | n2=en:increased levels of 3-alpha-7-alpha-12-alpha-trihydroxy-5-beta-cholestanoic acid (thca) in bile, urine, and serum | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased levels of carcinoembryonic antigen
n1=hyperlaxité ligamentaire | n2=en:increased levels of carcinoembryonic antigen | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased levels of dihydroxyacetone phosphate (dhap) in tissues and red cells
n1=hyperlaxité ligamentaire | n2=en:increased levels of dihydroxyacetone phosphate (dhap) in tissues and red cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased lipid
n1=hyperlaxité ligamentaire | n2=en:increased lipid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased long-chain acylcarnitine
n1=hyperlaxité ligamentaire | n2=en:increased long-chain acylcarnitine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased lysine in serum and csf
n1=hyperlaxité ligamentaire | n2=en:increased lysine in serum and csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased metabolic rate
n1=hyperlaxité ligamentaire | n2=en:increased metabolic rate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased n-acetyl-l-aspartic acid (naa) in urine, csf, and blood
n1=hyperlaxité ligamentaire | n2=en:increased n-acetyl-l-aspartic acid (naa) in urine, csf, and blood | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased nasal-potential difference (1 of 3 patients)
n1=hyperlaxité ligamentaire | n2=en:increased nasal-potential difference (1 of 3 patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased nasal-potential difference (some)
n1=hyperlaxité ligamentaire | n2=en:increased nasal-potential difference (some) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased neopterin in urine and csf
n1=hyperlaxité ligamentaire | n2=en:increased neopterin in urine and csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased npn
n1=hyperlaxité ligamentaire | n2=en:increased npn | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased number of platelets
n1=hyperlaxité ligamentaire | n2=en:increased number of platelets | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased or normal serum growth hormone (gh, 139250)
n1=hyperlaxité ligamentaire | n2=en:increased or normal serum growth hormone (gh, 139250) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased osmotic fragility
n1=hyperlaxité ligamentaire | n2=en:increased osmotic fragility | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased oxygen affinity (e.g. hb nunobiki 141800.0109)
n1=hyperlaxité ligamentaire | n2=en:increased oxygen affinity (e.g. hb nunobiki 141800.0109) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased peripheral blood monocytes
n1=hyperlaxité ligamentaire | n2=en:increased peripheral blood monocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased phytanic acid in body tissues and fluids
n1=hyperlaxité ligamentaire | n2=en:increased phytanic acid in body tissues and fluids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma 2-methylbutyrylcarnitine
n1=hyperlaxité ligamentaire | n2=en:increased plasma 2-methylbutyrylcarnitine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma and urinary pipecolic acid
n1=hyperlaxité ligamentaire | n2=en:increased plasma and urinary pipecolic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma branched-chain fatty acids
n1=hyperlaxité ligamentaire | n2=en:increased plasma branched-chain fatty acids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma creatine
n1=hyperlaxité ligamentaire | n2=en:increased plasma creatine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma dihydroxyphenylacetic acid (dopac)
n1=hyperlaxité ligamentaire | n2=en:increased plasma dihydroxyphenylacetic acid (dopac) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma free cholesterol
n1=hyperlaxité ligamentaire | n2=en:increased plasma free cholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma globotriaosylsphingosine (lyso-gb3)
n1=hyperlaxité ligamentaire | n2=en:increased plasma globotriaosylsphingosine (lyso-gb3) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma homogentisic acid (hga)
n1=hyperlaxité ligamentaire | n2=en:increased plasma homogentisic acid (hga) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma lactate
n1=hyperlaxité ligamentaire | n2=en:increased plasma lactate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma levels of bile acid intermediates
n1=hyperlaxité ligamentaire | n2=en:increased plasma levels of bile acid intermediates | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma levels of very long-chain fatty acids (vlcfa)
n1=hyperlaxité ligamentaire | n2=en:increased plasma levels of very long-chain fatty acids (vlcfa) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma long-chain acylcarnitines
n1=hyperlaxité ligamentaire | n2=en:increased plasma long-chain acylcarnitines | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma phospholipids
n1=hyperlaxité ligamentaire | n2=en:increased plasma phospholipids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma phytanic acid
n1=hyperlaxité ligamentaire | n2=en:increased plasma phytanic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma pipecolic acid
n1=hyperlaxité ligamentaire | n2=en:increased plasma pipecolic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma pristanic acid
n1=hyperlaxité ligamentaire | n2=en:increased plasma pristanic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma progastrin
n1=hyperlaxité ligamentaire | n2=en:increased plasma progastrin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma proglucagon
n1=hyperlaxité ligamentaire | n2=en:increased plasma proglucagon | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma proinsulin
n1=hyperlaxité ligamentaire | n2=en:increased plasma proinsulin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma renin activity
n1=hyperlaxité ligamentaire | n2=en:increased plasma renin activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased plasma vldl, ldl
n1=hyperlaxité ligamentaire | n2=en:increased plasma vldl, ldl | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased platelet aggregation with ristocetin
n1=hyperlaxité ligamentaire | n2=en:increased platelet aggregation with ristocetin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased prevalence among the native american lumbee indians
n1=hyperlaxité ligamentaire | n2=en:increased prevalence among the native american lumbee indians | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased pristanic acid
n1=hyperlaxité ligamentaire | n2=en:increased pristanic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased prv-1 (162860) mrna
n1=hyperlaxité ligamentaire | n2=en:increased prv-1 (162860) mrna | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased pyruvate in serum and csf
n1=hyperlaxité ligamentaire | n2=en:increased pyruvate in serum and csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased rai (radioactive iodine) uptake
n1=hyperlaxité ligamentaire | n2=en:increased rai (radioactive iodine) uptake | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased red cell mass
n1=hyperlaxité ligamentaire | n2=en:increased red cell mass | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased renal tubular phosphate reabsorption
n1=hyperlaxité ligamentaire | n2=en:increased renal tubular phosphate reabsorption | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased resting metabolic rate
n1=hyperlaxité ligamentaire | n2=en:increased resting metabolic rate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased sensitivity to adrenergic and cholinergic agents
n1=hyperlaxité ligamentaire | n2=en:increased sensitivity to adrenergic and cholinergic agents | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum 1,25-dihydroxyvitamin d
n1=hyperlaxité ligamentaire | n2=en:increased serum 1,25-dihydroxyvitamin d | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum 1,25-dihydroxyvitamin d3
n1=hyperlaxité ligamentaire | n2=en:increased serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum 18-hydroxycorticosterone (18-ohb)
n1=hyperlaxité ligamentaire | n2=en:increased serum 18-hydroxycorticosterone (18-ohb) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum acyl carnitines
n1=hyperlaxité ligamentaire | n2=en:increased serum acyl carnitines | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum acylcarnitine during febrile crisis
n1=hyperlaxité ligamentaire | n2=en:increased serum acylcarnitine during febrile crisis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum acylcarnitines
n1=hyperlaxité ligamentaire | n2=en:increased serum acylcarnitines | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum alanine
n1=hyperlaxité ligamentaire | n2=en:increased serum alanine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum alanine (1 patient)
n1=hyperlaxité ligamentaire | n2=en:increased serum alanine (1 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum alkaline phosphatase (in some patients)
n1=hyperlaxité ligamentaire | n2=en:increased serum alkaline phosphatase (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum alkaline phosphatase activity of skeletal origin
n1=hyperlaxité ligamentaire | n2=en:increased serum alkaline phosphatase activity of skeletal origin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum alpha-interferon (ifna1, 147660)
n1=hyperlaxité ligamentaire | n2=en:increased serum alpha-interferon (ifna1, 147660) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum alpha-mannosidase
n1=hyperlaxité ligamentaire | n2=en:increased serum alpha-mannosidase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum ammonia (group b)
n1=hyperlaxité ligamentaire | n2=en:increased serum ammonia (group b) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum and cerebrospinal fluid levels of pipecolic acid
n1=hyperlaxité ligamentaire | n2=en:increased serum and cerebrospinal fluid levels of pipecolic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum and csf glycine
n1=hyperlaxité ligamentaire | n2=en:increased serum and csf glycine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum and csf lactate
n1=hyperlaxité ligamentaire | n2=en:increased serum and csf lactate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum and urinary 2-oxoglutarate
n1=hyperlaxité ligamentaire | n2=en:increased serum and urinary 2-oxoglutarate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum and urinary lactate
n1=hyperlaxité ligamentaire | n2=en:increased serum and urinary lactate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum aryl-sulfatase a (10-20x)
n1=hyperlaxité ligamentaire | n2=en:increased serum aryl-sulfatase a (10-20x) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum arylsulfatase a (10-20x)
n1=hyperlaxité ligamentaire | n2=en:increased serum arylsulfatase a (10-20x) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum arylsulfatase a.
n1=hyperlaxité ligamentaire | n2=en:increased serum arylsulfatase a. | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum beta-carotene
n1=hyperlaxité ligamentaire | n2=en:increased serum beta-carotene | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum beta-hexosaminidase
n1=hyperlaxité ligamentaire | n2=en:increased serum beta-hexosaminidase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum beta-hexosaminidase (10-20x)
n1=hyperlaxité ligamentaire | n2=en:increased serum beta-hexosaminidase (10-20x) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum bile acid concentration during pregnancy, resolves postpartum
n1=hyperlaxité ligamentaire | n2=en:increased serum bile acid concentration during pregnancy, resolves postpartum | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum bile acids
n1=hyperlaxité ligamentaire | n2=en:increased serum bile acids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum bilirubin (in some patients)
n1=hyperlaxité ligamentaire | n2=en:increased serum bilirubin (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum bilirubin due to hemolysis
n1=hyperlaxité ligamentaire | n2=en:increased serum bilirubin due to hemolysis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum butyryl carnitine
n1=hyperlaxité ligamentaire | n2=en:increased serum butyryl carnitine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum c-reactive protein (crp, 123260)
n1=hyperlaxité ligamentaire | n2=en:increased serum c-reactive protein (crp, 123260) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum c-reactive protein, episodic
n1=hyperlaxité ligamentaire | n2=en:increased serum c-reactive protein, episodic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum c26-bile-acid intermediates
n1=hyperlaxité ligamentaire | n2=en:increased serum c26-bile-acid intermediates | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum c4 and c5 acylcarnitine esters
n1=hyperlaxité ligamentaire | n2=en:increased serum c4 and c5 acylcarnitine esters | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum cholesterol (in 3 of 10 patients)
n1=hyperlaxité ligamentaire | n2=en:increased serum cholesterol (in 3 of 10 patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum citrulline (group b)
n1=hyperlaxité ligamentaire | n2=en:increased serum citrulline (group b) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum creatine kinase (1 family)
n1=hyperlaxité ligamentaire | n2=en:increased serum creatine kinase (1 family) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum creatine kinase (less common)
n1=hyperlaxité ligamentaire | n2=en:increased serum creatine kinase (less common) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum creatine kinase (patient a)
n1=hyperlaxité ligamentaire | n2=en:increased serum creatine kinase (patient a) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum creatine kinase during episodes
n1=hyperlaxité ligamentaire | n2=en:increased serum creatine kinase during episodes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum creatine kinase in acute stage
n1=hyperlaxité ligamentaire | n2=en:increased serum creatine kinase in acute stage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum creatine kinase in patients with muscle involvement
n1=hyperlaxité ligamentaire | n2=en:increased serum creatine kinase in patients with muscle involvement | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum creatine kinase, mild
n1=hyperlaxité ligamentaire | n2=en:increased serum creatine kinase, mild | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum deoxyuridine
n1=hyperlaxité ligamentaire | n2=en:increased serum deoxyuridine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum direct bilirubin
n1=hyperlaxité ligamentaire | n2=en:increased serum direct bilirubin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum erythropoietin (epo, 133170)
n1=hyperlaxité ligamentaire | n2=en:increased serum erythropoietin (epo, 133170) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum ferritin
n1=hyperlaxité ligamentaire | n2=en:increased serum ferritin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum ferritin (in some patients)
n1=hyperlaxité ligamentaire | n2=en:increased serum ferritin (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum fgf23
n1=hyperlaxité ligamentaire | n2=en:increased serum fgf23 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum gamma-ggt (231950)
n1=hyperlaxité ligamentaire | n2=en:increased serum gamma-ggt (231950) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum glutamine
n1=hyperlaxité ligamentaire | n2=en:increased serum glutamine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum glycerol
n1=hyperlaxité ligamentaire | n2=en:increased serum glycerol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum glycine, leucine, isoleucine, valine
n1=hyperlaxité ligamentaire | n2=en:increased serum glycine, leucine, isoleucine, valine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum gm-csf
n1=hyperlaxité ligamentaire | n2=en:increased serum gm-csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum growth hormone levels
n1=hyperlaxité ligamentaire | n2=en:increased serum growth hormone levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum iduronate sulfatase
n1=hyperlaxité ligamentaire | n2=en:increased serum iduronate sulfatase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum iduronate sulfatase (10-20x)
n1=hyperlaxité ligamentaire | n2=en:increased serum iduronate sulfatase (10-20x) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum ige
n1=hyperlaxité ligamentaire | n2=en:increased serum ige | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum insulin-like growth factor-1 (igf1, 147740)
n1=hyperlaxité ligamentaire | n2=en:increased serum insulin-like growth factor-1 (igf1, 147740) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum lactate
n1=hyperlaxité ligamentaire | n2=en:increased serum lactate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum lactate (in some patients)
n1=hyperlaxité ligamentaire | n2=en:increased serum lactate (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum lactate (mild)
n1=hyperlaxité ligamentaire | n2=en:increased serum lactate (mild) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum lactate (patient a)
n1=hyperlaxité ligamentaire | n2=en:increased serum lactate (patient a) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum lactate dehydrogenase (in 1 family)
n1=hyperlaxité ligamentaire | n2=en:increased serum lactate dehydrogenase (in 1 family) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum lactate dehydrogenase (ldh)
n1=hyperlaxité ligamentaire | n2=en:increased serum lactate dehydrogenase (ldh) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum lactate during metabolic crisis
n1=hyperlaxité ligamentaire | n2=en:increased serum lactate during metabolic crisis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum lactate hydrogenase
n1=hyperlaxité ligamentaire | n2=en:increased serum lactate hydrogenase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum lactate in acute stage
n1=hyperlaxité ligamentaire | n2=en:increased serum lactate in acute stage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum lactate, particularly after exercise
n1=hyperlaxité ligamentaire | n2=en:increased serum lactate, particularly after exercise | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum levels of free plasma thyroid hormones
n1=hyperlaxité ligamentaire | n2=en:increased serum levels of free plasma thyroid hormones | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum lipoproteins
n1=hyperlaxité ligamentaire | n2=en:increased serum lipoproteins | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum lysine (group b)
n1=hyperlaxité ligamentaire | n2=en:increased serum lysine (group b) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum manganese
n1=hyperlaxité ligamentaire | n2=en:increased serum manganese | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum methionine
n1=hyperlaxité ligamentaire | n2=en:increased serum methionine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum methionine (reported in 2 cases)
n1=hyperlaxité ligamentaire | n2=en:increased serum methionine (reported in 2 cases) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum osteocalcin
n1=hyperlaxité ligamentaire | n2=en:increased serum osteocalcin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum pancreatic secretory trypsin inhibitor (psti)
n1=hyperlaxité ligamentaire | n2=en:increased serum pancreatic secretory trypsin inhibitor (psti) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum parathyroid hormone (pth)
n1=hyperlaxité ligamentaire | n2=en:increased serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum plasminogen activator inhibitor-1 (pai1, 173360)
n1=hyperlaxité ligamentaire | n2=en:increased serum plasminogen activator inhibitor-1 (pai1, 173360) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum prostaglandin e2
n1=hyperlaxité ligamentaire | n2=en:increased serum prostaglandin e2 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum pyruvate
n1=hyperlaxité ligamentaire | n2=en:increased serum pyruvate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum pyruvate in acute stage
n1=hyperlaxité ligamentaire | n2=en:increased serum pyruvate in acute stage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum pyruvate, mild
n1=hyperlaxité ligamentaire | n2=en:increased serum pyruvate, mild | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum ratio of corticosterone to 18-hydroxycorticosterone (18-ohb)
n1=hyperlaxité ligamentaire | n2=en:increased serum ratio of corticosterone to 18-hydroxycorticosterone (18-ohb) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum s-adenosylhomocysteine
n1=hyperlaxité ligamentaire | n2=en:increased serum s-adenosylhomocysteine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum s-adenosylmethionine
n1=hyperlaxité ligamentaire | n2=en:increased serum s-adenosylmethionine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum serotonin in 25%
n1=hyperlaxité ligamentaire | n2=en:increased serum serotonin in 25% | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum thrombopoietin may occur
n1=hyperlaxité ligamentaire | n2=en:increased serum thrombopoietin may occur | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum thymidine
n1=hyperlaxité ligamentaire | n2=en:increased serum thymidine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum thyroid-stimulating hormone (tsh)
n1=hyperlaxité ligamentaire | n2=en:increased serum thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum thyrotropin
n1=hyperlaxité ligamentaire | n2=en:increased serum thyrotropin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum total cholesterol
n1=hyperlaxité ligamentaire | n2=en:increased serum total cholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum transaminases (in 1 of 3 patients)
n1=hyperlaxité ligamentaire | n2=en:increased serum transaminases (in 1 of 3 patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum transferrin
n1=hyperlaxité ligamentaire | n2=en:increased serum transferrin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum triglycerides (in some patients)
n1=hyperlaxité ligamentaire | n2=en:increased serum triglycerides (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum triiodothyronine (t3)
n1=hyperlaxité ligamentaire | n2=en:increased serum triiodothyronine (t3) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum unconjugated bilirubin
n1=hyperlaxité ligamentaire | n2=en:increased serum unconjugated bilirubin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum uric acid
n1=hyperlaxité ligamentaire | n2=en:increased serum uric acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum vascular endothelial growth factor (vegf, 192240)
n1=hyperlaxité ligamentaire | n2=en:increased serum vascular endothelial growth factor (vegf, 192240) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum vitamin b12
n1=hyperlaxité ligamentaire | n2=en:increased serum vitamin b12 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum, cerebrospinal fluid, and urinary levels of alpha-aminoadipic semialdehyde
n1=hyperlaxité ligamentaire | n2=en:increased serum, cerebrospinal fluid, and urinary levels of alpha-aminoadipic semialdehyde | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum, urinary, and csf lysine
n1=hyperlaxité ligamentaire | n2=en:increased serum, urinary, and csf lysine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased serum, urinary, and csf saccharopine (in some patients)
n1=hyperlaxité ligamentaire | n2=en:increased serum, urinary, and csf saccharopine (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased sodium-potassium pump activity
n1=hyperlaxité ligamentaire | n2=en:increased sodium-potassium pump activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased soluble il2 receptor
n1=hyperlaxité ligamentaire | n2=en:increased soluble il2 receptor | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased succinyladenosine (s-ado) in serum, urine, and csf
n1=hyperlaxité ligamentaire | n2=en:increased succinyladenosine (s-ado) in serum, urine, and csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased succinylaminoimidazole carboxamide ribotide (saicar)
n1=hyperlaxité ligamentaire | n2=en:increased succinylaminoimidazole carboxamide ribotide (saicar) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased susceptibility to ebv infection
n1=hyperlaxité ligamentaire | n2=en:increased susceptibility to ebv infection | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased sweating due to hyperthyroidism
n1=hyperlaxité ligamentaire | n2=en:increased sweating due to hyperthyroidism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased thymine and dihydrothymine in bodily fluids
n1=hyperlaxité ligamentaire | n2=en:increased thymine and dihydrothymine in bodily fluids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased thyroid-stimulating hormone (tsh)
n1=hyperlaxité ligamentaire | n2=en:increased thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased tissue levels of free fatty acids
n1=hyperlaxité ligamentaire | n2=en:increased tissue levels of free fatty acids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased tissue levels of triglycerides
n1=hyperlaxité ligamentaire | n2=en:increased tissue levels of triglycerides | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased tissue long-chain acylcarnitines
n1=hyperlaxité ligamentaire | n2=en:increased tissue long-chain acylcarnitines | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased tissue long-chain fatty acids
n1=hyperlaxité ligamentaire | n2=en:increased tissue long-chain fatty acids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased total and conjugated bilirubin
n1=hyperlaxité ligamentaire | n2=en:increased total and conjugated bilirubin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased total bilirubin may occur
n1=hyperlaxité ligamentaire | n2=en:increased total bilirubin may occur | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased toxic thioguanine nucleotides (tgns) on standard doses of thiopurine drugs
n1=hyperlaxité ligamentaire | n2=en:increased toxic thioguanine nucleotides (tgns) on standard doses of thiopurine drugs | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased transferrin saturation (>60%)
n1=hyperlaxité ligamentaire | n2=en:increased transferrin saturation (>60%) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased triglycerides (less common)
n1=hyperlaxité ligamentaire | n2=en:increased triglycerides (less common) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased uracil and dihydrouracil in bodily fluids
n1=hyperlaxité ligamentaire | n2=en:increased uracil and dihydrouracil in bodily fluids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased uric acid level
n1=hyperlaxité ligamentaire | n2=en:increased uric acid level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased uric acid with exercise
n1=hyperlaxité ligamentaire | n2=en:increased uric acid with exercise | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary 2-alpha-ketoglutaric acid
n1=hyperlaxité ligamentaire | n2=en:increased urinary 2-alpha-ketoglutaric acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary 2-butanone
n1=hyperlaxité ligamentaire | n2=en:increased urinary 2-butanone | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary 2-hydroxybutyrate
n1=hyperlaxité ligamentaire | n2=en:increased urinary 2-hydroxybutyrate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary 2-ketoglutarate (variable)
n1=hyperlaxité ligamentaire | n2=en:increased urinary 2-ketoglutarate (variable) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary 2-methyl-3 hydroxybutyrate
n1=hyperlaxité ligamentaire | n2=en:increased urinary 2-methyl-3 hydroxybutyrate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary 2-methyl-3-hydroxybutyric acid
n1=hyperlaxité ligamentaire | n2=en:increased urinary 2-methyl-3-hydroxybutyric acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary 2-methylacetoacetic acid
n1=hyperlaxité ligamentaire | n2=en:increased urinary 2-methylacetoacetic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary 2-methylbutyryl glycine
n1=hyperlaxité ligamentaire | n2=en:increased urinary 2-methylbutyryl glycine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary 2-methylbutyrylglycine
n1=hyperlaxité ligamentaire | n2=en:increased urinary 2-methylbutyrylglycine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary 2-oxoglutaric acid
n1=hyperlaxité ligamentaire | n2=en:increased urinary 2-oxoglutaric acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary 3-methylcrotonylglycine
n1=hyperlaxité ligamentaire | n2=en:increased urinary 3-methylcrotonylglycine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary 3-methylglutaconic acid
n1=hyperlaxité ligamentaire | n2=en:increased urinary 3-methylglutaconic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary 3-oh-butyric acid
n1=hyperlaxité ligamentaire | n2=en:increased urinary 3-oh-butyric acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary 3-oh-isovaleric acid ketonuria
n1=hyperlaxité ligamentaire | n2=en:increased urinary 3-oh-isovaleric acid ketonuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary 3-oh-propionic acid
n1=hyperlaxité ligamentaire | n2=en:increased urinary 3-oh-propionic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary 7-biopterin (primapterin)
n1=hyperlaxité ligamentaire | n2=en:increased urinary 7-biopterin (primapterin) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary acetoacetic acid
n1=hyperlaxité ligamentaire | n2=en:increased urinary acetoacetic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary adenosine
n1=hyperlaxité ligamentaire | n2=en:increased urinary adenosine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary alpha-ketoglutaric acid, intermittent
n1=hyperlaxité ligamentaire | n2=en:increased urinary alpha-ketoglutaric acid, intermittent | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary and serum glycine
n1=hyperlaxité ligamentaire | n2=en:increased urinary and serum glycine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary carnitine
n1=hyperlaxité ligamentaire | n2=en:increased urinary carnitine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary carnitine esters
n1=hyperlaxité ligamentaire | n2=en:increased urinary carnitine esters | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary catecholamines
n1=hyperlaxité ligamentaire | n2=en:increased urinary catecholamines | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary catecholamines (with pheochromocytoma)
n1=hyperlaxité ligamentaire | n2=en:increased urinary catecholamines (with pheochromocytoma) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary citric acid cycle intermediates
n1=hyperlaxité ligamentaire | n2=en:increased urinary citric acid cycle intermediates | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary collagen type i n-telopeptide excretion (ntx) during hyperplastic callus formation
n1=hyperlaxité ligamentaire | n2=en:increased urinary collagen type i n-telopeptide excretion (ntx) during hyperplastic callus formation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary cortisol/cortisone ratio
n1=hyperlaxité ligamentaire | n2=en:increased urinary cortisol/cortisone ratio | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary creatine
n1=hyperlaxité ligamentaire | n2=en:increased urinary creatine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary creatine-to-creatinine ratio
n1=hyperlaxité ligamentaire | n2=en:increased urinary creatine-to-creatinine ratio | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary cross-linked n-telopetide of type i collagen
n1=hyperlaxité ligamentaire | n2=en:increased urinary cross-linked n-telopetide of type i collagen | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary cyclic amp (camp) in response to ddavp administration
n1=hyperlaxité ligamentaire | n2=en:increased urinary cyclic amp (camp) in response to ddavp administration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary cystine, arginine, lysine, and ornithine (hcs and 2p21del)
n1=hyperlaxité ligamentaire | n2=en:increased urinary cystine, arginine, lysine, and ornithine (hcs and 2p21del) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary delta-aminolevulinic acid (ala) and porphobilinogen (pbg) during acute attacks
n1=hyperlaxité ligamentaire | n2=en:increased urinary delta-aminolevulinic acid (ala) and porphobilinogen (pbg) during acute attacks | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary dicarboxylic acid, transient
n1=hyperlaxité ligamentaire | n2=en:increased urinary dicarboxylic acid, transient | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary dihydropyrimidines
n1=hyperlaxité ligamentaire | n2=en:increased urinary dihydropyrimidines | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary disaccharides (mannosyl-n-acetylglucosamine)
n1=hyperlaxité ligamentaire | n2=en:increased urinary disaccharides (mannosyl-n-acetylglucosamine) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary dopamine
n1=hyperlaxité ligamentaire | n2=en:increased urinary dopamine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary dopamine and dopamine metabolites (paradoxical)
n1=hyperlaxité ligamentaire | n2=en:increased urinary dopamine and dopamine metabolites (paradoxical) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary excretion of 4-hydroxybutyric acid (ghb)
n1=hyperlaxité ligamentaire | n2=en:increased urinary excretion of 4-hydroxybutyric acid (ghb) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary excretion of camp
n1=hyperlaxité ligamentaire | n2=en:increased urinary excretion of camp | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary excretion of coproporphyrin i
n1=hyperlaxité ligamentaire | n2=en:increased urinary excretion of coproporphyrin i | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary excretion of cystine
n1=hyperlaxité ligamentaire | n2=en:increased urinary excretion of cystine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary excretion of gamma-aminobutyric acid (gaba)
n1=hyperlaxité ligamentaire | n2=en:increased urinary excretion of gamma-aminobutyric acid (gaba) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary excretion of l-xylulose
n1=hyperlaxité ligamentaire | n2=en:increased urinary excretion of l-xylulose | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary formiminoglutamic acid (figlu)
n1=hyperlaxité ligamentaire | n2=en:increased urinary formiminoglutamic acid (figlu) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary free sialic acid (n-acetylneuraminic acid, 20-200x normal)
n1=hyperlaxité ligamentaire | n2=en:increased urinary free sialic acid (n-acetylneuraminic acid, 20-200x normal) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary free sialic acid excretion (n-acetylneuraminic acid, 5-20x normal) enlarged lysosomal vacuoles in lymphocytes and fibroblasts
n1=hyperlaxité ligamentaire | n2=en:increased urinary free sialic acid excretion (n-acetylneuraminic acid, 5-20x normal) enlarged lysosomal vacuoles in lymphocytes and fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary fumaric acid
n1=hyperlaxité ligamentaire | n2=en:increased urinary fumaric acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary glutaric acid
n1=hyperlaxité ligamentaire | n2=en:increased urinary glutaric acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary glycerol
n1=hyperlaxité ligamentaire | n2=en:increased urinary glycerol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary glycosphingolipids, particularly globotriaosylceramide
n1=hyperlaxité ligamentaire | n2=en:increased urinary glycosphingolipids, particularly globotriaosylceramide | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary hga
n1=hyperlaxité ligamentaire | n2=en:increased urinary hga | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary homovanillic acid (hva)
n1=hyperlaxité ligamentaire | n2=en:increased urinary homovanillic acid (hva) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary hydroxyisovaleric acid
n1=hyperlaxité ligamentaire | n2=en:increased urinary hydroxyisovaleric acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary hypoxanthine
n1=hyperlaxité ligamentaire | n2=en:increased urinary hypoxanthine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary isobutyryl glycine
n1=hyperlaxité ligamentaire | n2=en:increased urinary isobutyryl glycine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary ketones
n1=hyperlaxité ligamentaire | n2=en:increased urinary ketones | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary l-glycerate
n1=hyperlaxité ligamentaire | n2=en:increased urinary l-glycerate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary lactate
n1=hyperlaxité ligamentaire | n2=en:increased urinary lactate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary levels of maoa substrates (endogenous bioamines)
n1=hyperlaxité ligamentaire | n2=en:increased urinary levels of maoa substrates (endogenous bioamines) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary magnesium
n1=hyperlaxité ligamentaire | n2=en:increased urinary magnesium | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary malic acid
n1=hyperlaxité ligamentaire | n2=en:increased urinary malic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary mannose-containing oligosaccharides
n1=hyperlaxité ligamentaire | n2=en:increased urinary mannose-containing oligosaccharides | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary methylcitrate
n1=hyperlaxité ligamentaire | n2=en:increased urinary methylcitrate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary n-acetylated amino acids
n1=hyperlaxité ligamentaire | n2=en:increased urinary n-acetylated amino acids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary neopterin
n1=hyperlaxité ligamentaire | n2=en:increased urinary neopterin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary o-hydroxyphenylacetic acid, phenylpyruvic acid, phenylacetic acid and phenylacetylglutamine
n1=hyperlaxité ligamentaire | n2=en:increased urinary o-hydroxyphenylacetic acid, phenylpyruvic acid, phenylacetic acid and phenylacetylglutamine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary o-linked sialopeptides
n1=hyperlaxité ligamentaire | n2=en:increased urinary o-linked sialopeptides | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary oligosaccharides
n1=hyperlaxité ligamentaire | n2=en:increased urinary oligosaccharides | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary organic acids (in some patients)
n1=hyperlaxité ligamentaire | n2=en:increased urinary organic acids (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary orotic acid (in some patients)
n1=hyperlaxité ligamentaire | n2=en:increased urinary orotic acid (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary oxylate
n1=hyperlaxité ligamentaire | n2=en:increased urinary oxylate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary phospholipids
n1=hyperlaxité ligamentaire | n2=en:increased urinary phospholipids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary porphyrin precursors porphobilinogen (pbg) and delta-aminolevulinic acid (ala) during acute attacks
n1=hyperlaxité ligamentaire | n2=en:increased urinary porphyrin precursors porphobilinogen (pbg) and delta-aminolevulinic acid (ala) during acute attacks | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary potassium
n1=hyperlaxité ligamentaire | n2=en:increased urinary potassium | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary propionyl glycine
n1=hyperlaxité ligamentaire | n2=en:increased urinary propionyl glycine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary prostaglandin e2
n1=hyperlaxité ligamentaire | n2=en:increased urinary prostaglandin e2 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary s-sulfocysteine
n1=hyperlaxité ligamentaire | n2=en:increased urinary s-sulfocysteine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary sialylglycopeptides
n1=hyperlaxité ligamentaire | n2=en:increased urinary sialylglycopeptides | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary succinic acid
n1=hyperlaxité ligamentaire | n2=en:increased urinary succinic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary sulfatide excretion
n1=hyperlaxité ligamentaire | n2=en:increased urinary sulfatide excretion | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary sulfatides
n1=hyperlaxité ligamentaire | n2=en:increased urinary sulfatides | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary sulfite
n1=hyperlaxité ligamentaire | n2=en:increased urinary sulfite | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary taurine
n1=hyperlaxité ligamentaire | n2=en:increased urinary taurine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary thiosulfate
n1=hyperlaxité ligamentaire | n2=en:increased urinary thiosulfate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary thymine
n1=hyperlaxité ligamentaire | n2=en:increased urinary thymine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary tiglylglycine
n1=hyperlaxité ligamentaire | n2=en:increased urinary tiglylglycine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary tricarboxylic acid intermediates
n1=hyperlaxité ligamentaire | n2=en:increased urinary tricarboxylic acid intermediates | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary uracil
n1=hyperlaxité ligamentaire | n2=en:increased urinary uracil | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary urate
n1=hyperlaxité ligamentaire | n2=en:increased urinary urate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary vanillylmandelic acid (vma)
n1=hyperlaxité ligamentaire | n2=en:increased urinary vanillylmandelic acid (vma) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary, plasma, and csf d-2-hydroxyglutaric acid
n1=hyperlaxité ligamentaire | n2=en:increased urinary, plasma, and csf d-2-hydroxyglutaric acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary, plasma, and csf dihydrothymine
n1=hyperlaxité ligamentaire | n2=en:increased urinary, plasma, and csf dihydrothymine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary, plasma, and csf dihydrouracil
n1=hyperlaxité ligamentaire | n2=en:increased urinary, plasma, and csf dihydrouracil | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary, plasma, and csf l-2-hydroxyglutaric acid
n1=hyperlaxité ligamentaire | n2=en:increased urinary, plasma, and csf l-2-hydroxyglutaric acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary, plasma, and csf n-carbamyl-beta-alanine
n1=hyperlaxité ligamentaire | n2=en:increased urinary, plasma, and csf n-carbamyl-beta-alanine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urinary, plasma, and csf n-carbamyl-beta-aminoisobutyric acid
n1=hyperlaxité ligamentaire | n2=en:increased urinary, plasma, and csf n-carbamyl-beta-aminoisobutyric acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urine oligosaccharides
n1=hyperlaxité ligamentaire | n2=en:increased urine oligosaccharides | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urine porphyrins at times
n1=hyperlaxité ligamentaire | n2=en:increased urine porphyrins at times | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased urine vanillactic acid (vla)
n1=hyperlaxité ligamentaire | n2=en:increased urine vanillactic acid (vla) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased very-long chain fatty acids
n1=hyperlaxité ligamentaire | n2=en:increased very-long chain fatty acids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:increased vitamin e (alpha-tocopherol) levels
n1=hyperlaxité ligamentaire | n2=en:increased vitamin e (alpha-tocopherol) levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:incresased urinary pyruvate
n1=hyperlaxité ligamentaire | n2=en:incresased urinary pyruvate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:indirect bilirubin increased
n1=hyperlaxité ligamentaire | n2=en:indirect bilirubin increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:indirect hyperbilirubinemia
n1=hyperlaxité ligamentaire | n2=en:indirect hyperbilirubinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:induced termination of pregnancy complicated by metabolic disorder
n1=hyperlaxité ligamentaire | n2=en:induced termination of pregnancy complicated by metabolic disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:infantile hypophosphatasia
n1=hyperlaxité ligamentaire | n2=en:infantile hypophosphatasia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:inner and outer dynein arm defects, variable
n1=hyperlaxité ligamentaire | n2=en:inner and outer dynein arm defects, variable | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:inr increased
n1=hyperlaxité ligamentaire | n2=en:inr increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:insulin resistance, variable
n1=hyperlaxité ligamentaire | n2=en:insulin resistance, variable | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intermediate level of cellular sensitivity to uv light
n1=hyperlaxité ligamentaire | n2=en:intermediate level of cellular sensitivity to uv light | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intermittent 3-methylglutaconic aciduria
n1=hyperlaxité ligamentaire | n2=en:intermittent 3-methylglutaconic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intermittent dicarbonic aciduria
n1=hyperlaxité ligamentaire | n2=en:intermittent dicarbonic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intermittent ethylmalonic aciduria
n1=hyperlaxité ligamentaire | n2=en:intermittent ethylmalonic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intermittent hypothermia
n1=hyperlaxité ligamentaire | n2=en:intermittent hypothermia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intermittent increase of urinary ethylmalonic acid
n1=hyperlaxité ligamentaire | n2=en:intermittent increase of urinary ethylmalonic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intermittent lactic acidemia
n1=hyperlaxité ligamentaire | n2=en:intermittent lactic acidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intermittent pyrexia
n1=hyperlaxité ligamentaire | n2=en:intermittent pyrexia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intermittent severe hypoglycemia (in some patients)
n1=hyperlaxité ligamentaire | n2=en:intermittent severe hypoglycemia (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:interstitial deletion of 17p11.2 (most common is 3.7mb)
n1=hyperlaxité ligamentaire | n2=en:interstitial deletion of 17p11.2 (most common is 3.7mb) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:interstitial or terminal deletion of 18q
n1=hyperlaxité ligamentaire | n2=en:interstitial or terminal deletion of 18q | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intolerance to heat and fever
n1=hyperlaxité ligamentaire | n2=en:intolerance to heat and fever | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intolerance to protein
n1=hyperlaxité ligamentaire | n2=en:intolerance to protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intolerant of heat
n1=hyperlaxité ligamentaire | n2=en:intolerant of heat | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intracellular accumulation of unesterified cholesterol
n1=hyperlaxité ligamentaire | n2=en:intracellular accumulation of unesterified cholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intracellular fingerprint profiles on ultrastructural analysis
n1=hyperlaxité ligamentaire | n2=en:intracellular fingerprint profiles on ultrastructural analysis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intracellular glycosphingolipid deposition in all tissues of the body
n1=hyperlaxité ligamentaire | n2=en:intracellular glycosphingolipid deposition in all tissues of the body | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intracellular granular material on ultrastructural analysis
n1=hyperlaxité ligamentaire | n2=en:intracellular granular material on ultrastructural analysis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) can be found in various tissues (brain, liver, muscle, heart, skin)
n1=hyperlaxité ligamentaire | n2=en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) can be found in various tissues (brain, liver, muscle, heart, skin) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:intracellular redox disturbance (reduced cytoplasm and oxidized mitochondria (group b))
n1=hyperlaxité ligamentaire | n2=en:intracellular redox disturbance (reduced cytoplasm and oxidized mitochondria (group b)) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:iodide organification defect
n1=hyperlaxité ligamentaire | n2=en:iodide organification defect | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:iodine depletion
n1=hyperlaxité ligamentaire | n2=en:iodine depletion | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:iron binding capacity total increased
n1=hyperlaxité ligamentaire | n2=en:iron binding capacity total increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:iron deficiency
n1=hyperlaxité ligamentaire | n2=en:iron deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:iron deposition in basal ganglia, liver, pancreas, visceral organs detectable by ct and mri
n1=hyperlaxité ligamentaire | n2=en:iron deposition in basal ganglia, liver, pancreas, visceral organs detectable by ct and mri | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:iron low
n1=hyperlaxité ligamentaire | n2=en:iron low | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:iron metabolism disorders
n1=hyperlaxité ligamentaire | n2=en:iron metabolism disorders | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:iron overload (in some patients)
n1=hyperlaxité ligamentaire | n2=en:iron overload (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:iron-deficiency anemia
n1=hyperlaxité ligamentaire | n2=en:iron-deficiency anemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:irregular distribution of chondrocytes, enlarged chondrocyte lacunae, excessive fibrous matrix, perilacunar loss of glycosaminoglycan, excessive collagen aggregation
n1=hyperlaxité ligamentaire | n2=en:irregular distribution of chondrocytes, enlarged chondrocyte lacunae, excessive fibrous matrix, perilacunar loss of glycosaminoglycan, excessive collagen aggregation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:irregularly shaped sperm heads
n1=hyperlaxité ligamentaire | n2=en:irregularly shaped sperm heads | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:isochromosome 12p (i(12p))
n1=hyperlaxité ligamentaire | n2=en:isochromosome 12p (i(12p)) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:isochromosome often missing in lymphocyte
n1=hyperlaxité ligamentaire | n2=en:isochromosome often missing in lymphocyte | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:isovaleric acidemia
n1=hyperlaxité ligamentaire | n2=en:isovaleric acidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:isovalericaciduria
n1=hyperlaxité ligamentaire | n2=en:isovalericaciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:isovalerylglycinuria
n1=hyperlaxité ligamentaire | n2=en:isovalerylglycinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:karyomegaly may be found in other visceral organs
n1=hyperlaxité ligamentaire | n2=en:karyomegaly may be found in other visceral organs | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:karyotype analysis normal finding
n1=hyperlaxité ligamentaire | n2=en:karyotype analysis normal finding | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:keratan sulfate excretion in urine that decreases with age
n1=hyperlaxité ligamentaire | n2=en:keratan sulfate excretion in urine that decreases with age | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:keratan sulfaturia in some patients
n1=hyperlaxité ligamentaire | n2=en:keratan sulfaturia in some patients | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ketoacidosis
n1=hyperlaxité ligamentaire | n2=en:ketoacidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ketoacidosis, severe
n1=hyperlaxité ligamentaire | n2=en:ketoacidosis, severe | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ketonemia
n1=hyperlaxité ligamentaire | n2=en:ketonemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ketonuria
n1=hyperlaxité ligamentaire | n2=en:ketonuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ketonuria (1 patient)
n1=hyperlaxité ligamentaire | n2=en:ketonuria (1 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ketonuria, acute
n1=hyperlaxité ligamentaire | n2=en:ketonuria, acute | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ketonuria, marked
n1=hyperlaxité ligamentaire | n2=en:ketonuria, marked | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ketoses, metabolic
n1=hyperlaxité ligamentaire | n2=en:ketoses, metabolic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ketosis
n1=hyperlaxité ligamentaire | n2=en:ketosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ketosis is exacerbated by protein ingestion
n1=hyperlaxité ligamentaire | n2=en:ketosis is exacerbated by protein ingestion | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ketotic hypoglycemia
n1=hyperlaxité ligamentaire | n2=en:ketotic hypoglycemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:kidney crystallization
n1=hyperlaxité ligamentaire | n2=en:kidney crystallization | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:kypokalemia
n1=hyperlaxité ligamentaire | n2=en:kypokalemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:laboratory abnormalities
n1=hyperlaxité ligamentaire | n2=en:laboratory abnormalities | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lack of ciliary motility
n1=hyperlaxité ligamentaire | n2=en:lack of ciliary motility | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lack of excessive parenchymal iron storage
n1=hyperlaxité ligamentaire | n2=en:lack of excessive parenchymal iron storage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lack of lysosomal inclusions in visceral organs
n1=hyperlaxité ligamentaire | n2=en:lack of lysosomal inclusions in visceral organs | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lactate dehydrogenase increased
n1=hyperlaxité ligamentaire | n2=en:lactate dehydrogenase increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lactate high
n1=hyperlaxité ligamentaire | n2=en:lactate high | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lactate pyruvate ratio normal
n1=hyperlaxité ligamentaire | n2=en:lactate pyruvate ratio normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lactic acidemia
n1=hyperlaxité ligamentaire | n2=en:lactic acidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lactic acidemia (2p21del)
n1=hyperlaxité ligamentaire | n2=en:lactic acidemia (2p21del) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lactic acidosis
n1=hyperlaxité ligamentaire | n2=en:lactic acidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lactic acidosis (in some patients)
n1=hyperlaxité ligamentaire | n2=en:lactic acidosis (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lactic acidosis during infection
n1=hyperlaxité ligamentaire | n2=en:lactic acidosis during infection | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lactic acidosis in e3-deficiency
n1=hyperlaxité ligamentaire | n2=en:lactic acidosis in e3-deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lactic acidosis may occur with stress or infection
n1=hyperlaxité ligamentaire | n2=en:lactic acidosis may occur with stress or infection | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lactic acidosis, episodic
n1=hyperlaxité ligamentaire | n2=en:lactic acidosis, episodic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lactic acidosis, may be mild
n1=hyperlaxité ligamentaire | n2=en:lactic acidosis, may be mild | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lactose intolerance
n1=hyperlaxité ligamentaire | n2=en:lactose intolerance | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lacunar halos around chondrocytes in skeletal cartilage
n1=hyperlaxité ligamentaire | n2=en:lacunar halos around chondrocytes in skeletal cartilage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:langerhans cell histiocytosis
n1=hyperlaxité ligamentaire | n2=en:langerhans cell histiocytosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:large spermatozoa
n1=hyperlaxité ligamentaire | n2=en:large spermatozoa | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lethargy or loss of consciousness during illness or fasting
n1=hyperlaxité ligamentaire | n2=en:lethargy or loss of consciousness during illness or fasting | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:leukaemia
n1=hyperlaxité ligamentaire | n2=en:leukaemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:leukemia
n1=hyperlaxité ligamentaire | n2=en:leukemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:leukemia in remission
n1=hyperlaxité ligamentaire | n2=en:leukemia in remission | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:leukocyte disorders
n1=hyperlaxité ligamentaire | n2=en:leukocyte disorders | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:leukocyte inclusion bodies (em) - intermediate filaments and ribosome clusters irregularly dispersed in cytoplasm
n1=hyperlaxité ligamentaire | n2=en:leukocyte inclusion bodies (em) - intermediate filaments and ribosome clusters irregularly dispersed in cytoplasm | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:leukopenia
n1=hyperlaxité ligamentaire | n2=en:leukopenia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:leukotriene c4 synthetase deficiency
n1=hyperlaxité ligamentaire | n2=en:leukotriene c4 synthetase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:life-threatening metabolic decompensation
n1=hyperlaxité ligamentaire | n2=en:life-threatening metabolic decompensation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipc gene
n1=hyperlaxité ligamentaire | n2=en:lipc gene | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipc wt allele
n1=hyperlaxité ligamentaire | n2=en:lipc wt allele | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipemic index
n1=hyperlaxité ligamentaire | n2=en:lipemic index | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipid
n1=hyperlaxité ligamentaire | n2=en:lipid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipid metabolism and deposit disorders nec
n1=hyperlaxité ligamentaire | n2=en:lipid metabolism and deposit disorders nec | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipid metabolism disorder
n1=hyperlaxité ligamentaire | n2=en:lipid metabolism disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipid metabolism, inborn errors
n1=hyperlaxité ligamentaire | n2=en:lipid metabolism, inborn errors | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipid vacuoles in leukocytes (jordan bodies)
n1=hyperlaxité ligamentaire | n2=en:lipid vacuoles in leukocytes (jordan bodies) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipidemias
n1=hyperlaxité ligamentaire | n2=en:lipidemias | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipidose
n1=hyperlaxité ligamentaire | n2=en:lipidose | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipidosis acquired
n1=hyperlaxité ligamentaire | n2=en:lipidosis acquired | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipids abnormal
n1=hyperlaxité ligamentaire | n2=en:lipids abnormal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipiduria
n1=hyperlaxité ligamentaire | n2=en:lipiduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipodystrophy
n1=hyperlaxité ligamentaire | n2=en:lipodystrophy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipoidosis
n1=hyperlaxité ligamentaire | n2=en:lipoidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipomatosis
n1=hyperlaxité ligamentaire | n2=en:lipomatosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipopigment in extraneuronal cells
n1=hyperlaxité ligamentaire | n2=en:lipopigment in extraneuronal cells | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipoprotein disorder
n1=hyperlaxité ligamentaire | n2=en:lipoprotein disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipoprotein electrophoresis abnormal
n1=hyperlaxité ligamentaire | n2=en:lipoprotein electrophoresis abnormal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lipoprotein metabolism disorder
n1=hyperlaxité ligamentaire | n2=en:lipoprotein metabolism disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:little to absent aspartylglucosaminuria activity
n1=hyperlaxité ligamentaire | n2=en:little to absent aspartylglucosaminuria activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:liver enzymes abnormal
n1=hyperlaxité ligamentaire | n2=en:liver enzymes abnormal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:liver function tests normal
n1=hyperlaxité ligamentaire | n2=en:liver function tests normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:liver phosphorylase kinase (phk) deficiency
n1=hyperlaxité ligamentaire | n2=en:liver phosphorylase kinase (phk) deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:liver transaminases normal to slightly increased
n1=hyperlaxité ligamentaire | n2=en:liver transaminases normal to slightly increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:localized metabolic disorder
n1=hyperlaxité ligamentaire | n2=en:localized metabolic disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:long-chain dicarboxylic aciduria
n1=hyperlaxité ligamentaire | n2=en:long-chain dicarboxylic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:long-chain ketonuria
n1=hyperlaxité ligamentaire | n2=en:long-chain ketonuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:loss of ciliary beat coordination
n1=hyperlaxité ligamentaire | n2=en:loss of ciliary beat coordination | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:loss of galactose and sialic acid from multiple branches of complex type n-glycans (in some patients)
n1=hyperlaxité ligamentaire | n2=en:loss of galactose and sialic acid from multiple branches of complex type n-glycans (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:loss of heterozygosity in giant cell astrocytomas, angiomyolipomas, rhabdomyomas
n1=hyperlaxité ligamentaire | n2=en:loss of heterozygosity in giant cell astrocytomas, angiomyolipomas, rhabdomyomas | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low 25-oh-vitamin d level
n1=hyperlaxité ligamentaire | n2=en:low 25-oh-vitamin d level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low absolute lymphocyte count
n1=hyperlaxité ligamentaire | n2=en:low absolute lymphocyte count | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low acth level
n1=hyperlaxité ligamentaire | n2=en:low acth level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low alkaline phosphatase
n1=hyperlaxité ligamentaire | n2=en:low alkaline phosphatase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low apolipoprotein
n1=hyperlaxité ligamentaire | n2=en:low apolipoprotein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low cd4+ count
n1=hyperlaxité ligamentaire | n2=en:low cd4+ count | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low cholesterol esterification rates
n1=hyperlaxité ligamentaire | n2=en:low cholesterol esterification rates | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low circulating phosphate
n1=hyperlaxité ligamentaire | n2=en:low circulating phosphate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low copper and ceruloplasmin
n1=hyperlaxité ligamentaire | n2=en:low copper and ceruloplasmin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low csf creatine
n1=hyperlaxité ligamentaire | n2=en:low csf creatine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low csf creatinine
n1=hyperlaxité ligamentaire | n2=en:low csf creatinine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low density lipoprotein increased
n1=hyperlaxité ligamentaire | n2=en:low density lipoprotein increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low density lipoprotein receptor mutation
n1=hyperlaxité ligamentaire | n2=en:low density lipoprotein receptor mutation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low fasting glucose (in some patients)
n1=hyperlaxité ligamentaire | n2=en:low fasting glucose (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low free carnitine
n1=hyperlaxité ligamentaire | n2=en:low free carnitine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low growth hormone levels
n1=hyperlaxité ligamentaire | n2=en:low growth hormone levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low ldl cholesterol
n1=hyperlaxité ligamentaire | n2=en:low ldl cholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low leukocyte alkaline phosphatase activity
n1=hyperlaxité ligamentaire | n2=en:low leukocyte alkaline phosphatase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low level of c4 and c2
n1=hyperlaxité ligamentaire | n2=en:low level of c4 and c2 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low levels of cd11/cd18 (lfa-1 or leukocyte function antigen-1) glycoprotein
n1=hyperlaxité ligamentaire | n2=en:low levels of cd11/cd18 (lfa-1 or leukocyte function antigen-1) glycoprotein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low levels of serum mg(2+) in the absence of other electrolyte disturbances
n1=hyperlaxité ligamentaire | n2=en:low levels of serum mg(2+) in the absence of other electrolyte disturbances | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low maximal oxygen uptake on exercise testing
n1=hyperlaxité ligamentaire | n2=en:low maximal oxygen uptake on exercise testing | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low or absent adrenocorticotropic hormone (acth)
n1=hyperlaxité ligamentaire | n2=en:low or absent adrenocorticotropic hormone (acth) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low or absent adrenocorticotropic hormone (acth) in some patients
n1=hyperlaxité ligamentaire | n2=en:low or absent adrenocorticotropic hormone (acth) in some patients | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low or absent follicle stimulating hormone (fsh)
n1=hyperlaxité ligamentaire | n2=en:low or absent follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low or absent growth hormone (gh)
n1=hyperlaxité ligamentaire | n2=en:low or absent growth hormone (gh) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low or absent iga levels
n1=hyperlaxité ligamentaire | n2=en:low or absent iga levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low or absent igm levels
n1=hyperlaxité ligamentaire | n2=en:low or absent igm levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low or absent luteinizing hormone (lh)
n1=hyperlaxité ligamentaire | n2=en:low or absent luteinizing hormone (lh) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low or absent prolactin (pl)
n1=hyperlaxité ligamentaire | n2=en:low or absent prolactin (pl) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low or absent thyroid-stimulating hormone (tsh)
n1=hyperlaxité ligamentaire | n2=en:low or absent thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low or absent thyrotropin (tsh)
n1=hyperlaxité ligamentaire | n2=en:low or absent thyrotropin (tsh) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low or low-normal serum t4
n1=hyperlaxité ligamentaire | n2=en:low or low-normal serum t4 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low or normal serum calcium
n1=hyperlaxité ligamentaire | n2=en:low or normal serum calcium | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low or normal serum erythropoietin
n1=hyperlaxité ligamentaire | n2=en:low or normal serum erythropoietin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low or normal serum igm
n1=hyperlaxité ligamentaire | n2=en:low or normal serum igm | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low or undetectable c-peptide
n1=hyperlaxité ligamentaire | n2=en:low or undetectable c-peptide | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low or undetectable insulin
n1=hyperlaxité ligamentaire | n2=en:low or undetectable insulin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low plasma arginine
n1=hyperlaxité ligamentaire | n2=en:low plasma arginine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low plasma citrulline
n1=hyperlaxité ligamentaire | n2=en:low plasma citrulline | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low plasma free and total carnitine
n1=hyperlaxité ligamentaire | n2=en:low plasma free and total carnitine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low plasma hdl
n1=hyperlaxité ligamentaire | n2=en:low plasma hdl | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low plasma methionine
n1=hyperlaxité ligamentaire | n2=en:low plasma methionine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low plasma triglyceride level
n1=hyperlaxité ligamentaire | n2=en:low plasma triglyceride level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low plasma tryptophan (inflammatory type b)
n1=hyperlaxité ligamentaire | n2=en:low plasma tryptophan (inflammatory type b) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low procollagen 1 c-peptide (in some patients)
n1=hyperlaxité ligamentaire | n2=en:low procollagen 1 c-peptide (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low pyruvate carboxylase activity in liver and cultured fibroblasts
n1=hyperlaxité ligamentaire | n2=en:low pyruvate carboxylase activity in liver and cultured fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low rai (radioactive iodine) uptake
n1=hyperlaxité ligamentaire | n2=en:low rai (radioactive iodine) uptake | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low serum acth
n1=hyperlaxité ligamentaire | n2=en:low serum acth | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low serum alkaline phosphatase in heterozygotes
n1=hyperlaxité ligamentaire | n2=en:low serum alkaline phosphatase in heterozygotes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low serum alpha-fetoprotein (recessive)
n1=hyperlaxité ligamentaire | n2=en:low serum alpha-fetoprotein (recessive) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low serum anti-mullerian hormone (amh) levels
n1=hyperlaxité ligamentaire | n2=en:low serum anti-mullerian hormone (amh) levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low serum calcium
n1=hyperlaxité ligamentaire | n2=en:low serum calcium | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low serum ceruloplasmin
n1=hyperlaxité ligamentaire | n2=en:low serum ceruloplasmin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low serum concentration of intercellular adhesion molecule 1 (icam1)
n1=hyperlaxité ligamentaire | n2=en:low serum concentration of intercellular adhesion molecule 1 (icam1) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low serum cortisol
n1=hyperlaxité ligamentaire | n2=en:low serum cortisol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low serum igg and iga
n1=hyperlaxité ligamentaire | n2=en:low serum igg and iga | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low serum levels of branched-chain amino acids
n1=hyperlaxité ligamentaire | n2=en:low serum levels of branched-chain amino acids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low serum levels of ketone bodies
n1=hyperlaxité ligamentaire | n2=en:low serum levels of ketone bodies | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low serum magnesium
n1=hyperlaxité ligamentaire | n2=en:low serum magnesium | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low serum uric acid
n1=hyperlaxité ligamentaire | n2=en:low serum uric acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low to absent apo a-i (detroit 107680.0011)
n1=hyperlaxité ligamentaire | n2=en:low to absent apo a-i (detroit 107680.0011) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low to absent high density lipoprotein (hdl) (detroit 107680.0011)
n1=hyperlaxité ligamentaire | n2=en:low to absent high density lipoprotein (hdl) (detroit 107680.0011) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low to low-normal magnesium
n1=hyperlaxité ligamentaire | n2=en:low to low-normal magnesium | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low to normal plasma methionine
n1=hyperlaxité ligamentaire | n2=en:low to normal plasma methionine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low to normal serum calcium
n1=hyperlaxité ligamentaire | n2=en:low to normal serum calcium | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low to normal tsh (values may vary depending on the measurement methods used)
n1=hyperlaxité ligamentaire | n2=en:low to normal tsh (values may vary depending on the measurement methods used) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low to very low hdl cholesterol
n1=hyperlaxité ligamentaire | n2=en:low to very low hdl cholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low total serum protein
n1=hyperlaxité ligamentaire | n2=en:low total serum protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low urinary cyclic amp response to pth administration
n1=hyperlaxité ligamentaire | n2=en:low urinary cyclic amp response to pth administration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low urinary excretion of neutral 17-ketosteroids
n1=hyperlaxité ligamentaire | n2=en:low urinary excretion of neutral 17-ketosteroids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low urinary orotic acid
n1=hyperlaxité ligamentaire | n2=en:low urinary orotic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low-molecular-weight proteinuria
n1=hyperlaxité ligamentaire | n2=en:low-molecular-weight proteinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low-normal igm
n1=hyperlaxité ligamentaire | n2=en:low-normal igm | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low-normal platelet count (89-290 x 10(9)/l)
n1=hyperlaxité ligamentaire | n2=en:low-normal platelet count (89-290 x 10(9)/l) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low-to-normal csf lactate
n1=hyperlaxité ligamentaire | n2=en:low-to-normal csf lactate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:low-to-normal platelet count
n1=hyperlaxité ligamentaire | n2=en:low-to-normal platelet count | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lower total cholesterol
n1=hyperlaxité ligamentaire | n2=en:lower total cholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lymphoproliferative disorder
n1=hyperlaxité ligamentaire | n2=en:lymphoproliferative disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lysine-ketoglutarate reductase deficiency
n1=hyperlaxité ligamentaire | n2=en:lysine-ketoglutarate reductase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lysosomal storage disease
n1=hyperlaxité ligamentaire | n2=en:lysosomal storage disease | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lysosomal-like storage vacuoles in various tissues
n1=hyperlaxité ligamentaire | n2=en:lysosomal-like storage vacuoles in various tissues | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lysyl hydroxylase deficiency
n1=hyperlaxité ligamentaire | n2=en:lysyl hydroxylase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:lysyl pyridinoline/hydroxylysyl pyridinoline (lp/hp) ratio approximately 1
n1=hyperlaxité ligamentaire | n2=en:lysyl pyridinoline/hydroxylysyl pyridinoline (lp/hp) ratio approximately 1 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:macrophage infiltration of white adipose tissue
n1=hyperlaxité ligamentaire | n2=en:macrophage infiltration of white adipose tissue | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:malabsorption syndrome
n1=hyperlaxité ligamentaire | n2=en:malabsorption syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:malignant hyperthermia syndrome
n1=hyperlaxité ligamentaire | n2=en:malignant hyperthermia syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mandibuloacral dysplasia with type b lipodystrophy
n1=hyperlaxité ligamentaire | n2=en:mandibuloacral dysplasia with type b lipodystrophy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:march myoglobinuria
n1=hyperlaxité ligamentaire | n2=en:march myoglobinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:marked elevation of erythrocyte sedimentation rate
n1=hyperlaxité ligamentaire | n2=en:marked elevation of erythrocyte sedimentation rate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:marked elevation of serum c-reactive protein level (crp 123260)
n1=hyperlaxité ligamentaire | n2=en:marked elevation of serum c-reactive protein level (crp 123260) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:marked hypoalphalipoproteinemia (in some patients)
n1=hyperlaxité ligamentaire | n2=en:marked hypoalphalipoproteinemia (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:marked hypobetalipoproteinemia
n1=hyperlaxité ligamentaire | n2=en:marked hypobetalipoproteinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:markedly decreased coproporphyrinogen oxidase activity (harderoporphyria, lymphocytes)
n1=hyperlaxité ligamentaire | n2=en:markedly decreased coproporphyrinogen oxidase activity (harderoporphyria, lymphocytes) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:markedly decreased or absent serum 1,25-dihydroxyvitamin d3
n1=hyperlaxité ligamentaire | n2=en:markedly decreased or absent serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:markedly elevated sodium in urine, sweat, saliva, and stool
n1=hyperlaxité ligamentaire | n2=en:markedly elevated sodium in urine, sweat, saliva, and stool | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:markedly increased serum creatine kinase
n1=hyperlaxité ligamentaire | n2=en:markedly increased serum creatine kinase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:markedly reduced iga levels
n1=hyperlaxité ligamentaire | n2=en:markedly reduced iga levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:markedly reduced igg levels
n1=hyperlaxité ligamentaire | n2=en:markedly reduced igg levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mast cell activation syndrome
n1=hyperlaxité ligamentaire | n2=en:mast cell activation syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mastocytosis
n1=hyperlaxité ligamentaire | n2=en:mastocytosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:may have increased serum parathyroid hormone (pth)
n1=hyperlaxité ligamentaire | n2=en:may have increased serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mean platelet volume (mpv) 12.6fl
n1=hyperlaxité ligamentaire | n2=en:mean platelet volume (mpv) 12.6fl | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:median mean platelet volume (mpv) 12.5fl
n1=hyperlaxité ligamentaire | n2=en:median mean platelet volume (mpv) 12.5fl | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:median mean platelet volume (mpv) 18fl
n1=hyperlaxité ligamentaire | n2=en:median mean platelet volume (mpv) 18fl | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:median mean platelet volume (mpv) 20fl
n1=hyperlaxité ligamentaire | n2=en:median mean platelet volume (mpv) 20fl | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:median mean platelet volume 13fl
n1=hyperlaxité ligamentaire | n2=en:median mean platelet volume 13fl | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:medium chain dicarboxylic aciduria
n1=hyperlaxité ligamentaire | n2=en:medium chain dicarboxylic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:medium-chain acyl-coa dehydrogenase deficiency
n1=hyperlaxité ligamentaire | n2=en:medium-chain acyl-coa dehydrogenase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:melanaemia
n1=hyperlaxité ligamentaire | n2=en:melanaemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:melatonin rhythm phase-advanced by 3-4 hours
n1=hyperlaxité ligamentaire | n2=en:melatonin rhythm phase-advanced by 3-4 hours | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mephenytoin hydroxylation defect
n1=hyperlaxité ligamentaire | n2=en:mephenytoin hydroxylation defect | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic acidosis
n1=hyperlaxité ligamentaire | n2=en:metabolic acidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic acidosis (in some patients)
n1=hyperlaxité ligamentaire | n2=en:metabolic acidosis (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic acidosis (transient, resolves in infancy)
n1=hyperlaxité ligamentaire | n2=en:metabolic acidosis (transient, resolves in infancy) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic acidosis due to renal bicarbonate loss
n1=hyperlaxité ligamentaire | n2=en:metabolic acidosis due to renal bicarbonate loss | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic acidosis in infancy (in some patients)
n1=hyperlaxité ligamentaire | n2=en:metabolic acidosis in infancy (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic acidosis, nag, acidifying salts
n1=hyperlaxité ligamentaire | n2=en:metabolic acidosis, nag, acidifying salts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic acidosis, severe
n1=hyperlaxité ligamentaire | n2=en:metabolic acidosis, severe | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic alkalosis
n1=hyperlaxité ligamentaire | n2=en:metabolic alkalosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic and genetic disorder affecting the liver
n1=hyperlaxité ligamentaire | n2=en:metabolic and genetic disorder affecting the liver | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic aspects
n1=hyperlaxité ligamentaire | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic bone disorder
n1=hyperlaxité ligamentaire | n2=en:metabolic bone disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic crises
n1=hyperlaxité ligamentaire | n2=en:metabolic crises | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic decompensation precipitated by illness
n1=hyperlaxité ligamentaire | n2=en:metabolic decompensation precipitated by illness | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic disorder following molar and/or ectopic pregnancy
n1=hyperlaxité ligamentaire | n2=en:metabolic disorder following molar and/or ectopic pregnancy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic disorder of fetus
n1=hyperlaxité ligamentaire | n2=en:metabolic disorder of fetus | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic disorder of transport
n1=hyperlaxité ligamentaire | n2=en:metabolic disorder of transport | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic disorders following abortion and ectopic and molar pregnancy
n1=hyperlaxité ligamentaire | n2=en:metabolic disorders following abortion and ectopic and molar pregnancy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic features
n1=hyperlaxité ligamentaire | n2=en:metabolic features | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic renal disease
n1=hyperlaxité ligamentaire | n2=en:metabolic renal disease | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metabolic syndrome
n1=hyperlaxité ligamentaire | n2=en:metabolic syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metachromasia of white blood cells and fibroblasts
n1=hyperlaxité ligamentaire | n2=en:metachromasia of white blood cells and fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metachromatic deposits (sulfatide-containing) in central and peripheral nervous systems and visceral organs
n1=hyperlaxité ligamentaire | n2=en:metachromatic deposits (sulfatide-containing) in central and peripheral nervous systems and visceral organs | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metachromatic leukodystrophy due to saposin b deficiency
n1=hyperlaxité ligamentaire | n2=en:metachromatic leukodystrophy due to saposin b deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metal metabolism disorder
n1=hyperlaxité ligamentaire | n2=en:metal metabolism disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:metastatic malignant neoplasm in the bone marrow
n1=hyperlaxité ligamentaire | n2=en:metastatic malignant neoplasm in the bone marrow | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:methemoglobin concentration 12 to 19%
n1=hyperlaxité ligamentaire | n2=en:methemoglobin concentration 12 to 19% | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:methemoglobinemia
n1=hyperlaxité ligamentaire | n2=en:methemoglobinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:methemoglobinuria
n1=hyperlaxité ligamentaire | n2=en:methemoglobinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:methionine adenosyltransferase deficiency
n1=hyperlaxité ligamentaire | n2=en:methionine adenosyltransferase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:methioninuria
n1=hyperlaxité ligamentaire | n2=en:methioninuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:methylenetetrahydrofolate reductase deficiency
n1=hyperlaxité ligamentaire | n2=en:methylenetetrahydrofolate reductase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:methylglutaconic aciduria, mild
n1=hyperlaxité ligamentaire | n2=en:methylglutaconic aciduria, mild | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:methylmalonic acidemia
n1=hyperlaxité ligamentaire | n2=en:methylmalonic acidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:methylmalonic aciduria
n1=hyperlaxité ligamentaire | n2=en:methylmalonic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:methylmalonic aciduria, mild
n1=hyperlaxité ligamentaire | n2=en:methylmalonic aciduria, mild | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:methylmalonyl-coenzyme a mutase deficiency
n1=hyperlaxité ligamentaire | n2=en:methylmalonyl-coenzyme a mutase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:methylsuccinic aciduria
n1=hyperlaxité ligamentaire | n2=en:methylsuccinic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mevalonate kinase deficiency
n1=hyperlaxité ligamentaire | n2=en:mevalonate kinase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:microdeletion 22q11.2
n1=hyperlaxité ligamentaire | n2=en:microdeletion 22q11.2 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:microdeletion of chromosome 11q13 (43-490kb)
n1=hyperlaxité ligamentaire | n2=en:microdeletion of chromosome 11q13 (43-490kb) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:microduplication of chromosome 5p13
n1=hyperlaxité ligamentaire | n2=en:microduplication of chromosome 5p13 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:microscopic hematuria
n1=hyperlaxité ligamentaire | n2=en:microscopic hematuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:microsomal hmg-coa reductase decreased
n1=hyperlaxité ligamentaire | n2=en:microsomal hmg-coa reductase decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:microtubule disorganization in some cilia
n1=hyperlaxité ligamentaire | n2=en:microtubule disorganization in some cilia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mild elevation of cholesterol
n1=hyperlaxité ligamentaire | n2=en:mild elevation of cholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mild elevation of transaminases
n1=hyperlaxité ligamentaire | n2=en:mild elevation of transaminases | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mild elevation of triglycerides
n1=hyperlaxité ligamentaire | n2=en:mild elevation of triglycerides | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mild eosinophilia may occur
n1=hyperlaxité ligamentaire | n2=en:mild eosinophilia may occur | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mild hyperammonemia
n1=hyperlaxité ligamentaire | n2=en:mild hyperammonemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mild hypertriglyceridemia
n1=hyperlaxité ligamentaire | n2=en:mild hypertriglyceridemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mild metabolic acidosis
n1=hyperlaxité ligamentaire | n2=en:mild metabolic acidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mild to moderate hyperammonemia
n1=hyperlaxité ligamentaire | n2=en:mild to moderate hyperammonemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mild to moderate thrombocytopenia (40-120 x 10(9)/l)
n1=hyperlaxité ligamentaire | n2=en:mild to moderate thrombocytopenia (40-120 x 10(9)/l) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mild-moderate prolonged bleeding time
n1=hyperlaxité ligamentaire | n2=en:mild-moderate prolonged bleeding time | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mildly abnormal glycosylation of serum transferrin, type 1 pattern
n1=hyperlaxité ligamentaire | n2=en:mildly abnormal glycosylation of serum transferrin, type 1 pattern | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mildly decreased phosphaturic response to pth administration has been reported in some cases
n1=hyperlaxité ligamentaire | n2=en:mildly decreased phosphaturic response to pth administration has been reported in some cases | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mildly decreased serum creatinine
n1=hyperlaxité ligamentaire | n2=en:mildly decreased serum creatinine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mildly elevated acth
n1=hyperlaxité ligamentaire | n2=en:mildly elevated acth | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mildly elevated blood ammonia
n1=hyperlaxité ligamentaire | n2=en:mildly elevated blood ammonia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mildly elevated creatine phosphokinase
n1=hyperlaxité ligamentaire | n2=en:mildly elevated creatine phosphokinase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mildly elevated creatine phosphokinase (cpk) (120270.0002)
n1=hyperlaxité ligamentaire | n2=en:mildly elevated creatine phosphokinase (cpk) (120270.0002) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mildly elevated hdl in heterozygotes
n1=hyperlaxité ligamentaire | n2=en:mildly elevated hdl in heterozygotes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mildly elevated hepatic enzymes
n1=hyperlaxité ligamentaire | n2=en:mildly elevated hepatic enzymes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mildly elevated phosphoethanolamine urinary excretion in heterozygotes
n1=hyperlaxité ligamentaire | n2=en:mildly elevated phosphoethanolamine urinary excretion in heterozygotes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mildly elevated transaminases
n1=hyperlaxité ligamentaire | n2=en:mildly elevated transaminases | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mildly elevated urinary mevalonic acid
n1=hyperlaxité ligamentaire | n2=en:mildly elevated urinary mevalonic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mildly increased serum creatine kinase (in some patients)
n1=hyperlaxité ligamentaire | n2=en:mildly increased serum creatine kinase (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mildly increased serum lactate
n1=hyperlaxité ligamentaire | n2=en:mildly increased serum lactate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mildly prolonged bleeding time 10-12 minutes
n1=hyperlaxité ligamentaire | n2=en:mildly prolonged bleeding time 10-12 minutes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mitochondria dna deletion
n1=hyperlaxité ligamentaire | n2=en:mitochondria dna deletion | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mitochondrial complex i deficiency in muscle
n1=hyperlaxité ligamentaire | n2=en:mitochondrial complex i deficiency in muscle | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mitochondrial cytopathy
n1=hyperlaxité ligamentaire | n2=en:mitochondrial cytopathy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mitochondrial deletions
n1=hyperlaxité ligamentaire | n2=en:mitochondrial deletions | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mitochondrial diseases
n1=hyperlaxité ligamentaire | n2=en:mitochondrial diseases | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mitochondrial enzyme deficiency
n1=hyperlaxité ligamentaire | n2=en:mitochondrial enzyme deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mitochondrial malic enzyme reduced
n1=hyperlaxité ligamentaire | n2=en:mitochondrial malic enzyme reduced | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mitochondrial malonyl-coa decarboxylase activity in fibroblasts is very low (as low as 4%)
n1=hyperlaxité ligamentaire | n2=en:mitochondrial malonyl-coa decarboxylase activity in fibroblasts is very low (as low as 4%) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mitochondrial respiratory chain defects (skeletal muscle, fibroblasts)
n1=hyperlaxité ligamentaire | n2=en:mitochondrial respiratory chain defects (skeletal muscle, fibroblasts) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mitochondrial trifunctional protein deficiency
n1=hyperlaxité ligamentaire | n2=en:mitochondrial trifunctional protein deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mitotic lymphocyte and fibroblast cultures show mosaic variegated aneuploidy
n1=hyperlaxité ligamentaire | n2=en:mitotic lymphocyte and fibroblast cultures show mosaic variegated aneuploidy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mitotic lymphocyte and fibroblast cultures show mosaic variegated aneuploidy (50%) affecting all chromosomes
n1=hyperlaxité ligamentaire | n2=en:mitotic lymphocyte and fibroblast cultures show mosaic variegated aneuploidy (50%) affecting all chromosomes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mixed hyperlipidemia (disorder)
n1=hyperlaxité ligamentaire | n2=en:mixed hyperlipidemia (disorder) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mixed respiratory and metabolic acidosis
n1=hyperlaxité ligamentaire | n2=en:mixed respiratory and metabolic acidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:moderate to severe thrombocytopenia (30-90 x 10(9)/l)
n1=hyperlaxité ligamentaire | n2=en:moderate to severe thrombocytopenia (30-90 x 10(9)/l) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:moderately decreased to normal phk activity in skeletal muscle
n1=hyperlaxité ligamentaire | n2=en:moderately decreased to normal phk activity in skeletal muscle | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:molybdenum cofactor deficiency
n1=hyperlaxité ligamentaire | n2=en:molybdenum cofactor deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:monoclonal gammopathy
n1=hyperlaxité ligamentaire | n2=en:monoclonal gammopathy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:monomeric igm
n1=hyperlaxité ligamentaire | n2=en:monomeric igm | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mononuclear cell noncaseating granulomatous inflammation on biopsy (lung, skin, lip)
n1=hyperlaxité ligamentaire | n2=en:mononuclear cell noncaseating granulomatous inflammation on biopsy (lung, skin, lip) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:more than 50% of mitotic cells show premature chromatid separation (pcs) affecting all chromosomes
n1=hyperlaxité ligamentaire | n2=en:more than 50% of mitotic cells show premature chromatid separation (pcs) affecting all chromosomes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mosaic tetrasomy 12p in skin fibroblasts
n1=hyperlaxité ligamentaire | n2=en:mosaic tetrasomy 12p in skin fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mucopolysaccharidosis type iiid
n1=hyperlaxité ligamentaire | n2=en:mucopolysaccharidosis type iiid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:multi-tailed spermatozoa
n1=hyperlaxité ligamentaire | n2=en:multi-tailed spermatozoa | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:multiple autoantibodies
n1=hyperlaxité ligamentaire | n2=en:multiple autoantibodies | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:multiple organs (lung, liver, spleen, kidney, brain) contain foamy resident cells and histiocytes
n1=hyperlaxité ligamentaire | n2=en:multiple organs (lung, liver, spleen, kidney, brain) contain foamy resident cells and histiocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:multiple tissue biopsies show lysosomal storage disease
n1=hyperlaxité ligamentaire | n2=en:multiple tissue biopsies show lysosomal storage disease | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:multiple visceral organs (lung, liver, spleen, kidney) contain foamy resident cells and histiocytes
n1=hyperlaxité ligamentaire | n2=en:multiple visceral organs (lung, liver, spleen, kidney) contain foamy resident cells and histiocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:muscle and liver tissue show decreased activities of mitochondrial complexes i, ii, and iii
n1=hyperlaxité ligamentaire | n2=en:muscle and liver tissue show decreased activities of mitochondrial complexes i, ii, and iii | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:mutant mtdna threonine transfer rna gene (mttt, 590090) of questionable etiology
n1=hyperlaxité ligamentaire | n2=en:mutant mtdna threonine transfer rna gene (mttt, 590090) of questionable etiology | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:myelin basic protein measurement, spinal fluid
n1=hyperlaxité ligamentaire | n2=en:myelin basic protein measurement, spinal fluid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:myelodysplastic syndrome
n1=hyperlaxité ligamentaire | n2=en:myelodysplastic syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:myoglobinuria
n1=hyperlaxité ligamentaire | n2=en:myoglobinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:myoglobinuria (reported in 1 patient)
n1=hyperlaxité ligamentaire | n2=en:myoglobinuria (reported in 1 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:myoglobinuria after exertion
n1=hyperlaxité ligamentaire | n2=en:myoglobinuria after exertion | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:myoglobinuria after exertion (in some patients)
n1=hyperlaxité ligamentaire | n2=en:myoglobinuria after exertion (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:myoglobinuria with extreme exertion
n1=hyperlaxité ligamentaire | n2=en:myoglobinuria with extreme exertion | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:myoglobinuria, particularly after physical exertion (25% of patients)
n1=hyperlaxité ligamentaire | n2=en:myoglobinuria, particularly after physical exertion (25% of patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:myopathy with type i fiber atrophy on muscle biopsy
n1=hyperlaxité ligamentaire | n2=en:myopathy with type i fiber atrophy on muscle biopsy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:n-acetyl-alpha-d-glucosaminidase deficiency in fibroblasts
n1=hyperlaxité ligamentaire | n2=en:n-acetyl-alpha-d-glucosaminidase deficiency in fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:n-acetylgalactosamine-6-sulfatase deficiency in fibroblasts and leukocytes
n1=hyperlaxité ligamentaire | n2=en:n-acetylgalactosamine-6-sulfatase deficiency in fibroblasts and leukocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:n-glycosylation defect
n1=hyperlaxité ligamentaire | n2=en:n-glycosylation defect | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:nadh-cytochrome b(5) reductase deficiency
n1=hyperlaxité ligamentaire | n2=en:nadh-cytochrome b(5) reductase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:near-complete absence of vldl peak on density gradient ultracentrifugation (in some patients)
n1=hyperlaxité ligamentaire | n2=en:near-complete absence of vldl peak on density gradient ultracentrifugation (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:negative nitroblue tetrazolium (nbt) reduction test
n1=hyperlaxité ligamentaire | n2=en:negative nitroblue tetrazolium (nbt) reduction test | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:neonatal hemochromatosis
n1=hyperlaxité ligamentaire | n2=en:neonatal hemochromatosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:neonatal hyperbilirubinemia
n1=hyperlaxité ligamentaire | n2=en:neonatal hyperbilirubinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:neonatal hypocalcemia
n1=hyperlaxité ligamentaire | n2=en:neonatal hypocalcemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:neonatal hypoglycemia
n1=hyperlaxité ligamentaire | n2=en:neonatal hypoglycemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:neonatal or infantile metabolic ketoacidosis
n1=hyperlaxité ligamentaire | n2=en:neonatal or infantile metabolic ketoacidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:nephrotic syndrome
n1=hyperlaxité ligamentaire | n2=en:nephrotic syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:nephrotic syndrome - nphs1 associated
n1=hyperlaxité ligamentaire | n2=en:nephrotic syndrome - nphs1 associated | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:neuraminidase deficiency (white blood cells, fibroblasts, cultured amniotic cells)
n1=hyperlaxité ligamentaire | n2=en:neuraminidase deficiency (white blood cells, fibroblasts, cultured amniotic cells) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:neurofibrillary tangles and neuritic senile plaques rare
n1=hyperlaxité ligamentaire | n2=en:neurofibrillary tangles and neuritic senile plaques rare | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:neuropathy, hereditary motor and sensory, okinawa type
n1=hyperlaxité ligamentaire | n2=en:neuropathy, hereditary motor and sensory, okinawa type | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:neutral hyperaminoaciduria
n1=hyperlaxité ligamentaire | n2=en:neutral hyperaminoaciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:neutropenia
n1=hyperlaxité ligamentaire | n2=en:neutropenia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:neutropenia (in 1 patient)
n1=hyperlaxité ligamentaire | n2=en:neutropenia (in 1 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:neutrophilia, both basal and during infections
n1=hyperlaxité ligamentaire | n2=en:neutrophilia, both basal and during infections | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:nickel metabolic disorder
n1=hyperlaxité ligamentaire | n2=en:nickel metabolic disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no c8 antigen detected
n1=hyperlaxité ligamentaire | n2=en:no c8 antigen detected | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no cartilage staining with toluidine blue
n1=hyperlaxité ligamentaire | n2=en:no cartilage staining with toluidine blue | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no chromosomal breakage
n1=hyperlaxité ligamentaire | n2=en:no chromosomal breakage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no chromosome breakage
n1=hyperlaxité ligamentaire | n2=en:no chromosome breakage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no dicarboxylic aciduria
n1=hyperlaxité ligamentaire | n2=en:no dicarboxylic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no elevation of free fatty acids
n1=hyperlaxité ligamentaire | n2=en:no elevation of free fatty acids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no evidence of common prenatal infections
n1=hyperlaxité ligamentaire | n2=en:no evidence of common prenatal infections | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no evidence of intrauterine infection in mother or newborn
n1=hyperlaxité ligamentaire | n2=en:no evidence of intrauterine infection in mother or newborn | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no evidence of perinatal infection
n1=hyperlaxité ligamentaire | n2=en:no evidence of perinatal infection | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no hematuria
n1=hyperlaxité ligamentaire | n2=en:no hematuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no histochemical evidence of mitochondrial myopathy.
n1=hyperlaxité ligamentaire | n2=en:no histochemical evidence of mitochondrial myopathy. | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no hyperphenylalaninemia
n1=hyperlaxité ligamentaire | n2=en:no hyperphenylalaninemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no hyperuricemia
n1=hyperlaxité ligamentaire | n2=en:no hyperuricemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no increase in urinary cyclic amp (camp) in response to vasopressin or ddavp
n1=hyperlaxité ligamentaire | n2=en:no increase in urinary cyclic amp (camp) in response to vasopressin or ddavp | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no increase of muscle lactate with ischemic exercise testing
n1=hyperlaxité ligamentaire | n2=en:no increase of muscle lactate with ischemic exercise testing | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no increased sensitivity to oxidative species
n1=hyperlaxité ligamentaire | n2=en:no increased sensitivity to oxidative species | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no ketonuria
n1=hyperlaxité ligamentaire | n2=en:no ketonuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no ketosis
n1=hyperlaxité ligamentaire | n2=en:no ketosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no lactic acidosis
n1=hyperlaxité ligamentaire | n2=en:no lactic acidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no metabolic abnormalities
n1=hyperlaxité ligamentaire | n2=en:no metabolic abnormalities | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:no mucopolysacchariduria
n1=hyperlaxité ligamentaire | n2=en:no mucopolysacchariduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:non-neoplastic hematologic and lymphocytic disorder
n1=hyperlaxité ligamentaire | n2=en:non-neoplastic hematologic and lymphocytic disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:nonketotic hypoglycemia
n1=hyperlaxité ligamentaire | n2=en:nonketotic hypoglycemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal 46,xy karyotype
n1=hyperlaxité ligamentaire | n2=en:normal 46,xy karyotype | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal activity of von willebrand factor-cleaving protease
n1=hyperlaxité ligamentaire | n2=en:normal activity of von willebrand factor-cleaving protease | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal aldosterone
n1=hyperlaxité ligamentaire | n2=en:normal aldosterone | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal apoa-ii levels in homozygotes
n1=hyperlaxité ligamentaire | n2=en:normal apoa-ii levels in homozygotes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal arterial oxygen saturation
n1=hyperlaxité ligamentaire | n2=en:normal arterial oxygen saturation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal axonal flare response after intradermal histamine injection
n1=hyperlaxité ligamentaire | n2=en:normal axonal flare response after intradermal histamine injection | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal b12
n1=hyperlaxité ligamentaire | n2=en:normal b12 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal basal metabolic rate
n1=hyperlaxité ligamentaire | n2=en:normal basal metabolic rate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal baseline cortisol
n1=hyperlaxité ligamentaire | n2=en:normal baseline cortisol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal blood lactate
n1=hyperlaxité ligamentaire | n2=en:normal blood lactate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal calcium (female)
n1=hyperlaxité ligamentaire | n2=en:normal calcium (female) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal cd8+/cd4+ ratio
n1=hyperlaxité ligamentaire | n2=en:normal cd8+/cd4+ ratio | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal cerebrospinal fluid
n1=hyperlaxité ligamentaire | n2=en:normal cerebrospinal fluid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal ciliary structure and function
n1=hyperlaxité ligamentaire | n2=en:normal ciliary structure and function | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal collagen type i studies
n1=hyperlaxité ligamentaire | n2=en:normal collagen type i studies | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal complex ii activity
n1=hyperlaxité ligamentaire | n2=en:normal complex ii activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal concentration of parathyroid hormone
n1=hyperlaxité ligamentaire | n2=en:normal concentration of parathyroid hormone | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal constitutional karyotype
n1=hyperlaxité ligamentaire | n2=en:normal constitutional karyotype | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal csf 5-hiaa
n1=hyperlaxité ligamentaire | n2=en:normal csf 5-hiaa | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal csf 5-hydroxyindoleacetic acid (5-hiaa)
n1=hyperlaxité ligamentaire | n2=en:normal csf 5-hydroxyindoleacetic acid (5-hiaa) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal csf neurotransmitters
n1=hyperlaxité ligamentaire | n2=en:normal csf neurotransmitters | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal dermal hydroxylysine content
n1=hyperlaxité ligamentaire | n2=en:normal dermal hydroxylysine content | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal ellsworth-howard test, normal urinary camp response to parathyroid hormone (pth) administration
n1=hyperlaxité ligamentaire | n2=en:normal ellsworth-howard test, normal urinary camp response to parathyroid hormone (pth) administration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal endocrinologic studies (growth hormone, somatomedin c, thyroid function)
n1=hyperlaxité ligamentaire | n2=en:normal endocrinologic studies (growth hormone, somatomedin c, thyroid function) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal eosinophil peroxidase activity
n1=hyperlaxité ligamentaire | n2=en:normal eosinophil peroxidase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal erythrocyte gs activity
n1=hyperlaxité ligamentaire | n2=en:normal erythrocyte gs activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal exocrine pancreatic function
n1=hyperlaxité ligamentaire | n2=en:normal exocrine pancreatic function | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal extrarenal responses to ddavp administration
n1=hyperlaxité ligamentaire | n2=en:normal extrarenal responses to ddavp administration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal free urinary cortisol
n1=hyperlaxité ligamentaire | n2=en:normal free urinary cortisol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal g(s)-alpha levels (139320)
n1=hyperlaxité ligamentaire | n2=en:normal g(s)-alpha levels (139320) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal growth hormone responses to arginine, l-dopa, and propranolol stimulation
n1=hyperlaxité ligamentaire | n2=en:normal growth hormone responses to arginine, l-dopa, and propranolol stimulation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal iga levels
n1=hyperlaxité ligamentaire | n2=en:normal iga levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal igg levels
n1=hyperlaxité ligamentaire | n2=en:normal igg levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal igm levels
n1=hyperlaxité ligamentaire | n2=en:normal igm levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal isoelectric focusing of apolipoprotein ciii
n1=hyperlaxité ligamentaire | n2=en:normal isoelectric focusing of apolipoprotein ciii | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal isoelectric focusing of serum transferrin
n1=hyperlaxité ligamentaire | n2=en:normal isoelectric focusing of serum transferrin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal lactate (hcs)
n1=hyperlaxité ligamentaire | n2=en:normal lactate (hcs) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal leukocyte and platelet counts
n1=hyperlaxité ligamentaire | n2=en:normal leukocyte and platelet counts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal levels of complement factor h, but impaired function
n1=hyperlaxité ligamentaire | n2=en:normal levels of complement factor h, but impaired function | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal liver histology
n1=hyperlaxité ligamentaire | n2=en:normal liver histology | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal lysl hydroxylase activity
n1=hyperlaxité ligamentaire | n2=en:normal lysl hydroxylase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal lysosomal hydrolases
n1=hyperlaxité ligamentaire | n2=en:normal lysosomal hydrolases | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal lysyl hydroxylase activity
n1=hyperlaxité ligamentaire | n2=en:normal lysyl hydroxylase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal lysyl oxidase activity
n1=hyperlaxité ligamentaire | n2=en:normal lysyl oxidase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal male karyotype (46,xy)
n1=hyperlaxité ligamentaire | n2=en:normal male karyotype (46,xy) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal maltase, isomaltase, and sucrase activity
n1=hyperlaxité ligamentaire | n2=en:normal maltase, isomaltase, and sucrase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal mitochondrial respiratory chain complex i-v (hcs)
n1=hyperlaxité ligamentaire | n2=en:normal mitochondrial respiratory chain complex i-v (hcs) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal n-glycan analysis
n1=hyperlaxité ligamentaire | n2=en:normal n-glycan analysis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal number of t and b lymphocytes
n1=hyperlaxité ligamentaire | n2=en:normal number of t and b lymphocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal or decreased serum erythropoietin (epo, 133170)
n1=hyperlaxité ligamentaire | n2=en:normal or decreased serum erythropoietin (epo, 133170) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal or decreased serum potassium
n1=hyperlaxité ligamentaire | n2=en:normal or decreased serum potassium | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal or increased levels of serum arginine vasopressin (antidiuretic hormone, 192340)
n1=hyperlaxité ligamentaire | n2=en:normal or increased levels of serum arginine vasopressin (antidiuretic hormone, 192340) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal or increased serum creatine kinase
n1=hyperlaxité ligamentaire | n2=en:normal or increased serum creatine kinase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal or increased serum phosphate
n1=hyperlaxité ligamentaire | n2=en:normal or increased serum phosphate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal or increased serum phytanic acid
n1=hyperlaxité ligamentaire | n2=en:normal or increased serum phytanic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal or increased urinary cyclic amp response to pth administration
n1=hyperlaxité ligamentaire | n2=en:normal or increased urinary cyclic amp response to pth administration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal or mildly decreased arylsulfatase a activity
n1=hyperlaxité ligamentaire | n2=en:normal or mildly decreased arylsulfatase a activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal or mildly decreased serum levels of free thyroid hormones
n1=hyperlaxité ligamentaire | n2=en:normal or mildly decreased serum levels of free thyroid hormones | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal or mildly increased serum creatine kinase
n1=hyperlaxité ligamentaire | n2=en:normal or mildly increased serum creatine kinase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal or mildly increased serum gamma-ggt (231950)
n1=hyperlaxité ligamentaire | n2=en:normal or mildly increased serum gamma-ggt (231950) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal or mildly increased serum gamma-glutamyltransferase (ggt)
n1=hyperlaxité ligamentaire | n2=en:normal or mildly increased serum gamma-glutamyltransferase (ggt) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal or mildly increased thyroid-stimulating hormone (tsh)
n1=hyperlaxité ligamentaire | n2=en:normal or mildly increased thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal or mildly reduced serum cobalamin
n1=hyperlaxité ligamentaire | n2=en:normal or mildly reduced serum cobalamin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal or mildly reduced sphingomyelinase activity
n1=hyperlaxité ligamentaire | n2=en:normal or mildly reduced sphingomyelinase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal parathyroid hormone (female)
n1=hyperlaxité ligamentaire | n2=en:normal parathyroid hormone (female) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal phytanic acid
n1=hyperlaxité ligamentaire | n2=en:normal phytanic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal plasma and tissue carnitine
n1=hyperlaxité ligamentaire | n2=en:normal plasma and tissue carnitine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal plasma glycerol level at rest
n1=hyperlaxité ligamentaire | n2=en:normal plasma glycerol level at rest | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal plasma phytanic acid
n1=hyperlaxité ligamentaire | n2=en:normal plasma phytanic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal plasma renin
n1=hyperlaxité ligamentaire | n2=en:normal plasma renin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal plasma total homocysteine
n1=hyperlaxité ligamentaire | n2=en:normal plasma total homocysteine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal platelet aggregation response to arachidonic acid (aa)
n1=hyperlaxité ligamentaire | n2=en:normal platelet aggregation response to arachidonic acid (aa) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal platelet aggregation response to arachidonic acid (aa), adenosine 5'-diphosphate (adp), collagen, and ristocetin
n1=hyperlaxité ligamentaire | n2=en:normal platelet aggregation response to arachidonic acid (aa), adenosine 5'-diphosphate (adp), collagen, and ristocetin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal platelet aggregation response to epinephrine, adp, collagen, and ristocetin
n1=hyperlaxité ligamentaire | n2=en:normal platelet aggregation response to epinephrine, adp, collagen, and ristocetin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal platelet aggregation response to epinephrine, arachidonic acid (aa), adenosine 5'-diphosphate (adp), collagen, and ristocetin
n1=hyperlaxité ligamentaire | n2=en:normal platelet aggregation response to epinephrine, arachidonic acid (aa), adenosine 5'-diphosphate (adp), collagen, and ristocetin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal platelet aggregation studies with adp, collagen, and ristocetin
n1=hyperlaxité ligamentaire | n2=en:normal platelet aggregation studies with adp, collagen, and ristocetin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal platelet aggregation with adp, collagen, epinephrine
n1=hyperlaxité ligamentaire | n2=en:normal platelet aggregation with adp, collagen, epinephrine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal prolyl 4-hydroxylase activity
n1=hyperlaxité ligamentaire | n2=en:normal prolyl 4-hydroxylase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal pyridinoline excretion in urine
n1=hyperlaxité ligamentaire | n2=en:normal pyridinoline excretion in urine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal red cell counts
n1=hyperlaxité ligamentaire | n2=en:normal red cell counts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal renin level
n1=hyperlaxité ligamentaire | n2=en:normal renin level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal sedimentation rate
n1=hyperlaxité ligamentaire | n2=en:normal sedimentation rate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum 1,25-dihydroxyvitamin d3
n1=hyperlaxité ligamentaire | n2=en:normal serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum 25-hydroxyvitamin d3
n1=hyperlaxité ligamentaire | n2=en:normal serum 25-hydroxyvitamin d3 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum and mucosal iga
n1=hyperlaxité ligamentaire | n2=en:normal serum and mucosal iga | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum bile acids
n1=hyperlaxité ligamentaire | n2=en:normal serum bile acids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum biotin concentration
n1=hyperlaxité ligamentaire | n2=en:normal serum biotin concentration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum cobalamin
n1=hyperlaxité ligamentaire | n2=en:normal serum cobalamin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum cobalamin (vitamin b12)
n1=hyperlaxité ligamentaire | n2=en:normal serum cobalamin (vitamin b12) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum complement levels
n1=hyperlaxité ligamentaire | n2=en:normal serum complement levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum creatine kinase
n1=hyperlaxité ligamentaire | n2=en:normal serum creatine kinase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum erythropoietin (epo, 133170)
n1=hyperlaxité ligamentaire | n2=en:normal serum erythropoietin (epo, 133170) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum folate levels
n1=hyperlaxité ligamentaire | n2=en:normal serum folate levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum levels of gamma-ggt (231950)
n1=hyperlaxité ligamentaire | n2=en:normal serum levels of gamma-ggt (231950) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum lipoprotein levels
n1=hyperlaxité ligamentaire | n2=en:normal serum lipoprotein levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum liver enzymes
n1=hyperlaxité ligamentaire | n2=en:normal serum liver enzymes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum parathyroid hormone (pth)
n1=hyperlaxité ligamentaire | n2=en:normal serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum phosphorus
n1=hyperlaxité ligamentaire | n2=en:normal serum phosphorus | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum phytanic and pristanic acid
n1=hyperlaxité ligamentaire | n2=en:normal serum phytanic and pristanic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum plasmalogen
n1=hyperlaxité ligamentaire | n2=en:normal serum plasmalogen | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal serum transferrin profiles
n1=hyperlaxité ligamentaire | n2=en:normal serum transferrin profiles | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal sweat chloride (3 of 3 patients)
n1=hyperlaxité ligamentaire | n2=en:normal sweat chloride (3 of 3 patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal sweat electrolytes
n1=hyperlaxité ligamentaire | n2=en:normal sweat electrolytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal sweating
n1=hyperlaxité ligamentaire | n2=en:normal sweating | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal to elevated serum 1,25-dihydroxycholecalciferol (calcitriol)
n1=hyperlaxité ligamentaire | n2=en:normal to elevated serum 1,25-dihydroxycholecalciferol (calcitriol) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal to elevated total plasma carnitine
n1=hyperlaxité ligamentaire | n2=en:normal to elevated total plasma carnitine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal to increased plasma glycine
n1=hyperlaxité ligamentaire | n2=en:normal to increased plasma glycine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal to increased plasma threonine
n1=hyperlaxité ligamentaire | n2=en:normal to increased plasma threonine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal to mildly increased mucopolysacchariduria
n1=hyperlaxité ligamentaire | n2=en:normal to mildly increased mucopolysacchariduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal to mildly increased serum creatine kinase
n1=hyperlaxité ligamentaire | n2=en:normal to mildly increased serum creatine kinase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal to mildly increased serum parathyroid hormone (pth)
n1=hyperlaxité ligamentaire | n2=en:normal to mildly increased serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal to prolonged bleeding time
n1=hyperlaxité ligamentaire | n2=en:normal to prolonged bleeding time | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal to slightly elevated plasma cholesterol
n1=hyperlaxité ligamentaire | n2=en:normal to slightly elevated plasma cholesterol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal to slightly high alkaline phosphatase
n1=hyperlaxité ligamentaire | n2=en:normal to slightly high alkaline phosphatase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal total urinary coproporphyrin
n1=hyperlaxité ligamentaire | n2=en:normal total urinary coproporphyrin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal transferrin isoelectric focusing test
n1=hyperlaxité ligamentaire | n2=en:normal transferrin isoelectric focusing test | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal transferrin isoelectric profile
n1=hyperlaxité ligamentaire | n2=en:normal transferrin isoelectric profile | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal transferrin saturation
n1=hyperlaxité ligamentaire | n2=en:normal transferrin saturation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal tyrosinase
n1=hyperlaxité ligamentaire | n2=en:normal tyrosinase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal urinary 17-ketosteroids
n1=hyperlaxité ligamentaire | n2=en:normal urinary 17-ketosteroids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal urinary cyclic amp response to pth administration
n1=hyperlaxité ligamentaire | n2=en:normal urinary cyclic amp response to pth administration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal urinary orotic acid
n1=hyperlaxité ligamentaire | n2=en:normal urinary orotic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal urinary pterins
n1=hyperlaxité ligamentaire | n2=en:normal urinary pterins | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal-elevated plasma testosterone (male range)
n1=hyperlaxité ligamentaire | n2=en:normal-elevated plasma testosterone (male range) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal-to-decreased plasma glycine (fasting)
n1=hyperlaxité ligamentaire | n2=en:normal-to-decreased plasma glycine (fasting) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normal-to-slightly decreased glcnac phosphotransferase using artificial substrate (e.g., alpha-methylmannoside)
n1=hyperlaxité ligamentaire | n2=en:normal-to-slightly decreased glcnac phosphotransferase using artificial substrate (e.g., alpha-methylmannoside) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:normocalcemia
n1=hyperlaxité ligamentaire | n2=en:normocalcemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:nursing therapy
n1=hyperlaxité ligamentaire | n2=en:nursing therapy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:nutritional and metabolic diseases
n1=hyperlaxité ligamentaire | n2=en:nutritional and metabolic diseases | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:nutritional and metabolic disorders in diseases classified elsewhere
n1=hyperlaxité ligamentaire | n2=en:nutritional and metabolic disorders in diseases classified elsewhere | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:nutritional disorder
n1=hyperlaxité ligamentaire | n2=en:nutritional disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:nutritional management
n1=hyperlaxité ligamentaire | n2=en:nutritional management | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:occasional hypomagnesemia
n1=hyperlaxité ligamentaire | n2=en:occasional hypomagnesemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:occasionally mild elevation of csf protein
n1=hyperlaxité ligamentaire | n2=en:occasionally mild elevation of csf protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:oestradiol decreased
n1=hyperlaxité ligamentaire | n2=en:oestradiol decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:often integrated hbv sequences in hepatocellular carcinomas
n1=hyperlaxité ligamentaire | n2=en:often integrated hbv sequences in hepatocellular carcinomas | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:oligospermia or azoospermia
n1=hyperlaxité ligamentaire | n2=en:oligospermia or azoospermia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:organic acid metabolism disorder
n1=hyperlaxité ligamentaire | n2=en:organic acid metabolism disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:organic aciduria
n1=hyperlaxité ligamentaire | n2=en:organic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:organic aciduria (elevated beta-hydroxyisovalerate, beta-methylcrotonylglycine, beta-hydroxypropionate, methylcitrate, lactate, tiglylglycine)
n1=hyperlaxité ligamentaire | n2=en:organic aciduria (elevated beta-hydroxyisovalerate, beta-methylcrotonylglycine, beta-hydroxypropionate, methylcitrate, lactate, tiglylglycine) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:organic aciduria (elevated beta-hydroxyisovalerate, lactate, beta-methylcrotonylglycine, beta-hydroxypropionate, methylcitrate)
n1=hyperlaxité ligamentaire | n2=en:organic aciduria (elevated beta-hydroxyisovalerate, lactate, beta-methylcrotonylglycine, beta-hydroxypropionate, methylcitrate) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:organic aciduria, mild (in some patients)
n1=hyperlaxité ligamentaire | n2=en:organic aciduria, mild (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ornithine-delta-aminotransferase (oat) deficiency
n1=hyperlaxité ligamentaire | n2=en:ornithine-delta-aminotransferase (oat) deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:orotic acid crystalluria
n1=hyperlaxité ligamentaire | n2=en:orotic acid crystalluria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:orotic aciduria
n1=hyperlaxité ligamentaire | n2=en:orotic aciduria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:osteocalcin increased
n1=hyperlaxité ligamentaire | n2=en:osteocalcin increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other anaemias
n1=hyperlaxité ligamentaire | n2=en:other anaemias | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other cytogenic abnormalities have been associated with dgs phenotype including monosomy 10p13, 11p13, and 4q21
n1=hyperlaxité ligamentaire | n2=en:other cytogenic abnormalities have been associated with dgs phenotype including monosomy 10p13, 11p13, and 4q21 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other deficiency anemias
n1=hyperlaxité ligamentaire | n2=en:other deficiency anemias | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other diseases of blood and blood-forming organs
n1=hyperlaxité ligamentaire | n2=en:other diseases of blood and blood-forming organs | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other disorders of amino-acid metabolism
n1=hyperlaxité ligamentaire | n2=en:other disorders of amino-acid metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other disorders of carbohydrate metabolism
n1=hyperlaxité ligamentaire | n2=en:other disorders of carbohydrate metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other disorders of fluid, electrolyte and acid-base balance
n1=hyperlaxité ligamentaire | n2=en:other disorders of fluid, electrolyte and acid-base balance | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other disorders of lipoid metabolism
n1=hyperlaxité ligamentaire | n2=en:other disorders of lipoid metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other disorders of lipoprotein metabolism
n1=hyperlaxité ligamentaire | n2=en:other disorders of lipoprotein metabolism | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other health condition:find:pt:^patient:nom
n1=hyperlaxité ligamentaire | n2=en:other health condition:find:pt:^patient:nom | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other hematologic conditions
n1=hyperlaxité ligamentaire | n2=en:other hematologic conditions | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other hyperlipidaemia
n1=hyperlaxité ligamentaire | n2=en:other hyperlipidaemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other metabolic disorders
n1=hyperlaxité ligamentaire | n2=en:other metabolic disorders | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other specified diseases of blood and blood-forming organs
n1=hyperlaxité ligamentaire | n2=en:other specified diseases of blood and blood-forming organs | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other specified metabolic disorders
n1=hyperlaxité ligamentaire | n2=en:other specified metabolic disorders | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other specified transient hematological disorders of fetus or newborn
n1=hyperlaxité ligamentaire | n2=en:other specified transient hematological disorders of fetus or newborn | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other symptoms concerning nutrition, metabolism, and development
n1=hyperlaxité ligamentaire | n2=en:other symptoms concerning nutrition, metabolism, and development | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:other transitory neonatal endocrine and metabolic disturbances
n1=hyperlaxité ligamentaire | n2=en:other transitory neonatal endocrine and metabolic disturbances | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:overproduction of uric acid and purines
n1=hyperlaxité ligamentaire | n2=en:overproduction of uric acid and purines | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:p5c levels increased in urine
n1=hyperlaxité ligamentaire | n2=en:p5c levels increased in urine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pancreatic enzymes decreased
n1=hyperlaxité ligamentaire | n2=en:pancreatic enzymes decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pancreatic trypsinogen deficiency
n1=hyperlaxité ligamentaire | n2=en:pancreatic trypsinogen deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pancytopenia
n1=hyperlaxité ligamentaire | n2=en:pancytopenia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:panhypogammaglobulinemia
n1=hyperlaxité ligamentaire | n2=en:panhypogammaglobulinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:paradoxical increase or no change in serum aldosterone and blood pressure after dexamethasone administration
n1=hyperlaxité ligamentaire | n2=en:paradoxical increase or no change in serum aldosterone and blood pressure after dexamethasone administration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:paradoxical increased cortisol secretion on dexamethasone suppression test
n1=hyperlaxité ligamentaire | n2=en:paradoxical increased cortisol secretion on dexamethasone suppression test | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:paraproteinemia
n1=hyperlaxité ligamentaire | n2=en:paraproteinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:parathyroid hormone (pth) absent to low
n1=hyperlaxité ligamentaire | n2=en:parathyroid hormone (pth) absent to low | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:parathyroid hormone level increased
n1=hyperlaxité ligamentaire | n2=en:parathyroid hormone level increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:parathyroid hormone normal
n1=hyperlaxité ligamentaire | n2=en:parathyroid hormone normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:parathyroid hormone-related peptide (pthrp) absent to low
n1=hyperlaxité ligamentaire | n2=en:parathyroid hormone-related peptide (pthrp) absent to low | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:paroxysmal sweating
n1=hyperlaxité ligamentaire | n2=en:paroxysmal sweating | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:partial deficiency of factor xi (less common)
n1=hyperlaxité ligamentaire | n2=en:partial deficiency of factor xi (less common) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:partial deficiency of factor xi(c)
n1=hyperlaxité ligamentaire | n2=en:partial deficiency of factor xi(c) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:partial deficiency of factor xii(c)
n1=hyperlaxité ligamentaire | n2=en:partial deficiency of factor xii(c) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:partial deficiency of factor xiii (less common)
n1=hyperlaxité ligamentaire | n2=en:partial deficiency of factor xiii (less common) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:partial deficiency of factor xiii(c)
n1=hyperlaxité ligamentaire | n2=en:partial deficiency of factor xiii(c) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:partial deletion of long arm of chromosome 11 (11q23-qter)
n1=hyperlaxité ligamentaire | n2=en:partial deletion of long arm of chromosome 11 (11q23-qter) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:partial terminal deletion of short arm of chromosome 1 (1p36)
n1=hyperlaxité ligamentaire | n2=en:partial terminal deletion of short arm of chromosome 1 (1p36) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pathologic hemolysis
n1=hyperlaxité ligamentaire | n2=en:pathologic hemolysis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pathological aspects
n1=hyperlaxité ligamentaire | n2=en:pathological aspects | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:patient cells have increased levels of lmnb1 mrna and protein
n1=hyperlaxité ligamentaire | n2=en:patient cells have increased levels of lmnb1 mrna and protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:patient cells show a defect in transcription-coupled and global genome nucleotide excision repair
n1=hyperlaxité ligamentaire | n2=en:patient cells show a defect in transcription-coupled and global genome nucleotide excision repair | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:patient cells show abnormal mitochondrial morphology
n1=hyperlaxité ligamentaire | n2=en:patient cells show abnormal mitochondrial morphology | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:patient cells show defective dna repair in response to irradiation and free radical damage
n1=hyperlaxité ligamentaire | n2=en:patient cells show defective dna repair in response to irradiation and free radical damage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:patient cells show defective transcription-coupled and global genome nucleotide excision repair (ner)
n1=hyperlaxité ligamentaire | n2=en:patient cells show defective transcription-coupled and global genome nucleotide excision repair (ner) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:patient cells show increased chromosome breakage
n1=hyperlaxité ligamentaire | n2=en:patient cells show increased chromosome breakage | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:patient fibroblasts and muscle show decreased activities of mitochondrial complexes i, iii, and iv
n1=hyperlaxité ligamentaire | n2=en:patient fibroblasts and muscle show decreased activities of mitochondrial complexes i, iii, and iv | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:patients have supernumerary chromosome - 47,xx(or xy), +der(22), +(11:22)(q23:q11)
n1=hyperlaxité ligamentaire | n2=en:patients have supernumerary chromosome - 47,xx(or xy), +der(22), +(11:22)(q23:q11) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:patients with factor xiii alpha subunit deficiency usually also have decreased levels of plasma factor xiii beta subunit
n1=hyperlaxité ligamentaire | n2=en:patients with factor xiii alpha subunit deficiency usually also have decreased levels of plasma factor xiii beta subunit | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:patients with factor xiii beta subunit deficiency usually also have decreased levels of plasma factor xiii alpha subunit
n1=hyperlaxité ligamentaire | n2=en:patients with factor xiii beta subunit deficiency usually also have decreased levels of plasma factor xiii alpha subunit | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pcd shows separate and rod-shaped x chromosomes without discernible centromeres
n1=hyperlaxité ligamentaire | n2=en:pcd shows separate and rod-shaped x chromosomes without discernible centromeres | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pcs involves most of all chromosomes of a metaphase
n1=hyperlaxité ligamentaire | n2=en:pcs involves most of all chromosomes of a metaphase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pcs shows separate and splayed chromatids with discernible centromeres
n1=hyperlaxité ligamentaire | n2=en:pcs shows separate and splayed chromatids with discernible centromeres | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pediatric terminology
n1=hyperlaxité ligamentaire | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pentagastrin stimulation test
n1=hyperlaxité ligamentaire | n2=en:pentagastrin stimulation test | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:percentage of bone-derived alkaline phosphatase is >60% in patients versus 40% in healthy adult subjects
n1=hyperlaxité ligamentaire | n2=en:percentage of bone-derived alkaline phosphatase is >60% in patients versus 40% in healthy adult subjects | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:periodic fever, luteal phase-dependent (in some patients)
n1=hyperlaxité ligamentaire | n2=en:periodic fever, luteal phase-dependent (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:periodic fever, pre- and postovulation (in some patients)
n1=hyperlaxité ligamentaire | n2=en:periodic fever, pre- and postovulation (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:peroxisome deficiency
n1=hyperlaxité ligamentaire | n2=en:peroxisome deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:persistent ebv viremia
n1=hyperlaxité ligamentaire | n2=en:persistent ebv viremia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:persistent lactic acidosis
n1=hyperlaxité ligamentaire | n2=en:persistent lactic acidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:phenylpyruvic acidemia
n1=hyperlaxité ligamentaire | n2=en:phenylpyruvic acidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:phlebotomy
n1=hyperlaxité ligamentaire | n2=en:phlebotomy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:phosphate normal
n1=hyperlaxité ligamentaire | n2=en:phosphate normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:phosphaturia
n1=hyperlaxité ligamentaire | n2=en:phosphaturia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:phosphaturia (in some)
n1=hyperlaxité ligamentaire | n2=en:phosphaturia (in some) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:phosphaturia may disappear after a long period of time
n1=hyperlaxité ligamentaire | n2=en:phosphaturia may disappear after a long period of time | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:phospholipid antibody positive
n1=hyperlaxité ligamentaire | n2=en:phospholipid antibody positive | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:phosphomannomutase deficiency in leukocytes, fibroblasts, or liver
n1=hyperlaxité ligamentaire | n2=en:phosphomannomutase deficiency in leukocytes, fibroblasts, or liver | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:phosphomannose isomerase deficiency in leukocytes, fibroblasts, or liver
n1=hyperlaxité ligamentaire | n2=en:phosphomannose isomerase deficiency in leukocytes, fibroblasts, or liver | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:phosphorus metabolic disorder
n1=hyperlaxité ligamentaire | n2=en:phosphorus metabolic disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:phosphorylase kinase deficiency in liver and muscle
n1=hyperlaxité ligamentaire | n2=en:phosphorylase kinase deficiency in liver and muscle | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:phosphorylase kinase normal in muscle
n1=hyperlaxité ligamentaire | n2=en:phosphorylase kinase normal in muscle | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:physiopathological
n1=hyperlaxité ligamentaire | n2=en:physiopathological | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:phytanic acid accumulation
n1=hyperlaxité ligamentaire | n2=en:phytanic acid accumulation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:phytanic acid increased
n1=hyperlaxité ligamentaire | n2=en:phytanic acid increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pink urine
n1=hyperlaxité ligamentaire | n2=en:pink urine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pipecolic acid accumulation.
n1=hyperlaxité ligamentaire | n2=en:pipecolic acid accumulation. | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pipecolic acidemia
n1=hyperlaxité ligamentaire | n2=en:pipecolic acidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:placental transfusion syndromes
n1=hyperlaxité ligamentaire | n2=en:placental transfusion syndromes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:plasma aldosterone increased
n1=hyperlaxité ligamentaire | n2=en:plasma aldosterone increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:plasma aldosterone normal
n1=hyperlaxité ligamentaire | n2=en:plasma aldosterone normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:plasma ammonia not elevated
n1=hyperlaxité ligamentaire | n2=en:plasma ammonia not elevated | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:plasma catecholamines decreased
n1=hyperlaxité ligamentaire | n2=en:plasma catecholamines decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:plasma protein c deficiency
n1=hyperlaxité ligamentaire | n2=en:plasma protein c deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:plasma triglycerides increased
n1=hyperlaxité ligamentaire | n2=en:plasma triglycerides increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:plasmalogen deficiency
n1=hyperlaxité ligamentaire | n2=en:plasmalogen deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:platelet aggregation decreased
n1=hyperlaxité ligamentaire | n2=en:platelet aggregation decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:platelet antibody positive
n1=hyperlaxité ligamentaire | n2=en:platelet antibody positive | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:platelet count normal
n1=hyperlaxité ligamentaire | n2=en:platelet count normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:platelet factor 4 decreased
n1=hyperlaxité ligamentaire | n2=en:platelet factor 4 decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:platelet function test normal
n1=hyperlaxité ligamentaire | n2=en:platelet function test normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:platelet glycoprotein iiia deficiency
n1=hyperlaxité ligamentaire | n2=en:platelet glycoprotein iiia deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:platelets have decreased number of alpha-granules, large vacuoles, normal number of dense bodies on electron microscopy
n1=hyperlaxité ligamentaire | n2=en:platelets have decreased number of alpha-granules, large vacuoles, normal number of dense bodies on electron microscopy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pms excrete 10 to 200 times less metabolite in urine than wildtype (em)
n1=hyperlaxité ligamentaire | n2=en:pms excrete 10 to 200 times less metabolite in urine than wildtype (em) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pms have increased metabolic ratio of unchanged drug-to-metabolite in urine
n1=hyperlaxité ligamentaire | n2=en:pms have increased metabolic ratio of unchanged drug-to-metabolite in urine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pms show decreased levels of hepatic cyp2d6 enzyme
n1=hyperlaxité ligamentaire | n2=en:pms show decreased levels of hepatic cyp2d6 enzyme | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pms show deficient oxidation of debrisoquine
n1=hyperlaxité ligamentaire | n2=en:pms show deficient oxidation of debrisoquine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pms show impaired metabolism of debrisoquine and related drugs
n1=hyperlaxité ligamentaire | n2=en:pms show impaired metabolism of debrisoquine and related drugs | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pms show increased sensitivity to effects of medication
n1=hyperlaxité ligamentaire | n2=en:pms show increased sensitivity to effects of medication | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:polychromasia
n1=hyperlaxité ligamentaire | n2=en:polychromasia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:polycythemia
n1=hyperlaxité ligamentaire | n2=en:polycythemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:polydipsia
n1=hyperlaxité ligamentaire | n2=en:polydipsia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:polydipsia (in some patients)
n1=hyperlaxité ligamentaire | n2=en:polydipsia (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:polydipsia (in some)
n1=hyperlaxité ligamentaire | n2=en:polydipsia (in some) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:polymorphonuclear leukocytosis, episodic
n1=hyperlaxité ligamentaire | n2=en:polymorphonuclear leukocytosis, episodic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:polyploid sperm heads
n1=hyperlaxité ligamentaire | n2=en:polyploid sperm heads | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:polysyndactyly
n1=hyperlaxité ligamentaire | n2=en:polysyndactyly | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:polyuria
n1=hyperlaxité ligamentaire | n2=en:polyuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:poor anticoagulant response to exogenous activated protein c as measured by the activated partial thromboplastin time (aptt)
n1=hyperlaxité ligamentaire | n2=en:poor anticoagulant response to exogenous activated protein c as measured by the activated partial thromboplastin time (aptt) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:poor mitogenic response to growth factors
n1=hyperlaxité ligamentaire | n2=en:poor mitogenic response to growth factors | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:porphyria
n1=hyperlaxité ligamentaire | n2=en:porphyria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:positive antinuclear antibody test
n1=hyperlaxité ligamentaire | n2=en:positive antinuclear antibody test | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:positive kveim-siltzbach skin test
n1=hyperlaxité ligamentaire | n2=en:positive kveim-siltzbach skin test | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:positive urinary bratton-marshall test
n1=hyperlaxité ligamentaire | n2=en:positive urinary bratton-marshall test | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:positive urine dnph screening test
n1=hyperlaxité ligamentaire | n2=en:positive urine dnph screening test | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:post transplant distal limb syndrome
n1=hyperlaxité ligamentaire | n2=en:post transplant distal limb syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:postprandial hyperammonemia
n1=hyperlaxité ligamentaire | n2=en:postprandial hyperammonemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:postprandial hyperglycemia (early in disease course)
n1=hyperlaxité ligamentaire | n2=en:postprandial hyperglycemia (early in disease course) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:postprocedural endocrine and metabolic disorders, not elsewhere classified
n1=hyperlaxité ligamentaire | n2=en:postprocedural endocrine and metabolic disorders, not elsewhere classified | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:potassium abnormality
n1=hyperlaxité ligamentaire | n2=en:potassium abnormality | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:predominance of the d-stereoisomer
n1=hyperlaxité ligamentaire | n2=en:predominance of the d-stereoisomer | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pregnancy complications, hematologic
n1=hyperlaxité ligamentaire | n2=en:pregnancy complications, hematologic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pregnant mothers of affected children have decreased plasma and urinary estrogen
n1=hyperlaxité ligamentaire | n2=en:pregnant mothers of affected children have decreased plasma and urinary estrogen | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:premalignant hematologic condition
n1=hyperlaxité ligamentaire | n2=en:premalignant hematologic condition | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:premature centromere division (pcd) of the x chromosome observed in cultured lymphocytes during metaphase
n1=hyperlaxité ligamentaire | n2=en:premature centromere division (pcd) of the x chromosome observed in cultured lymphocytes during metaphase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:premature chromatid separation (pcs) observed in 5% to 50% cultured lymphocytes during metaphase
n1=hyperlaxité ligamentaire | n2=en:premature chromatid separation (pcs) observed in 5% to 50% cultured lymphocytes during metaphase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:premature chromosome condensation
n1=hyperlaxité ligamentaire | n2=en:premature chromosome condensation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:premature separation of centromeric heterochromatin
n1=hyperlaxité ligamentaire | n2=en:premature separation of centromeric heterochromatin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:presence of cytochrome b(-245)
n1=hyperlaxité ligamentaire | n2=en:presence of cytochrome b(-245) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:presence of glial fibrillary acidic proteins (gfap) in astrocytes
n1=hyperlaxité ligamentaire | n2=en:presence of glial fibrillary acidic proteins (gfap) in astrocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:presence of pc mrna
n1=hyperlaxité ligamentaire | n2=en:presence of pc mrna | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:presence of rosenthal fibers (cytoplasmic inclusions) in astrocytes
n1=hyperlaxité ligamentaire | n2=en:presence of rosenthal fibers (cytoplasmic inclusions) in astrocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:presence of serum anti-lu3 antibodies
n1=hyperlaxité ligamentaire | n2=en:presence of serum anti-lu3 antibodies | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:presence of the philadelphia chromosome (translocation of 9q34 and 22q11) in greater than 95% of patients
n1=hyperlaxité ligamentaire | n2=en:presence of the philadelphia chromosome (translocation of 9q34 and 22q11) in greater than 95% of patients | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:presence of vacuoles on muscle biopsy
n1=hyperlaxité ligamentaire | n2=en:presence of vacuoles on muscle biopsy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:primary health condition:find:pt:^patient:nom
n1=hyperlaxité ligamentaire | n2=en:primary health condition:find:pt:^patient:nom | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:primary immunoglobulin-related amyloidosis (al)
n1=hyperlaxité ligamentaire | n2=en:primary immunoglobulin-related amyloidosis (al) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:prolidase deficiency
n1=hyperlaxité ligamentaire | n2=en:prolidase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:prolinuria
n1=hyperlaxité ligamentaire | n2=en:prolinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:prolonged activated partial prothrombin time (appt)
n1=hyperlaxité ligamentaire | n2=en:prolonged activated partial prothrombin time (appt) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:prolonged activated partial thromboplastin time (aptt)
n1=hyperlaxité ligamentaire | n2=en:prolonged activated partial thromboplastin time (aptt) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:prolonged bleeding time
n1=hyperlaxité ligamentaire | n2=en:prolonged bleeding time | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:prolonged bleeding time (10 - >30 minutes)
n1=hyperlaxité ligamentaire | n2=en:prolonged bleeding time (10 - >30 minutes) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:prolonged partial thromboplastin time
n1=hyperlaxité ligamentaire | n2=en:prolonged partial thromboplastin time | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:prolonged partial thromboplastin time (ptt)
n1=hyperlaxité ligamentaire | n2=en:prolonged partial thromboplastin time (ptt) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:prolonged prothrombin and partial thromboplastin times
n1=hyperlaxité ligamentaire | n2=en:prolonged prothrombin and partial thromboplastin times | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:prolonged prothrombin time (pt)
n1=hyperlaxité ligamentaire | n2=en:prolonged prothrombin time (pt) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:prominent leukocytosis (30,000/ml)
n1=hyperlaxité ligamentaire | n2=en:prominent leukocytosis (30,000/ml) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:proper antibody response to protein vaccinations
n1=hyperlaxité ligamentaire | n2=en:proper antibody response to protein vaccinations | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:propionic acidemia
n1=hyperlaxité ligamentaire | n2=en:propionic acidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:protein c decreased
n1=hyperlaxité ligamentaire | n2=en:protein c decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:protein total decreased
n1=hyperlaxité ligamentaire | n2=en:protein total decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:protein urine absent
n1=hyperlaxité ligamentaire | n2=en:protein urine absent | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:proteinosis
n1=hyperlaxité ligamentaire | n2=en:proteinosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:proteinuria
n1=hyperlaxité ligamentaire | n2=en:proteinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:proteinuria (type ii, congenital)
n1=hyperlaxité ligamentaire | n2=en:proteinuria (type ii, congenital) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:proteinuria in those with cystic kidneys
n1=hyperlaxité ligamentaire | n2=en:proteinuria in those with cystic kidneys | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:proteostasis deficiencies
n1=hyperlaxité ligamentaire | n2=en:proteostasis deficiencies | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:prothrombin time increased
n1=hyperlaxité ligamentaire | n2=en:prothrombin time increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:prothrombin time low
n1=hyperlaxité ligamentaire | n2=en:prothrombin time low | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:proximal renal tubular acidosis
n1=hyperlaxité ligamentaire | n2=en:proximal renal tubular acidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pseudohyperkalemia, due to ex vivo efflux of potassium from red cells (in some patients)
n1=hyperlaxité ligamentaire | n2=en:pseudohyperkalemia, due to ex vivo efflux of potassium from red cells (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pseudohypertriglyceridemia in adult form
n1=hyperlaxité ligamentaire | n2=en:pseudohypertriglyceridemia in adult form | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:psychology qualifier
n1=hyperlaxité ligamentaire | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pt normal
n1=hyperlaxité ligamentaire | n2=en:pt normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:purine-pyrimidine metabolism, inborn errors
n1=hyperlaxité ligamentaire | n2=en:purine-pyrimidine metabolism, inborn errors | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:purpura and other haemorrhagic conditions
n1=hyperlaxité ligamentaire | n2=en:purpura and other haemorrhagic conditions | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pyrimidinuria
n1=hyperlaxité ligamentaire | n2=en:pyrimidinuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pyruvate-induced insulin secretion
n1=hyperlaxité ligamentaire | n2=en:pyruvate-induced insulin secretion | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:pyruvic acidemia
n1=hyperlaxité ligamentaire | n2=en:pyruvic acidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:radiotherapeutic
n1=hyperlaxité ligamentaire | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:raised c-reactive protein
n1=hyperlaxité ligamentaire | n2=en:raised c-reactive protein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:raised tsh level
n1=hyperlaxité ligamentaire | n2=en:raised tsh level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:rapid high rai (radioactive iodine) uptake and turnover
n1=hyperlaxité ligamentaire | n2=en:rapid high rai (radioactive iodine) uptake and turnover | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:rapid radioactive iodide (rai) discharge after thiocyanate or perchlorate
n1=hyperlaxité ligamentaire | n2=en:rapid radioactive iodide (rai) discharge after thiocyanate or perchlorate | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:rare occurrences of 9+0 or 8+1 cilia
n1=hyperlaxité ligamentaire | n2=en:rare occurrences of 9+0 or 8+1 cilia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:rbc count low
n1=hyperlaxité ligamentaire | n2=en:rbc count low | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reactive hypoglycemia
n1=hyperlaxité ligamentaire | n2=en:reactive hypoglycemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:rectilinear intracellular accumulation of autofluorescent lipopigment storage material
n1=hyperlaxité ligamentaire | n2=en:rectilinear intracellular accumulation of autofluorescent lipopigment storage material | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:recurrent episodes of dehydration
n1=hyperlaxité ligamentaire | n2=en:recurrent episodes of dehydration | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:recurrent fevers
n1=hyperlaxité ligamentaire | n2=en:recurrent fevers | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:recurrent hypoglycemia
n1=hyperlaxité ligamentaire | n2=en:recurrent hypoglycemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:recurring t(11,14) and t(14,19)(q32,q13.1) translocations
n1=hyperlaxité ligamentaire | n2=en:recurring t(11,14) and t(14,19)(q32,q13.1) translocations | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:red blood cell count raised
n1=hyperlaxité ligamentaire | n2=en:red blood cell count raised | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced (50%) activity of protoporphyrinogen oxidase (proto oxidase)
n1=hyperlaxité ligamentaire | n2=en:reduced (50%) activity of protoporphyrinogen oxidase (proto oxidase) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced aspartoacylase activity in cultured skin fibroblasts
n1=hyperlaxité ligamentaire | n2=en:reduced aspartoacylase activity in cultured skin fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced beating amplitudes in cilia
n1=hyperlaxité ligamentaire | n2=en:reduced beating amplitudes in cilia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced bending capacity of cilia
n1=hyperlaxité ligamentaire | n2=en:reduced bending capacity of cilia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced cd4+ count and proportionally increased cd8+ count
n1=hyperlaxité ligamentaire | n2=en:reduced cd4+ count and proportionally increased cd8+ count | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced cytosolic superoxide dismutase-1 (sod1)
n1=hyperlaxité ligamentaire | n2=en:reduced cytosolic superoxide dismutase-1 (sod1) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced electroretinogram (scotopic > photopic) becoming extinguished in older patients
n1=hyperlaxité ligamentaire | n2=en:reduced electroretinogram (scotopic > photopic) becoming extinguished in older patients | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced erythrocyte adenosine deaminase activity
n1=hyperlaxité ligamentaire | n2=en:reduced erythrocyte adenosine deaminase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced erythrocyte glucose/hexose transport
n1=hyperlaxité ligamentaire | n2=en:reduced erythrocyte glucose/hexose transport | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced erythrocyte gs activity
n1=hyperlaxité ligamentaire | n2=en:reduced erythrocyte gs activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced erythrocyte purine nucleoside phosphorylase activity
n1=hyperlaxité ligamentaire | n2=en:reduced erythrocyte purine nucleoside phosphorylase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced ferrochelatase activity
n1=hyperlaxité ligamentaire | n2=en:reduced ferrochelatase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced high-density lipoprotein
n1=hyperlaxité ligamentaire | n2=en:reduced high-density lipoprotein | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced iga
n1=hyperlaxité ligamentaire | n2=en:reduced iga | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced ige levels
n1=hyperlaxité ligamentaire | n2=en:reduced ige levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced igg levels, particularly igg2 subclass
n1=hyperlaxité ligamentaire | n2=en:reduced igg levels, particularly igg2 subclass | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced liver and red cell uroporphyrinogen decarboxylase (uro decarboxylase)
n1=hyperlaxité ligamentaire | n2=en:reduced liver and red cell uroporphyrinogen decarboxylase (uro decarboxylase) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced oxygen affinity (e.g. hb thionville 141800.0168)
n1=hyperlaxité ligamentaire | n2=en:reduced oxygen affinity (e.g. hb thionville 141800.0168) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced platelet aggregation response to adp, collagen, epinephrine
n1=hyperlaxité ligamentaire | n2=en:reduced platelet aggregation response to adp, collagen, epinephrine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced platelet aggregation response to collagen and thrombin
n1=hyperlaxité ligamentaire | n2=en:reduced platelet aggregation response to collagen and thrombin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced platelet glycoprotein ib complex
n1=hyperlaxité ligamentaire | n2=en:reduced platelet glycoprotein ib complex | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced serum uric acid
n1=hyperlaxité ligamentaire | n2=en:reduced serum uric acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced total and free carnitine in plasma and tissue
n1=hyperlaxité ligamentaire | n2=en:reduced total and free carnitine in plasma and tissue | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reduced unsaturated serum cobalamin binding capacity
n1=hyperlaxité ligamentaire | n2=en:reduced unsaturated serum cobalamin binding capacity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:rehabilitation aspects
n1=hyperlaxité ligamentaire | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:relatively low urinary pge-m levels
n1=hyperlaxité ligamentaire | n2=en:relatively low urinary pge-m levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:renal secondary osteodystrophia fibrosa
n1=hyperlaxité ligamentaire | n2=en:renal secondary osteodystrophia fibrosa | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:renal tubular acidosis
n1=hyperlaxité ligamentaire | n2=en:renal tubular acidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:renin decreased
n1=hyperlaxité ligamentaire | n2=en:renin decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:resistance to 1,25-dihydroxyvitamin d3
n1=hyperlaxité ligamentaire | n2=en:resistance to 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:resistance to activated protein c due to factor v leiden
n1=hyperlaxité ligamentaire | n2=en:resistance to activated protein c due to factor v leiden | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:respiratory alkalosis
n1=hyperlaxité ligamentaire | n2=en:respiratory alkalosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:respiratory cilia and sperm flagella show reduced coordination of beating activity
n1=hyperlaxité ligamentaire | n2=en:respiratory cilia and sperm flagella show reduced coordination of beating activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:respiratory epithelial show lack of ciliary movement or abnormal movement
n1=hyperlaxité ligamentaire | n2=en:respiratory epithelial show lack of ciliary movement or abnormal movement | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reticulin fibrosis of the bone marrow
n1=hyperlaxité ligamentaire | n2=en:reticulin fibrosis of the bone marrow | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reticulocyte count increased
n1=hyperlaxité ligamentaire | n2=en:reticulocyte count increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reticulocytosis
n1=hyperlaxité ligamentaire | n2=en:reticulocytosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:reye-like episode
n1=hyperlaxité ligamentaire | n2=en:reye-like episode | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:rhabdomyolysis in response to alcohol
n1=hyperlaxité ligamentaire | n2=en:rhabdomyolysis in response to alcohol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:rheumatoid factor negative
n1=hyperlaxité ligamentaire | n2=en:rheumatoid factor negative | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:rheumatoid factor positive (finding)
n1=hyperlaxité ligamentaire | n2=en:rheumatoid factor positive (finding) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:round, yellow-brown dha urine crystals
n1=hyperlaxité ligamentaire | n2=en:round, yellow-brown dha urine crystals | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:routine liver function tests normal
n1=hyperlaxité ligamentaire | n2=en:routine liver function tests normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:rowley-rosenberg syndrome
n1=hyperlaxité ligamentaire | n2=en:rowley-rosenberg syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:russell's viper venom assay may be prolonged or normal, depending on the genetic defect
n1=hyperlaxité ligamentaire | n2=en:russell's viper venom assay may be prolonged or normal, depending on the genetic defect | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:saccharopine dehydrogenase deficiency
n1=hyperlaxité ligamentaire | n2=en:saccharopine dehydrogenase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:salt-wasting syndrome of infancy
n1=hyperlaxité ligamentaire | n2=en:salt-wasting syndrome of infancy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:saposin a deficiency (finding)
n1=hyperlaxité ligamentaire | n2=en:saposin a deficiency (finding) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:sce normal in heterozygotes
n1=hyperlaxité ligamentaire | n2=en:sce normal in heterozygotes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:schirmer test shows alacrima
n1=hyperlaxité ligamentaire | n2=en:schirmer test shows alacrima | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:secondary decrease of plasma free carnitine
n1=hyperlaxité ligamentaire | n2=en:secondary decrease of plasma free carnitine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:secondary decreased activity of argininosuccinate synthetase (ass1)
n1=hyperlaxité ligamentaire | n2=en:secondary decreased activity of argininosuccinate synthetase (ass1) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:secondary decreases in complex i and iv activity
n1=hyperlaxité ligamentaire | n2=en:secondary decreases in complex i and iv activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:secondary hyperlipidemia
n1=hyperlaxité ligamentaire | n2=en:secondary hyperlipidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:seizures often associated with fever (63%)
n1=hyperlaxité ligamentaire | n2=en:seizures often associated with fever (63%) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:self-regulated protein restriction
n1=hyperlaxité ligamentaire | n2=en:self-regulated protein restriction | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:sepiapterin reductase deficiency (fibroblasts)
n1=hyperlaxité ligamentaire | n2=en:sepiapterin reductase deficiency (fibroblasts) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum acid phosphatase normal
n1=hyperlaxité ligamentaire | n2=en:serum acid phosphatase normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum acylcarnitine returns to borderline high or normal after resolution of fever
n1=hyperlaxité ligamentaire | n2=en:serum acylcarnitine returns to borderline high or normal after resolution of fever | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum albumin low result
n1=hyperlaxité ligamentaire | n2=en:serum albumin low result | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum aldosterone elevated
n1=hyperlaxité ligamentaire | n2=en:serum aldosterone elevated | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum alkaline phosphatase normal or mildly increased
n1=hyperlaxité ligamentaire | n2=en:serum alkaline phosphatase normal or mildly increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum alpha-1-antitrypsin (pi) deficiency
n1=hyperlaxité ligamentaire | n2=en:serum alpha-1-antitrypsin (pi) deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum ammonia increased
n1=hyperlaxité ligamentaire | n2=en:serum ammonia increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum amylase increased
n1=hyperlaxité ligamentaire | n2=en:serum amylase increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum and csf lactate may be increased
n1=hyperlaxité ligamentaire | n2=en:serum and csf lactate may be increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum bicarbonate decreased
n1=hyperlaxité ligamentaire | n2=en:serum bicarbonate decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum bicarbonate increased
n1=hyperlaxité ligamentaire | n2=en:serum bicarbonate increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum bilirubin increased
n1=hyperlaxité ligamentaire | n2=en:serum bilirubin increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum c-peptide and glucagon levels measurable
n1=hyperlaxité ligamentaire | n2=en:serum c-peptide and glucagon levels measurable | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum c-reactive protein may be increased
n1=hyperlaxité ligamentaire | n2=en:serum c-reactive protein may be increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum calcitonin level increased
n1=hyperlaxité ligamentaire | n2=en:serum calcitonin level increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum calcitonin, increased
n1=hyperlaxité ligamentaire | n2=en:serum calcitonin, increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum calcium elevated
n1=hyperlaxité ligamentaire | n2=en:serum calcium elevated | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum calcium normal
n1=hyperlaxité ligamentaire | n2=en:serum calcium normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum carnitine deficiency
n1=hyperlaxité ligamentaire | n2=en:serum carnitine deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum chloride level decreased (finding)
n1=hyperlaxité ligamentaire | n2=en:serum chloride level decreased (finding) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum cholesterol low or normal
n1=hyperlaxité ligamentaire | n2=en:serum cholesterol low or normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum cholesterol normal
n1=hyperlaxité ligamentaire | n2=en:serum cholesterol normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum cholesterol raised
n1=hyperlaxité ligamentaire | n2=en:serum cholesterol raised | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum complement decreased
n1=hyperlaxité ligamentaire | n2=en:serum complement decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum copper decreased
n1=hyperlaxité ligamentaire | n2=en:serum copper decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum corticosterone increased
n1=hyperlaxité ligamentaire | n2=en:serum corticosterone increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum cortisol decreased
n1=hyperlaxité ligamentaire | n2=en:serum cortisol decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum cortisol elevated
n1=hyperlaxité ligamentaire | n2=en:serum cortisol elevated | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum creatine kinase 20-70 times normal
n1=hyperlaxité ligamentaire | n2=en:serum creatine kinase 20-70 times normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum creatine kinase may be increased
n1=hyperlaxité ligamentaire | n2=en:serum creatine kinase may be increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum creatine kinase may be normal
n1=hyperlaxité ligamentaire | n2=en:serum creatine kinase may be normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum creatine kinase may be normal or elevated
n1=hyperlaxité ligamentaire | n2=en:serum creatine kinase may be normal or elevated | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum creatine kinase may be normal or increased
n1=hyperlaxité ligamentaire | n2=en:serum creatine kinase may be normal or increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum creatinine raised
n1=hyperlaxité ligamentaire | n2=en:serum creatinine raised | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum ferritin hyperglycosylation
n1=hyperlaxité ligamentaire | n2=en:serum ferritin hyperglycosylation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum ferritin normal
n1=hyperlaxité ligamentaire | n2=en:serum ferritin normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum folate low
n1=hyperlaxité ligamentaire | n2=en:serum folate low | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum folate normal
n1=hyperlaxité ligamentaire | n2=en:serum folate normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum gastrin increased
n1=hyperlaxité ligamentaire | n2=en:serum gastrin increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum growth hormone increased
n1=hyperlaxité ligamentaire | n2=en:serum growth hormone increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum homocysteine normal
n1=hyperlaxité ligamentaire | n2=en:serum homocysteine normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum immunoglobulin free light chain increased
n1=hyperlaxité ligamentaire | n2=en:serum immunoglobulin free light chain increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum immunoglobulin free light chain ratio abnormal
n1=hyperlaxité ligamentaire | n2=en:serum immunoglobulin free light chain ratio abnormal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum iron low (finding)
n1=hyperlaxité ligamentaire | n2=en:serum iron low (finding) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum iron normal
n1=hyperlaxité ligamentaire | n2=en:serum iron normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum iron raised
n1=hyperlaxité ligamentaire | n2=en:serum iron raised | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum lactate is usually normal
n1=hyperlaxité ligamentaire | n2=en:serum lactate is usually normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum lactate may be increased during encephalopathic exacerbations
n1=hyperlaxité ligamentaire | n2=en:serum lactate may be increased during encephalopathic exacerbations | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum lipid abnormal nos
n1=hyperlaxité ligamentaire | n2=en:serum lipid abnormal nos | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum lipid, elevated
n1=hyperlaxité ligamentaire | n2=en:serum lipid, elevated | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum lipids high (finding)
n1=hyperlaxité ligamentaire | n2=en:serum lipids high (finding) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum mitochondrial autoantibodies
n1=hyperlaxité ligamentaire | n2=en:serum mitochondrial autoantibodies | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum osmolality decreased
n1=hyperlaxité ligamentaire | n2=en:serum osmolality decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum phosphate concentration below normal
n1=hyperlaxité ligamentaire | n2=en:serum phosphate concentration below normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum phosphate normal
n1=hyperlaxité ligamentaire | n2=en:serum phosphate normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum pristanic acid increased
n1=hyperlaxité ligamentaire | n2=en:serum pristanic acid increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum prolactin decreased
n1=hyperlaxité ligamentaire | n2=en:serum prolactin decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum prolactin increased
n1=hyperlaxité ligamentaire | n2=en:serum prolactin increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum prostate specific antigen increased
n1=hyperlaxité ligamentaire | n2=en:serum prostate specific antigen increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum soluble fas ligand level increased
n1=hyperlaxité ligamentaire | n2=en:serum soluble fas ligand level increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum testosterone decreased
n1=hyperlaxité ligamentaire | n2=en:serum testosterone decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum testosterone level normal
n1=hyperlaxité ligamentaire | n2=en:serum testosterone level normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum thiamine is normal
n1=hyperlaxité ligamentaire | n2=en:serum thiamine is normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum thyroxine may be decreased or normal
n1=hyperlaxité ligamentaire | n2=en:serum thyroxine may be decreased or normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum total tryptase levels increased
n1=hyperlaxité ligamentaire | n2=en:serum total tryptase levels increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum transaminase increased
n1=hyperlaxité ligamentaire | n2=en:serum transaminase increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum transferrin glycosylation is normal
n1=hyperlaxité ligamentaire | n2=en:serum transferrin glycosylation is normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum transferrin isoelectric focusing shows type 2 pattern
n1=hyperlaxité ligamentaire | n2=en:serum transferrin isoelectric focusing shows type 2 pattern | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum transferrin shows normal or mild hypo-glycosylation
n1=hyperlaxité ligamentaire | n2=en:serum transferrin shows normal or mild hypo-glycosylation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum triglycerides increased
n1=hyperlaxité ligamentaire | n2=en:serum triglycerides increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:serum triglycerides normal
n1=hyperlaxité ligamentaire | n2=en:serum triglycerides normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:severe amyloid angiopathy
n1=hyperlaxité ligamentaire | n2=en:severe amyloid angiopathy | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:severe hypernatremia in neonatal period
n1=hyperlaxité ligamentaire | n2=en:severe hypernatremia in neonatal period | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:severe lactic acidosis
n1=hyperlaxité ligamentaire | n2=en:severe lactic acidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:severe thrombocytopenia (30-60 x 10(9)/l)
n1=hyperlaxité ligamentaire | n2=en:severe thrombocytopenia (30-60 x 10(9)/l) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:severely decreased activity of beta-1,4-mannosyltransferase (less than 10% of normal)
n1=hyperlaxité ligamentaire | n2=en:severely decreased activity of beta-1,4-mannosyltransferase (less than 10% of normal) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:severely decreased antigen levels of vwf and factor viii
n1=hyperlaxité ligamentaire | n2=en:severely decreased antigen levels of vwf and factor viii | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:severely decreased carnitine palmitoyltransferase ii (cpt ii) activity (less than 10% of normal) in multiple tissues
n1=hyperlaxité ligamentaire | n2=en:severely decreased carnitine palmitoyltransferase ii (cpt ii) activity (less than 10% of normal) in multiple tissues | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:severely decreased palmitate oxidation
n1=hyperlaxité ligamentaire | n2=en:severely decreased palmitate oxidation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:severely impaired ciliary motility
n1=hyperlaxité ligamentaire | n2=en:severely impaired ciliary motility | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:shortened metaphase
n1=hyperlaxité ligamentaire | n2=en:shortened metaphase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:shortened telomeres (1 patient)
n1=hyperlaxité ligamentaire | n2=en:shortened telomeres (1 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:shortened telomeres (classic feature, nola3 patient)
n1=hyperlaxité ligamentaire | n2=en:shortened telomeres (classic feature, nola3 patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:shortened telomeres (in 1 of 2 patients)
n1=hyperlaxité ligamentaire | n2=en:shortened telomeres (in 1 of 2 patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:siadh
n1=hyperlaxité ligamentaire | n2=en:siadh | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:sialylation defects
n1=hyperlaxité ligamentaire | n2=en:sialylation defects | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:sitosterolemia
n1=hyperlaxité ligamentaire | n2=en:sitosterolemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:skeletal muscle shows decreased activities of mitochondrial respiratory complexes i, iii, iv, and v
n1=hyperlaxité ligamentaire | n2=en:skeletal muscle shows decreased activities of mitochondrial respiratory complexes i, iii, iv, and v | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:skewed x-inactivation in females
n1=hyperlaxité ligamentaire | n2=en:skewed x-inactivation in females | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:skin diseases, metabolic
n1=hyperlaxité ligamentaire | n2=en:skin diseases, metabolic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:skin fibroblasts contain cytoplasmic membrane-bound granular inclusions
n1=hyperlaxité ligamentaire | n2=en:skin fibroblasts contain cytoplasmic membrane-bound granular inclusions | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:slightly elevated 24-hour mean plasma cortisol
n1=hyperlaxité ligamentaire | n2=en:slightly elevated 24-hour mean plasma cortisol | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:slightly increased serum alkaline phosphatase may occur
n1=hyperlaxité ligamentaire | n2=en:slightly increased serum alkaline phosphatase may occur | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:small adipocytes
n1=hyperlaxité ligamentaire | n2=en:small adipocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:smith-lemli-opitz syndrome
n1=hyperlaxité ligamentaire | n2=en:smith-lemli-opitz syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:smooth muscle antibodies positive
n1=hyperlaxité ligamentaire | n2=en:smooth muscle antibodies positive | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:some cilia show abnormal beating patterns or immotility
n1=hyperlaxité ligamentaire | n2=en:some cilia show abnormal beating patterns or immotility | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:some cilia show central complex and radial spoke defects
n1=hyperlaxité ligamentaire | n2=en:some cilia show central complex and radial spoke defects | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:some fragmented or disrupted golgi
n1=hyperlaxité ligamentaire | n2=en:some fragmented or disrupted golgi | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:some increase in monosialo- and trisialotransferrin (type 1/2 pattern)
n1=hyperlaxité ligamentaire | n2=en:some increase in monosialo- and trisialotransferrin (type 1/2 pattern) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:some patients carry a deletion of minimum of 8.1 mb on 2q32-q33
n1=hyperlaxité ligamentaire | n2=en:some patients carry a deletion of minimum of 8.1 mb on 2q32-q33 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:some tissues may have normal levels of 3-hydroxyacyl-coa dehydrogenase activity
n1=hyperlaxité ligamentaire | n2=en:some tissues may have normal levels of 3-hydroxyacyl-coa dehydrogenase activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:sphingolipidosis
n1=hyperlaxité ligamentaire | n2=en:sphingolipidosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:spongy degeneration of brain on histology
n1=hyperlaxité ligamentaire | n2=en:spongy degeneration of brain on histology | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:sterol 27-hydroxylase deficiency
n1=hyperlaxité ligamentaire | n2=en:sterol 27-hydroxylase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:stimulation of sympathetic fibers results in release of dopamine, not norepinephrine
n1=hyperlaxité ligamentaire | n2=en:stimulation of sympathetic fibers results in release of dopamine, not norepinephrine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:structural abnormalities seen on chromosome analysis
n1=hyperlaxité ligamentaire | n2=en:structural abnormalities seen on chromosome analysis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:subepithelial fibrin deposition with inflammation (pseudomembranous inflammation) of mucosal tissues
n1=hyperlaxité ligamentaire | n2=en:subepithelial fibrin deposition with inflammation (pseudomembranous inflammation) of mucosal tissues | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:submucosal macrophages filled with sphingolipids
n1=hyperlaxité ligamentaire | n2=en:submucosal macrophages filled with sphingolipids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:subsarcolemmal pleomorphic mitochondria on em
n1=hyperlaxité ligamentaire | n2=en:subsarcolemmal pleomorphic mitochondria on em | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:subtelomeric deletion of chromosome 16p
n1=hyperlaxité ligamentaire | n2=en:subtelomeric deletion of chromosome 16p | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:subtelomeric deletion of long arm of chromosome 3 (3q29)
n1=hyperlaxité ligamentaire | n2=en:subtelomeric deletion of long arm of chromosome 3 (3q29) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:sulfhemoglobinemia
n1=hyperlaxité ligamentaire | n2=en:sulfhemoglobinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:suppression of intact parathyroid hormone levels
n1=hyperlaxité ligamentaire | n2=en:suppression of intact parathyroid hormone levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:surgical aspects
n1=hyperlaxité ligamentaire | n2=en:surgical aspects | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:susceptible to hyperthermia
n1=hyperlaxité ligamentaire | n2=en:susceptible to hyperthermia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:sweat test normal
n1=hyperlaxité ligamentaire | n2=en:sweat test normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:symptoms concerning nutrition, metabolism, and development
n1=hyperlaxité ligamentaire | n2=en:symptoms concerning nutrition, metabolism, and development | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:synthetic defect of bile acids
n1=hyperlaxité ligamentaire | n2=en:synthetic defect of bile acids | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:systemic accumulation of very long chain fatty acids (vlcfa)
n1=hyperlaxité ligamentaire | n2=en:systemic accumulation of very long chain fatty acids (vlcfa) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:systemic amyloidosis may occur
n1=hyperlaxité ligamentaire | n2=en:systemic amyloidosis may occur | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:systemic mastocytosis
n1=hyperlaxité ligamentaire | n2=en:systemic mastocytosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:t cells may be increased or decreased
n1=hyperlaxité ligamentaire | n2=en:t cells may be increased or decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:t-cell deficit
n1=hyperlaxité ligamentaire | n2=en:t-cell deficit | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:t-lymphocytopenia
n1=hyperlaxité ligamentaire | n2=en:t-lymphocytopenia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:t1 transport protein (glucose-6-phosphate translocase) defect
n1=hyperlaxité ligamentaire | n2=en:t1 transport protein (glucose-6-phosphate translocase) defect | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:tay-sachs disease
n1=hyperlaxité ligamentaire | n2=en:tay-sachs disease | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:telomere shortening
n1=hyperlaxité ligamentaire | n2=en:telomere shortening | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:temperature instability
n1=hyperlaxité ligamentaire | n2=en:temperature instability | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:temperature rhythm phase-advanced by 3-4 hours
n1=hyperlaxité ligamentaire | n2=en:temperature rhythm phase-advanced by 3-4 hours | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ten percent of cases are secondary to submicroscopic deletions of 16p13.3 detectable by fish
n1=hyperlaxité ligamentaire | n2=en:ten percent of cases are secondary to submicroscopic deletions of 16p13.3 detectable by fish | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:tenascin x deficiency (serum and fibroblasts)
n1=hyperlaxité ligamentaire | n2=en:tenascin x deficiency (serum and fibroblasts) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:therapeutic aspects
n1=hyperlaxité ligamentaire | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:thrombocytopenia
n1=hyperlaxité ligamentaire | n2=en:thrombocytopenia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:thrombocytopenia (33-120 x 10(9)/l)
n1=hyperlaxité ligamentaire | n2=en:thrombocytopenia (33-120 x 10(9)/l) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:thrombocytopenia, mild-moderate (60-100 x 10(9)/l)
n1=hyperlaxité ligamentaire | n2=en:thrombocytopenia, mild-moderate (60-100 x 10(9)/l) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:thrombocytopenic purpura
n1=hyperlaxité ligamentaire | n2=en:thrombocytopenic purpura | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:thrombocytosis (in some patients)
n1=hyperlaxité ligamentaire | n2=en:thrombocytosis (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:thrombophilia
n1=hyperlaxité ligamentaire | n2=en:thrombophilia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:thrombosis
n1=hyperlaxité ligamentaire | n2=en:thrombosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:thymic hormone decreased
n1=hyperlaxité ligamentaire | n2=en:thymic hormone decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:thyroid dyshormonogenesis 3
n1=hyperlaxité ligamentaire | n2=en:thyroid dyshormonogenesis 3 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:thyroid dyshormonogenesis 4
n1=hyperlaxité ligamentaire | n2=en:thyroid dyshormonogenesis 4 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:thyroid dyshormonogenesis 5
n1=hyperlaxité ligamentaire | n2=en:thyroid dyshormonogenesis 5 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:thyroid hormone organification defect
n1=hyperlaxité ligamentaire | n2=en:thyroid hormone organification defect | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:thyroid hormones increased
n1=hyperlaxité ligamentaire | n2=en:thyroid hormones increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:thyroid peroxidase defect
n1=hyperlaxité ligamentaire | n2=en:thyroid peroxidase defect | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:tonofibril defect (cross-beta-protein structure)
n1=hyperlaxité ligamentaire | n2=en:tonofibril defect (cross-beta-protein structure) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:tophus
n1=hyperlaxité ligamentaire | n2=en:tophus | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:transaminitis
n1=hyperlaxité ligamentaire | n2=en:transaminitis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:transcobalamin ii deficiency
n1=hyperlaxité ligamentaire | n2=en:transcobalamin ii deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:transferase deficiency galactosemia
n1=hyperlaxité ligamentaire | n2=en:transferase deficiency galactosemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:transferrin saturation increased
n1=hyperlaxité ligamentaire | n2=en:transferrin saturation increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:transfusion reaction
n1=hyperlaxité ligamentaire | n2=en:transfusion reaction | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:transient eosinophilia in first decade
n1=hyperlaxité ligamentaire | n2=en:transient eosinophilia in first decade | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:transient hyperlipidemia
n1=hyperlaxité ligamentaire | n2=en:transient hyperlipidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:transient hyperphenylalaninemia occurs on oral loading test with phenylalanine
n1=hyperlaxité ligamentaire | n2=en:transient hyperphenylalaninemia occurs on oral loading test with phenylalanine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:transient neonatal hypocalcemia (2p21del)
n1=hyperlaxité ligamentaire | n2=en:transient neonatal hypocalcemia (2p21del) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:transient neonatal hypoglycemia (2p21del)
n1=hyperlaxité ligamentaire | n2=en:transient neonatal hypoglycemia (2p21del) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:translocation (x,7)(p11.3,q11.21) - in some patients
n1=hyperlaxité ligamentaire | n2=en:translocation (x,7)(p11.3,q11.21) - in some patients | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:translocation between 18q21 and 14q32
n1=hyperlaxité ligamentaire | n2=en:translocation between 18q21 and 14q32 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:translocation of chromosomes 9 and 13
n1=hyperlaxité ligamentaire | n2=en:translocation of chromosomes 9 and 13 | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:translocation or deletions involving 7p13 (severe case reports)
n1=hyperlaxité ligamentaire | n2=en:translocation or deletions involving 7p13 (severe case reports) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:transmission electron microscopy (tem) of patient respiratory cilia shows normal 9+2 axonemal composition
n1=hyperlaxité ligamentaire | n2=en:transmission electron microscopy (tem) of patient respiratory cilia shows normal 9+2 axonemal composition | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:triglyceride decreased
n1=hyperlaxité ligamentaire | n2=en:triglyceride decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:triglycerides
n1=hyperlaxité ligamentaire | n2=en:triglycerides | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:tryptophanuria
n1=hyperlaxité ligamentaire | n2=en:tryptophanuria | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:tsh decreased
n1=hyperlaxité ligamentaire | n2=en:tsh decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:tumor lysis syndrome
n1=hyperlaxité ligamentaire | n2=en:tumor lysis syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:tumor may secrete vasoactive intestinal peptide (vip)
n1=hyperlaxité ligamentaire | n2=en:tumor may secrete vasoactive intestinal peptide (vip) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:two alternative chimeric oncogene products called p210(bcr-abl) and p185(bcr-abl)
n1=hyperlaxité ligamentaire | n2=en:two alternative chimeric oncogene products called p210(bcr-abl) and p185(bcr-abl) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:type 1 collagen overmodification
n1=hyperlaxité ligamentaire | n2=en:type 1 collagen overmodification | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:type i, classic, decreased antithrombin iii levels
n1=hyperlaxité ligamentaire | n2=en:type i, classic, decreased antithrombin iii levels | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:type ii, normal antithrombin iii level but decreased activity
n1=hyperlaxité ligamentaire | n2=en:type ii, normal antithrombin iii level but decreased activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:type iii collagen defect
n1=hyperlaxité ligamentaire | n2=en:type iii collagen defect | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:tyrosine iodination defect
n1=hyperlaxité ligamentaire | n2=en:tyrosine iodination defect | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:tyrosine loss
n1=hyperlaxité ligamentaire | n2=en:tyrosine loss | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:tyrosinemia
n1=hyperlaxité ligamentaire | n2=en:tyrosinemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:tyrosinemia (transient, resolves in infancy)
n1=hyperlaxité ligamentaire | n2=en:tyrosinemia (transient, resolves in infancy) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:udp-galactose-4-epimerase deficiency in all cells ('generalized' or 'severe' form)
n1=hyperlaxité ligamentaire | n2=en:udp-galactose-4-epimerase deficiency in all cells ('generalized' or 'severe' form) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:ultra large von willebrand factor (ul-vwf) in plasma
n1=hyperlaxité ligamentaire | n2=en:ultra large von willebrand factor (ul-vwf) in plasma | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:undetectable dopamine beta-hydroxylase (dbh) protein in plasma, csf, or sympathetic fibers
n1=hyperlaxité ligamentaire | n2=en:undetectable dopamine beta-hydroxylase (dbh) protein in plasma, csf, or sympathetic fibers | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:undetectable epinephrine (adrenaline) in plasma, urine, csf
n1=hyperlaxité ligamentaire | n2=en:undetectable epinephrine (adrenaline) in plasma, urine, csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:undetectable norepinephrine (noradrenaline) in plasma, urine, csf
n1=hyperlaxité ligamentaire | n2=en:undetectable norepinephrine (noradrenaline) in plasma, urine, csf | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:undetectable plasma dbh activity
n1=hyperlaxité ligamentaire | n2=en:undetectable plasma dbh activity | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:undetectable serum arginine vasopressin, or antidiuretic hormone (adh, avp, 192340)
n1=hyperlaxité ligamentaire | n2=en:undetectable serum arginine vasopressin, or antidiuretic hormone (adh, avp, 192340) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:undetectable serum l-transferrin (homozygous patient)
n1=hyperlaxité ligamentaire | n2=en:undetectable serum l-transferrin (homozygous patient) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:undetectable urinary hypoxanthine
n1=hyperlaxité ligamentaire | n2=en:undetectable urinary hypoxanthine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:unexplained fever (in some patients)
n1=hyperlaxité ligamentaire | n2=en:unexplained fever (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:unexplained fevers
n1=hyperlaxité ligamentaire | n2=en:unexplained fevers | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:unexplained fevers (2 patients)
n1=hyperlaxité ligamentaire | n2=en:unexplained fevers (2 patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:unprocessed 3-oxoacyl coa thiolase
n1=hyperlaxité ligamentaire | n2=en:unprocessed 3-oxoacyl coa thiolase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:unresponsive to acth stimulation
n1=hyperlaxité ligamentaire | n2=en:unresponsive to acth stimulation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:unspecified endocrine and metabolic disturbances specific to the fetus and newborn
n1=hyperlaxité ligamentaire | n2=en:unspecified endocrine and metabolic disturbances specific to the fetus and newborn | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:unspecified hematological disorder specific to newborn
n1=hyperlaxité ligamentaire | n2=en:unspecified hematological disorder specific to newborn | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:upregulation of alpha-interferon-stimulated genes
n1=hyperlaxité ligamentaire | n2=en:upregulation of alpha-interferon-stimulated genes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:uremia
n1=hyperlaxité ligamentaire | n2=en:uremia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:uric acid normal
n1=hyperlaxité ligamentaire | n2=en:uric acid normal | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urinary calcium-creatinine ratio < 0.01:1 supports diagnosis
n1=hyperlaxité ligamentaire | n2=en:urinary calcium-creatinine ratio < 0.01:1 supports diagnosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urinary excretion of 2-ethyl-3-hydroxy-hexanoic acid
n1=hyperlaxité ligamentaire | n2=en:urinary excretion of 2-ethyl-3-hydroxy-hexanoic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urinary excretion of 2-ethyl-3-keto-hexanoic acid
n1=hyperlaxité ligamentaire | n2=en:urinary excretion of 2-ethyl-3-keto-hexanoic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urinary excretion of 2-ethyl-hexanedioic acid
n1=hyperlaxité ligamentaire | n2=en:urinary excretion of 2-ethyl-hexanedioic acid | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urinary excretion of 3-hydroxyisovaleric acid, chronic
n1=hyperlaxité ligamentaire | n2=en:urinary excretion of 3-hydroxyisovaleric acid, chronic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urinary excretion of 3-methylcrotonylglycine, chronic
n1=hyperlaxité ligamentaire | n2=en:urinary excretion of 3-methylcrotonylglycine, chronic | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urinary excretion of cationic amino acids (lysine, arginine, ornithine)
n1=hyperlaxité ligamentaire | n2=en:urinary excretion of cationic amino acids (lysine, arginine, ornithine) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urinary excretion of low-molecular-weight proteins, mild
n1=hyperlaxité ligamentaire | n2=en:urinary excretion of low-molecular-weight proteins, mild | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urinary excretion of mucopolysaccharides
n1=hyperlaxité ligamentaire | n2=en:urinary excretion of mucopolysaccharides | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urinary excretion of retinol-binding proteins (rbp) and vitamin d-binding proteins (dbp)
n1=hyperlaxité ligamentaire | n2=en:urinary excretion of retinol-binding proteins (rbp) and vitamin d-binding proteins (dbp) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urinary excretion of sialylated oligosaccharides
n1=hyperlaxité ligamentaire | n2=en:urinary excretion of sialylated oligosaccharides | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urinary loss of potassium, sodium, calcium, and chloride
n1=hyperlaxité ligamentaire | n2=en:urinary loss of potassium, sodium, calcium, and chloride | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urinary prostaglandin e
n1=hyperlaxité ligamentaire | n2=en:urinary prostaglandin e | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urine cortisol, increased
n1=hyperlaxité ligamentaire | n2=en:urine cortisol, increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urine occasionally port-wine in color secondary to porphobilinogen
n1=hyperlaxité ligamentaire | n2=en:urine occasionally port-wine in color secondary to porphobilinogen | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urine odor, maple syrup
n1=hyperlaxité ligamentaire | n2=en:urine odor, maple syrup | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urine osmolarity decreased
n1=hyperlaxité ligamentaire | n2=en:urine osmolarity decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urine uric acid decreased
n1=hyperlaxité ligamentaire | n2=en:urine uric acid decreased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:urocanase deficiency
n1=hyperlaxité ligamentaire | n2=en:urocanase deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:uroporphyrin i and coproporphyrin i are found in plasma, red blood cells, urine, and feces
n1=hyperlaxité ligamentaire | n2=en:uroporphyrin i and coproporphyrin i are found in plasma, red blood cells, urine, and feces | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:uroporphyrinogen iii cosynthase (uro cosynthase) deficiency in blood and fibroblasts
n1=hyperlaxité ligamentaire | n2=en:uroporphyrinogen iii cosynthase (uro cosynthase) deficiency in blood and fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:usf1 gene
n1=hyperlaxité ligamentaire | n2=en:usf1 gene | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:usf1 wt allele
n1=hyperlaxité ligamentaire | n2=en:usf1 wt allele | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:vacuolated lymphocytes
n1=hyperlaxité ligamentaire | n2=en:vacuolated lymphocytes | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:variable defects of inner dynein arms
n1=hyperlaxité ligamentaire | n2=en:variable defects of inner dynein arms | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:variable fever
n1=hyperlaxité ligamentaire | n2=en:variable fever | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:variable hyperlipidemia
n1=hyperlaxité ligamentaire | n2=en:variable hyperlipidemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:variable hypoglycemia
n1=hyperlaxité ligamentaire | n2=en:variable hypoglycemia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:variable respiratory chain enzyme deficiency
n1=hyperlaxité ligamentaire | n2=en:variable respiratory chain enzyme deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:variably decreased activity of mitochondrial respiratory complexes i, iii, iv, and v in fibroblasts and muscle
n1=hyperlaxité ligamentaire | n2=en:variably decreased activity of mitochondrial respiratory complexes i, iii, iv, and v in fibroblasts and muscle | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:variably increased serum creatine kinase
n1=hyperlaxité ligamentaire | n2=en:variably increased serum creatine kinase | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:variegated translocation mosaicism in cultured fibroblasts
n1=hyperlaxité ligamentaire | n2=en:variegated translocation mosaicism in cultured fibroblasts | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:very long chain fatty acid accumulation
n1=hyperlaxité ligamentaire | n2=en:very long chain fatty acid accumulation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:very long-chain fatty acids may be normal or increased
n1=hyperlaxité ligamentaire | n2=en:very long-chain fatty acids may be normal or increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:very low density lipoprotein increased
n1=hyperlaxité ligamentaire | n2=en:very low density lipoprotein increased | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:very low iga
n1=hyperlaxité ligamentaire | n2=en:very low iga | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:very low igg
n1=hyperlaxité ligamentaire | n2=en:very low igg | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:very low igm
n1=hyperlaxité ligamentaire | n2=en:very low igm | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:very low leptin level
n1=hyperlaxité ligamentaire | n2=en:very low leptin level | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:veterinary aspects
n1=hyperlaxité ligamentaire | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:viremia
n1=hyperlaxité ligamentaire | n2=en:viremia | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:vitamin b12 deficiency (in some patients)
n1=hyperlaxité ligamentaire | n2=en:vitamin b12 deficiency (in some patients) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:vitamin b12 deficiency (uncommon)
n1=hyperlaxité ligamentaire | n2=en:vitamin b12 deficiency (uncommon) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:vitamin d deficiency
n1=hyperlaxité ligamentaire | n2=en:vitamin d deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:vitamin k deficiency
n1=hyperlaxité ligamentaire | n2=en:vitamin k deficiency | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:warfarin
n1=hyperlaxité ligamentaire | n2=en:warfarin | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:wasting syndrome
n1=hyperlaxité ligamentaire | n2=en:wasting syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:water intoxication
n1=hyperlaxité ligamentaire | n2=en:water intoxication | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:water-electrolyte imbalance
n1=hyperlaxité ligamentaire | n2=en:water-electrolyte imbalance | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:white blood cell abnormality
n1=hyperlaxité ligamentaire | n2=en:white blood cell abnormality | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:widespread interstitial fibrosis (visceral organs)
n1=hyperlaxité ligamentaire | n2=en:widespread interstitial fibrosis (visceral organs) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:woodhouse sakati syndrome
n1=hyperlaxité ligamentaire | n2=en:woodhouse sakati syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:xanthine nephrolithiasis
n1=hyperlaxité ligamentaire | n2=en:xanthine nephrolithiasis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:xanthomatosis
n1=hyperlaxité ligamentaire | n2=en:xanthomatosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:zieve's syndrome
n1=hyperlaxité ligamentaire | n2=en:zieve's syndrome | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
en:zinc deficiency disorder
n1=hyperlaxité ligamentaire | n2=en:zinc deficiency disorder | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
éosinophilie
n1=hyperlaxité ligamentaire | n2=éosinophilie | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
fissurée
n1=hyperlaxité ligamentaire | n2=fissurée | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
globule blanc
n1=hyperlaxité ligamentaire | n2=globule blanc | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
globules
n1=hyperlaxité ligamentaire | n2=globules | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
globules blancs
n1=hyperlaxité ligamentaire | n2=globules blancs | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
grossesse
n1=hyperlaxité ligamentaire | n2=grossesse | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
hémogramme
n1=hyperlaxité ligamentaire | n2=hémogramme | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
HLC
n1=hyperlaxité ligamentaire | n2=HLC | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
hyperkeratosis
n1=hyperlaxité ligamentaire | n2=hyperkeratosis | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
hyperlipémies
n1=hyperlaxité ligamentaire | n2=hyperlipémies | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
hyperlipidémie
n1=hyperlaxité ligamentaire | n2=hyperlipidémie | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
hyperlipidémies
n1=hyperlaxité ligamentaire | n2=hyperlipidémies | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
hyperlymphocytose
n1=hyperlaxité ligamentaire | n2=hyperlymphocytose | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
infection
n1=hyperlaxité ligamentaire | n2=infection | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
infection
(contamination)
n1=hyperlaxité ligamentaire | n2=infection (contamination) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
inflammation
n1=hyperlaxité ligamentaire | n2=inflammation | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
inflammation
(médecine)
n1=hyperlaxité ligamentaire | n2=inflammation (médecine) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
leucémie
n1=hyperlaxité ligamentaire | n2=leucémie | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
leucocyte
n1=hyperlaxité ligamentaire | n2=leucocyte | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
leucocytose
n1=hyperlaxité ligamentaire | n2=leucocytose | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
leucocytose digestive
n1=hyperlaxité ligamentaire | n2=leucocytose digestive | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
leucocytoses
n1=hyperlaxité ligamentaire | n2=leucocytoses | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
leucopénie
n1=hyperlaxité ligamentaire | n2=leucopénie | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
lipémie
n1=hyperlaxité ligamentaire | n2=lipémie | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
lipide
n1=hyperlaxité ligamentaire | n2=lipide | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
lipidémie
n1=hyperlaxité ligamentaire | n2=lipidémie | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
lymphocyte
n1=hyperlaxité ligamentaire | n2=lymphocyte | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
maladie
n1=hyperlaxité ligamentaire | n2=maladie | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
Médecine
n1=hyperlaxité ligamentaire | n2=Médecine | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
monocyte
n1=hyperlaxité ligamentaire | n2=monocyte | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
neutrophile
n1=hyperlaxité ligamentaire | n2=neutrophile | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
nutrition
n1=hyperlaxité ligamentaire | n2=nutrition | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
polynucléaire
n1=hyperlaxité ligamentaire | n2=polynucléaire | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
post-partum
n1=hyperlaxité ligamentaire | n2=post-partum | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
sang
(hémoglobine)
n1=hyperlaxité ligamentaire | n2=sang (hémoglobine) | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
stress
n1=hyperlaxité ligamentaire | n2=stress | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
talonnière
n1=hyperlaxité ligamentaire | n2=talonnière | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 5 / 0.028 ->
taux excessif de lipide dans le sang
n1=hyperlaxité ligamentaire | n2=taux excessif de lipide dans le sang | rel=r_associated | relid=0 | w=5
- hyperlaxité ligamentaire --
r_associated #0: 1 / 0.006 ->
en:disease or syndrome
n1=hyperlaxité ligamentaire | n2=en:disease or syndrome | rel=r_associated | relid=0 | w=1
- hyperlaxité ligamentaire --
r_associated #0: 1 / 0.006 ->
en:syndrome
n1=hyperlaxité ligamentaire | n2=en:syndrome | rel=r_associated | relid=0 | w=1
| ≈ 488 relations entrantes
- médecine ---
r_associated #0: 130 -->
hyperlaxité ligamentaire
n1=médecine | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=130
- Ehlers-Danlos ---
r_associated #0: 40 -->
hyperlaxité ligamentaire
n1=Ehlers-Danlos | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=40
- syndrome de Hunter-Thompson-Reed ---
r_associated #0: 40 -->
hyperlaxité ligamentaire
n1=syndrome de Hunter-Thompson-Reed | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=40
- en:Hunter-Thompson-Reed's syndrome ---
r_associated #0: 36 -->
hyperlaxité ligamentaire
n1=en:Hunter-Thompson-Reed's syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=36
- en:joint hyperextensibility ---
r_associated #0: 36 -->
hyperlaxité ligamentaire
n1=en:joint hyperextensibility | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=36
- en:hypermobility syndrome ---
r_associated #0: 34 -->
hyperlaxité ligamentaire
n1=en:hypermobility syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=34
- en:clinical significant laxity ---
r_associated #0: 31 -->
hyperlaxité ligamentaire
n1=en:clinical significant laxity | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=31
- en:loose-jointedness ---
r_associated #0: 31 -->
hyperlaxité ligamentaire
n1=en:loose-jointedness | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=31
- en:excessive joint laxity ---
r_associated #0: 30 -->
hyperlaxité ligamentaire
n1=en:excessive joint laxity | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=30
- ehlers-danlos ---
r_associated #0: 25 -->
hyperlaxité ligamentaire
n1=ehlers-danlos | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=25
- Hunter-Thompson-Reed (syndrome de) ---
r_associated #0: 22 -->
hyperlaxité ligamentaire
n1=Hunter-Thompson-Reed (syndrome de) | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=22
- en:abscess of bursa of knee ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:abscess of bursa of knee | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:acquired deformity of joint of lower limb ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:acquired deformity of joint of lower limb | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:acquired deformity of joint of upper limb ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:acquired deformity of joint of upper limb | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:acquired fixed flexion deformity of joint of lower limb ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:acquired fixed flexion deformity of joint of lower limb | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:acquired fixed flexion deformity of joint of upper limb ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:acquired fixed flexion deformity of joint of upper limb | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:acrodysostosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:acrodysostosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:acromicric dysplasia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:acromicric dysplasia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:acute arthropathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:acute arthropathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:andersen syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:andersen syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:ankle impingement ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:ankle impingement | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:ankylosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:ankylosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:antley-bixler syndrome, autosomal dominant ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:antley-bixler syndrome, autosomal dominant | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthralgia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthralgia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthritis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthritis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthritis of knee ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthritis of knee | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthrofibrosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthrofibrosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthrogryposis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthrogryposis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthrogryposis multiplex congenita, neurogenic type (disorder) ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthrogryposis multiplex congenita, neurogenic type (disorder) | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathies nec ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathies nec | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy aggravated ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy aggravated | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy associated with a hematological disorder ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy associated with a hematological disorder | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy associated with a hypersensitivity reaction ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy associated with a hypersensitivity reaction | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy associated with another disorder ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy associated with another disorder | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy associated with dermatological disorder ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy associated with dermatological disorder | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy associated with non-infective gastrointestinal disorder ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy associated with non-infective gastrointestinal disorder | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy associated with other conditions classifiable elsewhere ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy associated with other conditions classifiable elsewhere | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy associated with other disorders classified elsewhere ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy associated with other disorders classified elsewhere | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy associated with other endocrine and metabolic disorders ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy associated with other endocrine and metabolic disorders | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy associated with respiratory disorder ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy associated with respiratory disorder | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy in behcet's syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy in behcet's syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy of elbow ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy of elbow | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy of joint of hand ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy of joint of hand | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy of knee joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy of knee joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy of multiple joints ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy of multiple joints | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy of pelvis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy of pelvis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy, unspecified, ankle and foot ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy, unspecified, ankle and foot | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy, unspecified, forearm ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy, unspecified, forearm | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy, unspecified, lower leg ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy, unspecified, lower leg | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy, unspecified, multiple sites ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy, unspecified, multiple sites | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy, unspecified, other specified sites ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy, unspecified, other specified sites | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy, unspecified, pelvic region and thigh ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy, unspecified, pelvic region and thigh | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy, unspecified, shoulder region ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy, unspecified, shoulder region | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthropathy, unspecified, upper arm ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthropathy, unspecified, upper arm | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthrosis of first carpometacarpal joint, unspecified ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthrosis of first carpometacarpal joint, unspecified | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthrosis, unspecified; ankle and foot ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthrosis, unspecified; ankle and foot | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthrosis, unspecified; forearm ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthrosis, unspecified; forearm | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthrosis, unspecified; hand ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthrosis, unspecified; hand | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthrosis, unspecified; lower leg ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthrosis, unspecified; lower leg | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthrosis, unspecified; multiple sites ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthrosis, unspecified; multiple sites | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthrosis, unspecified; other ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthrosis, unspecified; other | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthrosis, unspecified; pelvic region and thigh ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthrosis, unspecified; pelvic region and thigh | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthrosis, unspecified; shoulder region ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthrosis, unspecified; shoulder region | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthrosis, unspecified; site unspecified ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthrosis, unspecified; site unspecified | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:arthrosis, unspecified; upper arm ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:arthrosis, unspecified; upper arm | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:articular cartilage disorder ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:articular cartilage disorder | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:articular disc disorder of temporomandibular joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:articular disc disorder of temporomandibular joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:atelosteogenesis, type 1 ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:atelosteogenesis, type 1 | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:atlantoaxial instability ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:atlantoaxial instability | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:auriculo-condylar syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:auriculo-condylar syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:autosomal dominant epidermolysis bullosa simplex ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:autosomal dominant epidermolysis bullosa simplex | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:autosomal dominant hypophosphatemic bone disease ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:autosomal dominant hypophosphatemic bone disease | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:autosomal recessive distal osteolysis syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:autosomal recessive distal osteolysis syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:autosomal recessive muscular dystrophy with limb girdle distribution ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:autosomal recessive muscular dystrophy with limb girdle distribution | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:avascular necrosis of femoral head ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:avascular necrosis of femoral head | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:baller-gerold syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:baller-gerold syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:beare-stevenson cutis gyrata syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:beare-stevenson cutis gyrata syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:becker generalized myotonia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:becker generalized myotonia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:behcet syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:behcet syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:benign autosomal dominant osteopetrosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:benign autosomal dominant osteopetrosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:benign congenital myopathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:benign congenital myopathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:brachydactylous dwarfism mseleni type ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:brachydactylous dwarfism mseleni type | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:brachydactyly syndrome type b ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:brachydactyly syndrome type b | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:brachydactyly type a6 ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:brachydactyly type a6 | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:brachydactyly, type a1 (disorder) ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:brachydactyly, type a1 (disorder) | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:brachymesophalangy 2 and 5 ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:brachymesophalangy 2 and 5 | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:brachyolmia type 3 ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:brachyolmia type 3 | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:brody myopathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:brody myopathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:bursitis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:bursitis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:calcification of joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:calcification of joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:cap myopathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:cap myopathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:capsulitis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:capsulitis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:carpal collapse ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:carpal collapse | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:cartilage diseases ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:cartilage diseases | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:centronuclear myopathy 1 ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:centronuclear myopathy 1 | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:chondrodysplasia punctata syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:chondrodysplasia punctata syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:chondromalacias ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:chondromalacias | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:chronic arthropathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:chronic arthropathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:chronic infantile neurological cutaneous and articular syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:chronic infantile neurological cutaneous and articular syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:cleidocranial dysplasia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:cleidocranial dysplasia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:col1a1 associated connective tissue disorder ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:col1a1 associated connective tissue disorder | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:complete tear, rib ligament ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:complete tear, rib ligament | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:complete tear, sternum ligament ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:complete tear, sternum ligament | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:complete tear, wrist and/or hand ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:complete tear, wrist and/or hand | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:congenital anomaly of joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:congenital anomaly of joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:congenital bowing of long bone ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:congenital bowing of long bone | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:congenital hereditary muscular dystrophy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:congenital hereditary muscular dystrophy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:corneal dystrophy, congenital stromal ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:corneal dystrophy, congenital stromal | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:craniocervical syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:craniocervical syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:craniodiaphyseal dysplasia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:craniodiaphyseal dysplasia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:cricoarytenoid joint fixation ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:cricoarytenoid joint fixation | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:crouzon syndrome with acanthosis nigricans (disorder) ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:crouzon syndrome with acanthosis nigricans (disorder) | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:crowned dens syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:crowned dens syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:crystal arthropathic disorders ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:crystal arthropathic disorders | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:crystal arthropathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:crystal arthropathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:cutis laxa, autosomal dominant ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:cutis laxa, autosomal dominant | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:cutis laxa, autosomal recessive ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:cutis laxa, autosomal recessive | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:cystinosis, infantile nephropathic ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:cystinosis, infantile nephropathic | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:deposit joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:deposit joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:destruction joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:destruction joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:disorder of hip joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:disorder of hip joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:disorder of joint of ankle and/or foot ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:disorder of joint of ankle and/or foot | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:disorder of joint of shoulder region ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:disorder of joint of shoulder region | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:disorder of prosthetic joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:disorder of prosthetic joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:disorder of skeletal system ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:disorder of skeletal system | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:disorder of wrist joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:disorder of wrist joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:distal arthrogryposis syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:distal arthrogryposis syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:dorsopathy, unspecified ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:dorsopathy, unspecified | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:dysostosis multiplex group ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:dysostosis multiplex group | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:dysplasia, saddan ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:dysplasia, saddan | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:dystrophia myotonica 2 ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:dystrophia myotonica 2 | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:east (epilepsy, ataxia, sensorineural deafness, and tubulopathy) syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:east (epilepsy, ataxia, sensorineural deafness, and tubulopathy) syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:ectodermal dysplasia/ skin fragility syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:ectodermal dysplasia/ skin fragility syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:ehlers-danlos syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:ehlers-danlos syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:eosinophilic fasciitis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:eosinophilic fasciitis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:epidermolysis bullosa simplex with pyloric atresia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:epidermolysis bullosa simplex with pyloric atresia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:facet joint pain ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:facet joint pain | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:familial amyloid polyneuropathy, type v ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:familial amyloid polyneuropathy, type v | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:familial arthrogryposis-cholestatic hepatorenal syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:familial arthrogryposis-cholestatic hepatorenal syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:familial digital arthropathy and brachydactyly syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:familial digital arthropathy and brachydactyly syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:familial interstitial nephritis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:familial interstitial nephritis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:familial osteochondritis dissecans ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:familial osteochondritis dissecans | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:familial partial lipodystrophy, type 2 ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:familial partial lipodystrophy, type 2 | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:farber lipogranulomatosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:farber lipogranulomatosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:femoracetabular impingement ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:femoracetabular impingement | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:femoral trochlear dysplasia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:femoral trochlear dysplasia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:femur bifid with monodactylous ectrodactyly ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:femur bifid with monodactylous ectrodactyly | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:fibrocartilage lesion of joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:fibrocartilage lesion of joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:fibrodysplasia ossificans progressiva ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:fibrodysplasia ossificans progressiva | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:fibular hypoplasia and complex brachydactyly ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:fibular hypoplasia and complex brachydactyly | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:fistula of joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:fistula of joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:fleck corneal dystrophy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:fleck corneal dystrophy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:freeman-sheldon syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:freeman-sheldon syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:fronto-facio-nasal dysplasia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:fronto-facio-nasal dysplasia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:full thickness rotator cuff tear ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:full thickness rotator cuff tear | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:ganglion of joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:ganglion of joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:ganglion/synovial cyst - ankle/foot ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:ganglion/synovial cyst - ankle/foot | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:ganglion/synovial cyst - multiple joints ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:ganglion/synovial cyst - multiple joints | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:gaze palsy, familial horizontal, with progressive scoliosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:gaze palsy, familial horizontal, with progressive scoliosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:generalized myotonia of thomsen ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:generalized myotonia of thomsen | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:geroderma osteodysplastica ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:geroderma osteodysplastica | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:giacci familial neurogenic acroosteolysis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:giacci familial neurogenic acroosteolysis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:glycogen storage disease 0, liver ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:glycogen storage disease 0, liver | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:glycogen storage disease type x ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:glycogen storage disease type x | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:glycogen storage disease, muscular form ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:glycogen storage disease, muscular form | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:gouty tophus of prepatellar bursa ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:gouty tophus of prepatellar bursa | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:gurrieri sammito bellussi syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:gurrieri sammito bellussi syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:hallux limitus ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:hallux limitus | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:hallux rigidus ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:hallux rigidus | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:haspeslagh fryns muelenaere syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:haspeslagh fryns muelenaere syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:heberden's nodes with arthropathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:heberden's nodes with arthropathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:heide syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:heide syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:hemarthrosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:hemarthrosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:hereditary multiple exostoses ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:hereditary multiple exostoses | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:hereditary myopathy with early respiratory failure ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:hereditary myopathy with early respiratory failure | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:hereditary tubulointerstitial disorder ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:hereditary tubulointerstitial disorder | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:hip osteoarthritis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:hip osteoarthritis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:holoprosencephaly with fetal akinesia-hypokinesia sequence ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:holoprosencephaly with fetal akinesia-hypokinesia sequence | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:hyperextension ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:hyperextension | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:hypertrophic osteoarthropathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:hypertrophic osteoarthropathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:hypophosphatemic rickets with hypercalciuria, hereditary ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:hypophosphatemic rickets with hypercalciuria, hereditary | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:hypoplastic tibia and postaxial polydactyly syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:hypoplastic tibia and postaxial polydactyly syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 1 ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 1 | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:infectious myositis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:infectious myositis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:infective arthritis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:infective arthritis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:inflammatory polyarthropathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:inflammatory polyarthropathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:infrapatellar fat pad inflammation ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:infrapatellar fat pad inflammation | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:inherited arthrogryposis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:inherited arthrogryposis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:internasal dysostosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:internasal dysostosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:ischiopubic synchondrosis of van neck ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:ischiopubic synchondrosis of van neck | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:jackson-weiss syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:jackson-weiss syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint adhesion ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint adhesion | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint capsule rupture ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint capsule rupture | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint contracture ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint contracture | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint deformities, acquired ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint deformities, acquired | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint derangement ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint derangement | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint dislocation ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint dislocation | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint disorder, unspecified; ankle and foot ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint disorder, unspecified; ankle and foot | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint disorder, unspecified; forearm ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint disorder, unspecified; forearm | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint disorder, unspecified; lower leg ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint disorder, unspecified; lower leg | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint disorder, unspecified; multiple sites ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint disorder, unspecified; multiple sites | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint disorder, unspecified; pelvic region and thigh ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint disorder, unspecified; pelvic region and thigh | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint disorder, unspecified; shoulder region ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint disorder, unspecified; shoulder region | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint disorder, unspecified; upper arm ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint disorder, unspecified; upper arm | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint effusion ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint effusion | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint infection ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint infection | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint injury ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint injury | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint instability ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint instability | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint laxity ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint laxity | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint loose bodies ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint loose bodies | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint pain adverse event ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint pain adverse event | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint related disorders nec ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint related disorders nec | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint related signs and symptoms ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint related signs and symptoms | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:joint stiffness ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:joint stiffness | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:juxta-articular bone cyst ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:juxta-articular bone cyst | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:juxta-articular yaws nodules ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:juxta-articular yaws nodules | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:klippel-feil syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:klippel-feil syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:klippel-trenaunay-weber syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:klippel-trenaunay-weber syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:knee arthropathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:knee arthropathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:knee impingement syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:knee impingement syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:knobloch syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:knobloch syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:kuskokwim disease ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:kuskokwim disease | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:lateral patellar compression syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:lateral patellar compression syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:laurin-sandrow syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:laurin-sandrow syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:laxity of ligament ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:laxity of ligament | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:lesion of ligament of wrist and/or hand ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:lesion of ligament of wrist and/or hand | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:lethal congenital contracture syndrome 1 ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:lethal congenital contracture syndrome 1 | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:lethal congenital contracture syndrome 2 ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:lethal congenital contracture syndrome 2 | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:lethal congenital contracture syndrome type 3 ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:lethal congenital contracture syndrome type 3 | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:ligamentous laxity of elbow region ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:ligamentous laxity of elbow region | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:ligamentous laxity of wrist and/or hand ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:ligamentous laxity of wrist and/or hand | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:lissencephaly syndrome, norman-roberts type ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:lissencephaly syndrome, norman-roberts type | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:locking of joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:locking of joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:long-leg arthropathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:long-leg arthropathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:macdermot winter syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:macdermot winter syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:macular corneal dystrophy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:macular corneal dystrophy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:majeed syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:majeed syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:malignant neoplasm of costovertebral joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:malignant neoplasm of costovertebral joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:mandibuloacral dysplasia with type a lipodystrophy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:mandibuloacral dysplasia with type a lipodystrophy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:marden-walker syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:marden-walker syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:marfan syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:marfan syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:mechanical joint disorder ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:mechanical joint disorder | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:menkes disease ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:menkes disease | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:mesomelic dwarfism reinhardt pfeiffer type ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:mesomelic dwarfism reinhardt pfeiffer type | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:metacarpal joint disorder ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:metacarpal joint disorder | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:metaphyseal dysplasia, braun-tinschert type ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:metaphyseal dysplasia, braun-tinschert type | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:metatarsalgia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:metatarsalgia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:microcephaly cervical spine fusion anomalies ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:microcephaly cervical spine fusion anomalies | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:mild spondyloepiphyseal dysplasia due to col2a1 mutation with early onset osteoarthritis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:mild spondyloepiphyseal dysplasia due to col2a1 mutation with early onset osteoarthritis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:miller-mckusick-malvaux-syndrome (3m syndrome) ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:miller-mckusick-malvaux-syndrome (3m syndrome) | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:mitochondrial neurogastrointestinal encephalomyopathy syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:mitochondrial neurogastrointestinal encephalomyopathy syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:morquio syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:morquio syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:multicentric osteolysis nodulosis arthropathy spectrum ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:multicentric osteolysis nodulosis arthropathy spectrum | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:multifocal fibrosclerosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:multifocal fibrosclerosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:multiple congenital articular rigidities ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:multiple congenital articular rigidities | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:muscle amp deaminase deficiency ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:muscle amp deaminase deficiency | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:muscle calcification or ossification nos ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:muscle calcification or ossification nos | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:muscle contracture ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:muscle contracture | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:muscle l-lactate dehydrogenase deficiency ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:muscle l-lactate dehydrogenase deficiency | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:muscle, ligament and fascia disorders ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:muscle, ligament and fascia disorders | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:muscular wasting and disuse atrophy, not elsewhere classified in icd9cm ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:muscular wasting and disuse atrophy, not elsewhere classified in icd9cm | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:myopathy with abnormal lipid metabolism ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:myopathy with abnormal lipid metabolism | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:myopathy with exercise intolerance, swedish type ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:myopathy with exercise intolerance, swedish type | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:myopathy, distal, tateyama type ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:myopathy, distal, tateyama type | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:nail-patella syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:nail-patella syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:nathalie syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:nathalie syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:nemaline myopathy 3 ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:nemaline myopathy 3 | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:neurogenic arthropathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:neurogenic arthropathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:non-dystrophic myotonia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:non-dystrophic myotonia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:non-traumatic rupture of tendon of left shoulder ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:non-traumatic rupture of tendon of left shoulder | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:non-traumatic rupture of tendon of right shoulder ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:non-traumatic rupture of tendon of right shoulder | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:nonaka myopathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:nonaka myopathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:o/e - joint - passive greater than active movement ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:o/e - joint - passive greater than active movement | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:o/e - shoulder joint abnormal ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:o/e - shoulder joint abnormal | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:of the ligaments ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:of the ligaments | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:okihiro syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:okihiro syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:ossicular ankylosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:ossicular ankylosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:ossicular erosion ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:ossicular erosion | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:osteoarthritis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:osteoarthritis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:osteoarthropathy, secondary hypertrophic ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:osteoarthropathy, secondary hypertrophic | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:osteogenesis imperfecta, levin type ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:osteogenesis imperfecta, levin type | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other and unspecified arthropathies ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other and unspecified arthropathies | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other arthropathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other arthropathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other arthrosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other arthrosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other disorders of muscle, ligament, and fascia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other disorders of muscle, ligament, and fascia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other fibromatoses of muscle, ligament, and fascia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other fibromatoses of muscle, ligament, and fascia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other general diseases with articular involvement ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other general diseases with articular involvement | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other joint disorders ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other joint disorders | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other overlap syndromes ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other overlap syndromes | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified arthropathy, ankle and foot ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified arthropathy, ankle and foot | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified arthropathy, forearm ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified arthropathy, forearm | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified arthropathy, hand ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified arthropathy, hand | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified arthropathy, lower leg ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified arthropathy, lower leg | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified arthropathy, multiple sites ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified arthropathy, multiple sites | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified arthropathy, other specified sites ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified arthropathy, other specified sites | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified arthropathy, pelvic region and thigh ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified arthropathy, pelvic region and thigh | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified arthropathy, shoulder region ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified arthropathy, shoulder region | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified arthropathy, upper arm ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified arthropathy, upper arm | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified disorders of joint, other specified sites ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified disorders of joint, other specified sites | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified disorders of joint, site unspecified ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified disorders of joint, site unspecified | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified disorders of muscle ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified disorders of muscle | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified joint disorders; ankle and foot ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified joint disorders; ankle and foot | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified joint disorders; forearm ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified joint disorders; forearm | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified joint disorders; hand ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified joint disorders; hand | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified joint disorders; lower leg ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified joint disorders; lower leg | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified joint disorders; multiple sites ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified joint disorders; multiple sites | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified joint disorders; pelvic region and thigh ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified joint disorders; pelvic region and thigh | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified joint disorders; shoulder region ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified joint disorders; shoulder region | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified joint disorders; upper arm ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified joint disorders; upper arm | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other specified systemic involvement of connective tissue ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other specified systemic involvement of connective tissue | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other symptoms referable to joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other symptoms referable to joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other symptoms referable to joint, ankle and foot ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other symptoms referable to joint, ankle and foot | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other symptoms referable to joint, forearm ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other symptoms referable to joint, forearm | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other symptoms referable to joint, hand ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other symptoms referable to joint, hand | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other symptoms referable to joint, lower leg ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other symptoms referable to joint, lower leg | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other symptoms referable to joint, multiple sites ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other symptoms referable to joint, multiple sites | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other symptoms referable to joint, other specified sites ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other symptoms referable to joint, other specified sites | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other symptoms referable to joint, pelvic region and thigh ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other symptoms referable to joint, pelvic region and thigh | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other symptoms referable to joint, shoulder region ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other symptoms referable to joint, shoulder region | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other symptoms referable to joint, site unspecified ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other symptoms referable to joint, site unspecified | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other symptoms referable to joint, upper arm ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other symptoms referable to joint, upper arm | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:other systemic involvement of connective tissue ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:other systemic involvement of connective tissue | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:otoonychoperoneal syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:otoonychoperoneal syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:palmar fibromatosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:palmar fibromatosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:panniculitis, nodular nonsuppurative ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:panniculitis, nodular nonsuppurative | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:papillon-lefevre syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:papillon-lefevre syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:parietal foramina ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:parietal foramina | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:patellofemoral pain syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:patellofemoral pain syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:pelvic girdle pain ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:pelvic girdle pain | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:periarthritis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:periarthritis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:periarticular disorder ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:periarticular disorder | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:polyarthropathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:polyarthropathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:polyarthropathy (excl rheumatoid arthritis) ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:polyarthropathy (excl rheumatoid arthritis) | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:polyarticular arthritis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:polyarticular arthritis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:polyarticular arthropathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:polyarticular arthropathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:polymyalgia rheumatica ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:polymyalgia rheumatica | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:polyostotic fibrous dysplasia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:polyostotic fibrous dysplasia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:posterior perimaxillary faciosynostosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:posterior perimaxillary faciosynostosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:potassium aggravated myotonia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:potassium aggravated myotonia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:primary hypertrophic osteoarthropathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:primary hypertrophic osteoarthropathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:prune belly syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:prune belly syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:pseudocholinesterase deficiency ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:pseudocholinesterase deficiency | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:pseudogout ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:pseudogout | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:psoriatic arthritis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:psoriatic arthritis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:pulmonary interstitial glycogenosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:pulmonary interstitial glycogenosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:pyle metaphyseal dysplasia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:pyle metaphyseal dysplasia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:radial aplasia-thrombocytopenia syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:radial aplasia-thrombocytopenia syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:radial hypoplasia, triphalangeal thumbs and hypospadias ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:radial hypoplasia, triphalangeal thumbs and hypospadias | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:reardon hall slaney syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:reardon hall slaney syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:rheumatoid arthritis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:rheumatoid arthritis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:rheumatoid arthropathies ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:rheumatoid arthropathies | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:rhizomelic chondrodysplasia punctata ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:rhizomelic chondrodysplasia punctata | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:robinow syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:robinow syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:rotator cuff syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:rotator cuff syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:rubella arthralgia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:rubella arthralgia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:rupture of infraspinatus tendon ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:rupture of infraspinatus tendon | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:rupture of synovium - knee ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:rupture of synovium - knee | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:rupture subscapularis tendon ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:rupture subscapularis tendon | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:saito kuba tsuruta syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:saito kuba tsuruta syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:scaphycephaly ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:scaphycephaly | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:schnyder crystalline corneal dystrophy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:schnyder crystalline corneal dystrophy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:shoulder impingement syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:shoulder impingement syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:shwachman-diamond syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:shwachman-diamond syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:sjogren syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:sjogren syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:smith-mccort dysplasia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:smith-mccort dysplasia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:split-hand-foot malformation with long bone deficiency 1 ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:split-hand-foot malformation with long bone deficiency 1 | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:spondylarthropathies ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:spondylarthropathies | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:spondylo-ocular syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:spondylo-ocular syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:spondylocamptodactyly ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:spondylocamptodactyly | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:spondylocostal dysostosis 4, autosomal dominant ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:spondylocostal dysostosis 4, autosomal dominant | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:spondyloenchondrodysplasia ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:spondyloenchondrodysplasia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:spondyloenchondrodysplasia with immune dysregulation ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:spondyloenchondrodysplasia with immune dysregulation | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:spondyloepiphyseal dysplasia tarda, toledo type ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:spondyloepiphyseal dysplasia tarda, toledo type | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:spondyloepiphyseal dysplasia tarda, x-linked ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:spondyloepiphyseal dysplasia tarda, x-linked | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:spondyloepiphyseal dysplasia, omani type ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:spondyloepiphyseal dysplasia, omani type | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:stickler syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:stickler syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:subacute arthropathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:subacute arthropathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:suppurative arthritis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:suppurative arthritis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:supraspinatus tear ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:supraspinatus tear | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:syndrome, branchio-oculo-facial ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:syndrome, branchio-oculo-facial | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:synovial chondromatosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:synovial chondromatosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:synovial osteochondromatosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:synovial osteochondromatosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:synovial-like neoplasm ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:synovial-like neoplasm | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:synovitis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:synovitis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:syphilis of synovium ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:syphilis of synovium | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:systemic involvement of connective tissue, unspecified ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:systemic involvement of connective tissue, unspecified | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:tarsal-carpal coalition syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:tarsal-carpal coalition syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:temporomandibular joint disorder ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:temporomandibular joint disorder | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:temporomandibular joint dysfunction syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:temporomandibular joint dysfunction syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:tmem70 related mitochondrial encephalo-cardio-myopathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:tmem70 related mitochondrial encephalo-cardio-myopathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:transient arthropathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:transient arthropathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:transient arthropathy of multiple sites ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:transient arthropathy of multiple sites | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:transient arthropathy of the hand ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:transient arthropathy of the hand | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:transient arthropathy, ankle and foot ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:transient arthropathy, ankle and foot | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:transient arthropathy, forearm ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:transient arthropathy, forearm | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:transient arthropathy, lower leg ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:transient arthropathy, lower leg | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:transient arthropathy, other specified sites ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:transient arthropathy, other specified sites | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:transient arthropathy, pelvic region and thigh ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:transient arthropathy, pelvic region and thigh | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:transient arthropathy, shoulder region ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:transient arthropathy, shoulder region | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:transient arthropathy, upper arm ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:transient arthropathy, upper arm | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:traumatic arthropathy ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:traumatic arthropathy | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:treacher collins syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:treacher collins syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:triglyceride storage disease with ichthyosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:triglyceride storage disease with ichthyosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:type i acrocephalosyndactyly ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:type i acrocephalosyndactyly | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:type ii acrocephalopolysyndactyly ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:type ii acrocephalopolysyndactyly | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:type v acrocephalosyndactyly ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:type v acrocephalosyndactyly | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:ulna metaphyseal dysplasia syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:ulna metaphyseal dysplasia syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:ulnocarpal abutment syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:ulnocarpal abutment syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:unspecified disorder of joint, other specified sites ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:unspecified disorder of joint, other specified sites | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:unspecified disorder of knee joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:unspecified disorder of knee joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:verloes bourguignon syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:verloes bourguignon syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:vertebral foraminal stenosis ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:vertebral foraminal stenosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:villonodular synovitis of distal radioulnar joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:villonodular synovitis of distal radioulnar joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:villonodular synovitis of sternoclavicular joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:villonodular synovitis of sternoclavicular joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:villonodular synovitis of tibiofibular joint ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:villonodular synovitis of tibiofibular joint | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:wells jankovic syndrome ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:wells jankovic syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- en:whyte hemingway carpal tarsal phalangeal osteolyses ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=en:whyte hemingway carpal tarsal phalangeal osteolyses | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- hyperlaxité ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=hyperlaxité | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- hyperlaxité articulaire ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=hyperlaxité articulaire | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- instabilité ligamentaire ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=instabilité ligamentaire | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- laxité ligamentaire familiale ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=laxité ligamentaire familiale | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- ligamentaire ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=ligamentaire | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- orthodontie ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=orthodontie | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- syndrome d'hypermobilité ---
r_associated #0: 20 -->
hyperlaxité ligamentaire
n1=syndrome d'hypermobilité | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=20
- aclasie diaphysaire ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=aclasie diaphysaire | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- chondrodysplasie héréditaire déformante ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=chondrodysplasie héréditaire déformante | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- douleur dans une articulation ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=douleur dans une articulation | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- en:hypercinesia ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=en:hypercinesia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- en:hyperkeratosis of nipple and areola ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=en:hyperkeratosis of nipple and areola | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- exostose héréditaire multiple ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=exostose héréditaire multiple | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- hallus rigidus ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=hallus rigidus | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- hyperkeratosis follicularis et parafollicularis in cutem penetrans de Kyrle ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=hyperkeratosis follicularis et parafollicularis in cutem penetrans de Kyrle | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- hyperkeratosis lenticularis perstans de Flegel ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=hyperkeratosis lenticularis perstans de Flegel | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- hyperkinésie ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=hyperkinésie | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- hyperkinésie volitionnelle ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=hyperkinésie volitionnelle | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- hyperkératose nævoïde (hamartomateuse) du mamelon ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=hyperkératose nævoïde (hamartomateuse) du mamelon | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- hyperkératose talonnière fissurée ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=hyperkératose talonnière fissurée | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- hyperlacrymie ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=hyperlacrymie | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- hyperlactacidémie ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=hyperlactacidémie | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- hyperlaxité articulaire familiale ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=hyperlaxité articulaire familiale | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- hyperleucocytose ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=hyperleucocytose | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- hyperlipémie ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=hyperlipémie | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- synovites ---
r_associated #0: 15 -->
hyperlaxité ligamentaire
n1=synovites | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=15
- Hyperkinésie ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=Hyperkinésie | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- Hyperlaxité ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=Hyperlaxité | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- Hyperleucocytose ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=Hyperleucocytose | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- Hyperlipémie ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=Hyperlipémie | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- Orthodontie ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=Orthodontie | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- algie articulaire ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=algie articulaire | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- arachnodactylie ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=arachnodactylie | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- arthrogrypose ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=arthrogrypose | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- autres troubles articulaires précisés de la région de l'épaule ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=autres troubles articulaires précisés de la région de l'épaule | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- chondrodysplasie déformante héréditaire ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=chondrodysplasie déformante héréditaire | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- douleur articulaire ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=douleur articulaire | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- en:eds ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=en:eds | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- en:ehlers danlos syndrome ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=en:ehlers danlos syndrome | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- en:hyperkeratosis lenticularis perstans ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=en:hyperkeratosis lenticularis perstans | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- en:hyperkeratosis of fissured heel ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=en:hyperkeratosis of fissured heel | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- en:hyperkinesia ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=en:hyperkinesia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- en:hyperlacrymia ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=en:hyperlacrymia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- en:hyperlactacidemia ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=en:hyperlactacidemia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- en:hyperleukocytosis ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=en:hyperleukocytosis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- en:hyperlipemia ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=en:hyperlipemia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- en:hyperlipidaemia ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=en:hyperlipidaemia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- en:hyperlipidemia ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=en:hyperlipidemia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- en:orthodontia ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=en:orthodontia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- en:orthodontics ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=en:orthodontics | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- en:volitional hyperkinesia ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=en:volitional hyperkinesia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- hallux rigidus ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=hallux rigidus | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- hyperextension ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=hyperextension | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- lactate sanguin augmenté ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=lactate sanguin augmenté | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- maladie de Bessel-Hagen ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=maladie de Bessel-Hagen | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- maladie exostosante multiple ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=maladie exostosante multiple | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- maladie ostéogénique ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=maladie ostéogénique | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- polyarthropathie ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=polyarthropathie | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- polymyalgia rheumatica ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=polymyalgia rheumatica | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- pseudo-polyarthrite rhizomélique ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=pseudo-polyarthrite rhizomélique | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- spondylarthropathies ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=spondylarthropathies | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- synovitis ---
r_associated #0: 10 -->
hyperlaxité ligamentaire
n1=synovitis | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=10
- arthralgie ---
r_associated #0: 5 -->
hyperlaxité ligamentaire
n1=arthralgie | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=5
- arthrite ---
r_associated #0: 5 -->
hyperlaxité ligamentaire
n1=arthrite | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=5
- arthrite psoriasique ---
r_associated #0: 5 -->
hyperlaxité ligamentaire
n1=arthrite psoriasique | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=5
- arthropathie neurogénique ---
r_associated #0: 5 -->
hyperlaxité ligamentaire
n1=arthropathie neurogénique | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=5
- en:hyperlipoidaemia ---
r_associated #0: 5 -->
hyperlaxité ligamentaire
n1=en:hyperlipoidaemia | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=5
- maladie des exostoses multiples ---
r_associated #0: 5 -->
hyperlaxité ligamentaire
n1=maladie des exostoses multiples | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=5
- syndrome d'Ehlers-Danlos ---
r_associated #0: 5 -->
hyperlaxité ligamentaire
n1=syndrome d'Ehlers-Danlos | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=5
- syndrome de Stickler ---
r_associated #0: 5 -->
hyperlaxité ligamentaire
n1=syndrome de Stickler | n2=hyperlaxité ligamentaire | rel=r_associated | relid=0 | w=5
|